diff --git "a/input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_OV_clinicalMatrix" "b/input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_OV_clinicalMatrix" new file mode 100644--- /dev/null +++ "b/input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_OV_clinicalMatrix" @@ -0,0 +1,631 @@ +sampleID _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_OV _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode clinical_stage days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_pathologic_diagnosis_method initial_weight intermediate_dimension is_ffpe karnofsky_performance_score longest_dimension lost_follow_up lymphatic_invasion neoplasm_histologic_grade new_neoplasm_event_type new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status postoperative_rx_tx primary_therapy_outcome_success progression_determined_by radiation_therapy residual_tumor sample_type sample_type_id shortest_dimension tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_residual_disease tumor_tissue_site venous_invasion vial_number vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_OV_PDMRNAseq _GENOMIC_ID_data/public/TCGA/OV/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_OV_mutation_bcm_solid_gene _GENOMIC_ID_TCGA_OV_exp_u133a _GENOMIC_ID_TCGA_OV_hMethyl450 _GENOMIC_ID_TCGA_OV_miRNA_HiSeq _GENOMIC_ID_TCGA_OV_mutation_curated_bcm_solid_gene _GENOMIC_ID_TCGA_OV_hMethyl27 _GENOMIC_ID_TCGA_OV_mutation_wustl_hiseq_gene _GENOMIC_ID_TCGA_OV_RPPA_RBN _GENOMIC_ID_TCGA_OV_mutation_wustl_gene _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_OV_gistic2thd _GENOMIC_ID_TCGA_OV_PDMarray _GENOMIC_ID_TCGA_OV_RPPA _GENOMIC_ID_TCGA_OV_exp_HiSeq _GENOMIC_ID_TCGA_OV_gistic2 _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_OV_exp_HiSeq_exon _GENOMIC_ID_TCGA_OV_exp_HiSeqV2 _GENOMIC_ID_TCGA_OV_mutation_broad_gene _GENOMIC_ID_TCGA_OV_PDMarrayCNV _GENOMIC_ID_TCGA_OV_PDMRNAseqCNV _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_OV_mutation _GENOMIC_ID_TCGA_OV_G4502A_07_3 _GENOMIC_ID_TCGA_OV_G4502A_07_2 +TCGA-01-0628-11 TCGA-01-0628-11 TCGA-01-0628 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0628-11A 0.4 NO 0.4 Solid Tissue Normal 11 0.4 A 78fc9d0c-7cb2-475b-bd98-e36f04d16358 TCGA-01-0628-11A-01D-0383-05 TCGA-01-0628-11A-01R-0363-07 +TCGA-01-0629-11 TCGA-01-0629-11 TCGA-01-0629 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0629-11A-01D-0383-05 TCGA-01-0629-11A-01R-0363-07 +TCGA-01-0630-11 TCGA-01-0630-11 TCGA-01-0630 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0630-11A 0.4 NO 1 Solid Tissue Normal 11 0.4 A a87c0a4d-bb41-412c-abd4-7fa010fb18d8 TCGA-01-0630-11A-01D-0383-05 TCGA-01-0630-11A-01R-0363-07 +TCGA-01-0631-11 TCGA-01-0631-11 TCGA-01-0631 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0631-11A 0.8 NO 1 Solid Tissue Normal 11 0.8 A 0c490ce9-9178-4dfe-8384-208d3d2d46c5 TCGA-01-0631-11A-01D-0383-05 TCGA-01-0631-11A-01R-0363-07 +TCGA-01-0633-11 TCGA-01-0633-11 TCGA-01-0633 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0633-11A 0.4 NO 0.8 Solid Tissue Normal 11 0.3 A eb14ef88-0adc-424d-b0a7-dd449f0907c6 TCGA-01-0633-11A-01D-0383-05 TCGA-01-0633-11A-01R-0363-07 +TCGA-01-0636-11 TCGA-01-0636-11 TCGA-01-0636 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0636-11A 0.8 NO 1.1 Solid Tissue Normal 11 0.8 A f17680d1-12eb-45ad-83bc-ba3d14485d10 TCGA-01-0636-11A-01D-0383-05 TCGA-01-0636-11A-01R-0363-07 +TCGA-01-0637-11 TCGA-01-0637-11 TCGA-01-0637 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0637-11A 0.7 NO 0.7 Solid Tissue Normal 11 0.3 A c22da589-1714-4d0c-aa00-e16b466e8a64 TCGA-01-0637-11A-01D-0383-05 TCGA-01-0637-11A-01R-0363-07 +TCGA-01-0638-11 TCGA-01-0638-11 TCGA-01-0638 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0638-11A-02D-0383-05 TCGA-01-0638-11A-02R-0363-07 +TCGA-01-0639-11 TCGA-01-0639-11 TCGA-01-0639 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0639-11A 0.8 NO 0.9 Solid Tissue Normal 11 0.5 A c417e63f-8714-4777-af37-5b39e34492c9 TCGA-01-0639-11A-01D-0383-05 TCGA-01-0639-11A-01R-0363-07 +TCGA-01-0642-11 TCGA-01-0642-11 TCGA-01-0642 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-01-0642-11A 0.8 NO 0.8 Solid Tissue Normal 11 0.4 A 4a42ad28-e3d0-4ec8-9c54-40179a2e2953 TCGA-01-0642-11A-02D-0383-05 TCGA-01-0642-11A-02R-0363-07 +TCGA-04-1331-01 TCGA-04-1331-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1331 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 78 Bilateral TCGA-04-1331-F23906 TCGA-04-1331 TCGA-04-1331-01A Stage IIIC -28848 1336 0 1224 459 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.5 YES G3 Recurrence TCGA-04-1331.2CF541C5-B56A-4946-A5C4-DBB4D71D7908.pdf 1331 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 04 1-10 mm Ovary NO A DECEASED 2004 TCGA-04-1331-01 96db4ec8-524f-4a9a-a23c-30fade0992b7 TCGA-04-1331-01 TCGA-04-1331-01A-01D-0432-05 TCGA-04-1331-01A-01D-0428-01 TCGA-04-1331-01 TCGA-04-1331-01A-01D-0428-01 TCGA-04-1331-01A-01W-0486-08 TCGA-04-1331-01 TCGA-04-1331-01A-01W-0486-08 TCGA-04-1331-01A-01R-0436-07 +TCGA-04-1332-01 TCGA-04-1332-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1332 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-04-1332-F23911 TCGA-04-1332 Stage IIIC -25786 1247 0 1247 393 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 Recurrence 1332 Preoperative WITH TUMOR YES Imaging Study NO Primary Tumor 01 04 1-10 mm Ovary DECEASED 2002 e984c174-f724-49b0-84bf-788ff370d89f TCGA-04-1332-01A-01D-0432-05 TCGA-04-1332-01A-01W-0488-09 TCGA-04-1332-01A-01W-0488-09 TCGA-04-1332-01A-01D-0428-01 TCGA-04-1332-01 TCGA-04-1332-01A-01D-0428-01 TCGA-04-1332-01 TCGA-04-1332-01A-01W-0488-09 TCGA-04-1332-01A-01R-0436-07 +TCGA-04-1335-01 TCGA-04-1335-01 Squamous OV-like c1 OV-like c4 TCGA-04-1335 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-04-1335-F23924 TCGA-04-1335 TCGA-04-1335-01A Stage IB -21963 55 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 NO G2 TCGA-04-1335.A3CEAB60-287E-41D1-A0BD-12B6626BA574.pdf 1335 Preoperative WITH TUMOR NO NO Primary Tumor 01 0.4 04 Ovary NO A DECEASED 2005 51038814-3401-4377-a815-92b9ce678f3d TCGA-04-1335-01A-01D-0432-05 TCGA-04-1335-01A-21-20 TCGA-04-1335-01A-01D-0428-01 TCGA-04-1335-01 b1473202-11db-484b-8896-56abe5a3296e TCGA-04-1335-01A-01D-0428-01 TCGA-04-1335-01 TCGA-04-1335-01A-01R-0436-07 +TCGA-04-1336-01 TCGA-04-1336-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1336 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Bilateral TCGA-04-1336-F23926 TCGA-04-1336 TCGA-04-1336-01A Stage IIIB -20271 0 1495 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 NO G3 TCGA-04-1336.D66DA590-83E1-4607-8806-6402DF3F3385.pdf 1336 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 04 No Macroscopic disease Ovary A LIVING 2005 TCGA-04-1336-01 e53eba00-2869-4168-98aa-a6c491b69fc6 TCGA-04-1336-01 TCGA-04-1336-01A-01D-0432-05 TCGA-04-1336-01A-01W-0488-09 TCGA-04-1336-01A-21-20 TCGA-04-1336-01A-01W-0488-09 TCGA-04-1336-01A-01D-0428-01 TCGA-04-1336-01 7892f3fd-fdb3-43a0-8fd9-390927061f7a TCGA-04-1336-01A-01D-0428-01 TCGA-04-1336-01 TCGA-04-1336-01A-01W-0488-09 TCGA-04-1336-01A-01R-0436-07 +TCGA-04-1337-01 TCGA-04-1337-01 BRCA-LUAD+ UCEC Serous c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1337 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Bilateral TCGA-04-1337-F23931 TCGA-04-1337 TCGA-04-1337-01A Stage IIIC -28626 61 0 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 NO G2 TCGA-04-1337.BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31.pdf 1337 Preoperative WITH TUMOR NO NO Primary Tumor 01 0.3 04 No Macroscopic disease Ovary A DECEASED 2005 TCGA-04-1337-01 TCGA-04-1337-01A-01W-0484-10 543cc1e4-76ee-4e0a-80fa-7ad8477d8d40 TCGA-04-1337-01 TCGA-04-1337-01A-01W-0484-10 TCGA-04-1337-01A-01D-0432-05 TCGA-04-1337-01A-01D-0428-01 TCGA-04-1337-01 TCGA-04-1337-01A-01D-0428-01 TCGA-04-1337-01 TCGA-04-1337-01A-01W-0484-10 TCGA-04-1337-01A-01R-0436-07 +TCGA-04-1338-01 TCGA-04-1338-01 High C9-OV OV-like c1 OV-like c4 mutation cluster 5 TCGA-04-1338 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 78 Bilateral TCGA-04-1338-F23933 TCGA-04-1338 TCGA-04-1338-01A Stage IIIC -28789 0 1418 380 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-04-1338.889AF2DB-7FF9-45B1-8FD4-28D57CF870A7.pdf 1338 Preoperative WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.4 04 1-10 mm Ovary A LIVING 2005 TCGA-04-1338-01A-01W-0484-10 17aa44c9-3071-4184-9692-4c04fabb5a4b TCGA-04-1338-01A-01W-0484-10 TCGA-04-1338-01A-01D-0432-05 TCGA-04-1338-01A-21-20 TCGA-04-1338-01A-01D-0428-01 TCGA-04-1338-01 ee14145d-2ec8-4323-804e-c0a15371559b TCGA-04-1338-01A-01D-0428-01 TCGA-04-1338-01 TCGA-04-1338-01A-01W-0484-10 TCGA-04-1338-01A-01R-0436-07 +TCGA-04-1341-01 TCGA-04-1341-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 TCGA-04-1341 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 85 TCGA-04-1341-F23940 TCGA-04-1341 TCGA-04-1341-01A -31215 0 33 Scheduled Follow-up Submission 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 1 NO 1.5 G3 TCGA-04-1341.9DB095E5-19F0-4ECE-9E54-2F030190FDB5.pdf 1341 WITH TUMOR Complete Remission/Response NO Primary Tumor 01 0.4 NO YES 04 Ovary A LIVING 2006 TCGA-04-1341-01 a9e75af6-31c2-4d32-8c4e-ee9538e77b0e TCGA-04-1341-01 TCGA-04-1341-01A-01D-0432-05 TCGA-04-1341-01A-21-20 TCGA-04-1341-01A-01D-0428-01 TCGA-04-1341-01 9e5cf025-e667-4a73-94a3-e45255194ec3 TCGA-04-1341-01A-01D-0428-01 TCGA-04-1341-01 TCGA-04-1341-01A-01R-0436-07 +TCGA-04-1342-01 TCGA-04-1342-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1342 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 80 Bilateral TCGA-04-1342-F23942 TCGA-04-1342 TCGA-04-1342-01A Stage IV -29501 563 0 2 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 2 G2 TCGA-04-1342.B296EAFA-9EE4-4611-888A-FA0B58EC2A88.pdf 1342 Preoperative WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.2 04 >20 mm Ovary A DECEASED 2006 TCGA-04-1342-01 3cfa7f01-3d75-4c1a-8e7f-ac849f5fde70 TCGA-04-1342-01 TCGA-04-1342-01A-01D-0432-05 TCGA-04-1342-01A-21-20 TCGA-04-1342-01A-01D-0428-01 TCGA-04-1342-01 e79f6986-9f15-4826-901b-1a97c2b8ae42 TCGA-04-1342-01A-01D-0428-01 TCGA-04-1342-01A-01W-0486-08 TCGA-04-1342-01 TCGA-04-1342-01A-01W-0486-08 TCGA-04-1342-01A-01R-0436-07 +TCGA-04-1343-01 TCGA-04-1343-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1343 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 72 Bilateral TCGA-04-1343-F23949 TCGA-04-1343 TCGA-04-1343-01A Stage IV -26428 361 0 3 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G3 TCGA-04-1343.E62828D9-A46C-498F-9976-CC430D16057E.pdf 1343 Preoperative WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.4 04 >20 mm Ovary A DECEASED 2002 TCGA-04-1343-01 ecfe5ba4-b146-4757-894e-ee6e44f4ba5c TCGA-04-1343-01 TCGA-04-1343-01A-01D-0432-05 TCGA-04-1343-01A-01W-0488-09 TCGA-04-1343-01A-21-20 TCGA-04-1343-01A-01W-0488-09 TCGA-04-1343-01A-01D-0428-01 TCGA-04-1343-01 58f649ec-b1cd-4775-8c03-4ebdfe0ad072 TCGA-04-1343-01A-01D-0428-01 TCGA-04-1343-01 TCGA-04-1343-01A-01W-0488-09 TCGA-04-1343-01A-01R-0436-07 +TCGA-04-1346-01 TCGA-04-1346-01 High OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1346 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-04-1346-F23959 TCGA-04-1346 TCGA-04-1346-01A Stage IIIC -26865 0 1993 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 100 2 YES G2 TCGA-04-1346.40C05C93-8968-4FF0-855F-09E2F7FAAB68.pdf 1346 TUMOR FREE NO Complete Remission/Response NO Primary Tumor 01 0.3 04 Ovary A LIVING 2003 TCGA-04-1346-01 3b372510-9632-40d8-a82b-d58e0a0c0ba6 TCGA-04-1346-01 TCGA-04-1346-01A-01D-0432-05 TCGA-04-1346-01A-01W-0488-09 TCGA-04-1346-01A-01W-0488-09 TCGA-04-1346-01A-01D-0428-01 TCGA-04-1346-01 TCGA-04-1346-01A-01D-0428-01 TCGA-04-1346-01 TCGA-04-1346-01A-01W-0488-09 TCGA-04-1346-01A-01R-0436-07 +TCGA-04-1347-01 TCGA-04-1347-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1347 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 81 Bilateral TCGA-04-1347-F23961 TCGA-04-1347 TCGA-04-1347-01A Stage IV -29695 0 1919 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 100 1.1 NO G3 TCGA-04-1347.18BFB10C-5EDC-4253-A2A8-93533CB4B471.pdf 1347 Preoperative TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.1 04 No Macroscopic disease Ovary NO A LIVING 2004 TCGA-04-1347-01 886f150b-23d2-4000-b550-e0fda444ca61 TCGA-04-1347-01 TCGA-04-1347-01A-01D-0432-05 TCGA-04-1347-01A-01W-0488-09 TCGA-04-1347-01A-01W-0488-09 TCGA-04-1347-01A-01D-0428-01 TCGA-04-1347-01 TCGA-04-1347-01A-01D-0428-01 TCGA-04-1347-01 TCGA-04-1347-01A-01W-0488-09 TCGA-04-1347-01A-01R-0436-07 +TCGA-04-1348-01 TCGA-04-1348-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1348 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-04-1348-F23967 TCGA-04-1348 TCGA-04-1348-01A Stage IIIB -16236 1483 0 575 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 YES G3 Recurrence TCGA-04-1348.51B558EF-C11B-41A7-A7BF-15D201506006.pdf 1348 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.4 04 1-10 mm Ovary A DECEASED 2004 TCGA-04-1348-01 TCGA-04-1348-01 6b5e9411-a6df-45a9-8281-75228283c4f4 TCGA-04-1348-01 TCGA-04-1348-01A-01D-0460-05 TCGA-04-1348-01A-01W-0494-09 TCGA-04-1348-01A-21-20 TCGA-04-1348-01A-01W-0494-09 1465139e-d1b2-4026-a532-08513fe0ad4d TCGA-04-1348-01A-01D-0452-01 TCGA-04-1348-01 21a891e7-6da2-4d9e-a1e3-e760605d9dee TCGA-04-1348-01A-01D-0452-01 1465139e-d1b2-4026-a532-08513fe0ad4d 1465139e-d1b2-4026-a532-08513fe0ad4d TCGA-04-1348-01 TCGA-04-1348-01 1465139e-d1b2-4026-a532-08513fe0ad4d TCGA-04-1348-01A-01W-0494-09 TCGA-04-1348-01A-01R-0456-07 +TCGA-04-1349-01 TCGA-04-1349-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1349 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-04-1349-F23977 TCGA-04-1349 TCGA-04-1349-01A Stage IV -25213 656 0 428 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.1 YES G3 Recurrence TCGA-04-1349.8D470D24-17DD-4180-987E-F33FA31535AE.pdf 1349 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.2 04 Ovary A DECEASED 2004 TCGA-04-1349-01 83332db9-57b5-40ce-ad30-cf81d48a7cd6 TCGA-04-1349-01 TCGA-04-1349-01A-01D-0460-05 TCGA-04-1349-01A-01W-0494-09 TCGA-04-1349-01A-21-20 TCGA-04-1349-01A-01W-0494-09 TCGA-04-1349-01A-01D-0452-01 TCGA-04-1349-01 2a143727-7310-4103-beec-3522534165fe TCGA-04-1349-01A-01D-0452-01 TCGA-04-1349-01 TCGA-04-1349-01A-01W-0494-09 TCGA-04-1349-01A-01R-0456-07 +TCGA-04-1350-01 TCGA-04-1350-01 Squamous OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1350 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 46 Bilateral TCGA-04-1350-F23988 TCGA-04-1350 TCGA-04-1350-01A Stage IIIC -16942 1946 0 111 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-04-1350.C4BB615C-ABBA-4136-AAB4-52EA1FE88D14.pdf 1350 Preoperative WITH TUMOR NO Stable Disease Imaging Study NO Primary Tumor 01 0.4 04 >20 mm Ovary A DECEASED 2003 TCGA-04-1350-01 TCGA-04-1350-01A-01W-0490-10 339c6cc0-96b2-4225-b3bc-6cac497c7b92 TCGA-04-1350-01 TCGA-04-1350-01A-01W-0490-10 TCGA-04-1350-01A-01D-0460-05 TCGA-04-1350-01A-01D-0452-01 TCGA-04-1350-01 TCGA-04-1350-01A-01D-0452-01 TCGA-04-1350-01 TCGA-04-1350-01A-01W-0490-10 TCGA-04-1350-01A-01R-0456-07 +TCGA-04-1351-01 TCGA-04-1351-01 High OV-like c1 TCGA-04-1351 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 TCGA-04-1351-F24001 TCGA-04-1351 Stage IIIC -28045 0 1991 1658 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 100 G2 Recurrence 1351 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 04 Ovary LIVING 2004 TCGA-04-1351-01A-01W-0490-10 a8c3bbb4-24aa-4975-916a-50c6ba1f7eac TCGA-04-1351-01A-01W-0490-10 TCGA-04-1351-01A-01D-0460-05 TCGA-04-1351-01A-01D-0452-01 TCGA-04-1351-01 TCGA-04-1351-01A-01D-0452-01 TCGA-04-1351-01 TCGA-04-1351-01A-01R-0456-07 +TCGA-04-1353-01 TCGA-04-1353-01 High OV-like c1 TCGA-04-1353 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 TCGA-04-1353-F65201 TCGA-04-1353 Stage IIIC -23611 0 16 Scheduled Follow-up Submission 2014-9-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NO No 1353 Primary Tumor 01 NO YES 04 Ovary LIVING 2003 b4d1d595-41fa-4b9d-9f01-e820fdace4f6 TCGA-04-1353-01A-01D-1047-05 TCGA-04-1353-01A-01D-1526-09 TCGA-04-1353-01A-01D-1043-01 TCGA-04-1353-01 TCGA-04-1353-01A-01D-1043-01 TCGA-04-1353-01 TCGA-04-1353-01A-01R-1050-07 +TCGA-04-1353-11 TCGA-04-1353-11 TCGA-04-1353 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 TCGA-04-1353-F65201 TCGA-04-1353 TCGA-04-1353-11B Stage IIIC -23611 0 16 Scheduled Follow-up Submission 2014-9-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 0.4 NO 1.5 NO No 1353 Solid Tissue Normal 11 0.2 NO YES 04 Ovary B LIVING 2003 TCGA-04-1353-11B-01D-1047-05 +TCGA-04-1356-01 TCGA-04-1356-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1356 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-04-1356-F24005 TCGA-04-1356 TCGA-04-1356-01A Stage IIC -22855 1499 0 156 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 80 1.2 YES G3 Recurrence TCGA-04-1356.7D26B212-1DE7-43CC-A0DC-A9071C3A534F.pdf 1356 Preoperative WITH TUMOR NO Progressive Disease Physical Examination NO Primary Tumor 01 0.4 04 Ovary YES A DECEASED 2004 TCGA-04-1356-01 9e919b59-a80e-4165-ba65-02ae5c35e910 TCGA-04-1356-01 TCGA-04-1356-01A-01D-0460-05 TCGA-04-1356-01A-21-20 TCGA-04-1356-01A-01D-0452-01 TCGA-04-1356-01 6b9482bd-967a-447e-8f6f-324c7ec41b4d TCGA-04-1356-01A-01D-0452-01 TCGA-04-1356-01A-01W-0492-08 TCGA-04-1356-01 TCGA-04-1356-01A-01W-0492-08 TCGA-04-1356-01A-01R-0456-07 +TCGA-04-1357-01 TCGA-04-1357-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1357 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 TCGA-04-1357-F24009 TCGA-04-1357 Stage IIIB -18999 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES G3 1357 YES NO Primary Tumor 01 04 Ovary LIVING 2005 TCGA-04-1357-01 TCGA-04-1357-01 ab3d12c9-29b5-41b0-98dd-56670fe303d9 TCGA-04-1357-01 TCGA-04-1357-01A-01D-0460-05 TCGA-04-1357-01A-21-20 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01D-0452-01 TCGA-04-1357-01 fcbf9267-5e2a-4a94-8851-9f7151aee4a0 TCGA-04-1357-01A-01D-0452-01 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01W-0492-08 TCGA-04-1357-01 TCGA-04-1357-01 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01W-0492-08 TCGA-04-1357-01A-01R-0456-07 +TCGA-04-1360-01 TCGA-04-1360-01 High OV-like c1 OV-like c4 TCGA-04-1360 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 TCGA-04-1360-F24011 TCGA-04-1360 TCGA-04-1360-01A Stage IA -23993 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 0.8 NO 1 G3 TCGA-04-1360.D215D37F-D04B-44BC-AF17-D3B8C804A3E9.pdf 1360 YES NO Primary Tumor 01 0.4 04 Ovary A LIVING 2005 09afddf6-c527-4561-b476-cbc9bcc7ca24 TCGA-04-1360-01A-01D-0460-05 TCGA-04-1360-01A-21-20 TCGA-04-1360-01A-01D-0452-01 TCGA-04-1360-01 e470041a-5d0c-4818-8246-bd4530cc81e0 TCGA-04-1360-01A-01D-0452-01 TCGA-04-1360-01 TCGA-04-1360-01A-01R-0456-07 +TCGA-04-1361-01 TCGA-04-1361-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1361 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-04-1361-F24013 TCGA-04-1361 TCGA-04-1361-01A Stage IIIB -20860 0 989 927 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.8 G3 Recurrence TCGA-04-1361.5116FD62-7A2C-425A-A99E-D47C1B456961.pdf 1361 YES Stable Disease Imaging Study NO Primary Tumor 01 0.3 04 No Macroscopic disease Ovary A LIVING 2005 TCGA-04-1361-01 874772d1-76e5-4480-9fb5-0130d66f1b3a TCGA-04-1361-01 TCGA-04-1361-01A-01D-0460-05 TCGA-04-1361-01A-01W-0494-09 TCGA-04-1361-01A-21-20 TCGA-04-1361-01A-01W-0494-09 TCGA-04-1361-01A-01D-0452-01 TCGA-04-1361-01 62d06e8a-aed1-4904-8651-c9912e5b1eae TCGA-04-1361-01A-01D-0452-01 TCGA-04-1361-01 TCGA-04-1361-01A-01W-0494-09 TCGA-04-1361-01A-01R-0456-07 +TCGA-04-1362-01 TCGA-04-1362-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1362 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-04-1362-F24020 TCGA-04-1362 TCGA-04-1362-01A Stage IIC -21745 1348 0 223 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G3 Recurrence TCGA-04-1362.D3757F96-E669-4D0E-BBCB-41696AB72004.pdf 1362 Pre-Adjuvant Therapy WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.6 04 1-10 mm Ovary A DECEASED 2002 TCGA-04-1362-01 TCGA-04-1362-01 9dcb2e40-d569-439e-8359-4178124447b5 TCGA-04-1362-01 TCGA-04-1362-01A-01D-0460-05 TCGA-04-1362-01A-01W-0494-09 TCGA-04-1362-01A-21-20 TCGA-04-1362-01A-01W-0494-09 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 TCGA-04-1362-01A-01D-0452-01 TCGA-04-1362-01 e6a03e2b-8fcf-4ad5-9b40-be38c0b08786 TCGA-04-1362-01A-01D-0452-01 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 TCGA-04-1362-01 TCGA-04-1362-01 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 TCGA-04-1362-01A-01W-0494-09 TCGA-04-1362-01A-01R-0456-07 +TCGA-04-1364-01 TCGA-04-1364-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1364 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-04-1364-F24028 TCGA-04-1364 TCGA-04-1364-01A Stage IIIC -22294 1024 0 288 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.2 NO G3 Recurrence TCGA-04-1364.CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4.pdf 1364 Preoperative WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.3 04 1-10 mm Ovary A DECEASED 2003 TCGA-04-1364-01 TCGA-04-1364-01 TCGA-04-1364-01A-01W-0490-10 0e23070a-25c9-49b4-8c4a-a9994de3a312 TCGA-04-1364-01 TCGA-04-1364-01A-01W-0490-10 TCGA-04-1364-01A-01D-0460-05 2fadaf5a-402b-483d-bc26-08feb3dc162d TCGA-04-1364-01A-01D-0452-01 TCGA-04-1364-01 TCGA-04-1364-01A-01D-0452-01 2fadaf5a-402b-483d-bc26-08feb3dc162d 2fadaf5a-402b-483d-bc26-08feb3dc162d TCGA-04-1364-01 TCGA-04-1364-01 2fadaf5a-402b-483d-bc26-08feb3dc162d TCGA-04-1364-01A-01W-0490-10 TCGA-04-1364-01A-01R-0456-07 +TCGA-04-1365-01 TCGA-04-1365-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1365 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Left TCGA-04-1365-F24044 TCGA-04-1365 TCGA-04-1365-01A Stage IIIB -31925 0 2329 1328 1 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.2 NO G3 Recurrence TCGA-04-1365.049FC54E-4D17-4B68-9E41-268529C9F18F.pdf 1365 Preoperative WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.6 04 Ovary A LIVING 2003 TCGA-04-1365-01 TCGA-04-1365-01 TCGA-04-1365-01A-01W-0490-10 a64bec02-eddf-4723-90a8-6742267b4f51 TCGA-04-1365-01 TCGA-04-1365-01A-01W-0490-10 TCGA-04-1365-01A-01D-0460-05 2535da6b-39f0-41de-afd3-82cb37916b95 TCGA-04-1365-01A-01D-0452-01 TCGA-04-1365-01 TCGA-04-1365-01A-01D-0452-01 2535da6b-39f0-41de-afd3-82cb37916b95 2535da6b-39f0-41de-afd3-82cb37916b95 TCGA-04-1365-01 TCGA-04-1365-01 2535da6b-39f0-41de-afd3-82cb37916b95 TCGA-04-1365-01A-01W-0490-10 TCGA-04-1365-01A-01R-0456-07 +TCGA-04-1367-01 TCGA-04-1367-01 High OV-like c1 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-04-1367 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-04-1367-F62486 TCGA-04-1367 TCGA-04-1367-01A Stage IIIC -18577 0 3145 2997 0 Scheduled Follow-up Submission Progressive Disease 2014-7-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 100 0.7 NO NO G3 Progression of Disease NO TCGA-04-1367.78E00062-0996-45A9-80FC-125409EE370A.pdf 1367 Preoperative WITH TUMOR NO Progressive Disease Molecular Markers NO Primary Tumor 01 0.5 NO YES 04 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-04-1367-01 69b2dded-5eff-448b-8220-8163c264e63b TCGA-04-1367-01 TCGA-04-1367-01A-01D-0460-05 TCGA-04-1367-01A-01D-0452-01 TCGA-04-1367-01 TCGA-04-1367-01A-01D-0452-01 TCGA-04-1367-01A-01W-0492-08 TCGA-04-1367-01 TCGA-04-1367-01A-01W-0492-08 TCGA-04-1367-01A-01R-0456-07 +TCGA-04-1369-01 TCGA-04-1369-01 OV-like c1 OV-like c4 TCGA-04-1369 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1369-F24056 TCGA-04-1369 TCGA-04-1369-01A Stage IIIC -19571 642 0 315 0 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G2 Progression of Disease TCGA-04-1369.5C54C779-C561-4625-B8F0-029BE2D3C91B.pdf 1369 Pre-Adjuvant Therapy WITH TUMOR YES Imaging Study NO R1 Primary Tumor 01 0.2 04 1-10 mm Ovary A DECEASED 2004 940c48c2-f75f-498a-9c40-a33d65dfbce1 TCGA-04-1369-01A-02D-1047-05 TCGA-04-1369-01A-11-1562-20 TCGA-04-1369-01A-02D-1526-09 TCGA-04-1369-01 40f6f0ca-e0e0-4c0b-96b1-3d305aa93f95 TCGA-04-1369-01A-02R-1050-07 +TCGA-04-1369-11 TCGA-04-1369-11 TCGA-04-1369 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1369-F24056 TCGA-04-1369 TCGA-04-1369-11A Stage IIIC -19571 642 0 315 0 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.5 G2 Progression of Disease 1369 Pre-Adjuvant Therapy WITH TUMOR YES Imaging Study NO R1 Solid Tissue Normal 11 0.3 04 1-10 mm Ovary A DECEASED 2004 TCGA-04-1369-11A-01D-1047-05 +TCGA-04-1370-01 TCGA-04-1370-01 OV-like c4 TCGA-04-1370 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-04-1370-F24062 TCGA-04-1370 TCGA-04-1370-01A Stage IIIC -19329 0 1824 1 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2 G3 TCGA-04-1370.6E990DE9-ED0A-4152-A862-866FBF8A41DE.pdf 1370 Pre-Adjuvant Therapy YES NO R1 Primary Tumor 01 0.3 04 1-10 mm Ovary A LIVING 2004 TCGA-04-1370-01A-21-1562-20 4234f147-09cf-480f-bfca-5ae6c5d338f9 +TCGA-04-1371-01 TCGA-04-1371-01 High OV-like c1 TCGA-04-1371 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-04-1371-F24066 TCGA-04-1371 Stage IIIC -21243 0 2506 0 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1371 Pre-Adjuvant Therapy TUMOR FREE YES NO Primary Tumor 01 04 1-10 mm Ovary LIVING 2001 bf67f8d7-e33c-4b18-9801-4b78ce0b41bb TCGA-04-1371-01A-01D-0460-05 TCGA-04-1371-01A-01D-0452-01 TCGA-04-1371-01 TCGA-04-1371-01A-01D-0452-01 TCGA-04-1371-01 TCGA-04-1371-01A-01R-0456-07 +TCGA-04-1514-01 TCGA-04-1514-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1514 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-04-1514-F24071 TCGA-04-1514 TCGA-04-1514-01A Stage IIIA -16725 1720 0 1221 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.1 NO G2 Recurrence TCGA-04-1514.A0487B93-029F-48EB-AF5C-06A2F5A3FAAA.pdf 1514 Preoperative TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 04 No Macroscopic disease Ovary A DECEASED 2004 TCGA-04-1514-01 TCGA-04-1514-01 TCGA-04-1514-01A-01W-0552-10 c7e3fccc-4e03-4914-874c-e5034bcc6941 TCGA-04-1514-01 TCGA-04-1514-01A-01W-0552-10 TCGA-04-1514-01A-01D-0501-05 TCGA-04-1514-01A-21-1558-20 cc5e2498-a9e6-48be-bbda-9aa101546ca4 TCGA-04-1514-01A-01D-0497-01 TCGA-04-1514-01 8fcd1179-3170-4ca1-b961-dbaa7a391ea4 TCGA-04-1514-01A-01D-0497-01 cc5e2498-a9e6-48be-bbda-9aa101546ca4 cc5e2498-a9e6-48be-bbda-9aa101546ca4 TCGA-04-1514-01 TCGA-04-1514-01 cc5e2498-a9e6-48be-bbda-9aa101546ca4 TCGA-04-1514-01A-01W-0552-10 TCGA-04-1514-01A-01R-0504-07 +TCGA-04-1516-01 TCGA-04-1516-01 High OV-like c1 OV-like c4 TCGA-04-1516 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Left TCGA-04-1516-F24087 TCGA-04-1516 TCGA-04-1516-01A Stage IA -17768 0 1265 0 2010-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.6 G3 TCGA-04-1516.434BDC72-1BE6-4235-AFBA-10ADE94C8901.pdf 1516 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO R0 Primary Tumor 01 0.3 04 No Macroscopic disease Ovary A LIVING 2006 0c2520a9-0937-40b7-a09f-9f21a4726876 TCGA-04-1516-01A-01D-1047-05 TCGA-04-1516-01A-21-1558-20 TCGA-04-1516-01A-01D-1526-09 TCGA-04-1516-01A-01D-1043-01 TCGA-04-1516-01 556a186c-d6ab-4f84-9cac-2b237c3bb4fc TCGA-04-1516-01A-01D-1043-01 TCGA-04-1516-01 TCGA-04-1516-01A-01R-1050-07 +TCGA-04-1516-11 TCGA-04-1516-11 TCGA-04-1516 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Left TCGA-04-1516-F24087 TCGA-04-1516 TCGA-04-1516-11B Stage IA -17768 0 1265 0 2010-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 G3 1516 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 04 No Macroscopic disease Ovary B LIVING 2006 TCGA-04-1516-11B-01D-1047-05 +TCGA-04-1517-01 TCGA-04-1517-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-04-1517 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 79 Bilateral TCGA-04-1517-F24092 TCGA-04-1517 TCGA-04-1517-01A Stage IIIC -29045 608 0 349 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.5 NO G3 Recurrence TCGA-04-1517.ED992763-74E1-466F-A71A-AC0455AD40F6.pdf 1517 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 04 >20 mm Ovary NO A DECEASED 2006 TCGA-04-1517-01 TCGA-04-1517-01A-01W-0615-10 663aa6bd-30d1-47fb-8aec-2baece0cbb87 TCGA-04-1517-01 TCGA-04-1517-01A-01W-0615-10 TCGA-04-1517-01A-01D-0536-05 TCGA-04-1517-01A-21-1558-20 TCGA-04-1517-01A-01D-0533-01 TCGA-04-1517-01 9e4ae9f4-e1ef-40a6-af24-7ea99c9beccd TCGA-04-1517-01A-01D-0533-01 TCGA-04-1517-01 TCGA-04-1517-01A-01W-0615-10 TCGA-04-1517-01A-01R-0540-07 +TCGA-04-1519-01 TCGA-04-1519-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 TCGA-04-1519 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 TCGA-04-1519-F58470 TCGA-04-1519 TCGA-04-1519-01A Stage IIIC -17671 0 24 Scheduled Follow-up Submission 2014-4-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 0.4 NO 1.3 YES G3 TCGA-04-1519.53840C6E-E1AA-415E-BB85-8E1B8976F45C.pdf 1519 Primary Tumor 01 0.4 04 Ovary A LIVING 2007 TCGA-04-1519-01 TCGA-04-1519-01 TCGA-04-1519-01A-01W-0615-10 87caa261-28f0-4d9d-bec5-3842c715d23a TCGA-04-1519-01 TCGA-04-1519-01A-01W-0615-10 TCGA-04-1519-01A-01D-0536-05 TCGA-04-1519-01A-21-1558-20 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 TCGA-04-1519-01A-01D-0533-01 TCGA-04-1519-01 0ed2d853-f94d-49d0-856b-85d54e4817f5 TCGA-04-1519-01A-01D-0533-01 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 TCGA-04-1519-01 TCGA-04-1519-01 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 TCGA-04-1519-01A-01R-0540-07 +TCGA-04-1525-01 TCGA-04-1525-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-04-1525 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-04-1525-F24099 TCGA-04-1525 TCGA-04-1525-01A Stage IIIC -17469 1167 0 1167 213 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 2 NO G3 Recurrence TCGA-04-1525.B84E0C8B-B383-453F-9099-92B5445691D6.pdf 1525 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.2 04 1-10 mm Ovary NO A DECEASED 2005 TCGA-04-1525-01 TCGA-04-1525-01A-01W-0615-10 9fffbdac-8e68-4ea7-ba2f-b2f6156e9f15 TCGA-04-1525-01 TCGA-04-1525-01A-01W-0615-10 TCGA-04-1525-01A-01D-0536-05 TCGA-04-1525-01A-21-1558-20 TCGA-04-1525-01A-01D-0533-01 TCGA-04-1525-01 1ea5f6bb-950e-4383-b76b-f3918c0a0366 TCGA-04-1525-01A-01D-0533-01 TCGA-04-1525-01 TCGA-04-1525-01A-01W-0615-10 TCGA-04-1525-01A-01R-0540-07 +TCGA-04-1530-01 TCGA-04-1530-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1530 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-04-1530-F24104 TCGA-04-1530 TCGA-04-1530-01A Stage IIIC -25013 3622 0 350 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 NO G3 Recurrence TCGA-04-1530.6CB3AECE-ADBB-4AED-A036-2E2D28D68369.pdf 1530 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.4 04 1-10 mm Ovary NO A DECEASED 1995 TCGA-04-1530-01 TCGA-04-1530-01A-02W-0552-10 4271a8fa-e416-4274-8a37-49673f212605 TCGA-04-1530-01 TCGA-04-1530-01A-02W-0552-10 TCGA-04-1530-01A-02D-0501-05 TCGA-04-1530-01A-02D-0497-01 TCGA-04-1530-01 TCGA-04-1530-01A-02D-0497-01 TCGA-04-1530-01 TCGA-04-1530-01A-02W-0552-10 TCGA-04-1530-01A-02R-0504-07 +TCGA-04-1536-01 TCGA-04-1536-01 High OV-like c1 miRNA cluster 1 cluster 4 TCGA-04-1536 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-04-1536-F24110 TCGA-04-1536 Stage IV -21939 885 0 498 0 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 Recurrence 1536 WITH TUMOR YES Imaging Study NO Primary Tumor 01 04 1-10 mm Ovary DECEASED 2001 TCGA-04-1536-01 f2c0342a-1302-47ff-8615-8d3eb700e3a5 TCGA-04-1536-01 TCGA-04-1536-01A-01D-0536-05 TCGA-04-1536-01A-01D-0533-01 TCGA-04-1536-01 TCGA-04-1536-01A-01D-0533-01 TCGA-04-1536-01 TCGA-04-1536-01A-01R-0540-07 +TCGA-04-1542-01 TCGA-04-1542-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1542 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-04-1542-F24118 TCGA-04-1542 TCGA-04-1542-01A Stage IIIB -19263 2561 0 1020 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 NO G2 Recurrence TCGA-04-1542.E3103C8A-50CB-43FE-9670-2BFB5D1DC318.pdf 1542 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 04 1-10 mm Ovary A DECEASED 2001 TCGA-04-1542-01 7a29ab3a-5d05-47e9-bd87-2cf0285fc8a6 TCGA-04-1542-01 TCGA-04-1542-01A-01D-0501-05 TCGA-04-1542-01A-01W-0553-09 TCGA-04-1542-01A-21-1558-20 TCGA-04-1542-01A-01W-0553-09 TCGA-04-1542-01A-01D-0497-01 TCGA-04-1542-01 abafb551-fa90-465c-8122-6a8c2793c2d8 TCGA-04-1542-01A-01D-0497-01 TCGA-04-1542-01 TCGA-04-1542-01A-01W-0553-09 TCGA-04-1542-01A-01R-0504-07 +TCGA-04-1638-01 TCGA-04-1638-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-04-1638 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 57 TCGA-04-1638-F24136 TCGA-04-1638 TCGA-04-1638-01A Stage IV -20987 1686 0 298 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.6 G3 Recurrence TCGA-04-1638.5CA47F76-8E99-4594-B84C-FAC31BB42269.pdf 1638 Pre-Adjuvant Therapy TUMOR FREE YES Other Method NO Primary Tumor 01 0.3 04 No Macroscopic disease Ovary A DECEASED 2002 TCGA-04-1638-01 11e368d8-9506-45d7-90e6-3ddf23c9e903 TCGA-04-1638-01 TCGA-04-1638-01A-01D-0581-05 TCGA-04-1638-01A-21-1558-20 TCGA-04-1638-01A-01W-0639-09 TCGA-04-1638-01A-01D-0577-01 TCGA-04-1638-01 66049405-6d0c-4409-a9be-166eda4f96b6 TCGA-04-1638-01A-01D-0577-01 TCGA-04-1638-01 TCGA-04-1638-01A-01R-0584-07 +TCGA-04-1644-01 TCGA-04-1644-01 Squamous OV-like c1 OV-like c4 TCGA-04-1644 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-04-1644-F24145 TCGA-04-1644 TCGA-04-1644-01A Stage IIIC -17725 1487 0 634 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 G3 Progression of Disease TCGA-04-1644.7AA7FF0A-C1C4-42A1-A340-A1E03CED8DEB.pdf 1644 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.4 04 >20 mm Ovary A DECEASED 2002 5c14dcb5-1dd3-4eaa-a71a-e7b62d4698ee TCGA-04-1644-01B-01D-1047-05 TCGA-04-1644-01A-11-1562-20 TCGA-04-1644-01B-01D-1526-09 TCGA-04-1644-01B-01D-1043-01 TCGA-04-1644-01 3fa1c199-830d-486c-859f-2179bb86e5bf TCGA-04-1644-01B-01D-1043-01 TCGA-04-1644-01 TCGA-04-1644-01B-01R-1050-07 +TCGA-04-1644-11 TCGA-04-1644-11 TCGA-04-1644 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-04-1644-F24145 TCGA-04-1644 TCGA-04-1644-11A Stage IIIC -17725 1487 0 634 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.1 G3 Progression of Disease 1644 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Solid Tissue Normal 11 0.4 04 >20 mm Ovary A DECEASED 2002 TCGA-04-1644-11A-01D-1047-05 +TCGA-04-1646-01 TCGA-04-1646-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-04-1646 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-04-1646-F24152 TCGA-04-1646 Stage IIIC -22207 848 0 508 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1646 Pre-Adjuvant Therapy WITH TUMOR YES Imaging Study NO Primary Tumor 01 04 1-10 mm Ovary DECEASED 2003 TCGA-04-1646-01 d6a1fffb-cecf-4137-865c-95d7d95fae2d TCGA-04-1646-01 TCGA-04-1646-01A-01D-0581-05 TCGA-04-1646-01A-21-1558-20 TCGA-04-1646-01A-01W-0639-09 TCGA-04-1646-01A-01D-0577-01 TCGA-04-1646-01 c278e930-af50-4be7-a706-48a80e58b24f TCGA-04-1646-01A-01D-0577-01 TCGA-04-1646-01 TCGA-04-1646-01A-01R-0584-07 +TCGA-04-1648-01 TCGA-04-1648-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-04-1648 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 TCGA-04-1648-F24159 TCGA-04-1648 Stage IIIC -21113 871 0 412 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G2 Recurrence 1648 Pre-Adjuvant Therapy YES Molecular Markers NO Primary Tumor 01 04 1-10 mm Ovary DECEASED 2003 TCGA-04-1648-01 b145279e-8242-4087-9584-0519d4639d31 TCGA-04-1648-01 TCGA-04-1648-01A-01D-0581-05 TCGA-04-1648-01A-21-1558-20 TCGA-04-1648-01A-01W-0639-09 TCGA-04-1648-01A-01D-0577-01 TCGA-04-1648-01 f904c338-e425-42f1-a15e-b5eb2dcfe829 TCGA-04-1648-01A-01D-0577-01 TCGA-04-1648-01 TCGA-04-1648-01A-01R-0584-07 +TCGA-04-1649-01 TCGA-04-1649-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-04-1649 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-04-1649-F24168 TCGA-04-1649 TCGA-04-1649-01A Stage IIIC -27165 0 1966 1672 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.7 G3 Recurrence TCGA-04-1649.C0A1166D-7233-4843-A007-DDF16A45A5E8.pdf 1649 Preoperative NO Imaging Study NO Primary Tumor 01 0.3 04 1-10 mm Ovary A LIVING 2003 TCGA-04-1649-01 3ae3b762-3f04-450d-86db-44daec23ca9f TCGA-04-1649-01 TCGA-04-1649-01A-01D-0581-05 TCGA-04-1649-01A-21-1558-20 TCGA-04-1649-01A-01W-0639-09 TCGA-04-1649-01A-01D-0577-01 TCGA-04-1649-01 fd9ff078-e2fe-4ab6-9e62-445caba9e611 TCGA-04-1649-01A-01D-0577-01 TCGA-04-1649-01 TCGA-04-1649-01A-01R-0584-07 +TCGA-04-1651-01 TCGA-04-1651-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 TCGA-04-1651 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1651-F24172 TCGA-04-1651 TCGA-04-1651-01A Stage IIIC -19628 1102 0 990 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.4 NO 1.5 G3 Recurrence TCGA-04-1651.703BEFE1-07E0-48AE-826E-133A59F97068.pdf 1651 Pre-Adjuvant Therapy YES Imaging Study NO Primary Tumor 01 0.3 04 1-10 mm Ovary A DECEASED 2004 TCGA-04-1651-01 797b7d36-42e2-4f9d-9f8f-7d3fb52219ff TCGA-04-1651-01 TCGA-04-1651-01A-01D-0581-05 TCGA-04-1651-01A-21-1558-20 TCGA-04-1651-01A-01W-0639-09 TCGA-04-1651-01A-01D-0577-01 TCGA-04-1651-01 5c0f2819-0ecd-43de-aa9b-6073e34779e5 TCGA-04-1651-01A-01D-0577-01 TCGA-04-1651-01 TCGA-04-1651-01A-01R-0584-07 +TCGA-04-1652-01 TCGA-04-1652-01 High OV-like c1 miRNA cluster 1 cluster 2 TCGA-04-1652 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Right TCGA-04-1652-F24179 TCGA-04-1652 Stage IIIC -28101 969 0 880 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G2 Recurrence 1652 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 04 Ovary NO DECEASED 2004 TCGA-04-1652-01 dd1addbf-ba25-418f-98d9-efe155026fdd TCGA-04-1652-01 TCGA-04-1652-01A-01D-0581-05 TCGA-04-1652-01A-01W-0639-09 TCGA-04-1652-01A-01D-0577-01 TCGA-04-1652-01 TCGA-04-1652-01A-01D-0577-01 TCGA-04-1652-01 TCGA-04-1652-01A-01R-0584-07 +TCGA-04-1654-01 TCGA-04-1654-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-04-1654 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-04-1654-F24185 TCGA-04-1654 TCGA-04-1654-01A Stage IIIC -25387 1451 0 808 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.2 G2 Recurrence TCGA-04-1654.E6F4CDD1-DD1B-4C69-8A9F-0DCA88F8C539.pdf 1654 Pre-Adjuvant Therapy YES Imaging Study NO Primary Tumor 01 0.3 04 1-10 mm Ovary A DECEASED 1999 TCGA-04-1654-01 bf9a9a62-9471-41f7-b10f-35a1316f63c3 TCGA-04-1654-01 TCGA-04-1654-01A-02D-0652-05 TCGA-04-1654-01A-11-1562-20 TCGA-04-1654-01A-02D-0648-01 TCGA-04-1654-01 2b44138a-955e-46f3-bf8e-c8ace62e6389 TCGA-04-1654-01A-02D-0648-01 TCGA-04-1654-01 TCGA-04-1654-01A-02R-0655-07 +TCGA-04-1655-01 TCGA-04-1655-01 High OV-like c1 miRNA cluster 2 cluster 1 TCGA-04-1655 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-04-1655-F24191 TCGA-04-1655 TCGA-04-1655-01A Stage IIIB -17988 1380 0 819 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 1.1 G2 Recurrence TCGA-04-1655.D808763E-D67C-460C-B5D6-85CC5C1C05BC.pdf 1655 Pre-Adjuvant Therapy YES Physical Examination NO Primary Tumor 01 0.4 04 No Macroscopic disease Ovary A DECEASED 1999 TCGA-04-1655-01 461a33bb-1055-403e-b7e0-7f16d1c10f7b TCGA-04-1655-01 TCGA-04-1655-01A-01D-0563-05 TCGA-04-1655-01A-01W-0633-09 TCGA-04-1655-01A-01D-0559-01 TCGA-04-1655-01 TCGA-04-1655-01A-01D-0559-01 TCGA-04-1655-01 TCGA-04-1655-01A-01R-0566-07 +TCGA-09-0364-01 TCGA-09-0364-01 Squamous OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-09-0364 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 80 Right TCGA-09-0364-F24198 TCGA-09-0364 TCGA-09-0364-01A Stage IIC -29262 887 0 395 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO NO G3 Recurrence TCGA-09-0364.27b9efd3-7748-4deb-96a2-3869a19bfa6f.pdf 0364 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 09 11-20 mm Ovary NO A DECEASED 1998 TCGA-09-0364-01 TCGA-09-0364-01 TCGA-09-0364-01A-02W-0370-10 0ba4e8de-0013-421a-8605-efb4f3ebfc0a TCGA-09-0364-01 TCGA-09-0364-01A-02W-0370-10 TCGA-09-0364-01A-02D-0359-05 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 TCGA-09-0364-01A-02D-0356-01 TCGA-09-0364-01 TCGA-09-0364-01A-02D-0356-01 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 TCGA-09-0364-01 TCGA-09-0364-01 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 TCGA-09-0364-01A-02R-0363-07 +TCGA-09-0365-01 TCGA-09-0365-01 GBM OV-like c1 TCGA-09-0365 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Left TCGA-09-0365-F24203 TCGA-09-0365 TCGA-09-0365-01A Stage IIIC -25703 288 0 251 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NO NO G3 Recurrence TCGA-09-0365.459f8df7-b386-47c6-bf17-73af831441d4.pdf 0365 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 09 No Macroscopic disease Ovary NO A DECEASED 1999 16f6b497-da7d-4156-9b83-dda375a1c04f TCGA-09-0365-01A-02D-0359-05 TCGA-09-0365-01A-02D-0356-01 TCGA-09-0365-01 TCGA-09-0365-01A-02D-0356-01 TCGA-09-0365-01 TCGA-09-0365-01A-02R-0363-07 +TCGA-09-0366-01 TCGA-09-0366-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-09-0366 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-09-0366-F24207 TCGA-09-0366 Stage IIIC -20440 1757 0 190 2009-3-4 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection NO G3 Recurrence 0366 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 09 1-10 mm Ovary NO DECEASED 1999 TCGA-09-0366-01 TCGA-09-0366-01 e091ea57-ec3e-4357-8929-b4e149dfa3f5 TCGA-09-0366-01 TCGA-09-0366-01A-01D-0359-05 TCGA-09-0366-01A-01W-0372-09 TCGA-09-0366-01A-01W-0372-09 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 TCGA-09-0366-01A-01D-0356-01 TCGA-09-0366-01 TCGA-09-0366-01A-01D-0356-01 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 TCGA-09-0366-01 TCGA-09-0366-01 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 TCGA-09-0366-01A-01W-0372-09 TCGA-09-0366-01A-01R-0363-07 +TCGA-09-0367-01 TCGA-09-0367-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-09-0367 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-09-0367-F24212 TCGA-09-0367 TCGA-09-0367-01A Stage IIIC -24473 547 0 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO YES G3 TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89.pdf 0367 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 09 1-10 mm Ovary YES A DECEASED 2001 TCGA-09-0367-01 TCGA-09-0367-01 129c93c0-eb2f-47c5-acdc-4fd083e9dc8a TCGA-09-0367-01 TCGA-09-0367-01A-01D-0359-05 047e04aa-6a91-4535-b279-50430098e638 TCGA-09-0367-01A-01D-0356-01 TCGA-09-0367-01 TCGA-09-0367-01A-01D-0356-01 047e04aa-6a91-4535-b279-50430098e638 047e04aa-6a91-4535-b279-50430098e638 TCGA-09-0367-01 TCGA-09-0367-01 047e04aa-6a91-4535-b279-50430098e638 TCGA-09-0367-01A-01R-0363-07 +TCGA-09-0369-01 TCGA-09-0369-01 High C9-OV OV-like c1 OV-like c16 mutation cluster 5 TCGA-09-0369 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Left TCGA-09-0369-F24217 TCGA-09-0369 TCGA-09-0369-01A Stage IIIC -20705 1082 0 274 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO YES G3 Recurrence TCGA-09-0369.c052e190-b5c2-44bf-b5b0-2b37cde18cee.pdf 0369 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 09 No Macroscopic disease Ovary YES A DECEASED 2003 TCGA-09-0369-01 11197914-6f55-4542-9138-ad6b451c3350 TCGA-09-0369-01A-01D-0359-05 TCGA-09-0369-01A-01W-0372-09 TCGA-09-0369-01A-01W-0372-09 1f972766-2f58-4d41-b84c-3493ef2dd0c4 TCGA-09-0369-01A-01D-0356-01 TCGA-09-0369-01 TCGA-09-0369-01A-01D-0356-01 1f972766-2f58-4d41-b84c-3493ef2dd0c4 1f972766-2f58-4d41-b84c-3493ef2dd0c4 TCGA-09-0369-01 TCGA-09-0369-01 1f972766-2f58-4d41-b84c-3493ef2dd0c4 TCGA-09-0369-01A-01W-0372-09 TCGA-09-0369-01A-01R-0363-07 +TCGA-09-1659-01 TCGA-09-1659-01 High OV-like c1 mutation cluster 5 TCGA-09-1659 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-09-1659-F24226 TCGA-09-1659 TCGA-09-1659-01B Stage IIIC -18733 304 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G3 TCGA-09-1659.f10b2e12-02b2-42e0-a5b2-a02c1daabbdf.pdf 1659 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.4 09 >20 mm Ovary NO B DECEASED 1997 TCGA-09-1659-01 TCGA-09-1659-01B-01W-0615-10 5203ba2e-518a-4492-8f15-25182bff1dec TCGA-09-1659-01B-01W-0615-10 TCGA-09-1659-01B-01D-0536-05 32d5209e-2ef2-4ef0-b902-585542d7d16b TCGA-09-1659-01B-01D-0533-01 TCGA-09-1659-01 TCGA-09-1659-01B-01D-0533-01 32d5209e-2ef2-4ef0-b902-585542d7d16b 32d5209e-2ef2-4ef0-b902-585542d7d16b TCGA-09-1659-01 TCGA-09-1659-01 32d5209e-2ef2-4ef0-b902-585542d7d16b TCGA-09-1659-01B-01W-0615-10 TCGA-09-1659-01B-01R-0540-07 +TCGA-09-1661-01 TCGA-09-1661-01 High OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-09-1661 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 75 Right TCGA-09-1661-F24233 TCGA-09-1661 TCGA-09-1661-01B Stage IIIC -27486 1169 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.6 NO G3 TCGA-09-1661.1910251f-8c5c-4067-91dc-87bfdaf77283.pdf 1661 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.1 09 1-10 mm Ovary NO B DECEASED 2000 TCGA-09-1661-01 TCGA-09-1661-01B-01W-0615-10 956ee2ec-8a47-417a-a82b-dc4c91f9cf46 TCGA-09-1661-01 TCGA-09-1661-01B-01W-0615-10 TCGA-09-1661-01B-01D-0536-05 TCGA-09-1661-01B-01D-0533-01 TCGA-09-1661-01 TCGA-09-1661-01B-01D-0533-01 TCGA-09-1661-01 TCGA-09-1661-01B-01W-0615-10 TCGA-09-1661-01B-01R-0540-07 +TCGA-09-1662-01 TCGA-09-1662-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-09-1662 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Left TCGA-09-1662-F24243 TCGA-09-1662 TCGA-09-1662-01A Stage IV -21246 2717 0 1046 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 YES G3 Recurrence TCGA-09-1662.8e2676a4-2ac3-42af-be7d-cf74b6d82f2f.pdf 1662 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 09 1-10 mm Ovary YES A DECEASED 2001 TCGA-09-1662-01 TCGA-09-1662-01 TCGA-09-1662-01A-01W-0615-10 0fc0fc51-c5b7-428e-92c6-d55c8514b689 TCGA-09-1662-01 TCGA-09-1662-01A-01W-0615-10 TCGA-09-1662-01A-01D-0536-05 TCGA-09-1662-01A-21-1558-20 759060d9-af2e-4098-b4ee-7aa2214acba8 TCGA-09-1662-01A-01D-0533-01 TCGA-09-1662-01 253b785e-f10b-4d0e-88cb-4db4a3610c7c TCGA-09-1662-01A-01D-0533-01 759060d9-af2e-4098-b4ee-7aa2214acba8 759060d9-af2e-4098-b4ee-7aa2214acba8 TCGA-09-1662-01 TCGA-09-1662-01 759060d9-af2e-4098-b4ee-7aa2214acba8 TCGA-09-1662-01A-01W-0615-10 TCGA-09-1662-01A-01R-0540-07 +TCGA-09-1664-01 TCGA-09-1664-01 Squamous OV-like c1 OV-like c4 TCGA-09-1664 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 37 Bilateral TCGA-09-1664-F24268 TCGA-09-1664 Stage IIIC -13739 2279 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G1 1664 YES Complete Remission/Response NO Primary Tumor 01 09 1-10 mm Ovary NO DECEASED 2002 ab246047-1519-4cd8-b1c5-abb4ef58697a TCGA-09-1664-01A-01D-0581-05 TCGA-09-1664-01A-21-1558-20 TCGA-09-1664-01A-01W-0639-09 TCGA-09-1664-01A-01D-0577-01 TCGA-09-1664-01 e2007adb-55b1-4b8b-99c0-4e6a61a2da29 TCGA-09-1664-01A-01D-0577-01 TCGA-09-1664-01 TCGA-09-1664-01A-01R-0584-07 +TCGA-09-1665-01 TCGA-09-1665-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-1665 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 73 Left TCGA-09-1665-F24272 TCGA-09-1665 TCGA-09-1665-01B Stage IIIC -27010 1266 0 468 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 YES G2 Recurrence TCGA-09-1665.0e311879-9b25-453d-b41a-7cc3048bb05e.pdf 1665 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 09 No Macroscopic disease Ovary YES B DECEASED 2002 TCGA-09-1665-01 TCGA-09-1665-01B-01W-0615-10 5b880786-e40d-41ff-9fee-f542f1b5a27c TCGA-09-1665-01 TCGA-09-1665-01B-01W-0615-10 TCGA-09-1665-01B-01D-0536-05 TCGA-09-1665-01B-21-1558-20 TCGA-09-1665-01B-01D-0533-01 TCGA-09-1665-01 a565c52a-a226-47db-b68c-d579055e4c06 TCGA-09-1665-01B-01D-0533-01 TCGA-09-1665-01 TCGA-09-1665-01B-01W-0615-10 TCGA-09-1665-01B-01R-0540-07 +TCGA-09-1666-01 TCGA-09-1666-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-1666 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-09-1666-F24279 TCGA-09-1666 TCGA-09-1666-01A Stage IIIC -21066 0 1752 480 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 NO G3 Recurrence TCGA-09-1666.2de50dd9-b607-4a87-baae-468c4bf43205.pdf 1666 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 09 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-09-1666-01 TCGA-09-1666-01 TCGA-09-1666-01A-01W-0615-10 fc1d50d5-b097-41f0-a9b2-0efd207d6ebd TCGA-09-1666-01 TCGA-09-1666-01A-01W-0615-10 TCGA-09-1666-01A-01D-0536-05 TCGA-09-1666-01A-21-1558-20 529b7dd2-075c-4e93-b8c8-6990d3297c30 TCGA-09-1666-01A-01D-0533-01 TCGA-09-1666-01 aa4fad88-9a21-4085-9ac7-21b349113168 TCGA-09-1666-01A-01D-0533-01 529b7dd2-075c-4e93-b8c8-6990d3297c30 529b7dd2-075c-4e93-b8c8-6990d3297c30 TCGA-09-1666-01 TCGA-09-1666-01 529b7dd2-075c-4e93-b8c8-6990d3297c30 TCGA-09-1666-01A-01W-0615-10 TCGA-09-1666-01A-01R-0540-07 +TCGA-09-1667-01 TCGA-09-1667-01 High OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 TCGA-09-1667 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-09-1667-F24292 TCGA-09-1667 TCGA-09-1667-01C Stage IIC -22306 0 1882 460 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 NO G2 Recurrence TCGA-09-1667.0f3fbc34-6dce-467f-a837-442815ebc159.pdf 1667 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 09 No Macroscopic disease Ovary NO C LIVING 2004 TCGA-09-1667-01 TCGA-09-1667-01 64fbf0df-6693-4ea5-a868-925636d9d20f TCGA-09-1667-01 TCGA-09-1667-01C-01D-0536-05 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e TCGA-09-1667-01C-01D-0533-01 TCGA-09-1667-01 TCGA-09-1667-01C-01D-0533-01 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e TCGA-09-1667-01 TCGA-09-1667-01 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e TCGA-09-1667-01C-01R-0540-07 +TCGA-09-1668-01 TCGA-09-1668-01 Squamous OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-09-1668 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Right TCGA-09-1668-F24300 TCGA-09-1668 TCGA-09-1668-01B Stage IIIC -20972 0 1684 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.7 NO G3 TCGA-09-1668.7740b3ec-1d81-4408-be9e-45ccd7e91b3a.pdf 1668 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.3 09 Ovary NO B LIVING 2004 TCGA-09-1668-01 TCGA-09-1668-01 fe849a8b-cfb0-44a3-a264-75ccef069be3 TCGA-09-1668-01 TCGA-09-1668-01B-01D-0536-05 66894abe-8af5-4fd9-9a59-cf24e57fc07f TCGA-09-1668-01B-01D-0533-01 TCGA-09-1668-01 TCGA-09-1668-01B-01D-0533-01 66894abe-8af5-4fd9-9a59-cf24e57fc07f 66894abe-8af5-4fd9-9a59-cf24e57fc07f TCGA-09-1668-01 TCGA-09-1668-01 66894abe-8af5-4fd9-9a59-cf24e57fc07f TCGA-09-1668-01B-01R-0540-07 +TCGA-09-1669-01 TCGA-09-1669-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-1669 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Right TCGA-09-1669-F24305 TCGA-09-1669 TCGA-09-1669-01A Stage IIIA -20052 0 928 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.9 NO G3 TCGA-09-1669.7870b5a7-a96c-4e55-b56f-8eca45918251.pdf 1669 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.3 09 No Macroscopic disease Ovary NO A LIVING 2004 TCGA-09-1669-01 TCGA-09-1669-01 TCGA-09-1669-01A-01W-0615-10 01119e56-c4b0-4d4f-876c-fd34e4185af3 TCGA-09-1669-01 TCGA-09-1669-01A-01W-0615-10 TCGA-09-1669-01A-01D-0536-05 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 TCGA-09-1669-01A-01D-0533-01 TCGA-09-1669-01 TCGA-09-1669-01A-01D-0533-01 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 TCGA-09-1669-01 TCGA-09-1669-01 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 TCGA-09-1669-01A-01W-0615-10 TCGA-09-1669-01A-01R-0540-07 +TCGA-09-1670-01 TCGA-09-1670-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 TCGA-09-1670 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-09-1670-F24309 TCGA-09-1670 TCGA-09-1670-01A Stage IIIA -21147 0 547 547 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.6 NO G3 Recurrence TCGA-09-1670.5cc85cd9-99c4-4087-bdc5-8039b0369538.pdf 1670 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 09 No Macroscopic disease Ovary NO A LIVING 2005 TCGA-09-1670-01 TCGA-09-1670-01 99b305e7-c4d7-4174-955d-7618d91f84d0 TCGA-09-1670-01 TCGA-09-1670-01A-01D-0563-05 TCGA-09-1670-01A-21-1558-20 TCGA-09-1670-01A-01W-0633-09 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 TCGA-09-1670-01A-01D-0559-01 TCGA-09-1670-01 950ea36f-87d6-4730-b11d-e8eae3e0fe79 TCGA-09-1670-01A-01D-0559-01 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 TCGA-09-1670-01 TCGA-09-1670-01 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 TCGA-09-1670-01A-01R-0566-07 +TCGA-09-1672-01 TCGA-09-1672-01 BRCA-LUAD+ OV-like c1 TCGA-09-1672 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Right TCGA-09-1672-F24314 TCGA-09-1672 TCGA-09-1672-01A Stage IIIC -28556 0 178 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G1 TCGA-09-1672.103ad514-77dc-42fd-8cf2-31e9de128a74.pdf 1672 TUMOR FREE YES NO Primary Tumor 01 0.3 09 Ovary YES A LIVING 2008 67029a85-41d6-41a6-844e-cecf63941f3e TCGA-09-1672-01A-01D-0563-05 TCGA-09-1672-01A-01W-0633-09 TCGA-09-1672-01A-01D-0559-01 TCGA-09-1672-01 TCGA-09-1672-01A-01D-0559-01 TCGA-09-1672-01 TCGA-09-1672-01A-01R-0566-07 +TCGA-09-1673-01 TCGA-09-1673-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-09-1673 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-09-1673-F24318 TCGA-09-1673 TCGA-09-1673-01A Stage IV -18599 0 92 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 3 YES G3 TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450.pdf 1673 WITH TUMOR YES NO Primary Tumor 01 0.6 09 >20 mm Ovary YES A LIVING 2008 TCGA-09-1673-01 TCGA-09-1673-01 f45664bd-409f-4819-bb3f-b16ce74e7d9c TCGA-09-1673-01 TCGA-09-1673-01A-01D-0563-05 TCGA-09-1673-01A-21-1558-20 TCGA-09-1673-01A-01W-0633-09 37037dcf-fa69-4cd3-b83d-e474d69059b4 TCGA-09-1673-01A-01D-0559-01 TCGA-09-1673-01 ca0ee85f-6e38-447b-b232-49812c6e2a97 TCGA-09-1673-01A-01D-0559-01 37037dcf-fa69-4cd3-b83d-e474d69059b4 37037dcf-fa69-4cd3-b83d-e474d69059b4 TCGA-09-1673-01 TCGA-09-1673-01 37037dcf-fa69-4cd3-b83d-e474d69059b4 TCGA-09-1673-01A-01R-0566-07 +TCGA-09-1674-01 TCGA-09-1674-01 High C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 2 cluster 1 TCGA-09-1674 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 79 Bilateral TCGA-09-1674-F24322 TCGA-09-1674 TCGA-09-1674-01A Stage IIIC -28878 0 260 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2.1 NO G3 TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e.pdf 1674 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.7 09 1-10 mm Ovary NO A LIVING 2008 TCGA-09-1674-01 TCGA-09-1674-01 995f3a5f-4e3d-4e69-a473-4b53da943923 TCGA-09-1674-01 TCGA-09-1674-01A-01D-0563-05 TCGA-09-1674-01A-21-1558-20 TCGA-09-1674-01A-01W-0633-09 3a81f083-56dc-48a5-be8d-b69a146db93b TCGA-09-1674-01A-01D-0559-01 TCGA-09-1674-01 872b7aec-febf-4104-8269-bfb0c72fbeec TCGA-09-1674-01A-01D-0559-01 3a81f083-56dc-48a5-be8d-b69a146db93b 3a81f083-56dc-48a5-be8d-b69a146db93b TCGA-09-1674-01 TCGA-09-1674-01 3a81f083-56dc-48a5-be8d-b69a146db93b TCGA-09-1674-01A-01R-0566-07 +TCGA-09-1675-01 TCGA-09-1675-01 Squamous OV-like c1 TCGA-09-1675 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Left TCGA-09-1675-F24326 TCGA-09-1675 TCGA-09-1675-01B Stage IC -18596 0 2967 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1.1 NO G2 TCGA-09-1675.f981f103-fc2d-4f41-9f71-015f194391f5.pdf 1675 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.1 09 No Macroscopic disease Ovary NO B LIVING 2001 690beb52-7ca9-448a-a134-7317be4f8289 TCGA-09-1675-01B-01D-0563-05 TCGA-09-1675-01B-01W-0633-09 TCGA-09-1675-01B-01D-0559-01 TCGA-09-1675-01 TCGA-09-1675-01B-01D-0559-01 TCGA-09-1675-01 TCGA-09-1675-01B-01R-0566-07 +TCGA-09-2043-01 TCGA-09-2043-01 High OV-like c1 OV-like c4 TCGA-09-2043 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 69 Left TCGA-09-2043-F24332 TCGA-09-2043 TCGA-09-2043-01A Stage IC -25480 0 188 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2 NO G3 TCGA-09-2043.1fa4e0b8-344f-4ebb-b150-c3ace0ec4a00.pdf 2043 TUMOR FREE NO Complete Remission/Response NO Primary Tumor 01 0.1 09 No Macroscopic disease Ovary NO A LIVING 2009 dec0d15f-9489-4987-83ff-3613cf21c379 TCGA-09-2043-01A-01D-0708-05 TCGA-09-2043-01A-21-1560-20 TCGA-09-2043-01A-01D-0704-01 TCGA-09-2043-01 066f35fb-d0a8-4968-acf1-1da9ec81748e TCGA-09-2043-01A-01D-0704-01 TCGA-09-2043-01 TCGA-09-2043-01A-01R-0711-07 +TCGA-09-2044-01 TCGA-09-2044-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-09-2044 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 77 Right TCGA-09-2044-F24334 TCGA-09-2044 TCGA-09-2044-01B Stage IIB -28231 0 186 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.8 NO G3 TCGA-09-2044.42d7c4ad-b379-4dc0-ba67-16aa6ead89d9.pdf 2044 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 09 No Macroscopic disease Ovary NO B LIVING 2009 TCGA-09-2044-01 TCGA-09-2044-01 0b4c7448-2729-45db-b1b2-0fba79016c76 TCGA-09-2044-01 TCGA-09-2044-01B-01D-0708-05 TCGA-09-2044-01B-21-1560-20 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01D-0704-01 TCGA-09-2044-01 32c1a264-b1dd-4307-ab4d-f710ea9692cc TCGA-09-2044-01B-01D-0704-01 658b4847-33bc-414c-a2bb-ce9379ef57bd 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01W-0799-08 TCGA-09-2044-01 TCGA-09-2044-01 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01W-0799-08 TCGA-09-2044-01B-01R-0711-07 +TCGA-09-2045-01 TCGA-09-2045-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 8 TCGA-09-2045 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-09-2045-F24338 TCGA-09-2045 TCGA-09-2045-01A Stage IV -18285 1069 0 631 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 YES G2 Recurrence TCGA-09-2045.6c826e9d-b1aa-4c84-b294-c8fb41818da1.pdf 2045 WITH TUMOR YES Stable Disease Physical Examination NO Primary Tumor 01 0.4 09 1-10 mm Ovary YES A DECEASED 1996 TCGA-09-2045-01 TCGA-09-2045-01 4456d296-bac1-461d-bda9-d3c52aba590c TCGA-09-2045-01 TCGA-09-2045-01A-01D-0708-05 TCGA-09-2045-01A-21-1560-20 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01D-0704-01 TCGA-09-2045-01 51c5bf06-26be-471c-927c-1cb07bf10a2b TCGA-09-2045-01A-01D-0704-01 7b412fd9-4414-440f-b768-70666037c768 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01W-0799-08 TCGA-09-2045-01 TCGA-09-2045-01 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01W-0799-08 TCGA-09-2045-01A-01R-0711-07 +TCGA-09-2048-01 TCGA-09-2048-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-09-2048 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-09-2048-F24351 TCGA-09-2048 TCGA-09-2048-01A Stage IIIC -23043 138 0 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 YES G3 TCGA-09-2048.0755D708-ADF5-4219-ABC6-BCD9C2BCA089.pdf 2048 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.2 09 1-10 mm Ovary YES A DECEASED 1999 TCGA-09-2048-01 TCGA-09-2048-01 8d5f3a67-69eb-49b0-a1bc-f626eb70c76f TCGA-09-2048-01 TCGA-09-2048-01A-01D-0708-05 d3220bce-1bf3-47c4-951f-937dac7581be TCGA-09-2048-01A-01D-0704-01 TCGA-09-2048-01 TCGA-09-2048-01A-01D-0704-01 d3220bce-1bf3-47c4-951f-937dac7581be d3220bce-1bf3-47c4-951f-937dac7581be TCGA-09-2048-01 TCGA-09-2048-01 d3220bce-1bf3-47c4-951f-937dac7581be TCGA-09-2048-01A-01R-0711-07 +TCGA-09-2049-01 TCGA-09-2049-01 High C9-OV OV-like c1 OV-like c4 mutation cluster 8 TCGA-09-2049 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-09-2049-F24354 TCGA-09-2049 TCGA-09-2049-01D Stage IIIC -23410 0 3419 953 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 NO G3 Recurrence TCGA-09-2049.17564604-ce57-4087-887a-f97a5b280b26.pdf 2049 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 09 >20 mm Ovary NO D LIVING 1999 870e7182-fd31-4863-b19b-001fb9a2a11d TCGA-09-2049-01D-01D-0708-05 TCGA-09-2049-01D-21-1560-20 TCGA-09-2049-01D-01D-0704-01 TCGA-09-2049-01 ccaa932c-805b-4a2c-825f-d742a9fddb2c TCGA-09-2049-01D-01D-0704-01 TCGA-09-2049-01D-01W-0799-08 TCGA-09-2049-01 TCGA-09-2049-01D-01W-0799-08 TCGA-09-2049-01D-01R-0711-07 +TCGA-09-2050-01 TCGA-09-2050-01 High OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-2050 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 Bilateral TCGA-09-2050-F24367 TCGA-09-2050 TCGA-09-2050-01A Stage IIA -23987 0 2163 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.6 NO G2 TCGA-09-2050.fb343129-010d-430b-aae4-f7beb7122279.pdf 2050 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 09 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-09-2050-01 968defb5-7701-4ec8-9c4f-7b73a13b0411 TCGA-09-2050-01 TCGA-09-2050-01A-01D-0708-05 TCGA-09-2050-01A-01D-0704-01 TCGA-09-2050-01 TCGA-09-2050-01A-01D-0704-01 TCGA-09-2050-01A-01W-0799-08 TCGA-09-2050-01 TCGA-09-2050-01A-01W-0799-08 TCGA-09-2050-01A-01R-0711-07 +TCGA-09-2051-01 TCGA-09-2051-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-2051 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-09-2051-F24373 TCGA-09-2051 TCGA-09-2051-01A Stage IIIC -15650 0 1919 583 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 YES G3 Recurrence TCGA-09-2051.242a1ff3-05ad-4623-b5aa-9bb556e2cfa9.pdf 2051 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 09 No Macroscopic disease Ovary YES A LIVING 2004 TCGA-09-2051-01 TCGA-09-2051-01 34b0a38d-33f0-436f-a30b-4c730a37e27c TCGA-09-2051-01 TCGA-09-2051-01A-01D-0708-05 TCGA-09-2051-01A-21-1560-20 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01D-0704-01 TCGA-09-2051-01 5bcc9755-b429-47c1-9a00-af84edd803aa TCGA-09-2051-01A-01D-0704-01 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01W-0799-08 TCGA-09-2051-01 TCGA-09-2051-01 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01W-0799-08 TCGA-09-2051-01A-01R-0711-07 +TCGA-09-2053-01 TCGA-09-2053-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-2053 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 72 Left TCGA-09-2053-F24384 TCGA-09-2053 TCGA-09-2053-01C Stage IIIC -26433 0 1209 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.7 NO G3 TCGA-09-2053.0d28e549-3ed0-4a22-bac7-9cbe24e44f53.pdf 2053 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 09 No Macroscopic disease Ovary NO C LIVING 2005 TCGA-09-2053-01 00fdb098-d819-43f1-995d-a43f2499afe7 TCGA-09-2053-01 TCGA-09-2053-01C-01D-0667-05 TCGA-09-2053-01C-01D-0663-01 TCGA-09-2053-01 TCGA-09-2053-01C-01D-0663-01 TCGA-09-2053-01C-01W-0722-08 TCGA-09-2053-01 TCGA-09-2053-01C-01W-0722-08 TCGA-09-2053-01C-01R-0670-07 +TCGA-09-2054-01 TCGA-09-2054-01 High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 3 TCGA-09-2054 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-09-2054-F24388 TCGA-09-2054 TCGA-09-2054-01A Stage IIIC -21285 637 0 637 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 2 YES G3 TCGA-09-2054.4f0eb2a1-996c-4816-a956-835ce5085438.pdf 2054 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.4 09 1-10 mm Ovary YES A DECEASED 2005 TCGA-09-2054-01 TCGA-09-2054-01 f6aa28c5-b1f6-4552-82a7-a6a170814534 TCGA-09-2054-01 TCGA-09-2054-01A-01D-0667-05 TCGA-09-2054-01A-21-1560-20 5cd7faa0-323a-4ea3-a658-859d0336e0ac TCGA-09-2054-01A-01D-0663-01 TCGA-09-2054-01 3b31fec3-6dd6-4ef7-bcb4-8c67007f6937 TCGA-09-2054-01A-01D-0663-01 5cd7faa0-323a-4ea3-a658-859d0336e0ac 5cd7faa0-323a-4ea3-a658-859d0336e0ac TCGA-09-2054-01 TCGA-09-2054-01 5cd7faa0-323a-4ea3-a658-859d0336e0ac TCGA-09-2054-01A-01R-0670-07 +TCGA-09-2055-01 TCGA-09-2055-01 Squamous OV-like c1 OV-like c4 TCGA-09-2055 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Left TCGA-09-2055-F24395 TCGA-09-2055 TCGA-09-2055-01B Stage IC -17545 0 819 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.8 NO G3 TCGA-09-2055.4cff882a-1ce5-4586-a808-a7f00e319743.pdf 2055 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 09 No Macroscopic disease Ovary NO B LIVING 2007 7c240854-d066-4ecd-905d-1f6dea67d509 TCGA-09-2055-01B-01D-0708-05 TCGA-09-2055-01A-11-1563-20 TCGA-09-2055-01B-01D-0704-01 TCGA-09-2055-01 b02ef957-7893-4222-983a-3784ee59dfdd TCGA-09-2055-01B-01D-0704-01 TCGA-09-2055-01 TCGA-09-2055-01B-01R-0711-07 +TCGA-09-2056-01 TCGA-09-2056-01 BRCA-LUAD+ C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation c1uster 9 TCGA-09-2056 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-09-2056-F24399 TCGA-09-2056 TCGA-09-2056-01B Stage IIIC -22864 0 379 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.6 NO G3 TCGA-09-2056.67bdb457-cfb8-4052-bd33-bff86c736910.pdf 2056 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 09 No Macroscopic disease Ovary NO B LIVING 2008 TCGA-09-2056-01 6c194f10-5bf3-4331-b035-f50e93536dda TCGA-09-2056-01B-01D-0667-05 TCGA-09-2056-01B-21-1560-20 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01D-0663-01 TCGA-09-2056-01 568718ea-3d9d-4d09-b155-0b8467a10bbe TCGA-09-2056-01B-01D-0663-01 67670628-ad07-41ef-8977-890080616900 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01W-0722-08 TCGA-09-2056-01 TCGA-09-2056-01 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01W-0722-08 TCGA-09-2056-01B-01R-0670-07 +TCGA-10-0925-01 TCGA-10-0925-01 BRCA-LUAD+ OV-like c1 OV-like c4 TCGA-10-0925 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-10-0925-F24403 TCGA-10-0925 TCGA-10-0925-01B Stage IIIB -21498 1652 0 1652 558 2010-2-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 80 0.7 G1 Recurrence TCGA-10-0925.96f0f453-84f9-401a-9fd0-0a8712a87be5.pdf 0925 Preoperative WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 10 1-10 mm Ovary B DECEASED 2000 54016305-6747-489d-b09b-8db5be8409dc TCGA-10-0925-01B-01D-0652-05 TCGA-10-0925-01A-11-20 TCGA-10-0925-01B-01D-0648-01 TCGA-10-0925-01 ee2bb61b-4b7c-4cb4-b9e8-381285ad51f7 TCGA-10-0925-01B-01D-0648-01 TCGA-10-0925-01 TCGA-10-0925-01B-01R-0655-07 +TCGA-10-0926-01 TCGA-10-0926-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-10-0926 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-10-0926-F24413 TCGA-10-0926 TCGA-10-0926-01A Stage IIIC -23307 788 0 788 287 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 80 1 NO G3 Recurrence TCGA-10-0926.b940b1b3-8278-400e-b43a-e7897e0361b7.pdf 0926 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study YES Primary Tumor 01 0.6 10 11-20 mm Ovary NO A DECEASED 2000 892ce3d6-a97f-480f-85fb-5491e5ab9afa TCGA-10-0926-01A-01D-0402-05 TCGA-10-0926-01A-21-20 TCGA-10-0926-01A-01D-0399-01 TCGA-10-0926-01 fb5e42c3-de28-4dc9-8e33-c56685b72e5e TCGA-10-0926-01A-01D-0399-01 TCGA-10-0926-01A-01W-0420-08 TCGA-10-0926-01 TCGA-10-0926-01A-01W-0420-08 TCGA-10-0926-01A-01R-0406-07 +TCGA-10-0927-01 TCGA-10-0927-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-10-0927 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-10-0927-F24420 TCGA-10-0927 Stage IIIC -23982 2490 0 2478 1001 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G2 Recurrence 0927 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 10 1-10 mm Ovary DECEASED 2000 TCGA-10-0927-01 TCGA-10-0927-01A-02W-0419-10 c4ec4774-a95e-4097-bd99-7b0862020450 TCGA-10-0927-01 TCGA-10-0927-01A-02W-0419-10 TCGA-10-0927-01A-02D-0402-05 TCGA-10-0927-01A-02D-0399-01 TCGA-10-0927-01 TCGA-10-0927-01A-02D-0399-01 TCGA-10-0927-01 TCGA-10-0927-01 TCGA-10-0927-01A-02R-0406-07 +TCGA-10-0928-01 TCGA-10-0928-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 2 TCGA-10-0928 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Bilateral TCGA-10-0928-F24430 TCGA-10-0928 TCGA-10-0928-01A Stage IIIC -26066 563 0 563 0 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 NO G3 TCGA-10-0928.859b2662-493a-4ead-9ac7-0aa8d0a7a3d8.pdf 0928 WITH TUMOR YES NO Primary Tumor 01 0.4 10 1-10 mm Ovary NO A DECEASED 2000 TCGA-10-0928-01 TCGA-10-0928-01 TCGA-10-0928-01A-02W-0419-10 3534ce20-56e1-409a-a438-50513c622602 TCGA-10-0928-01 TCGA-10-0928-01A-02W-0419-10 TCGA-10-0928-01A-02D-0402-05 9aa3ae15-1033-46f1-a304-993f5d41cd50 TCGA-10-0928-01A-02D-0399-01 TCGA-10-0928-01 TCGA-10-0928-01A-02D-0399-01 9aa3ae15-1033-46f1-a304-993f5d41cd50 9aa3ae15-1033-46f1-a304-993f5d41cd50 TCGA-10-0928-01 TCGA-10-0928-01 9aa3ae15-1033-46f1-a304-993f5d41cd50 TCGA-10-0928-01A-02W-0419-10 TCGA-10-0928-01A-02R-0406-07 +TCGA-10-0930-01 TCGA-10-0930-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-10-0930 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Left TCGA-10-0930-F24432 TCGA-10-0930 TCGA-10-0930-01A Stage IIIC -25737 1040 0 1011 680 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 G3 Recurrence TCGA-10-0930.89034658-e10d-47d3-9ad8-d79aa51cf234.pdf 0930 WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 0.3 10 1-10 mm Ovary A DECEASED 2002 TCGA-10-0930-01 36457b1f-1ee7-4bdc-82f4-75f3fccceb66 TCGA-10-0930-01 TCGA-10-0930-01A-02D-0402-05 TCGA-10-0930-01A-02W-0421-09 TCGA-10-0930-01A-02W-0421-09 TCGA-10-0930-01A-02D-0399-01 TCGA-10-0930-01 TCGA-10-0930-01A-02D-0399-01 TCGA-10-0930-01 TCGA-10-0930-01A-02W-0421-09 TCGA-10-0930-01A-02R-0406-07 +TCGA-10-0931-01 TCGA-10-0931-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-10-0931 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-10-0931-F24440 TCGA-10-0931 TCGA-10-0931-01A Stage IIIC -16262 1000 0 982 300 1 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.5 G3 Recurrence TCGA-10-0931.45d8f828-6dfb-4e68-8282-f2ee74671461.pdf 0931 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 10 1-10 mm Ovary NO A DECEASED 2002 TCGA-10-0931-01 3d021366-16ec-4c18-8ce6-17beebce1e9c TCGA-10-0931-01 TCGA-10-0931-01A-01D-0402-05 TCGA-10-0931-01A-21-20 TCGA-10-0931-01A-01D-0399-01 TCGA-10-0931-01 25a69746-6f70-41eb-9805-6299ea0a4728 TCGA-10-0931-01A-01D-0399-01 TCGA-10-0931-01A-01W-0420-08 TCGA-10-0931-01 TCGA-10-0931-01A-01W-0420-08 TCGA-10-0931-01A-01R-0406-07 +TCGA-10-0933-01 TCGA-10-0933-01 High C9-OV UCEC Serous c4 OV-like c4 miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-10-0933 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-10-0933-F24454 TCGA-10-0933 TCGA-10-0933-01A Stage IIIC -28433 446 0 356 356 1 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1 G3 Recurrence TCGA-10-0933.f973309d-55dd-489b-a7ca-9348666a9129.pdf 0933 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 10 No Macroscopic disease Ovary A DECEASED 2003 TCGA-10-0933-01 99221367-1f21-45c5-944f-f734178e1468 TCGA-10-0933-01 TCGA-10-0933-01A-01D-0402-05 TCGA-10-0933-01A-01W-0421-09 TCGA-10-0933-01A-21-20 TCGA-10-0933-01A-01W-0421-09 TCGA-10-0933-01A-01D-0399-01 TCGA-10-0933-01 7c7459b2-2a24-4866-a4fc-e960ef606d39 TCGA-10-0933-01A-01D-0399-01 TCGA-10-0933-01 TCGA-10-0933-01A-01W-0421-09 TCGA-10-0933-01A-01R-0406-07 +TCGA-10-0934-01 TCGA-10-0934-01 High UCEC non-CIMP c3 miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-10-0934 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-10-0934-F24458 TCGA-10-0934 Stage IIIC -18602 204 0 119 111 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 Recurrence 0934 WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO Primary Tumor 01 10 1-10 mm Ovary DECEASED 2003 cb990c79-c1bf-45d1-88ff-04a916bf3a16 TCGA-10-0934-01A-02D-0402-05 TCGA-10-0934-01A-02D-0399-01 TCGA-10-0934-01 TCGA-10-0934-01A-02D-0399-01 TCGA-10-0934-01A-02W-0420-08 TCGA-10-0934-01 TCGA-10-0934-01A-02W-0420-08 TCGA-10-0934-01A-02R-0406-07 +TCGA-10-0935-01 TCGA-10-0935-01 BRCA-LUAD+ OV-like c1 mutation cluster 5 TCGA-10-0935 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 68 Bilateral TCGA-10-0935-F24462 TCGA-10-0935 Stage IIIC -25098 1078 0 1078 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 0935 WITH TUMOR YES NO Primary Tumor 01 10 1-10 mm Ovary YES DECEASED 2003 da4b7cf0-830b-42de-9bd5-fa065c331362 TCGA-10-0935-01A-03D-0402-05 TCGA-10-0935-01A-03W-0421-09 TCGA-10-0935-01A-03W-0421-09 TCGA-10-0935-01A-03D-0399-01 TCGA-10-0935-01 TCGA-10-0935-01A-03D-0399-01 TCGA-10-0935-01 TCGA-10-0935-01A-03W-0421-09 TCGA-10-0935-01A-02R-0406-07 +TCGA-10-0936-01 TCGA-10-0936-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 2 TCGA-10-0936 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 69 Bilateral TCGA-10-0936-F24466 TCGA-10-0936 TCGA-10-0936-01A Stage IIIC -25454 1123 0 1089 0 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G3 TCGA-10-0936.6b9a13e4-760e-476f-a0a7-fb42ab7c63c5.pdf 0936 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.5 10 >20 mm Ovary A DECEASED 2005 TCGA-10-0936-01 TCGA-10-0936-01 8492ae5a-2139-4159-8b99-133e01b12568 TCGA-10-0936-01 TCGA-10-0936-01A-01D-0402-05 TCGA-10-0936-01A-21-20 04112b9c-6ef4-49cd-bed8-43151b5bbe1f TCGA-10-0936-01A-01D-0399-01 TCGA-10-0936-01 5e8ac787-50cc-45ea-9fc4-efe67b6d05ff TCGA-10-0936-01A-01D-0399-01 04112b9c-6ef4-49cd-bed8-43151b5bbe1f 04112b9c-6ef4-49cd-bed8-43151b5bbe1f TCGA-10-0936-01 TCGA-10-0936-01 04112b9c-6ef4-49cd-bed8-43151b5bbe1f TCGA-10-0936-01A-01R-0406-07 +TCGA-10-0937-01 TCGA-10-0937-01 Squamous OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-10-0937 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-10-0937-F24476 TCGA-10-0937 Stage IIIC -16222 608 0 460 235 0 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 0937 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 10 1-10 mm Ovary DECEASED 2005 TCGA-10-0937-01A-02W-0419-10 a104dfcb-8b29-4ab3-99ad-9ccbac4b2d4d TCGA-10-0937-01A-02W-0419-10 TCGA-10-0937-01A-02D-0402-05 TCGA-10-0937-01A-02D-0399-01 TCGA-10-0937-01 TCGA-10-0937-01A-02D-0399-01 TCGA-10-0937-01 TCGA-10-0937-01A-02W-0419-10 TCGA-10-0937-01A-02R-0406-07 +TCGA-10-0938-01 TCGA-10-0938-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-10-0938 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 80 Bilateral TCGA-10-0938-F24483 TCGA-10-0938 TCGA-10-0938-01A Stage IIIC -29558 636 0 604 362 2 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 0.6 NO 1 G3 Progression of Disease TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92.pdf 0938 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.6 10 >20 mm Ovary A DECEASED 2002 TCGA-10-0938-01 TCGA-10-0938-01A-02W-0419-10 02e1cf40-826f-451a-bb3c-a3c7c94e8104 TCGA-10-0938-01 TCGA-10-0938-01A-02W-0419-10 TCGA-10-0938-01A-02D-0402-05 TCGA-10-0938-01A-02D-0399-01 TCGA-10-0938-01 TCGA-10-0938-01A-02D-0399-01 TCGA-10-0938-01 TCGA-10-0938-01A-02W-0419-10 TCGA-10-0938-01A-02R-0406-07 +TCGA-13-0714-01 TCGA-13-0714-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0714 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-0714-F24489 TCGA-13-0714 TCGA-13-0714-01A Stage IV -20109 189 0 189 110 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 80 1.2 G3 Progression of Disease TCGA-13-0714.96EB4BD1-CE3B-44D8-8095-076712A3E082.pdf 0714 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2000 TCGA-13-0714-01 TCGA-13-0714-01A-01W-0370-10 408156df-a8fa-4068-9b87-f92bd60ca873 TCGA-13-0714-01 TCGA-13-0714-01A-01W-0370-10 TCGA-13-0714-01A-01D-0359-05 TCGA-13-0714-01A-01D-0356-01 TCGA-13-0714-01 TCGA-13-0714-01A-01D-0356-01 TCGA-13-0714-01 TCGA-13-0714-01A-01W-0370-10 TCGA-13-0714-01A-01R-0363-07 +TCGA-13-0717-01 TCGA-13-0717-01 High OV-like c1 mutation cluster 8 TCGA-13-0717 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-13-0717-F24494 TCGA-13-0717 Stage IIIC -20042 748 0 748 294 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 0717 WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 13 >20 mm Ovary DECEASED 2000 TCGA-13-0717-01A-01W-0370-10 d6012831-3668-402e-8be1-849c011767a6 TCGA-13-0717-01A-01W-0370-10 TCGA-13-0717-01A-01D-0359-05 TCGA-13-0717-01A-01D-0356-01 TCGA-13-0717-01 TCGA-13-0717-01A-01D-0356-01 TCGA-13-0717-01 TCGA-13-0717-01A-01W-0370-10 TCGA-13-0717-01A-01R-0363-07 +TCGA-13-0720-01 TCGA-13-0720-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-13-0720 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-0720-F24498 TCGA-13-0720 TCGA-13-0720-01A Stage IIIC -17799 1355 0 1355 292 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 80 8 G3 Recurrence TCGA-13-0720.0A196866-A083-40AC-90E3-5ECA3B141645.pdf 0720 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2001 TCGA-13-0720-01 TCGA-13-0720-01A-01W-0370-10 595dacaa-2763-4482-998c-eb748907f146 TCGA-13-0720-01 TCGA-13-0720-01A-01W-0370-10 TCGA-13-0720-01A-01D-0359-05 TCGA-13-0720-01A-21-20 TCGA-13-0720-01A-01D-0356-01 TCGA-13-0720-01 5864cd1e-a0da-4553-b12b-75f8941ecbab TCGA-13-0720-01A-01D-0356-01 TCGA-13-0720-01 TCGA-13-0720-01A-01W-0370-10 TCGA-13-0720-01A-01R-0363-07 +TCGA-13-0723-01 TCGA-13-0723-01 High OV-like c1 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-13-0723 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 63 Bilateral TCGA-13-0723-F24503 TCGA-13-0723 TCGA-13-0723-01A Stage IIIC -23094 1204 0 1204 210 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.3 G3 Progression of Disease TCGA-13-0723.0A628FDD-EDDF-48BA-A083-8E2676DD9B5C.pdf 0723 WITH TUMOR YES Progressive Disease Molecular Markers NO Primary Tumor 01 0.3 13 >20 mm Ovary A DECEASED 2002 TCGA-13-0723-01 95906f3c-8c5d-4eb9-8183-a444efde2a18 TCGA-13-0723-01 TCGA-13-0723-01A-02D-0359-05 TCGA-13-0723-01A-02W-0372-09 TCGA-13-0723-01A-02W-0372-09 TCGA-13-0723-01A-02D-0356-01 TCGA-13-0723-01 TCGA-13-0723-01A-02D-0356-01 TCGA-13-0723-01 TCGA-13-0723-01A-02W-0372-09 TCGA-13-0723-01A-02R-0363-07 +TCGA-13-0724-01 TCGA-13-0724-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0724 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Right TCGA-13-0724-F24507 TCGA-13-0724 Stage IV -26342 83 0 83 83 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy 80 G3 Progression of Disease 0724 Preoperative WITH TUMOR YES Progressive Disease NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2002 TCGA-13-0724-01 fb6ffde7-3b9f-4f28-845c-e2bb245db90b TCGA-13-0724-01 TCGA-13-0724-01A-01D-0359-05 TCGA-13-0724-01A-01W-0372-09 TCGA-13-0724-01A-01W-0372-09 TCGA-13-0724-01A-01D-0356-01 TCGA-13-0724-01 TCGA-13-0724-01A-01D-0356-01 TCGA-13-0724-01 TCGA-13-0724-01A-01W-0372-09 TCGA-13-0724-01A-01R-0363-07 +TCGA-13-0725-01 TCGA-13-0725-01 Squamous OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 TCGA-13-0725 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-13-0725-F24510 TCGA-13-0725 TCGA-13-0725-01A Stage IIIC -16086 377 0 377 190 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.5 G3 Recurrence TCGA-13-0725.A6CD74F2-47A0-4790-BB81-6C636DA16ADC.pdf 0725 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2002 TCGA-13-0725-01 c030245e-982a-40d5-a03d-c7896105b062 TCGA-13-0725-01 TCGA-13-0725-01A-01D-0359-05 TCGA-13-0725-01A-21-20 TCGA-13-0725-01A-01D-0356-01 TCGA-13-0725-01 6701705e-cbfb-4af1-b1ab-898298de7c02 TCGA-13-0725-01A-01D-0356-01 TCGA-13-0725-01 TCGA-13-0725-01A-01R-0363-07 +TCGA-13-0726-01 TCGA-13-0726-01 Squamous OV-like c1 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0726 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-0726-F24515 TCGA-13-0726 Stage IIIC -20134 949 0 946 392 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection GX Recurrence 0726 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2002 TCGA-13-0726-01 ec64c4e0-8c79-4161-bc31-56abd101de2c TCGA-13-0726-01 TCGA-13-0726-01A-01D-0359-05 TCGA-13-0726-01A-01W-0372-09 TCGA-13-0726-01A-01W-0372-09 TCGA-13-0726-01A-01D-0356-01 TCGA-13-0726-01 TCGA-13-0726-01A-01D-0356-01 TCGA-13-0726-01 TCGA-13-0726-01A-01W-0372-09 TCGA-13-0726-01A-01R-0363-07 +TCGA-13-0727-01 TCGA-13-0727-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-13-0727 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-0727-F24519 TCGA-13-0727 Stage IIIC -26185 462 0 462 253 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 0727 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2003 TCGA-13-0727-01 TCGA-13-0727-01A-01W-0370-10 ccf2280b-6308-40ad-bf39-f222aa67a91b TCGA-13-0727-01 TCGA-13-0727-01A-01W-0370-10 TCGA-13-0727-01A-01D-0359-05 TCGA-13-0727-01A-01D-0356-01 TCGA-13-0727-01 TCGA-13-0727-01A-01D-0356-01 TCGA-13-0727-01 TCGA-13-0727-01A-01W-0370-10 TCGA-13-0727-01A-01R-0363-07 +TCGA-13-0730-01 TCGA-13-0730-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0730 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Bilateral TCGA-13-0730-F60695 TCGA-13-0730 TCGA-13-0730-01A Stage IIIC -26086 542 0 Scheduled Follow-up Submission 2014-6-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 0.6 NO 1.1 NO G3 TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf 0730 Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2003 TCGA-13-0730-01 TCGA-13-0730-01 TCGA-13-0730-01A-01W-0370-10 1bd423e8-af33-4277-8ded-7d8c3f675f4b TCGA-13-0730-01 TCGA-13-0730-01A-01W-0370-10 TCGA-13-0730-01A-01D-0359-05 754dfe07-22f4-4070-bbcb-10bfbb649def TCGA-13-0730-01A-01D-0356-01 TCGA-13-0730-01 TCGA-13-0730-01A-01D-0356-01 754dfe07-22f4-4070-bbcb-10bfbb649def 754dfe07-22f4-4070-bbcb-10bfbb649def TCGA-13-0730-01 TCGA-13-0730-01 754dfe07-22f4-4070-bbcb-10bfbb649def TCGA-13-0730-01A-01W-0370-10 TCGA-13-0730-01A-01R-0363-07 +TCGA-13-0751-01 TCGA-13-0751-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0751 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-13-0751-F24525 TCGA-13-0751 TCGA-13-0751-01A Stage IIIC -16304 1678 0 1678 653 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 GX Recurrence TCGA-13-0751.61280768-69DF-4601-BED6-E78C1F82E5BC.pdf 0751 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 1999 TCGA-13-0751-01 625f1703-3f6c-4434-b30d-8bf174c438d7 TCGA-13-0751-01 TCGA-13-0751-01A-01D-0359-05 TCGA-13-0751-01A-01D-0356-01 TCGA-13-0751-01 TCGA-13-0751-01A-01D-0356-01 TCGA-13-0751-01A-01D-0446-08 TCGA-13-0751-01 TCGA-13-0751-01 TCGA-13-0751-01A-01R-0363-07 +TCGA-13-0755-01 TCGA-13-0755-01 Squamous OV-like c1 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-13-0755 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 75 Bilateral TCGA-13-0755-F24531 TCGA-13-0755 Stage IV -27438 76 0 76 34 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 40 G3 Progression of Disease 0755 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2003 TCGA-13-0755-01 b14fdd08-b406-4db3-ac74-d1fdb6b213a2 TCGA-13-0755-01 TCGA-13-0755-01A-01D-0359-05 TCGA-13-0755-01A-01W-0372-09 TCGA-13-0755-01A-01W-0372-09 TCGA-13-0755-01A-01D-0356-01 TCGA-13-0755-01 TCGA-13-0755-01A-01D-0356-01 TCGA-13-0755-01 TCGA-13-0755-01A-01W-0372-09 TCGA-13-0755-01A-01R-0363-07 +TCGA-13-0757-01 TCGA-13-0757-01 High OV-like c1 miRNA cluster 2 cluster 1 TCGA-13-0757 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-0757-F24534 TCGA-13-0757 TCGA-13-0757-01A Stage IIIC -25999 340 0 340 293 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 60 0.9 G3 Recurrence TCGA-13-0757.81F1B0FB-CEB7-4313-AA0D-71DA495AEABE.pdf 0757 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2005 TCGA-13-0757-01 69337aad-1fe3-4b0e-943e-ca5ac6dc6076 TCGA-13-0757-01 TCGA-13-0757-01A-01D-0359-05 TCGA-13-0757-01A-01D-0356-01 TCGA-13-0757-01 TCGA-13-0757-01A-01D-0356-01 TCGA-13-0757-01 TCGA-13-0757-01A-01R-0363-07 +TCGA-13-0758-01 TCGA-13-0758-01 Squamous OV-like c1 TCGA-13-0758 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-13-0758-F24539 TCGA-13-0758 TCGA-13-0758-01A Stage IV -22088 346 0 346 212 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 60 1.3 G3 Progression of Disease TCGA-13-0758.37B557BB-D2C4-42A9-B224-F1DFFC9B8FE3.pdf 0758 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2005 4d8ca9f7-21f4-49d8-b985-53a096e48428 TCGA-13-0758-01A-01D-0359-05 TCGA-13-0758-01A-01D-0356-01 TCGA-13-0758-01 TCGA-13-0758-01A-01D-0356-01 TCGA-13-0758-01 TCGA-13-0758-01A-01R-0363-07 +TCGA-13-0760-01 TCGA-13-0760-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0760 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-13-0760-F24543 TCGA-13-0760 Stage IV -23036 351 0 351 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 80 G3 0760 Pre-Adjuvant Therapy YES NO Primary Tumor 01 13 No Macroscopic disease Ovary DECEASED 2006 TCGA-13-0760-01 TCGA-13-0760-01 TCGA-13-0760-01A-01D-0359-05 TCGA-13-0760-01A-01W-0372-09 TCGA-13-0760-01A-01W-0372-09 TCGA-13-0760-01A-01D-0356-01 TCGA-13-0760-01 TCGA-13-0760-01A-01D-0356-01 TCGA-13-0760-01 TCGA-13-0760-01A-01W-0372-09 TCGA-13-0760-01A-01R-0363-07 +TCGA-13-0761-01 TCGA-13-0761-01 Squamous OV-like c1 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-13-0761 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-13-0761-F72596 TCGA-13-0761 TCGA-13-0761-01A Stage IV -18697 1156 0 1036 424 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G3 YES TCGA-13-0761.9609319A-2534-4753-9C71-3F59BFD20F15.pdf 0761 WITH TUMOR Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A DECEASED 2006 TCGA-13-0761-01 TCGA-13-0761-01A-01W-0370-10 31361f65-a9de-4272-9de7-d884d15db3f0 TCGA-13-0761-01 TCGA-13-0761-01A-01W-0370-10 TCGA-13-0761-01A-01D-0359-05 TCGA-13-0761-01A-01D-0356-01 TCGA-13-0761-01 TCGA-13-0761-01A-01D-0356-01 TCGA-13-0761-01 TCGA-13-0761-01A-01W-0370-10 TCGA-13-0761-01A-01R-0363-07 +TCGA-13-0762-01 TCGA-13-0762-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 2 TCGA-13-0762 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 Bilateral TCGA-13-0762-F72597 TCGA-13-0762 Stage IIIC -23960 0 3400 1003 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 80 G3 YES 0762 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 No Macroscopic disease Ovary LIVING 2006 TCGA-13-0762-01 TCGA-13-0762-01A-01W-0370-10 f33f5749-bed4-403d-b311-176f59fb32bc TCGA-13-0762-01 TCGA-13-0762-01A-01W-0370-10 TCGA-13-0762-01A-01D-0359-05 TCGA-13-0762-01A-01D-0356-01 TCGA-13-0762-01 TCGA-13-0762-01A-01D-0356-01 TCGA-13-0762-01 TCGA-13-0762-01A-01W-0370-10 TCGA-13-0762-01A-01R-0363-07 +TCGA-13-0764-01 TCGA-13-0764-01 High OV-like c1 TCGA-13-0764 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-13-0764-F72599 TCGA-13-0764 Stage IV -22965 1881 0 944 272 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 80 G3 YES 0764 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary DECEASED 2006 b72f0610-8aaa-48ac-afed-333e5f4159cd TCGA-13-0764-01A-03D-0359-05 TCGA-13-0764-01A-03D-0356-01 TCGA-13-0764-01 TCGA-13-0764-01A-03D-0356-01 TCGA-13-0764-01 TCGA-13-0764-01A-03R-0363-07 +TCGA-13-0765-01 TCGA-13-0765-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0765 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-13-0765-F72600 TCGA-13-0765 TCGA-13-0765-01A Stage IIIC -18574 1389 0 869 668 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.2 G3 YES TCGA-13-0765.96588189-C273-4095-88C5-9E22368813C0.pdf 0765 WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2006 TCGA-13-0765-01 17962695-e9c2-45f2-b4a2-00b7bfd1ffd6 TCGA-13-0765-01 TCGA-13-0765-01A-01D-0359-05 TCGA-13-0765-01A-01W-0372-09 TCGA-13-0765-01A-01W-0372-09 TCGA-13-0765-01 TCGA-13-0765-01A-01W-0372-09 TCGA-13-0765-01A-01R-0363-07 +TCGA-13-0766-01 TCGA-13-0766-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 TCGA-13-0766 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 42 Bilateral TCGA-13-0766-F72601 TCGA-13-0766 TCGA-13-0766-01A Stage IIIC -15571 1725 0 651 628 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.7 G3 YES TCGA-13-0766.7F283E4B-70F9-4834-866C-B91024C74EA3.pdf 0766 WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2006 TCGA-13-0766-01 2b1e48b5-b8f4-4f57-8089-8293f470f466 TCGA-13-0766-01 TCGA-13-0766-01A-02D-0359-05 TCGA-13-0766-01A-02D-0356-01 TCGA-13-0766-01 TCGA-13-0766-01A-02D-0356-01 TCGA-13-0766-01 TCGA-13-0766-01A-02R-0363-07 +TCGA-13-0768-01 TCGA-13-0768-01 High OV-like c1 miRNA cluster 3 cluster 5 TCGA-13-0768 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-13-0768-F72603 TCGA-13-0768 TCGA-13-0768-01A Stage IIIC -26999 1784 0 257 398 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 60 0.8 G3 YES TCGA-13-0768.7D67D0D3-105C-4A00-B104-106BE26FEE2D.pdf 0768 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2008 TCGA-13-0768-01 282e4c72-a430-4a70-9393-c259a90d9ee3 TCGA-13-0768-01 TCGA-13-0768-01A-01D-0359-05 TCGA-13-0768-01A-01D-0356-01 TCGA-13-0768-01 TCGA-13-0768-01A-01D-0356-01 TCGA-13-0768-01 TCGA-13-0768-01A-01R-0363-07 +TCGA-13-0791-01 TCGA-13-0791-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0791 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-0791-F72604 TCGA-13-0791 TCGA-13-0791-01A Stage IIIC -21380 1224 0 1184 281 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 80 1.8 G3 YES TCGA-13-0791.BDF98098-6E0F-4387-9C2C-30CF1812073A.pdf 0791 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A DECEASED 2005 TCGA-13-0791-01 7290ea9e-baf6-4777-b512-ab1da9bf62cd TCGA-13-0791-01 TCGA-13-0791-01A-01D-0359-05 TCGA-13-0791-01A-01W-0372-09 TCGA-13-0791-01A-01W-0372-09 TCGA-13-0791-01A-01D-0356-01 TCGA-13-0791-01 TCGA-13-0791-01A-01D-0356-01 TCGA-13-0791-01 TCGA-13-0791-01A-01W-0372-09 TCGA-13-0791-01A-01R-0363-07 +TCGA-13-0791-02 TCGA-13-0791-02 OV-like c1 miRNA cluster 2 mutation cluster 5 TCGA-13-0791 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-0791-F72604 TCGA-13-0791 TCGA-13-0791-02A Stage IIIC -21380 1224 0 1184 281 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 80 1 G3 YES TCGA-13-0791.60B0A7B2-179E-47CE-908C-A1360EA6BB6B.pdf 0791 Pre-Adjuvant Therapy WITH TUMOR Recurrent Tumor 02 0.1 13 No Macroscopic disease Ovary A DECEASED 2005 TCGA-13-0791-02 3038dbe5-a4fd-4ebf-b582-503b3041822b TCGA-13-0791-02 TCGA-13-0791-02A-01D-0807-05 TCGA-13-0791-02A-01R-0810-07 +TCGA-13-0792-01 TCGA-13-0792-01 High OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0792 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 40 Bilateral TCGA-13-0792-F72605 TCGA-13-0792 TCGA-13-0792-01A Stage IIIC -14729 0 3602 816 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 80 1.2 G3 YES TCGA-13-0792.3FBB8BEC-64D0-4AC8-9E15-C8FA9627E451.pdf 0792 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A LIVING 2005 TCGA-13-0792-01 TCGA-13-0792-01A-01W-0370-10 3a6c89bc-5db4-4816-b7f4-d77cf1d8eb0b TCGA-13-0792-01 TCGA-13-0792-01A-01W-0370-10 TCGA-13-0792-01A-01D-0359-05 TCGA-13-0792-01A-01D-0356-01 TCGA-13-0792-01 TCGA-13-0792-01A-01D-0356-01 TCGA-13-0792-01 TCGA-13-0792-01A-01W-0370-10 TCGA-13-0792-01A-01R-0363-07 +TCGA-13-0793-01 TCGA-13-0793-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0793 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 40 Left TCGA-13-0793-F72606 TCGA-13-0793 TCGA-13-0793-01A Stage IV -14708 0 3263 351 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 80 1.6 G3 YES TCGA-13-0793.43781B94-0865-4824-94B9-1476AC2F8677.pdf 0793 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A LIVING 2006 TCGA-13-0793-01 TCGA-13-0793-01A-01W-0370-10 447c38c0-ac42-4a58-ad55-c1c68258cdf4 TCGA-13-0793-01 TCGA-13-0793-01A-01W-0370-10 TCGA-13-0793-01A-01D-0359-05 TCGA-13-0793-01A-03-20 TCGA-13-0793-01A-01D-0356-01 TCGA-13-0793-01 7a9e7c44-9e41-4f1c-bf87-3faa086b0306 TCGA-13-0793-01A-01D-0356-01 TCGA-13-0793-01 TCGA-13-0793-01A-01W-0370-10 TCGA-13-0793-01A-01R-0363-07 +TCGA-13-0794-01 TCGA-13-0794-01 BRCA-LUAD+ OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 TCGA-13-0794 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-13-0794-F72607 TCGA-13-0794 Stage IIIC -21945 1919 0 923 845 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 60 G3 YES 0794 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary DECEASED 2006 TCGA-13-0794-01 c9dd6b81-e436-410c-abe3-aefea5b82103 TCGA-13-0794-01 TCGA-13-0794-01A-01D-0359-05 TCGA-13-0794-01A-03-20 TCGA-13-0794-01A-01D-0356-01 TCGA-13-0794-01 fde6d311-beb0-4efa-92af-36b426444dd4 TCGA-13-0794-01A-01D-0356-01 TCGA-13-0794-01 TCGA-13-0794-01A-01R-0363-07 +TCGA-13-0795-01 TCGA-13-0795-01 High OV-like c1 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-0795 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Bilateral TCGA-13-0795-F72608 TCGA-13-0795 TCGA-13-0795-01A Stage IIIC -24403 619 0 596 325 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 0.9 NO 80 1.4 G3 YES TCGA-13-0795.B98206EC-73D1-404F-B497-BAD6C817D9B7.pdf 0795 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 >20 mm Ovary A DECEASED 2007 TCGA-13-0795-01 8a90ef9c-f444-4bff-92df-7356ec1c07ad TCGA-13-0795-01 TCGA-13-0795-01A-01D-0359-05 TCGA-13-0795-01A-01W-0372-09 TCGA-13-0795-01A-01W-0372-09 TCGA-13-0795-01A-01D-0356-01 TCGA-13-0795-01 TCGA-13-0795-01A-01D-0356-01 TCGA-13-0795-01 TCGA-13-0795-01A-01W-0372-09 TCGA-13-0795-01A-01R-0363-07 +TCGA-13-0797-01 TCGA-13-0797-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 TCGA-13-0797 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-13-0797-F72609 TCGA-13-0797 TCGA-13-0797-01A Stage IIIC -18051 0 2121 525 Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 80 1.6 G3 YES TCGA-13-0797.84ED21CA-E018-44C5-86E4-57927ABBCC9A.pdf 0797 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A LIVING 2008 TCGA-13-0797-01 9efea7f4-e521-4520-8abb-c764fa2a6a8c TCGA-13-0797-01 TCGA-13-0797-01A-01D-0359-05 TCGA-13-0797-01A-03-20 TCGA-13-0797-01A-01D-0356-01 TCGA-13-0797-01 0a64d08c-7d28-4c74-ab75-2ff02f1a4de0 TCGA-13-0797-01A-01D-0356-01 TCGA-13-0797-01 TCGA-13-0797-01A-01R-0363-07 +TCGA-13-0799-01 TCGA-13-0799-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-13-0799 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 44 Bilateral TCGA-13-0799-F72611 TCGA-13-0799 TCGA-13-0799-01A Stage IIIC -16171 0 2535 1262 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 80 1.6 G3 YES TCGA-13-0799.CBB83CF3-9846-409B-858B-C8A7E74CDFF1.pdf 0799 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A LIVING 2008 TCGA-13-0799-01 TCGA-13-0799-01 1197c1db-5ef3-475a-bbdb-c81da71b6ccf TCGA-13-0799-01 TCGA-13-0799-01A-01D-0359-05 TCGA-13-0799-01A-03-1562-20 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 TCGA-13-0799-01A-01D-0356-01 TCGA-13-0799-01 c91f1247-0579-4c10-8da1-2d62d276e58e TCGA-13-0799-01A-01D-0356-01 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 TCGA-13-0799-01 TCGA-13-0799-01 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 TCGA-13-0799-01A-01R-0363-07 +TCGA-13-0800-01 TCGA-13-0800-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 3 TCGA-13-0800 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-13-0800-F72612 TCGA-13-0800 TCGA-13-0800-01A Stage IIIC -19087 0 2661 1396 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.5 G3 YES TCGA-13-0800.E3206F00-3BC6-44B4-848E-F2ED70E094BD.pdf 0800 TUMOR FREE Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A LIVING 2008 TCGA-13-0800-01 TCGA-13-0800-01 b637c4e1-2685-4843-9d5f-f63db155b468 TCGA-13-0800-01 TCGA-13-0800-01A-01D-0359-05 TCGA-13-0800-01A-01W-0372-09 TCGA-13-0800-01A-03-1562-20 TCGA-13-0800-01A-01W-0372-09 cd93531b-4d92-4be3-95e5-032636dd1ad8 TCGA-13-0800-01A-01D-0356-01 TCGA-13-0800-01 81737798-92c9-46d7-a85c-751fc5b102e8 TCGA-13-0800-01A-01D-0356-01 cd93531b-4d92-4be3-95e5-032636dd1ad8 cd93531b-4d92-4be3-95e5-032636dd1ad8 TCGA-13-0800-01 TCGA-13-0800-01 cd93531b-4d92-4be3-95e5-032636dd1ad8 TCGA-13-0800-01A-01W-0372-09 TCGA-13-0800-01A-01R-0363-07 +TCGA-13-0801-01 TCGA-13-0801-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-13-0801 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Bilateral TCGA-13-0801-F72613 TCGA-13-0801 TCGA-13-0801-01A Stage IIIC -16812 1399 0 252 345 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 80 1.5 G3 YES TCGA-13-0801.FA63535E-7499-41E3-AFB1-98EB18DA7371.pdf 0801 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A DECEASED 2008 TCGA-13-0801-01 TCGA-13-0801-01 TCGA-13-0801-01A-01W-0370-10 98d97019-658a-4493-bea0-5c571e196889 TCGA-13-0801-01 TCGA-13-0801-01A-01W-0370-10 TCGA-13-0801-01A-01D-0359-05 TCGA-13-0801-01A-03-20 c51dee3c-5047-4dde-b454-2474de5cf025 TCGA-13-0801-01A-01D-0356-01 TCGA-13-0801-01 1c4d4161-a528-4601-b512-eb2d5ed8d992 TCGA-13-0801-01A-01D-0356-01 c51dee3c-5047-4dde-b454-2474de5cf025 c51dee3c-5047-4dde-b454-2474de5cf025 TCGA-13-0801-01 TCGA-13-0801-01 c51dee3c-5047-4dde-b454-2474de5cf025 TCGA-13-0801-01A-01R-0363-07 +TCGA-13-0802-01 TCGA-13-0802-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 TCGA-13-0802 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 79 Bilateral TCGA-13-0802-F72615 TCGA-13-0802 Stage IIIC -29075 1552 0 249 510 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 60 G3 YES 0802 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 No Macroscopic disease Ovary DECEASED 2008 TCGA-13-0802-01 TCGA-13-0802-01A-01W-0370-10 eb96b8fd-6402-434d-9b98-bfa40b4be522 TCGA-13-0802-01 TCGA-13-0802-01A-01W-0370-10 TCGA-13-0802-01A-01D-0359-05 TCGA-13-0802-01A-03-1562-20 TCGA-13-0802-01A-01D-0356-01 TCGA-13-0802-01 e8448d63-f837-4512-89bf-06201938b152 TCGA-13-0802-01A-01D-0356-01 TCGA-13-0802-01 TCGA-13-0802-01A-01R-0363-07 +TCGA-13-0803-01 TCGA-13-0803-01 High OV-like c1 miRNA cluster 2 cluster 1 TCGA-13-0803 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Bilateral TCGA-13-0803-F24629 TCGA-13-0803 Stage IIIC -29685 1334 0 1334 337 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 Recurrence 0803 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 13 No Macroscopic disease Ovary DECEASED 2001 TCGA-13-0803-01 f17806bc-e184-49dc-99aa-cd5547ebb032 TCGA-13-0803-01 TCGA-13-0803-01A-01D-0359-05 TCGA-13-0803-01A-01D-0356-01 TCGA-13-0803-01 TCGA-13-0803-01A-01D-0356-01 TCGA-13-0803-01 TCGA-13-0803-01A-01R-0363-07 +TCGA-13-0804-01 TCGA-13-0804-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0804 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-13-0804-F24633 TCGA-13-0804 TCGA-13-0804-01A Stage IIIC -27021 1073 0 1073 329 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.3 NO 1.5 G3 Recurrence TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf 0804 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2003 a7711b62-2471-4ee7-8461-279e9732e83b TCGA-13-0804-01A-01D-0359-05 TCGA-13-0804-01A-01W-0372-09 TCGA-13-0804-01A-03-20 TCGA-13-0804-01A-01W-0372-09 TCGA-13-0804-01A-01D-0356-01 TCGA-13-0804-01 50ffbcf0-99c5-4528-bd60-8a054b3566a8 TCGA-13-0804-01A-01D-0356-01 TCGA-13-0804-01 TCGA-13-0804-01A-01W-0372-09 TCGA-13-0804-01A-01R-0363-07 +TCGA-13-0805-01 TCGA-13-0805-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 TCGA-13-0805 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-13-0805-F24638 TCGA-13-0805 Stage IIIC -21014 1074 0 1073 177 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Progression of Disease 0805 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2005 TCGA-13-0805-01 fbd0a639-044c-453b-a29c-3d914f431bd9 TCGA-13-0805-01 TCGA-13-0805-01A-01D-0359-05 TCGA-13-0805-01A-01D-0356-01 TCGA-13-0805-01 TCGA-13-0805-01A-01D-0356-01 TCGA-13-0805-01 TCGA-13-0805-01A-01R-0363-07 +TCGA-13-0807-01 TCGA-13-0807-01 Squamous OV-like c1 mutation cluster 5 TCGA-13-0807 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 TCGA-13-0807-F24642 TCGA-13-0807 TCGA-13-0807-01B Stage IIIC -19890 414 0 414 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 TCGA-13-0807.E28B5574-1AC3-4E5E-BDD5-5B548E450F28.pdf 0807 YES NO R1 Primary Tumor 01 13 >20 mm Ovary B DECEASED 2005 8fee0dca-afdb-46a8-b7b3-e16ed7ba4e32 TCGA-13-0807-01B-02D-0402-05 TCGA-13-0807-01B-02W-0421-09 TCGA-13-0807-01B-02W-0421-09 TCGA-13-0807-01B-02D-0399-01 TCGA-13-0807-01 TCGA-13-0807-01B-02D-0399-01 TCGA-13-0807-01 TCGA-13-0807-01B-02W-0421-09 TCGA-13-0807-01B-01R-0406-07 +TCGA-13-0883-01 TCGA-13-0883-01 Squamous OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0883 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-13-0883-F24646 TCGA-13-0883 TCGA-13-0883-01A Stage IIIC -22395 2097 0 2097 819 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.1 NO 1.4 G3 Recurrence TCGA-13-0883.7AC6471C-1BA0-4AA5-9A2E-70413C9768F8.pdf 0883 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2002 TCGA-13-0883-01 8b92a7da-e2b2-41c4-9ea2-8c3f87c2f5e9 TCGA-13-0883-01 TCGA-13-0883-01A-02D-0402-05 TCGA-13-0883-01A-02D-0399-01 TCGA-13-0883-01 TCGA-13-0883-01A-02D-0399-01 TCGA-13-0883-01A-02W-0420-08 TCGA-13-0883-01 TCGA-13-0883-01A-02W-0420-08 TCGA-13-0883-01A-02R-0406-07 +TCGA-13-0884-01 TCGA-13-0884-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0884 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 39 Bilateral TCGA-13-0884-F24651 TCGA-13-0884 TCGA-13-0884-01B Stage IIIC -14538 3260 0 3260 1251 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.7 NO 1.3 G3 Recurrence TCGA-13-0884.D15552F3-1407-4C01-9B59-DFAC5D4EF095.pdf 0884 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 13 1-10 mm Ovary B DECEASED 1999 TCGA-13-0884-01 3b4e9ec5-9001-40af-8397-8802341611ad TCGA-13-0884-01 TCGA-13-0884-01B-01D-0460-05 TCGA-13-0884-01B-01W-0494-09 TCGA-13-0884-01B-21-1562-20 TCGA-13-0884-01B-01W-0494-09 TCGA-13-0884-01B-01D-0452-01 TCGA-13-0884-01 2185ae8b-2257-4cc5-b08d-cf91dffa760d TCGA-13-0884-01B-01D-0452-01 TCGA-13-0884-01 TCGA-13-0884-01B-01W-0494-09 TCGA-13-0884-01B-01R-0456-07 +TCGA-13-0885-01 TCGA-13-0885-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-0885 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 70 Left TCGA-13-0885-F72616 TCGA-13-0885 TCGA-13-0885-01A Stage IIIC -25763 0 3388 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 80 1.2 G3 TCGA-13-0885.81DFFD49-45F0-4A20-AC27-B8316B2E0289.pdf 0885 Pre-Adjuvant Therapy Primary Tumor 01 0.4 13 11-20 mm Ovary A LIVING 2000 TCGA-13-0885-01 22d268ea-7e43-46f4-8d1c-7a557d2f1664 TCGA-13-0885-01 TCGA-13-0885-01A-02D-0402-05 TCGA-13-0885-01A-02W-0421-09 TCGA-13-0885-01A-02W-0421-09 TCGA-13-0885-01A-02D-0399-01 TCGA-13-0885-01 TCGA-13-0885-01A-02D-0399-01 TCGA-13-0885-01 TCGA-13-0885-01A-02W-0421-09 TCGA-13-0885-01A-02R-0406-07 +TCGA-13-0886-01 TCGA-13-0886-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0886 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-13-0886-F72617 TCGA-13-0886 TCGA-13-0886-01A Stage IIIC -24724 0 4665 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G3 NO TCGA-13-0886.2FB5824C-F30B-4E0B-B787-CBF93A6A48AE.pdf 0886 TUMOR FREE Primary Tumor 01 0.5 13 1-10 mm Ovary A LIVING 2002 TCGA-13-0886-01 de22b463-bc0e-4f81-9a06-0e55353b1412 TCGA-13-0886-01 TCGA-13-0886-01A-01D-0402-05 TCGA-13-0886-01A-21-20 TCGA-13-0886-01A-01D-0399-01 TCGA-13-0886-01 97f40569-5280-4c67-831d-dc8fa952e0f8 TCGA-13-0886-01A-01D-0399-01 TCGA-13-0886-01A-01W-0420-08 TCGA-13-0886-01 TCGA-13-0886-01A-01W-0420-08 TCGA-13-0886-01A-01R-0406-07 +TCGA-13-0887-01 TCGA-13-0887-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0887 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-13-0887-F24668 TCGA-13-0887 TCGA-13-0887-01A Stage IIIC -15669 2028 0 2028 514 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 80 1.3 G3 Recurrence TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf 0887 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2002 TCGA-13-0887-01 3bc498df-2e02-4182-87f5-381fbde2f225 TCGA-13-0887-01 TCGA-13-0887-01A-01D-0402-05 TCGA-13-0887-01A-01W-0421-09 TCGA-13-0887-01A-21-20 TCGA-13-0887-01A-01W-0421-09 TCGA-13-0887-01A-01D-0399-01 TCGA-13-0887-01 0226becf-0ff4-4457-a446-0ed079324b0d TCGA-13-0887-01A-01D-0399-01 TCGA-13-0887-01 TCGA-13-0887-01A-01W-0421-09 TCGA-13-0887-01A-01R-0406-07 +TCGA-13-0888-01 TCGA-13-0888-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 TCGA-13-0888 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Right TCGA-13-0888-F72618 TCGA-13-0888 TCGA-13-0888-01A Stage IIIC -28498 2811 0 2141 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 80 1.2 G3 NO TCGA-13-0888.DFDEBDE5-C16E-4B29-9986-8EB557648AC5.pdf 0888 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A DECEASED 2003 TCGA-13-0888-01 2b24ddb3-3774-46ac-aa6f-48abfec30a81 TCGA-13-0888-01 TCGA-13-0888-01A-01D-0402-05 TCGA-13-0888-01A-21-20 TCGA-13-0888-01A-01D-0399-01 TCGA-13-0888-01 bb0f85fb-5126-4934-89bc-39e1044dee03 TCGA-13-0888-01A-01D-0399-01 TCGA-13-0888-01 TCGA-13-0888-01A-01R-0406-07 +TCGA-13-0889-01 TCGA-13-0889-01 Squamous UCEC Serous c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0889 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 75 Right TCGA-13-0889-F72619 TCGA-13-0889 TCGA-13-0889-01A Stage IV -27674 2894 0 1881 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.5 NO 60 1.5 GX TCGA-13-0889.262B6A57-D2DF-47E3-BDB2-1FB956D8ABE9.pdf 0889 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2003 TCGA-13-0889-01 TCGA-13-0889-01A-01W-0419-10 8f64648c-7481-4814-865a-c392da1968bd TCGA-13-0889-01 TCGA-13-0889-01A-01W-0419-10 TCGA-13-0889-01A-01D-0402-05 TCGA-13-0889-01A-01D-0399-01 TCGA-13-0889-01 TCGA-13-0889-01A-01D-0399-01 TCGA-13-0889-01 TCGA-13-0889-01A-01W-0419-10 TCGA-13-0889-01A-01R-0406-07 +TCGA-13-0890-01 TCGA-13-0890-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0890 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 Bilateral TCGA-13-0890-F72620 TCGA-13-0890 TCGA-13-0890-01A Stage IIIC -20770 0 4424 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 1.5 G3 NO TCGA-13-0890.78888517-0ADC-4A78-B7FA-9ACE201795AB.pdf 0890 TUMOR FREE Primary Tumor 01 0.4 13 1-10 mm Ovary A LIVING 2003 TCGA-13-0890-01 TCGA-13-0890-01 9b5c97b8-eba5-431b-96cc-c60f5ee91a62 TCGA-13-0890-01 TCGA-13-0890-01A-01D-0402-05 TCGA-13-0890-01A-01W-0421-09 TCGA-13-0890-01A-01W-0421-09 65cc3a15-cfa9-48fb-b9e4-801398b073b8 TCGA-13-0890-01A-01D-0399-01 TCGA-13-0890-01 TCGA-13-0890-01A-01D-0399-01 65cc3a15-cfa9-48fb-b9e4-801398b073b8 65cc3a15-cfa9-48fb-b9e4-801398b073b8 TCGA-13-0890-01 TCGA-13-0890-01 65cc3a15-cfa9-48fb-b9e4-801398b073b8 TCGA-13-0890-01A-01W-0421-09 TCGA-13-0890-01A-01R-0406-07 +TCGA-13-0891-01 TCGA-13-0891-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-0891 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-13-0891-F72621 TCGA-13-0891 TCGA-13-0891-01A Stage IV -26886 3128 0 2099 762 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1.2 NO 80 1.4 G3 YES TCGA-13-0891.7DF79B3C-8CD7-446D-A13A-BBB69DFE2394.pdf 0891 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A DECEASED 2003 TCGA-13-0891-01 7d27ea62-19e6-4032-9e7f-799be4d3eaef TCGA-13-0891-01 TCGA-13-0891-01A-01D-0402-05 TCGA-13-0891-01A-21-20 TCGA-13-0891-01A-01D-0399-01 TCGA-13-0891-01 f305890a-3b48-4e7b-8f31-f2653a5582b8 TCGA-13-0891-01A-01D-0399-01 TCGA-13-0891-01A-01W-0420-08 TCGA-13-0891-01 TCGA-13-0891-01A-01W-0420-08 TCGA-13-0891-01A-01R-0406-07 +TCGA-13-0893-01 TCGA-13-0893-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-0893 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-0893-F24690 TCGA-13-0893 TCGA-13-0893-01B Stage IIIC -17573 1319 0 1319 461 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.2 G3 Recurrence TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E.pdf 0893 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 11-20 mm Ovary B DECEASED 2003 TCGA-13-0893-01 TCGA-13-0893-01 901a306b-6a5b-4f94-aac0-6eb7c767bb2e TCGA-13-0893-01 TCGA-13-0893-01B-01D-0460-05 TCGA-13-0893-01B-01W-0494-09 TCGA-13-0893-01B-01W-0494-09 2b2d5fc7-b109-4d11-a632-db8016268840 TCGA-13-0893-01B-01D-0452-01 TCGA-13-0893-01 TCGA-13-0893-01B-01D-0452-01 2b2d5fc7-b109-4d11-a632-db8016268840 2b2d5fc7-b109-4d11-a632-db8016268840 TCGA-13-0893-01 TCGA-13-0893-01 2b2d5fc7-b109-4d11-a632-db8016268840 TCGA-13-0893-01B-01W-0494-09 TCGA-13-0893-01B-01R-0456-07 +TCGA-13-0894-01 TCGA-13-0894-01 High C9-OV Low purity c2 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0894 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-13-0894-F24695 TCGA-13-0894 TCGA-13-0894-01B Stage IIIC -19466 1509 0 1509 565 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.1 NO 80 1.5 G3 Recurrence TCGA-13-0894.305FFF39-3453-49A4-8ED6-0532C9119AF0.pdf 0894 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 13 1-10 mm Ovary B DECEASED 2003 TCGA-13-0894-01 2f62cd27-7bac-44c6-baa8-7e8593962402 TCGA-13-0894-01 TCGA-13-0894-01B-01D-0460-05 TCGA-13-0894-01B-01W-0494-09 TCGA-13-0894-01B-03-1562-20 TCGA-13-0894-01B-01W-0494-09 TCGA-13-0894-01 7e63800a-f2db-4a2a-82ab-2867707caf14 TCGA-13-0894-01B-01W-0494-09 TCGA-13-0894-01B-01R-0456-07 +TCGA-13-0897-01 TCGA-13-0897-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0897 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Right TCGA-13-0897-F72622 TCGA-13-0897 TCGA-13-0897-01A Stage IIIC -19894 2182 0 1748 554 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.5 NO 80 1.1 G3 YES TCGA-13-0897.058A5354-D36C-4398-AC2C-12447FDB0966.pdf 0897 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2004 TCGA-13-0897-01 TCGA-13-0897-01 5ae3b33e-162f-4784-b007-cce51fdcfa5e TCGA-13-0897-01 TCGA-13-0897-01A-01D-0402-05 TCGA-13-0897-01A-01W-0421-09 TCGA-13-0897-01A-21-20 TCGA-13-0897-01A-01W-0421-09 479b74bf-5003-45e1-9505-687146a5fc45 TCGA-13-0897-01A-01D-0399-01 TCGA-13-0897-01 7a6431cb-6461-4534-89e9-fc15b639bfac TCGA-13-0897-01A-01D-0399-01 479b74bf-5003-45e1-9505-687146a5fc45 479b74bf-5003-45e1-9505-687146a5fc45 TCGA-13-0897-01 TCGA-13-0897-01 479b74bf-5003-45e1-9505-687146a5fc45 TCGA-13-0897-01A-01W-0421-09 TCGA-13-0897-01A-01R-0406-07 +TCGA-13-0899-01 TCGA-13-0899-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0899 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-13-0899-F72623 TCGA-13-0899 TCGA-13-0899-01A Stage IIIC -22031 2012 0 1708 547 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.6 G3 YES TCGA-13-0899.AB15D325-CCD6-452F-8662-158E3153AFC4.pdf 0899 WITH TUMOR Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2004 TCGA-13-0899-01 TCGA-13-0899-01 f5878d06-b37c-49fd-8a70-aaaaa270a14c TCGA-13-0899-01 TCGA-13-0899-01A-01D-0402-05 TCGA-13-0899-01A-21-20 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01D-0399-01 TCGA-13-0899-01 eacc42b9-bd6e-468c-8560-6d699ae97737 TCGA-13-0899-01A-01D-0399-01 605d0aed-4637-4a09-82dd-eedd1aa76ca0 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01W-0420-08 TCGA-13-0899-01 TCGA-13-0899-01 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01W-0420-08 TCGA-13-0899-01A-01R-0406-07 +TCGA-13-0900-01 TCGA-13-0900-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 11 TCGA-13-0900 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-13-0900-F72637 TCGA-13-0900 TCGA-13-0900-01B Stage IIIC -21698 0 4077 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 60 1.5 G3 NO TCGA-13-0900.27A4B579-9123-431C-95B6-FBC5CB5142C9.pdf 0900 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.1 13 Ovary B LIVING 2004 TCGA-13-0900-01 TCGA-13-0900-01B-01W-0490-10 443f369f-d9cf-433a-a115-7934c20bf98a TCGA-13-0900-01 TCGA-13-0900-01B-01W-0490-10 TCGA-13-0900-01B-01D-0460-05 TCGA-13-0900-01B-01D-0452-01 TCGA-13-0900-01 TCGA-13-0900-01B-01D-0452-01 TCGA-13-0900-01 TCGA-13-0900-01B-01W-0490-10 TCGA-13-0900-01B-01R-0456-07 +TCGA-13-0901-01 TCGA-13-0901-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 TCGA-13-0901 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Bilateral TCGA-13-0901-F24712 TCGA-13-0901 TCGA-13-0901-01A Stage IIIC -15333 0 589 390 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 80 1.3 G3 Recurrence TCGA-13-0901.5613318C-D3D4-436D-B22F-BE8FC36D9686.pdf 0901 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 13 >20 mm Ovary A LIVING 2004 TCGA-13-0901-01 TCGA-13-0901-01B-01W-0490-10 9a07f778-ddd0-4290-af0b-9cf85da4b123 TCGA-13-0901-01 TCGA-13-0901-01B-01W-0490-10 TCGA-13-0901-01B-01D-0460-05 TCGA-13-0901-01A-21-20 TCGA-13-0901-01B-01D-0452-01 TCGA-13-0901-01 0f0ae870-f5a7-4572-998d-d39403507fbe TCGA-13-0901-01B-01D-0452-01 TCGA-13-0901-01 TCGA-13-0901-01B-01R-0456-07 +TCGA-13-0903-01 TCGA-13-0903-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0903 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 42 Bilateral TCGA-13-0903-F72624 TCGA-13-0903 TCGA-13-0903-01A Stage IV -15705 0 3887 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 80 1 G3 NO TCGA-13-0903.A0EC0825-B2E7-40A0-868C-8C93A5D01AD8.pdf 0903 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A LIVING 2004 TCGA-13-0903-01 0931f0af-d4ff-4d49-9671-44f7f972ad49 TCGA-13-0903-01 TCGA-13-0903-01A-01D-0402-05 TCGA-13-0903-01A-01W-0421-09 TCGA-13-0903-01A-21-20 TCGA-13-0903-01A-01W-0421-09 TCGA-13-0903-01A-01D-0399-01 TCGA-13-0903-01 1eb38ad5-a108-4461-8d9c-2246c4e5174c TCGA-13-0903-01A-01D-0399-01 TCGA-13-0903-01 TCGA-13-0903-01A-01W-0421-09 TCGA-13-0903-01A-01R-0406-07 +TCGA-13-0904-01 TCGA-13-0904-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 2 TCGA-13-0904 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-13-0904-F72625 TCGA-13-0904 TCGA-13-0904-01A Stage IIIC -23278 1532 0 1470 330 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 0.7 NO 80 1.5 G3 YES TCGA-13-0904.4355BCD7-7A04-4F75-9415-83D3D6E18A24.pdf 0904 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2004 TCGA-13-0904-01 8db1ce50-4f8c-40a6-a56b-8266f0a16d28 TCGA-13-0904-01 TCGA-13-0904-01A-02D-0402-05 TCGA-13-0904-01A-02D-0399-01 TCGA-13-0904-01 TCGA-13-0904-01A-02D-0399-01 TCGA-13-0904-01A-02W-0420-08 TCGA-13-0904-01 TCGA-13-0904-01A-02W-0420-08 TCGA-13-0904-01A-02R-0406-07 +TCGA-13-0905-01 TCGA-13-0905-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0905 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Left TCGA-13-0905-F72638 TCGA-13-0905 TCGA-13-0905-01B Stage IIIC -18757 0 3746 1535 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 80 1.2 G3 YES TCGA-13-0905.4EC6E47F-60BD-413E-9371-D70E1E89D0CA.pdf 0905 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 Ovary B LIVING 2005 TCGA-13-0905-01 05762312-1eb7-48bd-b497-97e2f94a86ff TCGA-13-0905-01 TCGA-13-0905-01B-01D-0460-05 TCGA-13-0905-01B-01D-0452-01 TCGA-13-0905-01 TCGA-13-0905-01B-01D-0452-01 TCGA-13-0905-01B-01W-0492-08 TCGA-13-0905-01 TCGA-13-0905-01B-01W-0492-08 TCGA-13-0905-01B-01R-0456-07 +TCGA-13-0906-01 TCGA-13-0906-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0906 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-13-0906-F72626 TCGA-13-0906 TCGA-13-0906-01A Stage IIIC -18383 0 3619 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 60 1.1 G3 NO TCGA-13-0906.D75790B2-C93F-4723-B691-84EE94656FF1.pdf 0906 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.4 13 1-10 mm Ovary A LIVING 2005 TCGA-13-0906-01 TCGA-13-0906-01A-01W-0419-10 8cba78d8-365d-4f21-9024-b1c65e7aebd9 TCGA-13-0906-01 TCGA-13-0906-01A-01W-0419-10 TCGA-13-0906-01A-01D-0402-05 TCGA-13-0906-01A-21-20 TCGA-13-0906-01A-01D-0399-01 TCGA-13-0906-01 80aaf315-cf54-47e5-b82a-1343e25938ca TCGA-13-0906-01A-01D-0399-01 TCGA-13-0906-01 TCGA-13-0906-01A-01W-0419-10 TCGA-13-0906-01A-01R-0406-07 +TCGA-13-0908-01 TCGA-13-0908-01 Squamous OV-like c1 miRNA cluster 2 cluster 6 TCGA-13-0908 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-0908-F72639 TCGA-13-0908 TCGA-13-0908-01B Stage IV -21422 1843 0 1364 552 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.3 NO 1.4 G3 YES TCGA-13-0908.AE735D44-31EA-4345-9B3E-E92C7F236569.pdf 0908 WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary B DECEASED 2005 TCGA-13-0908-01 1a0d9712-cc09-46fa-a588-2d9db23c751b TCGA-13-0908-01 TCGA-13-0908-01B-01D-0460-05 TCGA-13-0908-01B-01D-0452-01 TCGA-13-0908-01 TCGA-13-0908-01B-01D-0452-01 TCGA-13-0908-01 TCGA-13-0908-01B-01R-0456-07 +TCGA-13-0910-01 TCGA-13-0910-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0910 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-0910-F72627 TCGA-13-0910 Stage IIIC -21473 0 3548 1212 Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 60 G3 YES 0910 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary LIVING 2005 TCGA-13-0910-01 c86a6b6b-046a-46c9-a89d-d365adafedd7 TCGA-13-0910-01 TCGA-13-0910-01A-01D-0402-05 TCGA-13-0910-01A-01W-0421-09 TCGA-13-0910-01A-21-20 TCGA-13-0910-01A-01W-0421-09 TCGA-13-0910-01A-01D-0399-01 TCGA-13-0910-01 a7d2bac8-709d-455d-8613-e87b8fd8fe19 TCGA-13-0910-01A-01D-0399-01 TCGA-13-0910-01 TCGA-13-0910-01A-01W-0421-09 TCGA-13-0910-01A-01R-0406-07 +TCGA-13-0911-01 TCGA-13-0911-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0911 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Bilateral TCGA-13-0911-F72628 TCGA-13-0911 TCGA-13-0911-01A Stage IV -20276 1355 0 843 279 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 80 1.5 G3 YES TCGA-13-0911.0DE80BC5-8AA8-423A-B99B-9CD9883F27C2.pdf 0911 Pre-Adjuvant Therapy WITH TUMOR R1 Primary Tumor 01 0.8 13 1-10 mm Ovary A DECEASED 2005 TCGA-13-0911-01 68069103-49df-4246-8858-31d6b3571145 TCGA-13-0911-01 TCGA-13-0911-01A-01D-0402-05 TCGA-13-0911-01A-21-20 TCGA-13-0911-01A-01D-0399-01 TCGA-13-0911-01 c2fbc465-c862-412d-8966-d88e0e414316 TCGA-13-0911-01A-01D-0399-01 TCGA-13-0911-01A-01W-0420-08 TCGA-13-0911-01 TCGA-13-0911-01A-01W-0420-08 TCGA-13-0911-01A-01R-0406-07 +TCGA-13-0912-01 TCGA-13-0912-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0912 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-0912-F72629 TCGA-13-0912 TCGA-13-0912-01A Stage IIIC -21427 1145 0 1036 469 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 80 1.2 G3 YES TCGA-13-0912.E6BF50DE-3E1D-447C-88B6-497B3C4C835F.pdf 0912 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A DECEASED 2006 TCGA-13-0912-01 1daa5008-c4db-41ea-8e40-e551632f8bec TCGA-13-0912-01 TCGA-13-0912-01A-01D-0402-05 TCGA-13-0912-01A-01W-0421-09 TCGA-13-0912-01A-01W-0421-09 TCGA-13-0912-01A-01D-0399-01 TCGA-13-0912-01 TCGA-13-0912-01A-01D-0399-01 TCGA-13-0912-01 TCGA-13-0912-01A-01W-0421-09 TCGA-13-0912-01A-01R-0406-07 +TCGA-13-0913-01 TCGA-13-0913-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0913 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 53 Bilateral TCGA-13-0913-F72630 TCGA-13-0913 TCGA-13-0913-01A Stage IIIC -19573 0 3325 871 Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 80 1.3 G3 YES TCGA-13-0913.E8FB6EA9-586A-452F-B6A6-0746F16B51DB.pdf 0913 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A LIVING 2006 TCGA-13-0913-01 TCGA-13-0913-01 e993c6b2-05c7-4404-b8d8-a4e3ce8a8253 TCGA-13-0913-01 TCGA-13-0913-01A-01D-0402-05 TCGA-13-0913-01A-21-20 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01D-0399-01 TCGA-13-0913-01 8887c7f4-1bc4-4ec6-874f-453c17e1646e,0c76e11e-e654-49d5-9469-aec43bc8eb96 TCGA-13-0913-01A-01D-0399-01 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01W-0420-08 TCGA-13-0913-01 TCGA-13-0913-01 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01W-0420-08 TCGA-13-0913-01A-01R-0406-07 +TCGA-13-0913-02 TCGA-13-0913-02 C9-OV OV-like c1 miRNA cluster 2 mutation cluster 5 TCGA-13-0913 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 53 Bilateral TCGA-13-0913-F72630 TCGA-13-0913 TCGA-13-0913-02A Stage IIIC -19573 0 3325 871 Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 80 1.4 G3 YES TCGA-13-0913.61FBF10C-A508-4D83-971D-5A48BA81F08A.pdf 0913 Pre-Adjuvant Therapy WITH TUMOR Recurrent Tumor 02 0.3 13 No Macroscopic disease Ovary A LIVING 2006 TCGA-13-0913-02 b9367a1a-2b4b-4beb-a02f-743f826bf85d TCGA-13-0913-02 TCGA-13-0913-02A-01D-0807-05 8c5c67e0-0a80-43b4-b35f-ddd51163b452 TCGA-13-0913-02A-01R-0810-07 +TCGA-13-0916-01 TCGA-13-0916-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0916 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-13-0916-F72631 TCGA-13-0916 TCGA-13-0916-01A Stage IIIC -18189 0 1785 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 NO TCGA-13-0916.28A2A65C-70A2-40D2-A03A-F68884457C14.pdf 0916 TUMOR FREE Primary Tumor 01 0.6 13 No Macroscopic disease Ovary A LIVING 2006 TCGA-13-0916-01 TCGA-13-0916-01 468b249e-69a0-4728-a0a3-cbe7fad18499 TCGA-13-0916-01 TCGA-13-0916-01A-01D-0402-05 TCGA-13-0916-01A-21-20 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01D-0399-01 TCGA-13-0916-01 3a88bad5-3325-409f-8023-5e2df3ba1bf4 TCGA-13-0916-01A-01D-0399-01 63c52e46-68cf-4dac-9bd7-37081daa4474 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01W-0420-08 TCGA-13-0916-01 TCGA-13-0916-01 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01W-0420-08 TCGA-13-0916-01A-01R-0406-07 +TCGA-13-0919-01 TCGA-13-0919-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-0919 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-13-0919-F72632 TCGA-13-0919 Stage IIIC -19337 0 2571 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 80 G3 NO 0919 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 13 No Macroscopic disease Ovary LIVING 2007 TCGA-13-0919-01 TCGA-13-0919-01A-01W-0419-10 f00f1225-2b6a-4d61-a3e1-909fd595b624 TCGA-13-0919-01 TCGA-13-0919-01A-01W-0419-10 TCGA-13-0919-01A-01D-0402-05 TCGA-13-0919-01A-01D-0399-01 TCGA-13-0919-01 TCGA-13-0919-01A-01D-0399-01 TCGA-13-0919-01 TCGA-13-0919-01A-01W-0419-10 TCGA-13-0919-01A-01R-0406-07 +TCGA-13-0920-01 TCGA-13-0920-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0920 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 Bilateral TCGA-13-0920-F72633 TCGA-13-0920 TCGA-13-0920-01A Stage IIIC -24064 1484 0 420 297 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 G3 YES TCGA-13-0920.6880B406-08B2-43CE-9274-5826B1BE9114.pdf 0920 WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2007 TCGA-13-0920-01 TCGA-13-0920-01 f109f013-990a-4e2d-9bce-b3dce60e5b0f TCGA-13-0920-01 TCGA-13-0920-01A-01D-0402-05 TCGA-13-0920-01A-01W-0421-09 TCGA-13-0920-01A-21-20 TCGA-13-0920-01A-01W-0421-09 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 TCGA-13-0920-01A-01D-0399-01 TCGA-13-0920-01 1aaaee17-5206-42cc-b678-f4a4e712ae54 TCGA-13-0920-01A-01D-0399-01 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 TCGA-13-0920-01 TCGA-13-0920-01 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 TCGA-13-0920-01A-01W-0421-09 TCGA-13-0920-01A-01R-0406-07 +TCGA-13-0921-01 TCGA-13-0921-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 TCGA-13-0921 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 72 Bilateral TCGA-13-0921-F72634 TCGA-13-0921 TCGA-13-0921-01A Stage IIIC -26606 1483 0 141 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 G3 TCGA-13-0921.307EC276-EE89-45D3-8B61-4F217C0F61C4.pdf 0921 TUMOR FREE Primary Tumor 01 0.2 13 No Macroscopic disease Ovary A DECEASED 2008 TCGA-13-0921-01 d4b09b28-c890-406a-97d4-3354bb5484c6 TCGA-13-0921-01 TCGA-13-0921-01A-01D-0402-05 TCGA-13-0921-01A-21-20 TCGA-13-0921-01A-01D-0399-01 TCGA-13-0921-01 56e2b31e-e133-45fa-a38c-9f1c8825194c TCGA-13-0921-01A-01D-0399-01 TCGA-13-0921-01 TCGA-13-0921-01A-01R-0406-07 +TCGA-13-0923-01 TCGA-13-0923-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0923 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Right TCGA-13-0923-F72635 TCGA-13-0923 TCGA-13-0923-01A Stage IIIC -27081 0 2547 1719 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 YES TCGA-13-0923.06AB5B8C-7B57-43B0-8376-7A05C58AFC1A.pdf 0923 TUMOR FREE Primary Tumor 01 13 No Macroscopic disease Ovary A LIVING 2008 TCGA-13-0923-01 5e88feda-6485-4934-9c79-2c5c88e908de TCGA-13-0923-01 TCGA-13-0923-01A-01D-0402-05 TCGA-13-0923-01A-01D-0399-01 TCGA-13-0923-01 TCGA-13-0923-01A-01D-0399-01 TCGA-13-0923-01A-01W-0420-08 TCGA-13-0923-01 TCGA-13-0923-01A-01W-0420-08 TCGA-13-0923-01A-01R-0406-07 +TCGA-13-0924-01 TCGA-13-0924-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0924 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-13-0924-F72636 TCGA-13-0924 TCGA-13-0924-01A Stage IV -16670 0 2614 962 Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NO G3 YES TCGA-13-0924.2EA17F21-1594-430A-97E3-29C5F49CB3BC.pdf 0924 WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary A LIVING 2008 TCGA-13-0924-01 TCGA-13-0924-01 b0dae9c4-1401-4b88-94cb-bef931901b94 TCGA-13-0924-01 TCGA-13-0924-01A-01D-0402-05 TCGA-13-0924-01A-01W-0421-09 TCGA-13-0924-01A-01W-0421-09 85a4c41b-9829-48f8-9c7a-a9de870332b6 TCGA-13-0924-01A-01D-0399-01 TCGA-13-0924-01 TCGA-13-0924-01A-01D-0399-01 85a4c41b-9829-48f8-9c7a-a9de870332b6 85a4c41b-9829-48f8-9c7a-a9de870332b6 TCGA-13-0924-01 TCGA-13-0924-01 85a4c41b-9829-48f8-9c7a-a9de870332b6 TCGA-13-0924-01A-01W-0421-09 TCGA-13-0924-01A-01R-0406-07 +TCGA-13-1403-01 TCGA-13-1403-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1403 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Left TCGA-13-1403-F72653 TCGA-13-1403 TCGA-13-1403-01A Stage IIIC -17697 2345 0 331 418 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.9 NO 1.2 G3 YES TCGA-13-1403.435619AB-01F5-4AC3-8D28-A8CC0054699F.pdf 1403 WITH TUMOR Primary Tumor 01 0.4 13 Ovary A DECEASED 2008 TCGA-13-1403-01 TCGA-13-1403-01 88424970-6ba5-4c0f-ac01-f06513be5b42 TCGA-13-1403-01 TCGA-13-1403-01A-01D-0460-05 TCGA-13-1403-01A-01W-0494-09 TCGA-13-1403-01A-01W-0494-09 3217dd54-d41c-4c63-8bab-ff2c4baaee10 TCGA-13-1403-01A-01D-0452-01 TCGA-13-1403-01 TCGA-13-1403-01A-01D-0452-01 3217dd54-d41c-4c63-8bab-ff2c4baaee10 3217dd54-d41c-4c63-8bab-ff2c4baaee10 TCGA-13-1403-01 TCGA-13-1403-01 3217dd54-d41c-4c63-8bab-ff2c4baaee10 TCGA-13-1403-01A-01W-0494-09 TCGA-13-1403-01A-01R-0456-07 +TCGA-13-1404-01 TCGA-13-1404-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1404 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Bilateral TCGA-13-1404-F72655 TCGA-13-1404 TCGA-13-1404-01A Stage IIIC -17784 0 2469 1581 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 60 1.5 G3 YES TCGA-13-1404.39B73962-A374-4521-BFBB-F10D117979F9.pdf 1404 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A LIVING 2008 TCGA-13-1404-01 454548ae-a10c-4811-a88b-5e893ffe1caa TCGA-13-1404-01 TCGA-13-1404-01A-01D-0460-05 TCGA-13-1404-01A-01W-0494-09 TCGA-13-1404-01A-21-1562-20 TCGA-13-1404-01A-01W-0494-09 TCGA-13-1404-01A-01D-0452-01 TCGA-13-1404-01 b9dd3b0f-e45a-400a-8078-5d421d257726 TCGA-13-1404-01A-01D-0452-01 TCGA-13-1404-01 TCGA-13-1404-01A-01W-0494-09 TCGA-13-1404-01A-01R-0456-07 +TCGA-13-1405-01 TCGA-13-1405-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1405 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-13-1405-F72656 TCGA-13-1405 TCGA-13-1405-01A Stage IV -18218 868 0 224 228 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.3 NO 80 1.3 G3 YES TCGA-13-1405.DFB9F8B2-986C-4963-B2D2-837E54174CF0.pdf 1405 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.5 13 1-10 mm Ovary A DECEASED 2008 TCGA-13-1405-01 TCGA-13-1405-01 04d8cf12-0689-4e2d-a8e9-771920563560 TCGA-13-1405-01 TCGA-13-1405-01A-01D-0460-05 TCGA-13-1405-01A-01W-0494-09 TCGA-13-1405-01A-21-1562-20 TCGA-13-1405-01A-01W-0494-09 044d949f-0eb4-44c9-8327-90226936fc7c TCGA-13-1405-01A-01D-0452-01 TCGA-13-1405-01 79cd114a-31d2-468d-92e6-5ea925e61918 TCGA-13-1405-01A-01D-0452-01 044d949f-0eb4-44c9-8327-90226936fc7c 044d949f-0eb4-44c9-8327-90226936fc7c TCGA-13-1405-01 TCGA-13-1405-01 044d949f-0eb4-44c9-8327-90226936fc7c TCGA-13-1405-01A-01W-0494-09 TCGA-13-1405-01A-01R-0456-07 +TCGA-13-1407-01 TCGA-13-1407-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-1407 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-13-1407-F72657 TCGA-13-1407 Stage IIIC -18896 0 2534 1333 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 YES 1407 WITH TUMOR Primary Tumor 01 13 Ovary LIVING 2008 TCGA-13-1407-01 TCGA-13-1407-01A-01W-0490-10 ba5b2281-2b96-47e8-92b9-0221c434b4e9 TCGA-13-1407-01 TCGA-13-1407-01A-01W-0490-10 TCGA-13-1407-01A-01D-0460-05 TCGA-13-1407-01A-01D-0452-01 TCGA-13-1407-01 TCGA-13-1407-01A-01D-0452-01 TCGA-13-1407-01 TCGA-13-1407-01A-01W-0490-10 TCGA-13-1407-01A-01R-0456-07 +TCGA-13-1408-01 TCGA-13-1408-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation cluster 14 TCGA-13-1408 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 TCGA-13-1408-F72659 TCGA-13-1408 TCGA-13-1408-01A Stage IIIC -21635 1680 0 180 765 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.8 G3 YES TCGA-13-1408.39435FCB-699F-4A2F-9005-E67C9A41C766.pdf 1408 WITH TUMOR Primary Tumor 01 0.3 13 >20 mm Ovary A DECEASED 2008 TCGA-13-1408-01 TCGA-13-1408-01A-01W-0490-10 3f056922-bdb4-4a8f-8a4d-9116cae32ae8 TCGA-13-1408-01 TCGA-13-1408-01A-01W-0490-10 TCGA-13-1408-01A-01D-0460-05 TCGA-13-1408-01A-21-1562-20 TCGA-13-1408-01A-01D-0452-01 TCGA-13-1408-01 c9dc89ec-e887-4acc-90a5-6fd20f4a1483 TCGA-13-1408-01A-01D-0452-01 TCGA-13-1408-01 TCGA-13-1408-01A-01W-0490-10 TCGA-13-1408-01A-01R-0456-07 +TCGA-13-1409-01 TCGA-13-1409-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1409 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 TCGA-13-1409-F72660 TCGA-13-1409 TCGA-13-1409-01A Stage IIIC -26836 1742 0 208 690 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 1 NO 60 1.6 G3 YES TCGA-13-1409.3F18B612-EE50-4459-8CAF-61A12157DD8A.pdf 1409 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.6 13 1-10 mm Ovary A DECEASED 2008 TCGA-13-1409-01 c4293c0c-8d5d-40b4-9f84-42633383f950 TCGA-13-1409-01 TCGA-13-1409-01A-01D-0460-05 TCGA-13-1409-01A-21-20 TCGA-13-1409-01A-01D-0452-01 TCGA-13-1409-01 8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25 TCGA-13-1409-01A-01D-0452-01 TCGA-13-1409-01A-01W-0492-08 TCGA-13-1409-01 TCGA-13-1409-01A-01W-0492-08 TCGA-13-1409-01A-01R-0456-07 +TCGA-13-1410-01 TCGA-13-1410-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1410 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Bilateral TCGA-13-1410-F72661 TCGA-13-1410 TCGA-13-1410-01A Stage IV -20950 0 2464 319 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 60 1.9 GX YES TCGA-13-1410.0F641D88-673B-48C4-97F5-730DA3FD343C.pdf 1410 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.5 13 Ovary A LIVING 2008 TCGA-13-1410-01 TCGA-13-1410-01 e8da901b-05d8-4448-8e0c-52c558fe2ea8 TCGA-13-1410-01 TCGA-13-1410-01A-01D-0460-05 TCGA-13-1410-01A-21-20 fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01D-0452-01 TCGA-13-1410-01 3f2151ce-1e04-4a0e-8ded-e59696b705cb TCGA-13-1410-01A-01D-0452-01 fdda1428-ad6b-4337-a959-83bae1f9664b fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01W-0492-08 TCGA-13-1410-01 TCGA-13-1410-01 fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01W-0492-08 TCGA-13-1410-01A-01R-0456-07 +TCGA-13-1411-01 TCGA-13-1411-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-1411 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 81 TCGA-13-1411-F72662 TCGA-13-1411 TCGA-13-1411-01A Stage IIIC -29874 531 0 128 238 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 1.7 G3 YES TCGA-13-1411.F73F2D6F-3FD9-4457-921A-9EE0E47A6470.pdf 1411 WITH TUMOR Primary Tumor 01 0.3 13 >20 mm Ovary A DECEASED 2008 TCGA-13-1411-01 TCGA-13-1411-01 88a02ee5-0e09-4181-ad62-88ec7f877f45 TCGA-13-1411-01 TCGA-13-1411-01A-01D-0460-05 TCGA-13-1411-01A-01W-0494-09 TCGA-13-1411-01A-21-20 TCGA-13-1411-01A-01W-0494-09 0069c63d-f699-41d4-9798-9a109d1c09df TCGA-13-1411-01A-01D-0452-01 TCGA-13-1411-01 438d9016-0b99-46f7-b8ad-21c125f4bedd TCGA-13-1411-01A-01D-0452-01 0069c63d-f699-41d4-9798-9a109d1c09df 0069c63d-f699-41d4-9798-9a109d1c09df TCGA-13-1411-01 TCGA-13-1411-01 0069c63d-f699-41d4-9798-9a109d1c09df TCGA-13-1411-01A-01W-0494-09 TCGA-13-1411-01A-01R-0456-07 +TCGA-13-1412-01 TCGA-13-1412-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1412 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 41 Bilateral TCGA-13-1412-F72669 TCGA-13-1412 TCGA-13-1412-01A Stage IV -15119 984 0 162 409 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 80 1.1 G3 YES TCGA-13-1412.D36FA0B4-9605-498F-B815-1BE4BF64E100.pdf 1412 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2008 TCGA-13-1412-01 54620fb3-d7d9-4d00-a77b-4d8dcfee4d55 TCGA-13-1412-01 TCGA-13-1412-01A-01D-0460-05 TCGA-13-1412-01A-01W-0494-09 TCGA-13-1412-01A-21-20 TCGA-13-1412-01A-01W-0494-09 TCGA-13-1412-01A-01D-0452-01 TCGA-13-1412-01 b22eb00b-8fcc-4fd5-b396-1169f7f025fd TCGA-13-1412-01A-01D-0452-01 TCGA-13-1412-01 TCGA-13-1412-01A-01W-0494-09 TCGA-13-1412-01A-01R-0456-07 +TCGA-13-1477-01 TCGA-13-1477-01 Iq C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-13-1477 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 49 Bilateral TCGA-13-1477-F24839 TCGA-13-1477 TCGA-13-1477-01A Stage IV -18111 1662 0 1662 235 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 1.3 NO 1.3 G2 Progression of Disease TCGA-13-1477.2507FA0F-9709-4B5D-9EC1-907637FB373A.pdf 1477 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.3 13 1-10 mm Ovary A DECEASED 2000 TCGA-13-1477-01 7bc1d947-f625-418c-b577-c66aea3e33c4 TCGA-13-1477-01 TCGA-13-1477-01A-01D-0475-05 TCGA-13-1477-01A-21-1562-20 TCGA-13-1477-01A-01D-0472-01 TCGA-13-1477-01 fa473bf9-b927-4d17-ac77-ad0e52f01cac TCGA-13-1477-01A-01D-0472-01 TCGA-13-1477-01A-01D-0472-08 TCGA-13-1477-01 TCGA-13-1477-01A-01D-0472-08 TCGA-13-1477-01A-01R-0479-07 +TCGA-13-1479-01 TCGA-13-1479-01 TCGA-13-1479 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-13-1479-01A-01D-0475-05 TCGA-13-1479-01A-01R-0479-07 +TCGA-13-1481-01 TCGA-13-1481-01 High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1481 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 76 Right TCGA-13-1481-F24843 TCGA-13-1481 TCGA-13-1481-01A Stage IIIC -27898 2648 0 2648 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.3 NO 1.4 G2 TCGA-13-1481.4832CBA4-9482-4A2A-A9E1-4E8489B0F157.pdf 1481 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2000 TCGA-13-1481-01 TCGA-13-1481-01 2b0cdd7b-9556-4bd5-bf80-1daa495b38e3 TCGA-13-1481-01 TCGA-13-1481-01A-01D-0475-05 TCGA-13-1481-01A-01W-0549-09 TCGA-13-1481-01A-21-1562-20 TCGA-13-1481-01A-01W-0549-09 761f9668-304f-4e22-87cd-2005aa86152c TCGA-13-1481-01A-01D-0472-01 TCGA-13-1481-01 8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a TCGA-13-1481-01A-01D-0472-01 761f9668-304f-4e22-87cd-2005aa86152c 761f9668-304f-4e22-87cd-2005aa86152c TCGA-13-1481-01 TCGA-13-1481-01 761f9668-304f-4e22-87cd-2005aa86152c TCGA-13-1481-01A-01W-0549-09 TCGA-13-1481-01A-01R-0479-07 +TCGA-13-1482-01 TCGA-13-1482-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1482 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 TCGA-13-1482-F24848 TCGA-13-1482 Stage IV -19178 1877 0 1877 602 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 80 G2 Recurrence 1482 Preoperative WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 13 >20 mm Ovary DECEASED 2000 TCGA-13-1482-01 c2b1ef9b-a1b3-4fe9-b35f-841893a6092d TCGA-13-1482-01 TCGA-13-1482-01A-01D-0475-05 TCGA-13-1482-01A-01W-0549-09 TCGA-13-1482-01A-21-1562-20 TCGA-13-1482-01A-01W-0549-09 TCGA-13-1482-01A-01D-0472-01 TCGA-13-1482-01 db641a43-1973-4213-a4ed-42fa9ff8e8ec TCGA-13-1482-01A-01D-0472-01 TCGA-13-1482-01 TCGA-13-1482-01A-01W-0549-09 TCGA-13-1482-01A-01R-0479-07 +TCGA-13-1483-01 TCGA-13-1483-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-1483 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 TCGA-13-1483-F24852 TCGA-13-1483 TCGA-13-1483-01A Stage IIIC -22342 895 0 895 297 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1.4 NO 60 1.8 G3 Recurrence TCGA-13-1483.c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db.pdf 1483 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Molecular Markers NO Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2000 TCGA-13-1483-01 ba90cac1-6c52-4111-99f5-8cb3cb11faeb TCGA-13-1483-01 TCGA-13-1483-01A-01D-0475-05 TCGA-13-1483-01A-01W-0549-09 TCGA-13-1483-01A-21-1562-20 TCGA-13-1483-01A-01W-0549-09 TCGA-13-1483-01A-01D-0472-01 TCGA-13-1483-01 3ab7ed23-61b4-4c74-8668-25b7ee186bf7 TCGA-13-1483-01A-01D-0472-01 TCGA-13-1483-01 TCGA-13-1483-01A-01W-0549-09 TCGA-13-1483-01A-01R-0479-07 +TCGA-13-1484-01 TCGA-13-1484-01 High C9-OV OV-like c1 BRCA basal-like c6 miRNA cluster 1 cluster 6 mutation cluster 8 TCGA-13-1484 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 TCGA-13-1484-F72640 TCGA-13-1484 TCGA-13-1484-01A Stage IIIC -22698 3785 0 2982 497 Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 0.6 NO 80 1.5 G3 YES TCGA-13-1484.CF223E16-1613-4FAB-A4DA-86D5ECE7B55E.pdf 1484 Preoperative WITH TUMOR Primary Tumor 01 0.3 13 Ovary A DECEASED 2000 TCGA-13-1484-01 53f117b0-5e33-4abf-9720-e3358f62ed9a TCGA-13-1484-01 TCGA-13-1484-01A-01D-0475-05 TCGA-13-1484-01A-21-1562-20 TCGA-13-1484-01A-01D-0472-01 TCGA-13-1484-01 d48335c8-f1dd-472d-a4d6-6ad7eb5d081d TCGA-13-1484-01A-01D-0472-01 TCGA-13-1484-01A-01W-0545-08 TCGA-13-1484-01 TCGA-13-1484-01A-01W-0545-08 TCGA-13-1484-01A-01R-0479-07 +TCGA-13-1485-01 TCGA-13-1485-01 High OV-like c1 miRNA cluster 3 cluster 6 TCGA-13-1485 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-1485-F24861 TCGA-13-1485 Stage IV -17642 629 0 629 170 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 80 G2 Progression of Disease 1485 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 13 1-10 mm Ovary DECEASED 2001 TCGA-13-1485-01 a1378617-e3ff-4bfa-adef-03e4c07512fa TCGA-13-1485-01 TCGA-13-1485-01A-02D-0475-05 TCGA-13-1485-01A-02D-0472-01 TCGA-13-1485-01 TCGA-13-1485-01A-02D-0472-01 TCGA-13-1485-01 TCGA-13-1485-01A-02R-0479-07 +TCGA-13-1487-01 TCGA-13-1487-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1487 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 TCGA-13-1487-F24865 TCGA-13-1487 Stage IV -27176 681 0 681 412 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection GX Recurrence 1487 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 13 Ovary DECEASED 2002 TCGA-13-1487-01 a7c48735-a4be-424a-a3cd-125cf2e2a274 TCGA-13-1487-01 TCGA-13-1487-01A-01D-0475-05 TCGA-13-1487-01A-21-1562-20 TCGA-13-1487-01A-01D-0472-01 TCGA-13-1487-01 f10389e0-3564-4067-b82a-d0be5d5eec92 TCGA-13-1487-01A-01D-0472-01 TCGA-13-1487-01A-01D-0472-08 TCGA-13-1487-01 TCGA-13-1487-01A-01D-0472-08 TCGA-13-1487-01A-01R-0479-07 +TCGA-13-1488-01 TCGA-13-1488-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1488 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-13-1488-F24871 TCGA-13-1488 TCGA-13-1488-01A Stage IV -21726 2154 0 2154 351 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 80 2.3 G3 Recurrence TCGA-13-1488.79A91E41-0B59-4328-B7BB-2B4EEAD46A89.pdf 1488 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 13 11-20 mm Ovary A DECEASED 2002 TCGA-13-1488-01 6b1d30b6-321c-4d55-bf9f-dfb4be92210b TCGA-13-1488-01 TCGA-13-1488-01A-01D-0475-05 TCGA-13-1488-01A-01W-0549-09 TCGA-13-1488-01A-21-1562-20 TCGA-13-1488-01A-01W-0549-09 TCGA-13-1488-01A-01D-0472-01 TCGA-13-1488-01 1ec3bf38-f06e-4789-a298-cde202cf3649 TCGA-13-1488-01A-01D-0472-01 TCGA-13-1488-01 TCGA-13-1488-01A-01W-0549-09 TCGA-13-1488-01A-01R-0479-07 +TCGA-13-1489-01 TCGA-13-1489-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-13-1489 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 70 Bilateral TCGA-13-1489-F72641 TCGA-13-1489 Stage IIIC -25768 2553 0 2521 806 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 80 G2 YES 1489 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 13 Ovary DECEASED 2002 TCGA-13-1489-01 aeb47cad-0087-4bf3-aa09-3751a6dcb269 TCGA-13-1489-01 TCGA-13-1489-01A-01D-0475-05 TCGA-13-1489-01A-01W-0549-09 TCGA-13-1489-01A-21-1562-20 TCGA-13-1489-01A-01W-0549-09 TCGA-13-1489-01A-01D-0472-01 TCGA-13-1489-01 f99befac-a46e-43a1-91b7-e4a492dae82f,c35fe897-f2eb-4dcb-a571-89f2c27ffa6a TCGA-13-1489-01A-01D-0472-01 TCGA-13-1489-01 TCGA-13-1489-01A-01W-0549-09 TCGA-13-1489-01A-01R-0479-07 +TCGA-13-1489-02 TCGA-13-1489-02 C9-OV OV-like c1 OV-like c16 miRNA cluster 3 mutation cluster 5 TCGA-13-1489 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 70 Bilateral TCGA-13-1489-F72641 TCGA-13-1489 TCGA-13-1489-02A Stage IIIC -25768 2553 0 2521 806 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 80 1 G2 YES TCGA-13-1489.639712E8-5C63-433C-8F23-4C78FF37D8FC.pdf 1489 Pre-Adjuvant Therapy TUMOR FREE Recurrent Tumor 02 0.4 13 Ovary A DECEASED 2002 TCGA-13-1489-02 141d2716-c6c3-4495-b30f-12dc204d77a3 TCGA-13-1489-02 TCGA-13-1489-02A-01D-0807-05 d8cd1ca1-dc00-4a48-ab81-5d23daed6fce d95612da-1768-4b34-bb28-607208c05c38 d8cd1ca1-dc00-4a48-ab81-5d23daed6fce d8cd1ca1-dc00-4a48-ab81-5d23daed6fce d8cd1ca1-dc00-4a48-ab81-5d23daed6fce TCGA-13-1489-02A-01R-0810-07 +TCGA-13-1491-01 TCGA-13-1491-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1491 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-1491-F24884 TCGA-13-1491 TCGA-13-1491-01A Stage IIIC -20262 1595 0 1595 508 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 0.6 NO 60 2 G3 Recurrence TCGA-13-1491.051EAB19-C9CF-407E-A0C3-19CB76368C22.pdf 1491 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 13 Ovary A DECEASED 2002 TCGA-13-1491-01 7ae5754b-5508-416e-96ec-fe3221d6e2ff TCGA-13-1491-01 TCGA-13-1491-01A-01D-0475-05 TCGA-13-1491-01A-01W-0549-09 TCGA-13-1491-01A-21-1562-20 TCGA-13-1491-01A-01W-0549-09 TCGA-13-1491-01A-01D-0472-01 TCGA-13-1491-01 a2142ff2-fb53-4517-b0d5-9f25ba91ea1a TCGA-13-1491-01A-01D-0472-01 TCGA-13-1491-01 TCGA-13-1491-01A-01W-0549-09 TCGA-13-1491-01A-01R-0479-07 +TCGA-13-1492-01 TCGA-13-1492-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1492 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 TCGA-13-1492-F72643 TCGA-13-1492 TCGA-13-1492-01A Stage IIIC -24332 3819 0 2237 Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1.2 NO 80 2.5 G3 NO TCGA-13-1492.566BE185-8A2E-43C4-9762-65216AB9AC44.pdf 1492 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.4 13 Ovary A DECEASED 2002 TCGA-13-1492-01 c37d0090-3b9a-4832-934a-299d8a7f6a2d TCGA-13-1492-01 TCGA-13-1492-01A-01D-0475-05 TCGA-13-1492-01A-21-1562-20 TCGA-13-1492-01A-01D-0472-01 TCGA-13-1492-01 943e741f-3371-4167-99e0-fd795663874c TCGA-13-1492-01A-01D-0472-01 TCGA-13-1492-01A-01D-0472-08 TCGA-13-1492-01 TCGA-13-1492-01A-01D-0472-08 TCGA-13-1492-01A-01R-0479-07 +TCGA-13-1494-01 TCGA-13-1494-01 Squamous C9-OV OV-like c1 KIRC-like c1 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1494 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 43 Bilateral TCGA-13-1494-F72644 TCGA-13-1494 Stage IV -15993 2856 0 1162 693 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy G3 YES 1494 WITH TUMOR Primary Tumor 01 13 Ovary DECEASED 2004 TCGA-13-1494-01 d8a57388-6e4e-4865-a68f-7485dec8304f TCGA-13-1494-01 TCGA-13-1494-01A-01D-0475-05 TCGA-13-1494-01A-21-1562-20 TCGA-13-1494-01A-01D-0472-01 TCGA-13-1494-01 af9b3f69-ef63-4303-85c6-8f6936dc6b6e TCGA-13-1494-01A-01D-0472-01 TCGA-13-1494-01A-01W-0545-08 TCGA-13-1494-01 TCGA-13-1494-01A-01W-0545-08 TCGA-13-1494-01A-01R-0479-07 +TCGA-13-1495-01 TCGA-13-1495-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-1495 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-13-1495-F72645 TCGA-13-1495 TCGA-13-1495-01A Stage IIIC -22046 2749 0 1498 977 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.5 NO 80 2.1 G2 YES TCGA-13-1495.51F0A8BF-0E86-402D-BE9F-D41771ED98A3.pdf 1495 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2004 TCGA-13-1495-01 2476b238-9e59-49ae-ac0d-456ad4fe4ffc TCGA-13-1495-01 TCGA-13-1495-01A-01D-0475-05 TCGA-13-1495-01A-21-1562-20 TCGA-13-1495-01A-01D-0472-01 TCGA-13-1495-01 15443f5b-51c9-496d-bf7a-99693ca3b943 TCGA-13-1495-01A-01D-0472-01 TCGA-13-1495-01A-01W-0545-08 TCGA-13-1495-01 TCGA-13-1495-01A-01W-0545-08 TCGA-13-1495-01A-01R-0479-07 +TCGA-13-1496-01 TCGA-13-1496-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1496 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 Bilateral TCGA-13-1496-F24904 TCGA-13-1496 TCGA-13-1496-01A Stage IIIC -23993 129 0 129 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.1 G3 TCGA-13-1496.BCDD1BDE-689B-455D-81A7-C2522417E055.pdf 1496 YES NO Primary Tumor 01 0.3 13 >20 mm Ovary A DECEASED 2004 TCGA-13-1496-01 e75a75ac-204d-48b0-891e-c3d6e979d4d4 TCGA-13-1496-01 TCGA-13-1496-01A-01D-0475-05 TCGA-13-1496-01A-21-1562-20 TCGA-13-1496-01A-01D-0472-01 TCGA-13-1496-01 35781069-501d-45c3-b3f0-7292b0186211 TCGA-13-1496-01A-01D-0472-01 TCGA-13-1496-01A-01W-0545-08 TCGA-13-1496-01 TCGA-13-1496-01A-01W-0545-08 TCGA-13-1496-01A-01R-0479-07 +TCGA-13-1497-01 TCGA-13-1497-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1497 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 47 TCGA-13-1497-F72646 TCGA-13-1497 Stage IIIC -17528 0 3871 813 Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 80 G3 YES 1497 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 13 Ovary LIVING 2004 TCGA-13-1497-01 TCGA-13-1497-01 d53c30c7-126f-40ec-9e02-4a1d2a3e2681 TCGA-13-1497-01 TCGA-13-1497-01A-01D-0475-05 TCGA-13-1497-01A-01W-0549-09 TCGA-13-1497-01A-01W-0549-09 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 TCGA-13-1497-01A-01D-0472-01 TCGA-13-1497-01 TCGA-13-1497-01A-01D-0472-01 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 TCGA-13-1497-01 TCGA-13-1497-01 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 TCGA-13-1497-01A-01W-0549-09 TCGA-13-1497-01A-01R-0479-07 +TCGA-13-1498-01 TCGA-13-1498-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-1498 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 TCGA-13-1498-F72647 TCGA-13-1498 TCGA-13-1498-01A Stage IIIC -26820 2012 0 1144 534 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 60 1.1 G3 YES TCGA-13-1498.0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1.pdf 1498 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2006 TCGA-13-1498-01 TCGA-13-1498-01 0fe423b7-115f-48a2-bc4a-9eec87f319e2 TCGA-13-1498-01 TCGA-13-1498-01A-01D-0475-05 TCGA-13-1498-01A-01W-0549-09 TCGA-13-1498-01A-21-1562-20 TCGA-13-1498-01A-01W-0549-09 176d1ca2-eb1d-4f49-9b10-c129c822fa5a TCGA-13-1498-01A-01D-0472-01 TCGA-13-1498-01 17dca857-f830-4be9-9f2b-5619ae7eb73f TCGA-13-1498-01A-01D-0472-01 176d1ca2-eb1d-4f49-9b10-c129c822fa5a 176d1ca2-eb1d-4f49-9b10-c129c822fa5a TCGA-13-1498-01 TCGA-13-1498-01 176d1ca2-eb1d-4f49-9b10-c129c822fa5a TCGA-13-1498-01A-01W-0549-09 TCGA-13-1498-01A-01R-0479-07 +TCGA-13-1499-01 TCGA-13-1499-01 Squamous C9-OV Low purity c2 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1499 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 TCGA-13-1499-F72649 TCGA-13-1499 TCGA-13-1499-01A Stage IIIC -20668 0 3500 583 Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 1.1 NO 80 2.1 G3 YES TCGA-13-1499.3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0.pdf 1499 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 Ovary A LIVING 2005 TCGA-13-1499-01 f54b35ad-c934-4df9-ba57-089c4c9d5c1e TCGA-13-1499-01 TCGA-13-1499-01A-01D-0475-05 TCGA-13-1499-01A-01W-0549-09 TCGA-13-1499-01A-21-1562-20 TCGA-13-1499-01A-01W-0549-09 TCGA-13-1499-01A-01D-0472-01 TCGA-13-1499-01 21c833c6-d2bc-4308-a233-894c7a6636f1 TCGA-13-1499-01A-01D-0472-01 TCGA-13-1499-01 TCGA-13-1499-01A-01W-0549-09 TCGA-13-1499-01A-01R-0479-07 +TCGA-13-1500-01 TCGA-13-1500-01 Squamous OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 TCGA-13-1500 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-1500-F24926 TCGA-13-1500 TCGA-13-1500-01A Stage IIIC -26172 425 0 425 253 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.2 NO 80 1.7 G3 Recurrence TCGA-13-1500.BFC92139-677F-4AD6-93D4-B479B8121449.pdf 1500 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Molecular Markers NO Primary Tumor 01 0.4 13 11-20 mm Ovary A DECEASED 2006 TCGA-13-1500-01 6bd685eb-c19d-404d-bb70-0d7590034653 TCGA-13-1500-01 TCGA-13-1500-01A-01D-0475-05 TCGA-13-1500-01A-21-1562-20 TCGA-13-1500-01A-01D-0472-01 TCGA-13-1500-01 639afc90-9b92-45f2-a350-6b7e355bbcbc TCGA-13-1500-01A-01D-0472-01 TCGA-13-1500-01 TCGA-13-1500-01A-01R-0479-07 +TCGA-13-1501-01 TCGA-13-1501-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-1501 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-13-1501-F72651 TCGA-13-1501 TCGA-13-1501-01A Stage IV -18393 1314 0 999 392 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.2 NO 80 1.5 G3 YES TCGA-13-1501.7D27D441-D069-4674-A761-299E315D67C1.pdf 1501 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2006 TCGA-13-1501-01 cf8ec1d5-56c7-45b7-8208-58fc6f5d6aa6 TCGA-13-1501-01 TCGA-13-1501-01A-01D-0475-05 TCGA-13-1501-01A-21-1562-20 TCGA-13-1501-01A-01D-0472-01 TCGA-13-1501-01 9f507427-22ed-408e-807f-39a90244bef4 TCGA-13-1501-01A-01D-0472-01 TCGA-13-1501-01A-01W-0545-08 TCGA-13-1501-01 TCGA-13-1501-01A-01W-0545-08 TCGA-13-1501-01A-01R-0479-07 +TCGA-13-1504-01 TCGA-13-1504-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1504 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 68 Bilateral TCGA-13-1504-F72652 TCGA-13-1504 TCGA-13-1504-01A Stage IIIC -25008 1059 0 504 548 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 60 1.6 G3 YES TCGA-13-1504.DB8A8258-9893-4968-A91B-5D9D319D0585.pdf 1504 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 Ovary A DECEASED 2007 TCGA-13-1504-01 6ad70118-653d-4476-b26c-4e276f556aaf TCGA-13-1504-01 TCGA-13-1504-01A-01D-0475-05 TCGA-13-1504-01A-21-1562-20 TCGA-13-1504-01A-01D-0472-01 TCGA-13-1504-01 f1e3f6ff-3c3d-4045-9ab3-bf5803828428 TCGA-13-1504-01A-01D-0472-01 TCGA-13-1504-01A-01W-0545-08 TCGA-13-1504-01 TCGA-13-1504-01A-01W-0545-08 TCGA-13-1504-01A-01R-0479-07 +TCGA-13-1505-01 TCGA-13-1505-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1505 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-13-1505-F72674 TCGA-13-1505 TCGA-13-1505-01A Stage IIIC -23238 0 1998 1561 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.2 G3 YES TCGA-13-1505.ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF.pdf 1505 WITH TUMOR Primary Tumor 01 0.3 13 1-10 mm Ovary A LIVING 2008 TCGA-13-1505-01 TCGA-13-1505-01 3237c7be-aa7d-47d1-8c46-8d6b4ce5d1c4 TCGA-13-1505-01 TCGA-13-1505-01A-01D-0475-05 TCGA-13-1505-01A-21-1562-20 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-01 TCGA-13-1505-01 d15e55f3-d7f1-4276-9fe1-17cc18dc2515 TCGA-13-1505-01A-01D-0472-01 7774b7d4-2935-4b9b-bf76-312a625629e1 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-08 TCGA-13-1505-01 TCGA-13-1505-01 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-08 TCGA-13-1505-01A-01R-0479-07 +TCGA-13-1506-01 TCGA-13-1506-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-1506 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-13-1506-F72675 TCGA-13-1506 TCGA-13-1506-01A Stage IIIC -16734 1039 0 134 666 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 80 1.1 G3 YES TCGA-13-1506.88E423FF-4070-4F01-A0B0-41B45443E762.pdf 1506 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.2 13 Ovary A DECEASED 2008 TCGA-13-1506-01 TCGA-13-1506-01 e9c25372-66bb-4c51-9b0f-8fb53262f48b TCGA-13-1506-01 TCGA-13-1506-01A-01D-0475-05 TCGA-13-1506-01A-01W-0549-09 TCGA-13-1506-01A-21-1562-20 TCGA-13-1506-01A-01W-0549-09 927c7b6d-3997-453b-81b1-b947341d5819 TCGA-13-1506-01A-01D-0472-01 TCGA-13-1506-01 6bdc5656-6cff-48e4-9625-e953d683aed5 TCGA-13-1506-01A-01D-0472-01 927c7b6d-3997-453b-81b1-b947341d5819 927c7b6d-3997-453b-81b1-b947341d5819 TCGA-13-1506-01 TCGA-13-1506-01 927c7b6d-3997-453b-81b1-b947341d5819 TCGA-13-1506-01A-01W-0549-09 TCGA-13-1506-01A-01R-0479-07 +TCGA-13-1507-01 TCGA-13-1507-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1507 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 77 Bilateral TCGA-13-1507-F72677 TCGA-13-1507 TCGA-13-1507-01A Stage IIIC -28445 1993 0 145 324 1 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.1 NO 60 2 G3 YES TCGA-13-1507.0B6D1513-8119-459C-8D5A-8942B8C31179.pdf 1507 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A DECEASED 2008 TCGA-13-1507-01 TCGA-13-1507-01 c374d509-5dff-45a7-bb49-b7e273b6f229 TCGA-13-1507-01 TCGA-13-1507-01A-01D-0475-05 TCGA-13-1507-01A-01W-0549-09 TCGA-13-1507-01A-21-1562-20 TCGA-13-1507-01A-01W-0549-09 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 TCGA-13-1507-01A-01D-0472-01 TCGA-13-1507-01 307d0834-99b0-416a-aafb-60d7ec74406f TCGA-13-1507-01A-01D-0472-01 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 TCGA-13-1507-01 TCGA-13-1507-01 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 TCGA-13-1507-01A-01W-0549-09 TCGA-13-1507-01A-01R-0479-07 +TCGA-13-1509-01 TCGA-13-1509-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1509 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Bilateral TCGA-13-1509-F72678 TCGA-13-1509 TCGA-13-1509-01A Stage IV -23481 0 2438 578 Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.5 NO 40 1.7 G3 YES TCGA-13-1509.5FB47FA9-299B-4466-A324-20D44C788F8B.pdf 1509 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A LIVING 2008 TCGA-13-1509-01 36181328-ff8f-4ad6-9521-7020c689acfe TCGA-13-1509-01 TCGA-13-1509-01A-01D-0475-05 TCGA-13-1509-01A-01W-0549-09 TCGA-13-1509-01A-21-1562-20 TCGA-13-1509-01A-01W-0549-09 TCGA-13-1509-01A-01D-0472-01 TCGA-13-1509-01 a35cc137-a072-4287-8248-dbc4df213144 TCGA-13-1509-01A-01D-0472-01 TCGA-13-1509-01 TCGA-13-1509-01A-01W-0549-09 TCGA-13-1509-01A-01R-0479-07 +TCGA-13-1510-01 TCGA-13-1510-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1510 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Left TCGA-13-1510-F72679 TCGA-13-1510 TCGA-13-1510-01A Stage IIIC -22708 1359 0 78 1189 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 2 G3 YES TCGA-13-1510.D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D.pdf 1510 WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A DECEASED 2008 TCGA-13-1510-01 614859a5-6f16-4f6b-8c26-60646708c1ba TCGA-13-1510-01 TCGA-13-1510-01A-02D-0475-05 TCGA-13-1510-01A-02D-0472-01 TCGA-13-1510-01 TCGA-13-1510-01A-02D-0472-01 TCGA-13-1510-01A-02D-0472-08 TCGA-13-1510-01 TCGA-13-1510-01A-02D-0472-08 TCGA-13-1510-01A-02R-0479-07 +TCGA-13-1511-01 TCGA-13-1511-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-13-1511 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-13-1511-F72680 TCGA-13-1511 TCGA-13-1511-01A Stage IV -19258 1650 0 119 459 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.6 NO 60 2.2 G3 YES TCGA-13-1511.CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0.pdf 1511 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2008 TCGA-13-1511-01 TCGA-13-1511-01 96a8f10e-4b72-4262-9ad7-3ba062ce7f85 TCGA-13-1511-01 TCGA-13-1511-01A-01D-0475-05 TCGA-13-1511-01A-21-1562-20 ccd83080-7a51-4952-b4af-d13e9c182bc0 TCGA-13-1511-01A-01D-0472-01 TCGA-13-1511-01 a5d23561-577b-4b73-979e-8908b15b223e TCGA-13-1511-01A-01D-0472-01 ccd83080-7a51-4952-b4af-d13e9c182bc0 ccd83080-7a51-4952-b4af-d13e9c182bc0 TCGA-13-1511-01 TCGA-13-1511-01 ccd83080-7a51-4952-b4af-d13e9c182bc0 TCGA-13-1511-01A-01R-0479-07 +TCGA-13-1512-01 TCGA-13-1512-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-13-1512 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-13-1512-F72681 TCGA-13-1512 TCGA-13-1512-01A Stage IIIC -18134 0 442 427 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1.4 NO 60 2 G3 YES TCGA-13-1512.66DC098E-9ADD-4446-AB6D-FEA35D5FD33B.pdf 1512 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A LIVING 2008 TCGA-13-1512-01 TCGA-13-1512-01 59b113ee-0571-4e46-b437-9c48e04697eb TCGA-13-1512-01 TCGA-13-1512-01A-01D-0475-05 TCGA-13-1512-01A-21-1558-20 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01D-0472-01 TCGA-13-1512-01 70bd95ea-f6ca-4b5a-b744-e174576d1063 TCGA-13-1512-01A-01D-0472-01 67e85198-4b8c-45db-b433-683b1899f3ea 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01W-0545-08 TCGA-13-1512-01 TCGA-13-1512-01 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01W-0545-08 TCGA-13-1512-01A-01R-0479-07 +TCGA-13-1817-01 TCGA-13-1817-01 High Cluster 6 OV-like c4 TCGA-13-1817 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-13-1817-F24974 TCGA-13-1817 TCGA-13-1817-01A Stage IIIC -20771 1024 0 1024 541 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.5 G3 Recurrence TCGA-13-1817.76F55E61-714E-4C20-A9BD-2ECF28E5444F.pdf 1817 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 13 >20 mm Ovary A DECEASED 2001 aad798d8-5b4a-4f23-8ebe-fb68cb37fd51 TCGA-13-1817-01A-01D-0807-05 TCGA-13-1817-01A-21-1559-20 TCGA-13-1817-01A-01D-2069-01 TCGA-13-1817-01 82a5bb6f-81aa-4ba2-9a74-c0a7ea48cabc,cfa86d7b-f1c9-42b9-8d0e-dc7366aec542 TCGA-13-1817-01A-01D-2069-01 TCGA-13-1817-01 TCGA-13-1817-01A-01R-0810-07 +TCGA-13-1817-02 TCGA-13-1817-02 Cluster 6 TCGA-13-1817 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-13-1817-F24974 TCGA-13-1817 TCGA-13-1817-02A Stage IIIC -20771 1024 0 1024 541 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 G3 Recurrence TCGA-13-1817.AF88642C-B18E-4C22-A8B7-C6B2D259B4E9.pdf 1817 WITH TUMOR YES Partial Remission/Response Imaging Study NO Recurrent Tumor 02 0.4 13 >20 mm Ovary A DECEASED 2001 29cf6928-081b-4498-89b3-89bd24b61608 TCGA-13-1817-02A-01D-0807-05 5823971e-18e2-4fec-8872-a309b1a6914f TCGA-13-1817-02A-01R-0810-07 +TCGA-13-1819-01 TCGA-13-1819-01 High OV-like c1 OV-like c4 TCGA-13-1819 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Right TCGA-13-1819-F72642 TCGA-13-1819 TCGA-13-1819-01A Stage IIC -21635 2025 0 1946 429 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 G3 YES TCGA-13-1819.27225767-34C2-48F2-A347-867FDDC907E9.pdf 1819 WITH TUMOR Primary Tumor 01 0.4 13 No Macroscopic disease Ovary A DECEASED 2004 3816ef10-585d-4480-bee6-d3d3fe9cbef5 TCGA-13-1819-01A-01D-0807-05 TCGA-13-1819-01A-21-1559-20 TCGA-13-1819-01A-01D-2069-01 TCGA-13-1819-01 249b311f-42e8-4ae2-88a1-11e80c3c02f9,6b5c65d5-0279-43ca-80fb-ef142bf820b7 TCGA-13-1819-01A-01D-2069-01 TCGA-13-1819-01 TCGA-13-1819-01A-01R-0810-07 +TCGA-13-1819-02 TCGA-13-1819-02 OV-like c1 TCGA-13-1819 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Right TCGA-13-1819-F72642 TCGA-13-1819 TCGA-13-1819-02A Stage IIC -21635 2025 0 1946 429 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2.1 G3 YES TCGA-13-1819.EABB4610-CCE8-4DC5-A416-0FABFA634056.pdf 1819 WITH TUMOR Recurrent Tumor 02 0.3 13 No Macroscopic disease Ovary A DECEASED 2004 71492b0a-c202-4688-bb17-1828ed1d9d97 TCGA-13-1819-02A-01D-0807-05 f3945f2a-3281-446e-b8b9-d65ac2c770a9 TCGA-13-1819-02A-01R-0810-07 +TCGA-13-2057-01 TCGA-13-2057-01 High UCEC Serous c4 TCGA-13-2057 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-13-2057-F72682 TCGA-13-2057 TCGA-13-2057-01A Stage IIIC -21554 0 2434 897 Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 1.5 NO 60 3 G3 YES TCGA-13-2057.112EC7A2-A410-4D98-A974-BD6BF75E156F.pdf 2057 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.3 13 No Macroscopic disease Ovary A LIVING 2008 0b1c95cf-0eb2-4297-956e-85702b3bbbc3 TCGA-13-2057-01A-02D-1047-05 TCGA-13-2057-01A-02D-1526-09 TCGA-13-2057-01A-02D-1043-01 TCGA-13-2057-01 TCGA-13-2057-01A-02D-1043-01 TCGA-13-2057-01 TCGA-13-2057-01A-02R-1050-07 +TCGA-13-2059-01 TCGA-13-2059-01 High OV-like c1 OV-like c4 TCGA-13-2059 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-13-2059-F72684 TCGA-13-2059 TCGA-13-2059-01A Stage IIIC -18449 0 2387 1005 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 80 2 G3 YES TCGA-13-2059.E3673116-F004-4011-A609-D8E1693DBA62.pdf 2059 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.4 13 1-10 mm Ovary A LIVING 2009 96ef4c4d-9292-4281-b23d-8e29fe47119f TCGA-13-2059-01A-01D-1047-05 TCGA-13-2059-01A-03-1563-20 TCGA-13-2059-01A-01D-1526-09 TCGA-13-2059-01A-01D-1043-01 TCGA-13-2059-01 6af82345-1327-40dc-bbe3-1a4b5feb1da5 TCGA-13-2059-01A-01D-1043-01 TCGA-13-2059-01 TCGA-13-2059-01A-01R-1050-07 +TCGA-13-2060-01 TCGA-13-2060-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-2060 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-13-2060-F72683 TCGA-13-2060 TCGA-13-2060-01A Stage IV -18635 0 2369 1475 Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.5 NO 80 2.5 G3 YES TCGA-13-2060.F6986C14-4627-424E-81C5-74E1CE38D52D.pdf 2060 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.5 13 1-10 mm Ovary A LIVING 2009 TCGA-13-2060-01 TCGA-13-2060-01 60beab4b-53c5-4c97-af8f-21f4076b4850 TCGA-13-2060-01 TCGA-13-2060-01A-01D-0708-05 TCGA-13-2060-01A-21-1560-20 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01D-0704-01 TCGA-13-2060-01 19465a94-b5e9-4700-8f19-0724f72dd3a4 TCGA-13-2060-01A-01D-0704-01 32de1e4d-198a-4616-8227-4d633c80124b 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01W-0799-08 TCGA-13-2060-01 TCGA-13-2060-01 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01W-0799-08 TCGA-13-2060-01A-01R-0711-07 +TCGA-13-2061-01 TCGA-13-2061-01 Squamous OV-like c1 OV-like c4 TCGA-13-2061 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-13-2061-F72686 TCGA-13-2061 TCGA-13-2061-01A Stage IIIC -21543 0 2339 Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.5 NO 80 1.9 G3 NO TCGA-13-2061.57D9D913-A6F9-4406-BF4D-0770004131D5.pdf 2061 Pre-Adjuvant Therapy TUMOR FREE Primary Tumor 01 0.5 13 No Macroscopic disease Ovary A LIVING 2009 7183ed35-46c8-49c5-b247-09d01df7f6de TCGA-13-2061-01A-01D-1047-05 TCGA-13-2061-01A-03-1563-20 TCGA-13-2061-01A-01D-1526-09 TCGA-13-2061-01A-01D-1043-01 TCGA-13-2061-01 7fd07232-c71d-43b3-8f05-8855c8028871 TCGA-13-2061-01A-01D-1043-01 TCGA-13-2061-01 TCGA-13-2061-01A-01R-1050-07 +TCGA-13-2065-01 TCGA-13-2065-01 Squamous OV-like c1 OV-like c4 TCGA-13-2065 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Bilateral TCGA-13-2065-F72688 TCGA-13-2065 Stage IIIC -25973 0 1993 946 Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 YES 2065 WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary LIVING 2009 d020829d-93e8-4b1d-9b6e-006efc029547 TCGA-13-2065-01A-01D-1047-05 TCGA-13-2065-01A-03-1563-20 TCGA-13-2065-01A-01D-1526-09 TCGA-13-2065-01A-01D-1043-01 TCGA-13-2065-01 c8f40939-b3f0-4392-bad8-38608d23f320 TCGA-13-2065-01A-01D-1043-01 TCGA-13-2065-01 TCGA-13-2065-01A-01R-1050-07 +TCGA-13-2066-01 TCGA-13-2066-01 OV-like c1 UCEC-like c5 TCGA-13-2066 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-13-2066-F72687 TCGA-13-2066 Stage IV -18170 2133 0 295 1028 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 80 G3 YES 2066 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 13 1-10 mm Ovary DECEASED 2009 bfe15bbc-6ec4-4c49-b86d-4b01aa23093a TCGA-13-2066-01A-01D-1047-05 TCGA-13-2066-01A-03-1562-20 TCGA-13-2066-01A-01D-1526-09 TCGA-13-2066-01 f2fa59a1-7ceb-4483-9925-3b2707f18d51 TCGA-13-2066-01A-01R-1050-07 +TCGA-13-2071-01 TCGA-13-2071-01 Squamous OV-like c1 TCGA-13-2071 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-13-2071-F72689 TCGA-13-2071 TCGA-13-2071-01A Stage IV -23367 773 0 191 322 Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 2 NO 80 2.5 G3 YES TCGA-13-2071.882BE278-9263-466C-BF61-E30543690FD7.pdf 2071 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.6 13 1-10 mm Ovary A DECEASED 2009 97c72a04-f6a3-4f0e-89ca-8b6a47ee6d25 TCGA-13-2071-01A-02D-1047-05 TCGA-13-2071-01A-02D-1526-09 TCGA-13-2071-01A-02D-1043-01 TCGA-13-2071-01 TCGA-13-2071-01A-02D-1043-01 TCGA-13-2071-01 TCGA-13-2071-01A-02R-1050-07 +TCGA-13-A5FT-01 TCGA-13-A5FT-01 TCGA-13-A5FT TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-13-A5FT-F72595 TCGA-13-A5FT TCGA-13-A5FT-01A Stage IIIC -24743 1211 0 2143 Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 230 NO 70 G3 NO true No TCGA-13-A5FT.B67517DE-A483-4563-8698-51CB95DC5CF1.pdf A5FT Pre-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO RX Primary Tumor 01 NO YES 13 No Macroscopic disease Ovary A LIVING 2009 TCGA-13-A5FT-01 TCGA-13-A5FT-01 TCGA-13-A5FT-01A-11D-A409-05 TCGA-13-A5FT-01 819ce36b-9256-4ea0-947f-694029850c9d TCGA-13-A5FT-01A-11D-A402-01 2066E3C1-00C3-4264-AA5A-A441AA209F55 TCGA-13-A5FT-01A-11R-A406-31 TCGA-13-A5FT-01A-11D-A402-01 819ce36b-9256-4ea0-947f-694029850c9d TCGA-13-A5FT-01A-11R-A406-31 819ce36b-9256-4ea0-947f-694029850c9d TCGA-13-A5FT-01 819ce36b-9256-4ea0-947f-694029850c9d +TCGA-13-A5FU-01 TCGA-13-A5FU-01 TCGA-13-A5FU TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-13-A5FU TCGA-13-A5FU-01A Stage IV -22256 1151 256 0 2013-5-26 FEMALE Serous Cystadenocarcinoma No C48.0 8441/3 C48.0 YES Tumor resection 210 NO 50 G3 NO true No TCGA-13-A5FU.81DED60F-76BC-47E8-A15C-4488C6FDA1A5.pdf A5FU Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NO R2 Primary Tumor 01 NO YES 13 1-10 mm Ovary A DECEASED 2009 TCGA-13-A5FU-01 TCGA-13-A5FU-01A-11D-A409-05 TCGA-13-A5FU-01 TCGA-13-A5FU-01A-11D-A402-01 71773ABF-D6B1-46D1-BE6D-95F3B01E04A4 TCGA-13-A5FU-01A-11D-A402-01 +TCGA-20-0987-01 TCGA-20-0987-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-20-0987 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-20-0987-F25518 TCGA-20-0987 Stage IIIC -22287 701 0 442 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy G3 Recurrence 0987 WITH TUMOR YES Physical Examination NO Primary Tumor 01 20 1-10 mm Ovary DECEASED 2004 e770e1d2-f6bc-4fc0-87c5-15f0939a189b TCGA-20-0987-01A-02D-0432-05 TCGA-20-0987-01A-02D-0428-01 TCGA-20-0987-01 TCGA-20-0987-01A-02D-0428-01 TCGA-20-0987-01A-02W-0486-08 TCGA-20-0987-01 TCGA-20-0987-01A-02W-0486-08 TCGA-20-0987-01A-02R-0436-07 +TCGA-20-0990-01 TCGA-20-0990-01 High OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-20-0990 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-20-0990-F25523 TCGA-20-0990 TCGA-20-0990-01A Stage IIIC -27170 0 789 871 1 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 0.6 NO 0.7 G3 Recurrence TCGA-20-0990.2380A6A4-8F10-40BE-BEE6-DCC116803763.pdf 0990 Post-Adjuvant Therapy WITH TUMOR YES Molecular Markers NO Primary Tumor 01 0.3 20 Ovary A LIVING 2005 TCGA-20-0990-01 8179bb45-deba-42a6-9306-73030e4aa5d8 TCGA-20-0990-01 TCGA-20-0990-01A-01D-0432-05 TCGA-20-0990-01A-01D-0428-01 TCGA-20-0990-01 TCGA-20-0990-01A-01D-0428-01 TCGA-20-0990-01A-01W-0486-08 TCGA-20-0990-01 TCGA-20-0990-01A-01W-0486-08 TCGA-20-0990-01A-01R-0436-07 +TCGA-20-0991-01 TCGA-20-0991-01 High OV-like c1 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-20-0991 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Right TCGA-20-0991-F25530 TCGA-20-0991 Stage IIB -28694 0 797 0 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 0991 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 20 No Macroscopic disease Ovary LIVING 2006 TCGA-20-0991-01 bc5c2691-a35b-4548-99ed-7a3e6e95153f TCGA-20-0991-01 TCGA-20-0991-01A-03D-0432-05 TCGA-20-0991-01A-03D-0428-01 TCGA-20-0991-01 TCGA-20-0991-01A-03D-0428-01 TCGA-20-0991-01A-03D-0428-08 TCGA-20-0991-01 TCGA-20-0991-01A-03D-0428-08 TCGA-20-0991-01A-01R-0436-07 +TCGA-20-0996-01 TCGA-20-0996-01 Kirc+ OV-like c1 TCGA-20-0996 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-20-0996-F25533 TCGA-20-0996 Stage IIIC -21572 0 2196 0 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G2 0996 Post-Adjuvant Therapy WITH TUMOR YES NO Primary Tumor 01 20 1-10 mm Ovary LIVING 2001 c1396756-4582-49ae-ac88-857ff11b377d TCGA-20-0996-01A-03D-0432-05 TCGA-20-0996-01A-03D-0428-01 TCGA-20-0996-01 TCGA-20-0996-01A-03D-0428-01 TCGA-20-0996-01 TCGA-20-0996-01A-02R-0436-07 +TCGA-20-1682-01 TCGA-20-1682-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-20-1682 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 Bilateral TCGA-20-1682-F25540 TCGA-20-1682 TCGA-20-1682-01A Stage IIIC -20583 0 837 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1 YES GX TCGA-20-1682.cf49ea4d-478c-469d-ace2-7ef52b66a332.pdf 1682 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 20 11-20 mm Ovary YES A LIVING 2007 TCGA-20-1682-01 TCGA-20-1682-01 3feadfdb-a932-4ead-8a20-59698a0655ae TCGA-20-1682-01 TCGA-20-1682-01A-01D-0563-05 TCGA-20-1682-01A-21-1558-20 TCGA-20-1682-01A-01W-0633-09 f03d023b-cba8-413d-a88d-0378ee7b7748 TCGA-20-1682-01A-01D-0559-01 TCGA-20-1682-01 a999220b-fed5-446d-8bba-c4c59428d473 TCGA-20-1682-01A-01D-0559-01 f03d023b-cba8-413d-a88d-0378ee7b7748 f03d023b-cba8-413d-a88d-0378ee7b7748 TCGA-20-1682-01 TCGA-20-1682-01 f03d023b-cba8-413d-a88d-0378ee7b7748 TCGA-20-1682-01A-01R-0566-07 +TCGA-20-1683-01 TCGA-20-1683-01 High C9-OV Cluster 6 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 TCGA-20-1683 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-20-1683-F25544 TCGA-20-1683 TCGA-20-1683-01A Stage IIIC -24006 0 772 618 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 G3 Recurrence TCGA-20-1683.5a83e4b3-8be2-4628-bd4b-93d040b43856.pdf 1683 Post-Adjuvant Therapy TUMOR FREE YES Stable Disease Molecular Markers NO Primary Tumor 01 0.4 20 No Macroscopic disease Ovary A LIVING 2007 TCGA-20-1683-01 TCGA-20-1683-01 f44d8a5e-bb22-4961-bfa5-be4ba92c8729 TCGA-20-1683-01 TCGA-20-1683-01A-01D-0563-05 TCGA-20-1683-01A-21-1558-20 TCGA-20-1683-01A-01W-0633-09 e78c6cd7-67f2-4ac8-9dd9-c46392459835 TCGA-20-1683-01A-01D-0559-01 TCGA-20-1683-01 78abd251-6a19-4b51-bd1d-7c8dba5f324e TCGA-20-1683-01A-01D-0559-01 e78c6cd7-67f2-4ac8-9dd9-c46392459835 e78c6cd7-67f2-4ac8-9dd9-c46392459835 TCGA-20-1683-01 TCGA-20-1683-01 e78c6cd7-67f2-4ac8-9dd9-c46392459835 TCGA-20-1683-01A-01R-0566-07 +TCGA-20-1684-01 TCGA-20-1684-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-20-1684 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-20-1684-F25549 TCGA-20-1684 TCGA-20-1684-01A Stage IIIC -18755 0 581 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 NO G3 TCGA-20-1684.3ce61823-9e89-424f-9ce2-a8987420b2a9.pdf 1684 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 20 1-10 mm Ovary NO A LIVING 2007 TCGA-20-1684-01 TCGA-20-1684-01 c0d9b7e3-7c05-4db3-a77e-ae8a6a4ab4e7 TCGA-20-1684-01 TCGA-20-1684-01A-01D-0563-05 TCGA-20-1684-01A-21-1558-20 TCGA-20-1684-01A-01W-0633-09 91b2872a-73bc-4f52-a8f6-96ce81cbef8a TCGA-20-1684-01A-01D-0559-01 TCGA-20-1684-01 8ba9a6e5-3dc8-4e7b-80ca-17470663b495 TCGA-20-1684-01A-01D-0559-01 91b2872a-73bc-4f52-a8f6-96ce81cbef8a 91b2872a-73bc-4f52-a8f6-96ce81cbef8a TCGA-20-1684-01 TCGA-20-1684-01 91b2872a-73bc-4f52-a8f6-96ce81cbef8a TCGA-20-1684-01A-01R-0566-07 +TCGA-20-1685-01 TCGA-20-1685-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-20-1685 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-20-1685-F25554 TCGA-20-1685 TCGA-20-1685-01A Stage IIIC -16745 0 508 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 NO G3 TCGA-20-1685.09b7c163-7ad3-42a2-bc06-32bd55f80327.pdf 1685 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 20 1-10 mm Ovary NO A LIVING 2008 TCGA-20-1685-01 TCGA-20-1685-01 923bc90c-b380-4710-b062-5c3deb27de44 TCGA-20-1685-01 TCGA-20-1685-01A-01D-0563-05 TCGA-20-1685-01A-21-1558-20 TCGA-20-1685-01A-01W-0633-09 9f6dd4ad-0130-46fe-9c49-72f378a753fe TCGA-20-1685-01A-01D-0559-01 TCGA-20-1685-01 b1b57151-ff27-4b55-bf89-6e25a61f1060 TCGA-20-1685-01A-01D-0559-01 9f6dd4ad-0130-46fe-9c49-72f378a753fe 9f6dd4ad-0130-46fe-9c49-72f378a753fe TCGA-20-1685-01 TCGA-20-1685-01 9f6dd4ad-0130-46fe-9c49-72f378a753fe TCGA-20-1685-01A-01R-0566-07 +TCGA-20-1686-01 TCGA-20-1686-01 High OV-like c1 BRCA basal-like c6 miRNA cluster 2 cluster 2 TCGA-20-1686 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 75 Bilateral TCGA-20-1686-F25559 TCGA-20-1686 TCGA-20-1686-01A Stage IIIC -27588 0 89 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.8 NO G3 TCGA-20-1686.c87ff195-1793-455a-bb19-e495a915befe.pdf 1686 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 20 No Macroscopic disease Ovary A LIVING 2008 TCGA-20-1686-01 91fb24d3-6a1d-4fd1-9bf3-d891ab25017c TCGA-20-1686-01 TCGA-20-1686-01A-01D-0563-05 TCGA-20-1686-01A-21-1558-20 TCGA-20-1686-01A-01W-0633-09 TCGA-20-1686-01A-01D-0559-01 TCGA-20-1686-01 92c3ac1c-3e84-4448-8587-8c95329d0549 TCGA-20-1686-01A-01D-0559-01 TCGA-20-1686-01 TCGA-20-1686-01A-01R-0566-07 +TCGA-20-1687-01 TCGA-20-1687-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 TCGA-20-1687 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Bilateral TCGA-20-1687-F25563 TCGA-20-1687 TCGA-20-1687-01A Stage IV -16961 0 81 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.8 YES G3 TCGA-20-1687.e966d90f-0e5f-42e6-b487-1f10fbef204f.pdf 1687 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 20 No Macroscopic disease Ovary A LIVING 2008 TCGA-20-1687-01 TCGA-20-1687-01 7221f0cf-2235-4717-938b-425c949730e3 TCGA-20-1687-01 TCGA-20-1687-01A-01D-0563-05 TCGA-20-1687-01A-21-1558-20 TCGA-20-1687-01A-01W-0633-09 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 TCGA-20-1687-01A-01D-0559-01 TCGA-20-1687-01 a3332b9e-1a9c-4a7e-81c0-e19de968609b TCGA-20-1687-01A-01D-0559-01 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 TCGA-20-1687-01 TCGA-20-1687-01 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 TCGA-20-1687-01A-01R-0566-07 +TCGA-23-1021-01 TCGA-23-1021-01 High OV-like c1 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-23-1021 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Right TCGA-23-1021-F25567 TCGA-23-1021 Stage IV -16484 1446 0 1446 1181 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Locoregional Disease YES 1021 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 23 >20 mm Ovary YES DECEASED 2004 TCGA-23-1021-01 eb55cb66-59d1-4b7c-a99e-3dd5e38cca85 TCGA-23-1021-01 TCGA-23-1021-01B-01D-0432-05 TCGA-23-1021-01B-01W-0488-09 TCGA-23-1021-01B-01W-0488-09 TCGA-23-1021-01B-01D-0428-01 TCGA-23-1021-01 TCGA-23-1021-01B-01D-0428-01 TCGA-23-1021-01 TCGA-23-1021-01B-01W-0488-09 TCGA-23-1021-01B-01R-0436-07 +TCGA-23-1022-01 TCGA-23-1022-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1022 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Left TCGA-23-1022-F25576 TCGA-23-1022 TCGA-23-1022-01A Stage IIIC -24798 1511 0 450 2009-2-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.7 YES G3 Recurrence TCGA-23-1022.1A674838-E992-4E9B-82AE-FAFA0AD3BF56.pdf 1022 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 23 1-10 mm Ovary YES A DECEASED 2003 TCGA-23-1022-01 430ab09f-2d3f-4a3d-9aac-d6c678e983db TCGA-23-1022-01 TCGA-23-1022-01A-02D-0432-05 TCGA-23-1022-01A-02W-0488-09 TCGA-23-1022-01A-02W-0488-09 TCGA-23-1022-01A-02D-0428-01 TCGA-23-1022-01 TCGA-23-1022-01A-02D-0428-01 TCGA-23-1022-01 TCGA-23-1022-01A-02W-0488-09 TCGA-23-1022-01A-01R-0436-07 +TCGA-23-1023-01 TCGA-23-1023-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-23-1023 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-23-1023-F25587 TCGA-23-1023 TCGA-23-1023-01R Stage IIIC -23826 0 1233 490 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G3 Recurrence TCGA-23-1023.98EBC356-C54E-4C1E-9726-BA61397DDA38.pdf 1023 WITH TUMOR YES Complete Remission/Response Other Method NO Recurrent Tumor 02 0.3 23 1-10 mm Ovary YES R LIVING 2005 TCGA-23-1023-01 TCGA-23-1023-01 TCGA-23-1023-01A-03W-0484-10 fcd199f1-6a2a-4b56-977a-6e0959335ca9,d00090cb-c5e2-427f-bdee-5602808ec406 TCGA-23-1023-01 TCGA-23-1023-01A-03W-0484-10 TCGA-23-1023-01A-03D-0432-05,TCGA-23-1023-01R-01D-0807-05 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf TCGA-23-1023-01A-03D-0428-01 TCGA-23-1023-01 TCGA-23-1023-01A-03D-0428-01 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf TCGA-23-1023-01 TCGA-23-1023-01 69bec2db-02c3-46ca-b17b-60eae9a1e0bf,1c88dde8-4fe6-49e9-8d76-40668ed783ff TCGA-23-1023-01A-03W-0484-10 TCGA-23-1023-01R-01R-0810-07,TCGA-23-1023-01A-02R-0436-07 +TCGA-23-1024-01 TCGA-23-1024-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-1024 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Right TCGA-23-1024-F25604 TCGA-23-1024 TCGA-23-1024-01A Stage IV -19052 0 468 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.8 G3 TCGA-23-1024.1CCE5978-6A4D-427A-9875-47617F6A4258.pdf 1024 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.2 23 1-10 mm Ovary A LIVING 2007 TCGA-23-1024-01 TCGA-23-1024-01A-02W-0484-10 15e969ea-df91-4ade-9f5f-91f317ac7573 TCGA-23-1024-01 TCGA-23-1024-01A-02W-0484-10 TCGA-23-1024-01A-02D-0432-05 TCGA-23-1024-01A-02D-0428-01 TCGA-23-1024-01 TCGA-23-1024-01A-02D-0428-01 TCGA-23-1024-01 TCGA-23-1024-01A-02W-0484-10 TCGA-23-1024-01A-02R-0436-07 +TCGA-23-1026-01 TCGA-23-1026-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-23-1026 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Left TCGA-23-1026-F25610 TCGA-23-1026 TCGA-23-1026-01B Stage IIIC -16442 0 816 797 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 G3 Recurrence TCGA-23-1026.E41E1018-422B-4B4A-8732-C9389847830D.pdf 1026 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 23 1-10 mm Ovary B LIVING 2004 TCGA-23-1026-01 TCGA-23-1026-01 TCGA-23-1026-01B-01W-0484-10 fca7646c-094b-4720-a550-f3e066f24431 TCGA-23-1026-01 TCGA-23-1026-01B-01W-0484-10 TCGA-23-1026-01B-01D-0432-05 973907c7-f259-4d1a-b9df-68db1837af91 TCGA-23-1026-01B-01D-0428-01 TCGA-23-1026-01 TCGA-23-1026-01B-01D-0428-01 973907c7-f259-4d1a-b9df-68db1837af91 973907c7-f259-4d1a-b9df-68db1837af91 TCGA-23-1026-01 TCGA-23-1026-01 973907c7-f259-4d1a-b9df-68db1837af91 TCGA-23-1026-01B-01W-0484-10 TCGA-23-1026-01B-01R-0436-07 +TCGA-23-1027-01 TCGA-23-1027-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1027 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Right TCGA-23-1027-F25616 TCGA-23-1027 Stage IIIC -17588 976 0 966 114 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1027 YES Progressive Disease NO Primary Tumor 01 23 1-10 mm Ovary YES DECEASED 2005 TCGA-23-1027-01 TCGA-23-1027-01 acb73086-38dd-4ed6-9d1c-d14dcd155936 TCGA-23-1027-01 TCGA-23-1027-01A-02D-0432-05 edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02D-0428-01 TCGA-23-1027-01 TCGA-23-1027-01A-02D-0428-01 edbc81a6-2593-45c5-8131-3c4615d1807f edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02W-0486-08 TCGA-23-1027-01 TCGA-23-1027-01 edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02W-0486-08 TCGA-23-1027-01A-02R-0436-07 +TCGA-23-1028-01 TCGA-23-1028-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-1028 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 43 Left TCGA-23-1028-F25624 TCGA-23-1028 TCGA-23-1028-01A Stage IIIC -16018 0 1503 133 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.8 YES G3 Recurrence TCGA-23-1028.CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2.pdf 1028 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 23 1-10 mm Ovary YES A LIVING 2004 TCGA-23-1028-01 TCGA-23-1028-01A-01W-0484-10 511adb99-1cae-481e-8da7-f4cdc4d5f385 TCGA-23-1028-01 TCGA-23-1028-01A-01W-0484-10 TCGA-23-1028-01A-01D-0432-05 TCGA-23-1028-01A-01D-0428-01 TCGA-23-1028-01 TCGA-23-1028-01A-01D-0428-01 TCGA-23-1028-01 TCGA-23-1028-01A-01W-0484-10 TCGA-23-1028-01A-01R-0436-07 +TCGA-23-1029-01 TCGA-23-1029-01 Squamous OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 TCGA-23-1029 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Right TCGA-23-1029-F25639 TCGA-23-1029 TCGA-23-1029-01B Stage IIIC -16889 0 268 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 G3 TCGA-23-1029.89E1F403-12CB-442A-9588-CF5C0AC0E0A6.pdf 1029 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 23 1-10 mm Ovary B LIVING 2007 TCGA-23-1029-01 TCGA-23-1029-01 fcd48515-450a-4a24-b92d-8fb4eb4890b3 TCGA-23-1029-01 TCGA-23-1029-01B-01D-0581-05 TCGA-23-1029-01B-01W-0639-09 9a54d0fe-f998-4866-bb1f-92be472d843a TCGA-23-1029-01B-01D-0577-01 TCGA-23-1029-01 TCGA-23-1029-01B-01D-0577-01 9a54d0fe-f998-4866-bb1f-92be472d843a 9a54d0fe-f998-4866-bb1f-92be472d843a TCGA-23-1029-01 TCGA-23-1029-01 9a54d0fe-f998-4866-bb1f-92be472d843a TCGA-23-1029-01B-01R-0584-07 +TCGA-23-1030-01 TCGA-23-1030-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-1030 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-23-1030-F25643 TCGA-23-1030 Stage IIIC -23416 0 886 544 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1030 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 23 1-10 mm Ovary YES LIVING 2006 TCGA-23-1030-01 b1f62bf0-8681-4b6d-ab78-a7c5757770a4 TCGA-23-1030-01 TCGA-23-1030-01A-02D-0432-05 TCGA-23-1030-01A-02D-0428-01 TCGA-23-1030-01 TCGA-23-1030-01A-02D-0428-01 TCGA-23-1030-01A-02W-0486-08 TCGA-23-1030-01 TCGA-23-1030-01A-02W-0486-08 TCGA-23-1030-01A-02R-0436-07 +TCGA-23-1031-01 TCGA-23-1031-01 High OV-like c1 mutation cluster 5 TCGA-23-1031 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Left TCGA-23-1031-F25649 TCGA-23-1031 Stage IV -22225 575 0 575 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1031 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 23 1-10 mm Ovary DECEASED 2003 c85b3936-20a5-41cb-ad0d-d184c2c1f6d9 TCGA-23-1031-01A-01D-0432-05 TCGA-23-1031-01A-01D-0428-01 TCGA-23-1031-01 TCGA-23-1031-01A-01D-0428-01 TCGA-23-1031-01A-01W-0486-08 TCGA-23-1031-01 TCGA-23-1031-01A-01W-0486-08 TCGA-23-1031-01A-01R-0436-07 +TCGA-23-1032-01 TCGA-23-1032-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1032 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Right TCGA-23-1032-F25659 TCGA-23-1032 TCGA-23-1032-01A Stage IV -26715 84 0 68 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 G3 TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50.pdf 1032 WITH TUMOR NO NO Primary Tumor 01 0.6 23 1-10 mm Ovary A DECEASED 2002 TCGA-23-1032-01 986863dd-b61b-48c2-a37c-af21fed7e778 TCGA-23-1032-01 TCGA-23-1032-01A-02D-0432-05 TCGA-23-1032-01A-02D-0428-01 TCGA-23-1032-01 TCGA-23-1032-01A-02D-0428-01 TCGA-23-1032-01A-02W-0486-08 TCGA-23-1032-01 TCGA-23-1032-01A-02W-0486-08 TCGA-23-1032-01A-02R-0436-07 +TCGA-23-1107-01 TCGA-23-1107-01 High OV-like c1 miRNA cluster 2 cluster 1 TCGA-23-1107 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Left TCGA-23-1107-F25661 TCGA-23-1107 TCGA-23-1107-01A Stage IV -21561 9 0 9 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G3 TCGA-23-1107.700802e6-8058-4485-8210-3e5b8f10bbf3.pdf 1107 WITH TUMOR NO NO Primary Tumor 01 0.6 23 >20 mm Ovary A DECEASED 1999 TCGA-23-1107-01 TCGA-23-1107-01A-01W-0484-10 7f426322-5acf-4d04-8bd6-93ec56bffd0f TCGA-23-1107-01 TCGA-23-1107-01A-01W-0484-10 TCGA-23-1107-01A-01D-0432-05 TCGA-23-1107-01 TCGA-23-1107-01A-01R-0436-07 +TCGA-23-1109-01 TCGA-23-1109-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 TCGA-23-1109 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 62 Right TCGA-23-1109-F25663 TCGA-23-1109 Stage IIIC -23002 1562 0 1562 987 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1109 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 23 1-10 mm Ovary DECEASED 1999 TCGA-23-1109-01 TCGA-23-1109-01 TCGA-23-1109-01A-01W-0484-10 ef6ecfd8-badc-4863-a3d5-fc20161f09dc TCGA-23-1109-01 TCGA-23-1109-01A-01W-0484-10 TCGA-23-1109-01A-01D-0432-05 TCGA-23-1109-01A-21-1562-20 d47e074a-f78e-40c5-8af4-f737ce010041 TCGA-23-1109-01A-01D-0428-01 TCGA-23-1109-01 b8d71b4b-6d11-47da-b15d-a3eac835a9a9 TCGA-23-1109-01A-01D-0428-01 d47e074a-f78e-40c5-8af4-f737ce010041 d47e074a-f78e-40c5-8af4-f737ce010041 TCGA-23-1109-01 TCGA-23-1109-01 d47e074a-f78e-40c5-8af4-f737ce010041 TCGA-23-1109-01A-01R-0436-07 +TCGA-23-1110-01 TCGA-23-1110-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-23-1110 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Right TCGA-23-1110-F25666 TCGA-23-1110 TCGA-23-1110-01A Stage IIIC -15383 0 1658 326 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 YES G3 Recurrence TCGA-23-1110.07361efd-0b7d-4dcb-afe3-464200f59ac0.pdf 1110 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 23 No Macroscopic disease Ovary YES A LIVING 2003 TCGA-23-1110-01 811e848e-6289-4821-8640-c645e2b3f57e TCGA-23-1110-01 TCGA-23-1110-01A-01D-0432-05 TCGA-23-1110-01A-11-1562-20 TCGA-23-1110-01A-01D-0428-01 TCGA-23-1110-01 e36ba512-a711-4e42-80ce-94edb0be836e TCGA-23-1110-01A-01D-0428-01 TCGA-23-1110-01A-01D-0428-08 TCGA-23-1110-01 TCGA-23-1110-01A-01D-0428-08 TCGA-23-1110-01A-01R-0436-07 +TCGA-23-1111-01 TCGA-23-1111-01 High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 4 TCGA-23-1111 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Right TCGA-23-1111-F25672 TCGA-23-1111 TCGA-23-1111-01A Stage IIIC -23171 0 98 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 0.9 YES G3 TCGA-23-1111.ba3ae03c-74d4-4b5f-849f-71466bae7c0e.pdf 1111 YES NO Primary Tumor 01 0.4 23 >20 mm Ovary A LIVING 2008 TCGA-23-1111-01 TCGA-23-1111-01 190f5d18-230f-417f-b10c-992c28dcf418 TCGA-23-1111-01 TCGA-23-1111-01A-01D-0581-05 TCGA-23-1111-01A-21-20 TCGA-23-1111-01A-01W-0639-09 f38e46dc-67b9-448a-8d24-507291e55bca TCGA-23-1111-01A-01D-0577-01 TCGA-23-1111-01 8e14b0f8-af54-486f-9ecc-8b62eb434ad4 TCGA-23-1111-01A-01D-0577-01 f38e46dc-67b9-448a-8d24-507291e55bca f38e46dc-67b9-448a-8d24-507291e55bca TCGA-23-1111-01 TCGA-23-1111-01 f38e46dc-67b9-448a-8d24-507291e55bca TCGA-23-1111-01A-01R-0584-07 +TCGA-23-1113-01 TCGA-23-1113-01 Squamous OV-like c1 miRNA cluster 2 cluster 1 TCGA-23-1113 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Left TCGA-23-1113-F25677 TCGA-23-1113 Stage IV -17791 949 0 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 1113 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 23 1-10 mm Ovary DECEASED 2002 TCGA-23-1113-01 a418120d-175f-4f72-b81f-02528d563418 TCGA-23-1113-01 TCGA-23-1113-01A-01D-0432-05 TCGA-23-1113-01A-01D-0428-01 TCGA-23-1113-01 TCGA-23-1113-01A-01D-0428-01 TCGA-23-1113-01 TCGA-23-1113-01A-01R-0436-07 +TCGA-23-1114-01 TCGA-23-1114-01 High OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 TCGA-23-1114 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Left TCGA-23-1114-F25685 TCGA-23-1114 TCGA-23-1114-01B Stage IIIC -20409 2089 0 2089 634 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G3 Recurrence TCGA-23-1114.d5c00586-d7e4-4909-be2b-ffc4f9ef2e82.pdf 1114 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 23 No Macroscopic disease Ovary B DECEASED 2000 TCGA-23-1114-01 TCGA-23-1114-01 7ee203ae-339a-4534-9e72-0dd723890ad1 TCGA-23-1114-01 TCGA-23-1114-01B-01D-0563-05 TCGA-23-1114-01B-01W-0633-09 7cfe1419-65be-4860-9f99-75f4a139d9ac TCGA-23-1114-01B-01D-0559-01 TCGA-23-1114-01 TCGA-23-1114-01B-01D-0559-01 7cfe1419-65be-4860-9f99-75f4a139d9ac 7cfe1419-65be-4860-9f99-75f4a139d9ac TCGA-23-1114-01 TCGA-23-1114-01 7cfe1419-65be-4860-9f99-75f4a139d9ac TCGA-23-1114-01B-01R-0566-07 +TCGA-23-1116-01 TCGA-23-1116-01 High OV-like c1 mutation cluster 8 TCGA-23-1116 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 83 Left TCGA-23-1116-F72416 TCGA-23-1116 Stage IIIC -30464 592 0 139 286 Additional New Tumor Event Progressive Disease 2015-6-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO YES G3 Recurrence YES 1116 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 23 >20 mm Ovary YES DECEASED 2008 e7a2e1cf-9175-4d4b-9f6a-ccace71a5267 TCGA-23-1116-01A-01D-0432-05 TCGA-23-1116-01A-01D-0428-01 TCGA-23-1116-01 TCGA-23-1116-01A-01D-0428-01 TCGA-23-1116-01A-01W-0486-08 TCGA-23-1116-01 TCGA-23-1116-01A-01W-0486-08 TCGA-23-1116-01A-01R-0436-07 +TCGA-23-1117-01 TCGA-23-1117-01 High OV-like c1 mutation cluster 8 TCGA-23-1117 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Left TCGA-23-1117-F25699 TCGA-23-1117 TCGA-23-1117-01A Stage IIIC -15690 1013 0 418 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.7 YES G3 Recurrence TCGA-23-1117.abc636a1-677d-49e5-9259-5b5b828a575e.pdf 1117 WITH TUMOR NO Complete Remission/Response Other Method YES Primary Tumor 01 0.4 23 1-10 mm Ovary YES A DECEASED 1998 7cf2b05a-4475-44db-af64-1889f8073941 TCGA-23-1117-01A-02D-0432-05 TCGA-23-1117-01A-02W-0488-09 TCGA-23-1117-01A-02W-0488-09 TCGA-23-1117-01A-02D-0428-01 TCGA-23-1117-01 TCGA-23-1117-01A-02D-0428-01 TCGA-23-1117-01 TCGA-23-1117-01A-02W-0488-09 TCGA-23-1117-01A-02R-0436-07 +TCGA-23-1118-01 TCGA-23-1118-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-1118 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Left TCGA-23-1118-F25708 TCGA-23-1118 Stage IIIC -16471 0 2616 2009-2-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 1118 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 23 >20 mm Ovary YES LIVING 2001 TCGA-23-1118-01 cbd86cfc-faa7-40dd-a544-3c0dba5849aa TCGA-23-1118-01 TCGA-23-1118-01A-01D-0432-05 TCGA-23-1118-01A-01W-0488-09 TCGA-23-1118-01A-01W-0488-09 TCGA-23-1118-01A-01D-0428-01 TCGA-23-1118-01 TCGA-23-1118-01A-01D-0428-01 TCGA-23-1118-01 TCGA-23-1118-01A-01W-0488-09 TCGA-23-1118-01A-01R-0436-07 +TCGA-23-1119-01 TCGA-23-1119-01 Squamous OV-like c1 miRNA cluster 1 cluster 4 TCGA-23-1119 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-23-1119-F25711 TCGA-23-1119 TCGA-23-1119-01A Stage IIIC -23686 0 3953 3378 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 YES G3 Recurrence TCGA-23-1119.86389912-6945-49e6-9255-e7a41fde197a.pdf 1119 TUMOR FREE YES Complete Remission/Response Other Method NO Primary Tumor 01 0.6 23 1-10 mm Ovary YES A LIVING 1997 TCGA-23-1119-01 TCGA-23-1119-01A-02W-0484-10 14dd1630-da1d-47ca-bae2-457903a26761 TCGA-23-1119-01 TCGA-23-1119-01A-02W-0484-10 TCGA-23-1119-01A-02D-0432-05 TCGA-23-1119-01A-02D-0428-01 TCGA-23-1119-01 TCGA-23-1119-01A-02D-0428-01 TCGA-23-1119-01 TCGA-23-1119-01A-02R-0436-07 +TCGA-23-1120-01 TCGA-23-1120-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 3 mutation cluster 2 TCGA-23-1120 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Right TCGA-23-1120-F25715 TCGA-23-1120 TCGA-23-1120-01A Stage IIIC -22148 0 130 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.8 NO G3 TCGA-23-1120.e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37.pdf 1120 YES Complete Remission/Response NO Primary Tumor 01 0.6 23 1-10 mm Ovary NO A LIVING 2008 TCGA-23-1120-01 TCGA-23-1120-01 TCGA-23-1120-01A-02W-0484-10 0486be96-3c9f-41a7-9115-295646258378 TCGA-23-1120-01 TCGA-23-1120-01A-02W-0484-10 TCGA-23-1120-01A-02D-0432-05 9b64998e-eed9-428b-97ac-4de398caaf81 TCGA-23-1120-01A-02D-0428-01 TCGA-23-1120-01 TCGA-23-1120-01A-02D-0428-01 9b64998e-eed9-428b-97ac-4de398caaf81 9b64998e-eed9-428b-97ac-4de398caaf81 TCGA-23-1120-01 TCGA-23-1120-01 9b64998e-eed9-428b-97ac-4de398caaf81 TCGA-23-1120-01A-02W-0484-10 TCGA-23-1120-01A-02R-0436-07 +TCGA-23-1121-01 TCGA-23-1121-01 High Cluster 5 OV-like c4 miRNA cluster 1 cluster 5 TCGA-23-1121 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Left TCGA-23-1121-F25719 TCGA-23-1121 TCGA-23-1121-01A Stage IIIC -18983 0 194 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.2 YES G3 TCGA-23-1121.ed14039c-9ecf-4e01-9a1c-7a227847b8a3.pdf 1121 YES NO Primary Tumor 01 0.6 23 >20 mm Ovary A LIVING 2008 TCGA-23-1121-01 e3fca11d-248c-4852-ad4b-09867693fd39 TCGA-23-1121-01 TCGA-23-1121-01A-01D-0432-05 TCGA-23-1121-01A-11-1562-20 TCGA-23-1121-01A-01D-0428-01 TCGA-23-1121-01 97eb2839-fc59-4c0a-a075-b5fd802799c6 TCGA-23-1121-01A-01D-0428-01 TCGA-23-1121-01 TCGA-23-1121-01A-01R-0436-07 +TCGA-23-1122-01 TCGA-23-1122-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1122 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Left TCGA-23-1122-F25724 TCGA-23-1122 TCGA-23-1122-01A Stage IIIC -19537 1189 0 447 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.1 NO G3 Recurrence TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba.pdf 1122 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 23 1-10 mm Ovary A DECEASED 1998 TCGA-23-1122-01 TCGA-23-1122-01 c619e051-c770-4ed9-957b-b27ec8784864 TCGA-23-1122-01 TCGA-23-1122-01A-01D-0432-05 TCGA-23-1122-01A-11-1562-20 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01D-0428-01 TCGA-23-1122-01 2877f544-7459-4a43-9e89-a014008f6a58 TCGA-23-1122-01A-01D-0428-01 54b75801-ad36-49a1-b0c2-edc0053b897e 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01W-0486-08 TCGA-23-1122-01 TCGA-23-1122-01 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01W-0486-08 TCGA-23-1122-01A-01R-0436-07 +TCGA-23-1123-01 TCGA-23-1123-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-23-1123 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Left TCGA-23-1123-F25733 TCGA-23-1123 TCGA-23-1123-01A Stage IIIC -21552 1018 0 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 YES G3 TCGA-23-1123.28f9189b-24eb-4540-8551-4eaacc296c20.pdf 1123 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.6 23 11-20 mm Ovary A DECEASED 1998 TCGA-23-1123-01 TCGA-23-1123-01 c7657407-5f4d-441a-a943-90315de8c660 TCGA-23-1123-01 TCGA-23-1123-01A-01D-0432-05 TCGA-23-1123-01A-01W-0488-09 TCGA-23-1123-01A-11-1562-20 TCGA-23-1123-01A-01W-0488-09 71543abc-9f15-48d9-994d-e7b963a4d8f3 TCGA-23-1123-01A-01D-0428-01 TCGA-23-1123-01 184da43f-2906-495a-a714-031b30a78cdb TCGA-23-1123-01A-01D-0428-01 71543abc-9f15-48d9-994d-e7b963a4d8f3 71543abc-9f15-48d9-994d-e7b963a4d8f3 TCGA-23-1123-01 TCGA-23-1123-01 71543abc-9f15-48d9-994d-e7b963a4d8f3 TCGA-23-1123-01A-01W-0488-09 TCGA-23-1123-01A-01R-0436-07 +TCGA-23-1124-01 TCGA-23-1124-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-23-1124 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Left TCGA-23-1124-F25739 TCGA-23-1124 Stage IIIC -23005 1768 0 641 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1124 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 23 No Macroscopic disease Ovary YES DECEASED 1999 TCGA-23-1124-01 e707d0a2-6e26-48dc-9020-ae36b666321a TCGA-23-1124-01 TCGA-23-1124-01A-01D-0432-05 TCGA-23-1124-01A-01W-0488-09 TCGA-23-1124-01A-11-1562-20 TCGA-23-1124-01A-01W-0488-09 TCGA-23-1124-01A-01D-0428-01 TCGA-23-1124-01 fe87e0a2-b27c-402c-81d8-ec0d24e7ce81 TCGA-23-1124-01A-01D-0428-01 TCGA-23-1124-01 TCGA-23-1124-01A-01W-0488-09 TCGA-23-1124-01A-01R-0436-07 +TCGA-23-1809-01 TCGA-23-1809-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-23-1809 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Right TCGA-23-1809-F25753 TCGA-23-1809 TCGA-23-1809-01A Stage IIC -23111 0 16 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.9 NO G3 TCGA-23-1809.f69b3aba-61df-4fd8-94d7-9bb80692464c.pdf 1809 YES NO Primary Tumor 01 0.4 23 1-10 mm Ovary NO A LIVING 2009 TCGA-23-1809-01 TCGA-23-1809-01 2bf22a99-e464-4889-9c1c-0208d5df2f36 TCGA-23-1809-01 TCGA-23-1809-01A-01D-0563-05 TCGA-23-1809-01A-21-1559-20 TCGA-23-1809-01A-01W-0633-09 ac764277-4d48-489a-8625-f27541b11258 TCGA-23-1809-01A-01D-0559-01 TCGA-23-1809-01 2341af5b-d30e-4ae0-9384-119f66a797ed TCGA-23-1809-01A-01D-0559-01 ac764277-4d48-489a-8625-f27541b11258 ac764277-4d48-489a-8625-f27541b11258 TCGA-23-1809-01 TCGA-23-1809-01 ac764277-4d48-489a-8625-f27541b11258 TCGA-23-1809-01A-01R-0566-07 +TCGA-23-2072-01 TCGA-23-2072-01 High OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-2072 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-23-2072-F25757 TCGA-23-2072 TCGA-23-2072-01A Stage IV -21523 759 0 476 2009-11-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e.pdf 2072 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.2 23 >20 mm Ovary A DECEASED 2000 TCGA-23-2072-01 5ba9bc54-191b-4a8b-8571-24a780a2e7d5 TCGA-23-2072-01 TCGA-23-2072-01A-01D-0667-05 TCGA-23-2072-01A-01D-0663-01 TCGA-23-2072-01 TCGA-23-2072-01A-01D-0663-01 TCGA-23-2072-01A-01W-0722-08 TCGA-23-2072-01 TCGA-23-2072-01A-01W-0722-08 TCGA-23-2072-01A-01R-0670-07 +TCGA-23-2077-01 TCGA-23-2077-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 8 TCGA-23-2077 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Left TCGA-23-2077-F25763 TCGA-23-2077 TCGA-23-2077-01A Stage IIIC -16552 0 3525 1232 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.1 NO G3 Recurrence TCGA-23-2077.55589297-f28e-422c-beee-6cb19a2350be.pdf 2077 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 23 No Macroscopic disease Ovary YES A LIVING 1999 TCGA-23-2077-01 TCGA-23-2077-01 2db607b0-cd7f-4686-9f85-a119b089ed7f TCGA-23-2077-01 TCGA-23-2077-01A-01D-0667-05 TCGA-23-2077-01A-21-1560-20 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01D-0663-01 TCGA-23-2077-01 3848ccad-5f29-40f6-8407-05e548a3b8e5 TCGA-23-2077-01A-01D-0663-01 16c61c5a-a9b3-4022-9b79-d593e3519794 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01W-0722-08 TCGA-23-2077-01 TCGA-23-2077-01 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01W-0722-08 TCGA-23-2077-01A-01R-0670-07 +TCGA-23-2078-01 TCGA-23-2078-01 Squamous C9-OV OV-like c1 KIRC-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-2078 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Bilateral TCGA-23-2078-F25771 TCGA-23-2078 TCGA-23-2078-01A Stage IIIC -24223 0 2661 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.9 YES G3 TCGA-23-2078.19ed5fbe-17e1-43f3-bfa0-32f474a00be8.pdf 2078 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 23 No Macroscopic disease Ovary YES A LIVING 2001 TCGA-23-2078-01 TCGA-23-2078-01 ec2fe757-24f2-4ffc-bf20-f6d6632eb775 TCGA-23-2078-01 TCGA-23-2078-01A-01D-0667-05 TCGA-23-2078-01A-21-1560-20 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01D-0663-01 TCGA-23-2078-01 5ea02416-3cd8-443c-8336-4ad367757f38 TCGA-23-2078-01A-01D-0663-01 9f35075d-4d81-44f2-a672-12028d6231be 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01W-0722-08 TCGA-23-2078-01 TCGA-23-2078-01 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01W-0722-08 TCGA-23-2078-01A-01R-0670-07 +TCGA-23-2079-01 TCGA-23-2079-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation c1uster 9 TCGA-23-2079 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 46 Bilateral TCGA-23-2079-F25775 TCGA-23-2079 TCGA-23-2079-01A Stage IIIC -17122 0 2788 283 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G3 Recurrence TCGA-23-2079.66ace408-fc31-463b-a218-94fdef0afaaf.pdf 2079 TUMOR FREE YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 23 No Macroscopic disease Ovary YES A LIVING 2001 TCGA-23-2079-01 6bbbfad0-800f-4537-99f2-6d5f1e5bdab0 TCGA-23-2079-01 TCGA-23-2079-01A-01D-0667-05 TCGA-23-2079-01A-21-1560-20 TCGA-23-2079-01A-01D-0663-01 TCGA-23-2079-01 527e6a80-10fe-4b9d-9169-63ea62681e4a TCGA-23-2079-01A-01D-0663-01 TCGA-23-2079-01A-01W-0722-08 TCGA-23-2079-01 TCGA-23-2079-01A-01W-0722-08 TCGA-23-2079-01A-01R-0670-07 +TCGA-23-2081-01 TCGA-23-2081-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-23-2081 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-23-2081-F25781 TCGA-23-2081 TCGA-23-2081-01A Stage IV -18162 2342 0 250 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 YES G3 Locoregional Disease YES TCGA-23-2081.05dc597f-052a-461e-a67c-27dac0d10972.pdf 2081 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.5 23 1-10 mm Ovary A DECEASED 2000 TCGA-23-2081-01 TCGA-23-2081-01 c5bdab9f-b9fc-4f96-bc7b-b5a65ec3cf68 TCGA-23-2081-01 TCGA-23-2081-01A-01D-0667-05 TCGA-23-2081-01A-21-1560-20 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01D-0663-01 TCGA-23-2081-01 330a8af7-1a12-46a0-8ede-ca4e244de117 TCGA-23-2081-01A-01D-0663-01 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01W-0722-08 TCGA-23-2081-01 TCGA-23-2081-01 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01W-0722-08 TCGA-23-2081-01A-01R-0670-07 +TCGA-23-2084-01 TCGA-23-2084-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 TCGA-23-2084 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Right TCGA-23-2084-F25795 TCGA-23-2084 TCGA-23-2084-01A Stage IV -16493 1516 0 619 2009-11-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.4 YES G3 Recurrence TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc.pdf 2084 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 23 No Macroscopic disease Ovary YES A DECEASED 2000 TCGA-23-2084-01 TCGA-23-2084-01 6c08e99a-bd74-4e72-8d22-4295edfe6225 TCGA-23-2084-01 TCGA-23-2084-01A-02D-0667-05 858a382c-49dc-4990-8c0f-017fedd9a6db TCGA-23-2084-01A-02D-0663-01 TCGA-23-2084-01 TCGA-23-2084-01A-02D-0663-01 858a382c-49dc-4990-8c0f-017fedd9a6db 858a382c-49dc-4990-8c0f-017fedd9a6db TCGA-23-2084-01 TCGA-23-2084-01 858a382c-49dc-4990-8c0f-017fedd9a6db TCGA-23-2084-01A-02R-0670-07 +TCGA-23-2641-01 TCGA-23-2641-01 Squamous OV-like c1 OV-like c4 TCGA-23-2641 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 85 Left TCGA-23-2641-F25810 TCGA-23-2641 TCGA-23-2641-01A Stage IIIC -31232 0 84 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 YES G3 TCGA-23-2641.0b8f79ba-dbf1-4978-9661-bb0b0dcc8768.pdf 2641 YES NO Primary Tumor 01 0.6 23 1-10 mm Ovary A LIVING 2009 c7559a8a-552e-44e1-97dd-d3a333a5e283 TCGA-23-2641-01A-01D-1047-05 TCGA-23-2641-01A-21-20 TCGA-23-2641-01A-01D-1526-09 TCGA-23-2641-01A-01D-1043-01 TCGA-23-2641-01 42dc7e58-4deb-4a79-8b08-67295835b807 TCGA-23-2641-01A-01D-1043-01 TCGA-23-2641-01 TCGA-23-2641-01A-01R-1050-07 +TCGA-23-2643-01 TCGA-23-2643-01 High OV-like c1 OV-like c4 TCGA-23-2643 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Right TCGA-23-2643-F25812 TCGA-23-2643 TCGA-23-2643-01A Stage IIIC -27093 0 143 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.2 G3 TCGA-23-2643.8481bd3e-147d-4a67-acdd-08fea5be431a.pdf 2643 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 23 1-10 mm Ovary A LIVING 2009 02d0fc82-4de5-4543-88e1-b069652b6c4b TCGA-23-2643-01A-01D-1047-05 TCGA-23-2643-01A-21-20 TCGA-23-2643-01A-01D-1526-09 TCGA-23-2643-01A-01D-1043-01 TCGA-23-2643-01 061c8e23-337c-49f7-84bb-9289b1e71595 TCGA-23-2643-01A-01D-1043-01 TCGA-23-2643-01 TCGA-23-2643-01A-01R-1050-07 +TCGA-23-2645-01 TCGA-23-2645-01 High OV-like c1 OV-like c4 TCGA-23-2645 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Right TCGA-23-2645-F25818 TCGA-23-2645 TCGA-23-2645-01A Stage IIIC -19758 0 137 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 YES G3 TCGA-23-2645.e1651bbc-ed16-4e45-b6f8-283459d72568.pdf 2645 YES NO Primary Tumor 01 0.5 23 No Macroscopic disease Ovary A LIVING 2009 f6880438-40e9-4c78-ac4b-fbdf71637a68 TCGA-23-2645-01A-01D-1047-05 TCGA-23-2645-01A-21-20 TCGA-23-2645-01A-01W-1091-09 TCGA-23-2645-01A-01D-1043-01 TCGA-23-2645-01 7326a637-b5db-47d8-a114-030db3a91417 TCGA-23-2645-01A-01D-1043-01 TCGA-23-2645-01 TCGA-23-2645-01A-01R-1050-07 +TCGA-23-2647-01 TCGA-23-2647-01 OV-like c1 OV-like c4 TCGA-23-2647 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-23-2647-F25820 TCGA-23-2647 Stage IIIC -18205 0 135 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 2647 YES NO Primary Tumor 01 23 1-10 mm Ovary YES LIVING 2009 f50b14e1-8106-4823-9bbd-68cf5f17189b TCGA-23-2647-01A-01D-1047-05 TCGA-23-2647-01A-21-20 TCGA-23-2647-01A-01D-1526-09 TCGA-23-2647-01 eeaa45e2-a17d-475c-b9a9-fbec7fa7ecd1 TCGA-23-2647-01A-01R-1050-07 +TCGA-23-2649-01 TCGA-23-2649-01 OV-like c1 OV-like c4 TCGA-23-2649 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Left TCGA-23-2649-F25822 TCGA-23-2649 TCGA-23-2649-01A Stage IIIC -22210 0 116 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.3 YES G3 TCGA-23-2649.7a0bd8e4-1c7b-4bbc-bddc-e06902fc4db5.pdf 2649 YES NO Primary Tumor 01 0.3 23 1-10 mm Ovary YES A LIVING 2009 408178f3-62ee-4c5d-a160-355deedc69c8 TCGA-23-2649-01A-01D-1047-05 TCGA-23-2649-01A-21-20 TCGA-23-2649-01A-01D-1526-09 TCGA-23-2649-01 2d3ae942-c1d4-4e80-a0e1-4b7fbc15952a TCGA-23-2649-01A-01R-1050-07 +TCGA-24-0966-01 TCGA-24-0966-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 mutation cluster 2 TCGA-24-0966 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Bilateral TCGA-24-0966-F25875 TCGA-24-0966 TCGA-24-0966-01A Stage IIIC -28529 0 232 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.3 YES G3 TCGA-24-0966.99D5CA9E-3E3F-4037-96B9-9D4A34C614B3.pdf 0966 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.7 24 >20 mm Ovary A LIVING 2008 TCGA-24-0966-01 5f1ed5e0-4a91-404f-a3b9-e855ff3ac303 TCGA-24-0966-01 TCGA-24-0966-01A-01D-0402-05 TCGA-24-0966-01A-01W-0977-09 TCGA-24-0966-01A-21-1562-20 TCGA-24-0966-01A-01W-0977-09 TCGA-24-0966-01A-01D-0399-01 TCGA-24-0966-01 02ebd198-faca-4fb3-ba5a-531389b4fffa TCGA-24-0966-01A-01D-0399-01 TCGA-24-0966-01 TCGA-24-0966-01A-01W-0977-09 TCGA-24-0966-01A-01R-0406-07 +TCGA-24-0968-01 TCGA-24-0968-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-0968 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Left TCGA-24-0968-F25880 TCGA-24-0968 Stage IIIC -21664 0 598 2009-3-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) YES G3 0968 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 24 1-10 mm Ovary DECEASED 2005 TCGA-24-0968-01 TCGA-24-0968-01A-01W-0484-10 e6f5bb0e-aab8-4243-b233-e07b2e5811f4 TCGA-24-0968-01 TCGA-24-0968-01A-01W-0484-10 TCGA-24-0968-01A-01D-0432-05 TCGA-24-0968-01A-01D-0428-01 TCGA-24-0968-01 TCGA-24-0968-01A-01D-0428-01 TCGA-24-0968-01 TCGA-24-0968-01A-01W-0484-10 TCGA-24-0968-01A-01R-0436-07 +TCGA-24-0970-01 TCGA-24-0970-01 High C9-OV Low purity c2 OV-like c4 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-24-0970 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-24-0970-F25870 TCGA-24-0970 TCGA-24-0970-01B Stage IIIC -23276 354 0 354 280 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 0.8 NO 2 YES G3 Recurrence TCGA-24-0970.50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F.pdf 0970 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.8 24 >20 mm Ovary B DECEASED 2005 TCGA-24-0970-01 ec3d35b4-27f6-4dd6-a6f2-596eed1a6547 TCGA-24-0970-01 TCGA-24-0970-01B-01D-0432-05 TCGA-24-0970-01B-11-1562-20 TCGA-24-0970-01B-01D-0428-01 TCGA-24-0970-01 02d6074d-90c9-472f-a355-c799e2c96f4a TCGA-24-0970-01B-01D-0428-01 TCGA-24-0970-01B-01W-0486-08 TCGA-24-0970-01 TCGA-24-0970-01B-01W-0486-08 TCGA-24-0970-01B-01R-0436-07 +TCGA-24-0975-01 TCGA-24-0975-01 High C9-OV Low purity c2 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-24-0975 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-24-0975-F25861 TCGA-24-0975 TCGA-24-0975-01A Stage IIIC -21417 663 0 663 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.5 G3 TCGA-24-0975.8AA65DCA-E057-486F-AEFA-D8A3485416EC.pdf 0975 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.7 24 1-10 mm Ovary A DECEASED 2004 TCGA-24-0975-01 TCGA-24-0975-01 9f531d00-af98-4a8e-9614-74c063fa2f15 TCGA-24-0975-01 TCGA-24-0975-01B-02D-0432-05 a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02D-0428-01 TCGA-24-0975-01 TCGA-24-0975-01B-02D-0428-01 a16723c4-d5b1-40a0-9890-570351738879 a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02W-0486-08 TCGA-24-0975-01 TCGA-24-0975-01 a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02W-0486-08 TCGA-24-0975-01A-02R-0436-07 +TCGA-24-0979-01 TCGA-24-0979-01 High C9-OV Low purity c2 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-0979 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Bilateral TCGA-24-0979-F25891 TCGA-24-0979 TCGA-24-0979-01A Stage IV -19595 1264 0 1264 428 2009-5-11 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 0.8 G3 Recurrence TCGA-24-0979.3385E5B4-EBD4-4317-8805-EE6EA47A2E4A.pdf 0979 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 >20 mm Ovary A DECEASED 2003 TCGA-24-0979-01 3a1401ac-2bfc-4baa-9018-bb71de5cfb51 TCGA-24-0979-01 TCGA-24-0979-01A-01D-0432-05 TCGA-24-0979-01A-21-20 TCGA-24-0979-01A-01D-0428-01 TCGA-24-0979-01 1c5c8013-17c7-4be1-888c-ab0da1e3afdd TCGA-24-0979-01A-01D-0428-01 TCGA-24-0979-01A-01W-0486-08 TCGA-24-0979-01 TCGA-24-0979-01A-01W-0486-08 TCGA-24-0979-01A-01R-0436-07 +TCGA-24-0980-01 TCGA-24-0980-01 Squamous C9-OV OV-like c1 OV-like c4 mutation cluster 5 TCGA-24-0980 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-0980-F25896 TCGA-24-0980 Stage IIIC -19579 233 0 233 145 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) YES G3 Recurrence 0980 WITH TUMOR YES Progressive Disease Other Method NO Primary Tumor 01 24 >20 mm Ovary DECEASED 2003 eed170f8-eef5-4e58-8dda-64324bf900e2 TCGA-24-0980-01A-01D-0402-05 TCGA-24-0980-01A-01W-0421-09 TCGA-24-0980-01A-21-20 TCGA-24-0980-01A-01W-0421-09 TCGA-24-0980-01A-01D-0399-01 TCGA-24-0980-01 e09cff37-f92b-48f7-a2d6-e72b68d0a8b4 TCGA-24-0980-01A-01D-0399-01 TCGA-24-0980-01 TCGA-24-0980-01A-01W-0421-09 TCGA-24-0980-01A-01R-0406-07 +TCGA-24-0981-01 TCGA-24-0981-01 TCGA-24-0981 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-24-0981-01A-01D-0432-05 TCGA-24-0981-01A-01R-0436-07 +TCGA-24-0982-01 TCGA-24-0982-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-0982 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-24-0982-F25900 TCGA-24-0982 Stage IIIC -28201 679 0 679 153 2009-3-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 Recurrence 0982 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 24 1-10 mm Ovary DECEASED 2003 TCGA-24-0982-01 fc2dbc4a-dd8a-4174-a186-15ceaaaac881 TCGA-24-0982-01 TCGA-24-0982-01A-01D-0432-05 TCGA-24-0982-01A-01W-0488-09 TCGA-24-0982-01A-21-20 TCGA-24-0982-01A-01W-0488-09 TCGA-24-0982-01A-01D-0428-01 TCGA-24-0982-01 d712585f-3d02-4e1a-a11a-4ffac7295711 TCGA-24-0982-01A-01D-0428-01 TCGA-24-0982-01 TCGA-24-0982-01A-01W-0488-09 TCGA-24-0982-01A-01R-0436-07 +TCGA-24-1103-01 TCGA-24-1103-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1103 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-24-1103-F25824 TCGA-24-1103 TCGA-24-1103-01A Stage IIIC -18583 1646 0 1646 678 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-24-1103.B9628222-5530-4A82-9F13-2773173A0C95.pdf 1103 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1103-01 TCGA-24-1103-01 77d9fb44-1cbe-41aa-8abe-e66fa774a33e TCGA-24-1103-01 TCGA-24-1103-01A-01D-0432-05 TCGA-24-1103-01A-01W-0488-09 TCGA-24-1103-01A-11-1562-20 TCGA-24-1103-01A-01W-0488-09 202abe19-20e0-4ea9-8653-bf5145da351c TCGA-24-1103-01A-01D-0428-01 TCGA-24-1103-01 6f0a19c3-b3d6-44da-8962-79cd723f0fab TCGA-24-1103-01A-01D-0428-01 202abe19-20e0-4ea9-8653-bf5145da351c 202abe19-20e0-4ea9-8653-bf5145da351c TCGA-24-1103-01 TCGA-24-1103-01 202abe19-20e0-4ea9-8653-bf5145da351c TCGA-24-1103-01A-01W-0488-09 TCGA-24-1103-01A-01R-0436-07 +TCGA-24-1104-01 TCGA-24-1104-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-24-1104 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 56 Left TCGA-24-1104-F25834 TCGA-24-1104 TCGA-24-1104-01A Stage IV -20527 1933 0 1933 959 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.5 G3 Recurrence TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41.pdf 1104 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.7 24 >20 mm Ovary A DECEASED 2001 TCGA-24-1104-01 14fde2bb-46b6-410f-89c6-f32a6f084668 TCGA-24-1104-01 TCGA-24-1104-01A-01D-0432-05 TCGA-24-1104-01A-01W-0488-09 TCGA-24-1104-01A-21-1562-20 TCGA-24-1104-01A-01W-0488-09 TCGA-24-1104-01A-01D-0428-01 TCGA-24-1104-01 14177a50-0360-47ce-b24b-3468b4a2b75f TCGA-24-1104-01A-01D-0428-01 TCGA-24-1104-01 TCGA-24-1104-01A-01W-0488-09 TCGA-24-1104-01A-01R-0436-07 +TCGA-24-1105-01 TCGA-24-1105-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1105 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 36 Bilateral TCGA-24-1105-F25844 TCGA-24-1105 TCGA-24-1105-01A Stage IIIC -13187 1442 0 1442 470 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.4 G3 Recurrence TCGA-24-1105.DE593AFC-BC21-4183-94A6-B8BA9931B70F.pdf 1105 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.8 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1105-01 TCGA-24-1105-01A-01W-0484-10 9840b4a9-5f2f-4263-905f-e395092e2cea TCGA-24-1105-01 TCGA-24-1105-01A-01W-0484-10 TCGA-24-1105-01A-01D-0432-05 TCGA-24-1105-01A-21-1562-20 TCGA-24-1105-01A-01D-0428-01 TCGA-24-1105-01 ea5d304a-364c-4633-860b-f2e7be2ca00e TCGA-24-1105-01A-01D-0428-01 TCGA-24-1105-01 TCGA-24-1105-01A-01W-0484-10 TCGA-24-1105-01A-01R-0436-07 +TCGA-24-1413-01 TCGA-24-1413-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1413 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-24-1413-F25910 TCGA-24-1413 TCGA-24-1413-01A Stage IIIC -18846 0 192 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.1 YES G3 TCGA-24-1413.2ca18d08-e930-4244-a0d5-316dfbca0fb4.pdf 1413 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1413-01 TCGA-24-1413-01 78f0e50d-6dc9-4c74-8674-3cb6800ea7a6 TCGA-24-1413-01 TCGA-24-1413-01A-01D-0460-05 TCGA-24-1413-01A-01W-0494-09 TCGA-24-1413-01A-01W-0494-09 545867ef-1299-410d-bbbf-d6c189344b0f TCGA-24-1413-01A-01D-0452-01 TCGA-24-1413-01 TCGA-24-1413-01A-01D-0452-01 545867ef-1299-410d-bbbf-d6c189344b0f 545867ef-1299-410d-bbbf-d6c189344b0f TCGA-24-1413-01 TCGA-24-1413-01 545867ef-1299-410d-bbbf-d6c189344b0f TCGA-24-1413-01A-01W-0494-09 TCGA-24-1413-01A-01R-0456-07 +TCGA-24-1416-01 TCGA-24-1416-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 3 TCGA-24-1416 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 34 Bilateral TCGA-24-1416-F25914 TCGA-24-1416 TCGA-24-1416-01A Stage IV -12772 0 194 2009-4-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G3 TCGA-24-1416.c5a7b8b5-65b5-47d0-84dc-882024042a6f.pdf 1416 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1416-01 TCGA-24-1416-01 f46fbaaf-21ba-40c3-9e27-db0febe3b250 TCGA-24-1416-01 TCGA-24-1416-01A-01D-0475-05 TCGA-24-1416-01A-01W-0549-09 TCGA-24-1416-01A-21-20 TCGA-24-1416-01A-01W-0549-09 67fcea16-d5bc-4edd-b66d-bfc5d56d976d TCGA-24-1416-01A-01D-0472-01 TCGA-24-1416-01 0eda7c90-97fe-4184-b8ad-73e7820c3b7e TCGA-24-1416-01A-01D-0472-01 67fcea16-d5bc-4edd-b66d-bfc5d56d976d 67fcea16-d5bc-4edd-b66d-bfc5d56d976d TCGA-24-1416-01 TCGA-24-1416-01 67fcea16-d5bc-4edd-b66d-bfc5d56d976d TCGA-24-1416-01A-01W-0549-09 TCGA-24-1416-01A-01R-0479-07 +TCGA-24-1417-01 TCGA-24-1417-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1417 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Left TCGA-24-1417-F25920 TCGA-24-1417 TCGA-24-1417-01A Stage IV -19775 0 238 2009-4-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.3 G3 TCGA-24-1417.4058a172-a0f6-4c91-9c79-aab63525340f.pdf 1417 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1417-01 TCGA-24-1417-01 68f0717d-5edc-43f0-bbde-606574f02b4f TCGA-24-1417-01 TCGA-24-1417-01A-01D-0475-05 TCGA-24-1417-01A-01W-0549-09 TCGA-24-1417-01A-21-20 TCGA-24-1417-01A-01W-0549-09 e76a7745-3193-4650-9a7a-c96329690be3 TCGA-24-1417-01A-01D-0472-01 TCGA-24-1417-01 4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a TCGA-24-1417-01A-01D-0472-01 e76a7745-3193-4650-9a7a-c96329690be3 e76a7745-3193-4650-9a7a-c96329690be3 TCGA-24-1417-01 TCGA-24-1417-01 e76a7745-3193-4650-9a7a-c96329690be3 TCGA-24-1417-01A-01W-0549-09 TCGA-24-1417-01A-01R-0479-07 +TCGA-24-1418-01 TCGA-24-1418-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1418 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 68 Bilateral TCGA-24-1418-F25924 TCGA-24-1418 TCGA-24-1418-01A Stage IIIC -24842 0 243 0 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1.2 NO 1.2 G3 TCGA-24-1418.14fdb291-ba79-4852-9242-02dc191ca8c5.pdf 1418 Other TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 >20 mm Ovary A LIVING 2008 TCGA-24-1418-01 TCGA-24-1418-01 8302128a-2f41-42d9-8ebc-ceedb67f2919 TCGA-24-1418-01 TCGA-24-1418-01A-01D-0475-05 TCGA-24-1418-01A-01W-0549-09 TCGA-24-1418-01A-01W-0549-09 4e701e9f-9127-4d61-8a72-7e440b969fbe TCGA-24-1418-01A-01D-0472-01 TCGA-24-1418-01 TCGA-24-1418-01A-01D-0472-01 4e701e9f-9127-4d61-8a72-7e440b969fbe 4e701e9f-9127-4d61-8a72-7e440b969fbe TCGA-24-1418-01 TCGA-24-1418-01 4e701e9f-9127-4d61-8a72-7e440b969fbe TCGA-24-1418-01A-01W-0549-09 TCGA-24-1418-01A-01R-0479-07 +TCGA-24-1419-01 TCGA-24-1419-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1419 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-24-1419-F25929 TCGA-24-1419 TCGA-24-1419-01A Stage IIIC -22659 0 239 2009-4-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.8 G3 TCGA-24-1419.0a8c75aa-8031-4f1d-9dba-9029b009d677.pdf 1419 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 11-20 mm Ovary A LIVING 2008 TCGA-24-1419-01 TCGA-24-1419-01 8edd134e-95e4-47d2-9a2a-b68b0ca427ea TCGA-24-1419-01 TCGA-24-1419-01A-01D-0475-05 TCGA-24-1419-01A-21-20 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01D-0472-01 TCGA-24-1419-01 e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc TCGA-24-1419-01A-01D-0472-01 7bf43d51-2714-419e-a52f-863ca54c90e5 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01W-0545-08 TCGA-24-1419-01 TCGA-24-1419-01 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01W-0545-08 TCGA-24-1419-01A-01R-0479-07 +TCGA-24-1422-01 TCGA-24-1422-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1422 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 82 Bilateral TCGA-24-1422-F25934 TCGA-24-1422 TCGA-24-1422-01A Stage IIIC -30234 23 0 23 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.8 G3 TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f.pdf 1422 NO NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 2008 TCGA-24-1422-01 48e00661-f995-42b5-9400-3391914a90d9 TCGA-24-1422-01 TCGA-24-1422-01A-01D-0475-05 TCGA-24-1422-01A-21-1562-20 TCGA-24-1422-01A-01D-0472-01 TCGA-24-1422-01 52fbe264-2840-4bae-86a9-17f09ebe5053 TCGA-24-1422-01A-01D-0472-01 TCGA-24-1422-01A-01W-0545-08 TCGA-24-1422-01 TCGA-24-1422-01A-01W-0545-08 TCGA-24-1422-01A-01R-0479-07 +TCGA-24-1423-01 TCGA-24-1423-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1423 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 61 Bilateral TCGA-24-1423-F25936 TCGA-24-1423 TCGA-24-1423-01A Stage IIIC -22281 0 190 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.8 YES G3 TCGA-24-1423.47331163-68e9-44fd-8b80-b9f70058957f.pdf 1423 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.6 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1423-01 TCGA-24-1423-01 670fe1e4-f612-4797-a926-41cd2da84843 TCGA-24-1423-01 TCGA-24-1423-01A-01D-0475-05 TCGA-24-1423-01A-21-1562-20 b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01D-0472-01 TCGA-24-1423-01 5a0afbd0-e504-46d6-b268-2b04d7f8be98 TCGA-24-1423-01A-01D-0472-01 b493df11-1929-4e35-ac44-49057cdbd86b b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01W-0545-08 TCGA-24-1423-01 TCGA-24-1423-01 b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01W-0545-08 TCGA-24-1423-01A-01R-0479-07 +TCGA-24-1424-01 TCGA-24-1424-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-1424 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-24-1424-F25941 TCGA-24-1424 Stage IIIC -24545 0 183 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1424 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 24 1-10 mm Ovary LIVING 2008 TCGA-24-1424-01 TCGA-24-1424-01 fdda2c0b-816d-4e49-83e8-2e40d4444f0c TCGA-24-1424-01 TCGA-24-1424-01A-01D-0475-05 TCGA-24-1424-01A-01W-0549-09 TCGA-24-1424-01A-21-1562-20 TCGA-24-1424-01A-01W-0549-09 d3fbcdaa-11af-4233-9700-57c6e1628c4b TCGA-24-1424-01A-01D-0472-01 TCGA-24-1424-01 b64c050d-b09e-4fbb-a906-b5d5e3904149 TCGA-24-1424-01A-01D-0472-01 d3fbcdaa-11af-4233-9700-57c6e1628c4b d3fbcdaa-11af-4233-9700-57c6e1628c4b TCGA-24-1424-01 TCGA-24-1424-01 d3fbcdaa-11af-4233-9700-57c6e1628c4b TCGA-24-1424-01A-01W-0549-09 TCGA-24-1424-01A-01R-0479-07 +TCGA-24-1425-01 TCGA-24-1425-01 Squamous OV-like c1 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-24-1425 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-24-1425-F25946 TCGA-24-1425 Stage IIIC -16764 0 181 0 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1425 Other TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 24 1-10 mm Ovary LIVING 2008 TCGA-24-1425-01 TCGA-24-1425-01 f112ed71-765e-48bc-a5ab-196f42740078 TCGA-24-1425-01 TCGA-24-1425-01A-02D-0501-05 TCGA-24-1425-01A-02W-0553-09 TCGA-24-1425-01A-02W-0553-09 f580e84b-b405-43dc-9dae-4588cedf435f TCGA-24-1425-01A-02D-0497-01 TCGA-24-1425-01 TCGA-24-1425-01A-02D-0497-01 f580e84b-b405-43dc-9dae-4588cedf435f f580e84b-b405-43dc-9dae-4588cedf435f TCGA-24-1425-01 TCGA-24-1425-01 f580e84b-b405-43dc-9dae-4588cedf435f TCGA-24-1425-01A-02W-0553-09 TCGA-24-1425-01A-02R-0504-07 +TCGA-24-1426-01 TCGA-24-1426-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-1426 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 43 Bilateral TCGA-24-1426-F25951 TCGA-24-1426 TCGA-24-1426-01A Stage IIIC -15949 0 163 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1.2 YES G3 TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb.pdf 1426 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1426-01 8395c4e0-d327-472d-a7e6-3af3e2cbb0be TCGA-24-1426-01 TCGA-24-1426-01A-01D-0475-05 TCGA-24-1426-01A-01W-0549-09 TCGA-24-1426-01A-01W-0549-09 TCGA-24-1426-01A-01D-0472-01 TCGA-24-1426-01 TCGA-24-1426-01A-01D-0472-01 TCGA-24-1426-01 TCGA-24-1426-01A-01W-0549-09 TCGA-24-1426-01A-01R-0479-07 +TCGA-24-1427-01 TCGA-24-1427-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-1427 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Bilateral TCGA-24-1427-F25956 TCGA-24-1427 TCGA-24-1427-01A Stage IIIC -21423 0 147 2009-4-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.7 YES G3 TCGA-24-1427.af63c4e2-2f77-4311-bfe2-ee45cfd200bb.pdf 1427 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.7 24 >20 mm Ovary A LIVING 2008 TCGA-24-1427-01 TCGA-24-1427-01 5beadb09-fe3f-44aa-8c20-fdf66e0a68ca TCGA-24-1427-01 TCGA-24-1427-01A-01D-0475-05 TCGA-24-1427-01A-01W-0549-09 TCGA-24-1427-01A-21-1562-20 TCGA-24-1427-01A-01W-0549-09 5a505632-422c-4083-b867-82a7a503b314 TCGA-24-1427-01A-01D-0472-01 TCGA-24-1427-01 87a8658e-3143-4074-9988-b0fed3d25f8b TCGA-24-1427-01A-01D-0472-01 5a505632-422c-4083-b867-82a7a503b314 5a505632-422c-4083-b867-82a7a503b314 TCGA-24-1427-01 TCGA-24-1427-01 5a505632-422c-4083-b867-82a7a503b314 TCGA-24-1427-01A-01W-0549-09 TCGA-24-1427-01A-01R-0479-07 +TCGA-24-1428-01 TCGA-24-1428-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-24-1428 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Left TCGA-24-1428-F25960 TCGA-24-1428 TCGA-24-1428-01A Stage IIIC -18306 0 529 448 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 G3 Recurrence TCGA-24-1428.9fcdd584-25e6-4a5a-ae15-f2956de32822.pdf 1428 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1428-01 TCGA-24-1428-01 c9eb8b63-8b8a-47eb-8fb1-11b089bf4a00 TCGA-24-1428-01 TCGA-24-1428-01A-01D-0475-05 TCGA-24-1428-01A-01W-0549-09 TCGA-24-1428-01A-21-1562-20 TCGA-24-1428-01A-01W-0549-09 30b9b778-1422-4842-ae99-658b8b1d7605 TCGA-24-1428-01A-01D-0472-01 TCGA-24-1428-01 66bafc53-dafe-493e-8ede-22866b714a76 TCGA-24-1428-01A-01D-0472-01 30b9b778-1422-4842-ae99-658b8b1d7605 30b9b778-1422-4842-ae99-658b8b1d7605 TCGA-24-1428-01 TCGA-24-1428-01 30b9b778-1422-4842-ae99-658b8b1d7605 TCGA-24-1428-01A-01W-0549-09 TCGA-24-1428-01A-01R-0479-07 +TCGA-24-1430-01 TCGA-24-1430-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-24-1430 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-24-1430-F25966 TCGA-24-1430 TCGA-24-1430-01A Stage IIIC -24939 863 0 863 449 1 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.7 NO 2 G3 Recurrence TCGA-24-1430.d0f95ced-e33f-4796-a6a4-3030f8e21761.pdf 1430 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.8 24 >20 mm Ovary A DECEASED 2000 TCGA-24-1430-01 TCGA-24-1430-01 0bad8ba4-8a10-49d9-a2f6-5e833fb9f2da TCGA-24-1430-01 TCGA-24-1430-01A-01D-0475-05 TCGA-24-1430-01A-21-1562-20 4c19d12e-0160-4d01-b621-65335156488b TCGA-24-1430-01A-01D-0472-01 TCGA-24-1430-01 7dbdc93e-9d1d-48fe-92eb-9615eac2adb6 TCGA-24-1430-01A-01D-0472-01 4c19d12e-0160-4d01-b621-65335156488b 4c19d12e-0160-4d01-b621-65335156488b TCGA-24-1430-01 TCGA-24-1430-01 4c19d12e-0160-4d01-b621-65335156488b TCGA-24-1430-01A-01R-0479-07 +TCGA-24-1431-01 TCGA-24-1431-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-1431 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-1431-F25977 TCGA-24-1431 Stage IIIC -24758 567 0 583 199 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1431 WITH TUMOR YES Imaging Study NO Primary Tumor 01 24 1-10 mm Ovary DECEASED 1999 TCGA-24-1431-01 e5aed4a1-b8f1-44bd-957c-94acfca519a7 TCGA-24-1431-01 TCGA-24-1431-01A-01D-0475-05 TCGA-24-1431-01A-21-1562-20 TCGA-24-1431-01A-01D-0472-01 TCGA-24-1431-01 a2ff2d82-073d-4ea0-b407-5a68de79f622 TCGA-24-1431-01A-01D-0472-01 TCGA-24-1431-01A-01D-0472-08 TCGA-24-1431-01 TCGA-24-1431-01A-01D-0472-08 TCGA-24-1431-01A-01R-0479-07 +TCGA-24-1434-01 TCGA-24-1434-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1434 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-24-1434-F25984 TCGA-24-1434 TCGA-24-1434-01A Stage IIIC -21810 568 0 568 337 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 1.5 YES G3 Recurrence TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961.pdf 1434 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1434-01 TCGA-24-1434-01 a6c7ca3f-b07b-46d5-a1ba-f1c88a358229 TCGA-24-1434-01 TCGA-24-1434-01A-01D-0475-05 TCGA-24-1434-01A-21-1562-20 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01D-0472-01 TCGA-24-1434-01 0106e887-2791-4c17-9260-07bd927e5d9b TCGA-24-1434-01A-01D-0472-01 368f21cd-dd07-440d-89f5-5874e37fe63b 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01W-0545-08 TCGA-24-1434-01 TCGA-24-1434-01 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01W-0545-08 TCGA-24-1434-01A-01R-0479-07 +TCGA-24-1435-01 TCGA-24-1435-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 2 TCGA-24-1435 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-24-1435-F25993 TCGA-24-1435 TCGA-24-1435-01A Stage IIIC -21107 1324 0 1324 505 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 NO G3 Recurrence TCGA-24-1435.d1574b6c-6cc1-45bc-86d0-97585d8a5c93.pdf 1435 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1435-01 TCGA-24-1435-01 ac8a9858-933c-4d44-ae0c-e8b964344d0c TCGA-24-1435-01 TCGA-24-1435-01A-01D-0475-05 TCGA-24-1435-01A-01W-0549-09 TCGA-24-1435-01A-21-1562-20 TCGA-24-1435-01A-01W-0549-09 c20ba763-e310-448a-9c85-0b4f680e6196 TCGA-24-1435-01A-01D-0472-01 TCGA-24-1435-01 591cd2fa-3920-42e9-a1ed-d76898930e6f TCGA-24-1435-01A-01D-0472-01 c20ba763-e310-448a-9c85-0b4f680e6196 c20ba763-e310-448a-9c85-0b4f680e6196 TCGA-24-1435-01 TCGA-24-1435-01 c20ba763-e310-448a-9c85-0b4f680e6196 TCGA-24-1435-01A-01W-0549-09 TCGA-24-1435-01A-01R-0479-07 +TCGA-24-1436-01 TCGA-24-1436-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1436 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Right TCGA-24-1436-F26004 TCGA-24-1436 TCGA-24-1436-01A Stage IIIC -20881 260 0 260 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 YES G3 TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12.pdf 1436 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.3 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1436-01 TCGA-24-1436-01 432c75c7-ece9-49a3-8f6e-ceb61c30ca10 TCGA-24-1436-01 TCGA-24-1436-01A-01D-0475-05 TCGA-24-1436-01A-01W-0549-09 TCGA-24-1436-01A-21-1563-20 TCGA-24-1436-01A-01W-0549-09 45ff767a-721a-4d89-b5e9-0c6e7eba476d TCGA-24-1436-01A-01D-0472-01 TCGA-24-1436-01 d6aaae43-70fd-461e-b240-8ba220221828 TCGA-24-1436-01A-01D-0472-01 45ff767a-721a-4d89-b5e9-0c6e7eba476d 45ff767a-721a-4d89-b5e9-0c6e7eba476d TCGA-24-1436-01 TCGA-24-1436-01 45ff767a-721a-4d89-b5e9-0c6e7eba476d TCGA-24-1436-01A-01W-0549-09 TCGA-24-1436-01A-01R-0479-07 +TCGA-24-1463-01 TCGA-24-1463-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 2 mutation cluster 2 TCGA-24-1463 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-24-1463-F26009 TCGA-24-1463 TCGA-24-1463-01A Stage IIIC -25734 2218 0 2218 971 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 2 G3 Recurrence TCGA-24-1463.864CB084-569A-47F0-A83D-F3FA649A6B00.pdf 1463 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 >20 mm Ovary A DECEASED 2000 TCGA-24-1463-01 TCGA-24-1463-01 28787351-5cbd-4d64-910c-e306e7f65d8e TCGA-24-1463-01 TCGA-24-1463-01A-01D-0475-05 TCGA-24-1463-01A-01W-0549-09 TCGA-24-1463-01A-21-1562-20 TCGA-24-1463-01A-01W-0549-09 939d41b7-9ccb-4cf6-be16-f2792aece5eb TCGA-24-1463-01A-01D-0472-01 TCGA-24-1463-01 62f0c11f-4f42-45f6-9916-f4470a096431 TCGA-24-1463-01A-01D-0472-01 939d41b7-9ccb-4cf6-be16-f2792aece5eb 939d41b7-9ccb-4cf6-be16-f2792aece5eb TCGA-24-1463-01 TCGA-24-1463-01 939d41b7-9ccb-4cf6-be16-f2792aece5eb TCGA-24-1463-01A-01W-0549-09 TCGA-24-1463-01A-01R-0479-07 +TCGA-24-1464-01 TCGA-24-1464-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1464 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 70 Left TCGA-24-1464-F26022 TCGA-24-1464 TCGA-24-1464-01A Stage IIIC -25874 379 0 379 323 1 2009-3-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.5 YES G3 Recurrence TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E.pdf 1464 Post-Adjuvant Therapy WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.7 24 >20 mm Ovary A DECEASED 1998 TCGA-24-1464-01 2ed4bcf3-8abb-454c-a19d-54101ccf222f TCGA-24-1464-01 TCGA-24-1464-01A-01D-0475-05 TCGA-24-1464-01A-01W-0549-09 TCGA-24-1464-01A-21-1562-20 TCGA-24-1464-01A-01W-0549-09 TCGA-24-1464-01A-01D-0472-01 TCGA-24-1464-01 eef306a8-dd2b-4d8e-90c2-cb05094fd5f2 TCGA-24-1464-01A-01D-0472-01 TCGA-24-1464-01 TCGA-24-1464-01A-01W-0549-09 TCGA-24-1464-01A-01R-0479-07 +TCGA-24-1466-01 TCGA-24-1466-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-24-1466 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-1466-F26028 TCGA-24-1466 TCGA-24-1466-01A Stage IIIC -27307 1373 0 1373 491 2009-4-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.7 G3 Recurrence TCGA-24-1466.BA86880B-184B-4CB7-8BBF-100D5CBD76C0.pdf 1466 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1998 TCGA-24-1466-01 2f2c0eed-dd98-42f0-af6e-7c2290a12f37 TCGA-24-1466-01 TCGA-24-1466-01A-01D-0475-05 TCGA-24-1466-01A-21-1562-20 TCGA-24-1466-01A-01D-0472-01 TCGA-24-1466-01 b5bd0882-705b-4f50-a748-8dc096d39717 TCGA-24-1466-01A-01D-0472-01 TCGA-24-1466-01A-01W-0545-08 TCGA-24-1466-01 TCGA-24-1466-01A-01W-0545-08 TCGA-24-1466-01A-01R-0479-07 +TCGA-24-1467-01 TCGA-24-1467-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-24-1467 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Right TCGA-24-1467-F26039 TCGA-24-1467 TCGA-24-1467-01A Stage IIIC -18652 3224 0 3224 1253 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.3 YES G3 Recurrence TCGA-24-1467.6949EFBE-C2EA-4767-B194-2343254F2752.pdf 1467 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.7 24 1-10 mm Ovary A DECEASED 1998 TCGA-24-1467-01 TCGA-24-1467-01 f521b01e-14ea-4350-ad50-ce4dfa9594b6 TCGA-24-1467-01 TCGA-24-1467-01A-01D-0475-05 TCGA-24-1467-01A-21-1562-20 22902cdb-69f7-4bfc-a5c3-a56229ee501d TCGA-24-1467-01A-01D-0472-01 TCGA-24-1467-01 efc7b16f-9e40-480e-b0ba-0a92cc54c0b9 TCGA-24-1467-01A-01D-0472-01 22902cdb-69f7-4bfc-a5c3-a56229ee501d 22902cdb-69f7-4bfc-a5c3-a56229ee501d TCGA-24-1467-01 TCGA-24-1467-01 22902cdb-69f7-4bfc-a5c3-a56229ee501d TCGA-24-1467-01A-01R-0479-07 +TCGA-24-1469-01 TCGA-24-1469-01 High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-24-1469 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Right TCGA-24-1469-F26060 TCGA-24-1469 TCGA-24-1469-01A Stage IIIC -25937 0 277 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 G3 TCGA-24-1469.8f0b80d0-cf56-477c-898b-bb92934f64d4.pdf 1469 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 1-10 mm Ovary A LIVING 2008 TCGA-24-1469-01 TCGA-24-1469-01 1a83a75d-e788-407c-afae-326d9a553604 TCGA-24-1469-01 TCGA-24-1469-01A-01D-0501-05 TCGA-24-1469-01A-01W-0553-09 TCGA-24-1469-01A-21-1562-20 TCGA-24-1469-01A-01W-0553-09 7b6fe6e3-145b-46e6-884e-fcec23514674 TCGA-24-1469-01A-01D-0497-01 TCGA-24-1469-01 6f95df6b-dcdc-4727-8cf5-76b30b6ae455 TCGA-24-1469-01A-01D-0497-01 7b6fe6e3-145b-46e6-884e-fcec23514674 7b6fe6e3-145b-46e6-884e-fcec23514674 TCGA-24-1469-01 TCGA-24-1469-01 7b6fe6e3-145b-46e6-884e-fcec23514674 TCGA-24-1469-01A-01W-0553-09 TCGA-24-1469-01A-01R-0504-07 +TCGA-24-1470-01 TCGA-24-1470-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1470 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Bilateral TCGA-24-1470-F26064 TCGA-24-1470 Stage IIIB -20007 0 105 1 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1470 Other TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 24 1-10 mm Ovary LIVING 2009 TCGA-24-1470-01 a10cd463-df96-48b7-a4cc-21268bce6eb0 TCGA-24-1470-01 TCGA-24-1470-01A-01D-0501-05 TCGA-24-1470-01A-01W-0553-09 TCGA-24-1470-01A-21-1562-20 TCGA-24-1470-01A-01W-0553-09 TCGA-24-1470-01A-01D-0497-01 TCGA-24-1470-01 c9231718-6532-4ff2-b83f-4050d75b82fe TCGA-24-1470-01A-01D-0497-01 TCGA-24-1470-01 TCGA-24-1470-01A-01W-0553-09 TCGA-24-1470-01A-01R-0504-07 +TCGA-24-1471-01 TCGA-24-1471-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 13 TCGA-24-1471 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Left TCGA-24-1471-F26069 TCGA-24-1471 TCGA-24-1471-01A Stage IIIC -22081 0 36 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 YES G3 TCGA-24-1471.d20b8ed1-c74e-4ee8-9ae2-5512429810bc.pdf 1471 YES NO Primary Tumor 01 0.5 24 >20 mm Ovary A LIVING 2009 TCGA-24-1471-01 2434de17-87b9-44f4-85b9-e07932d062ae TCGA-24-1471-01 TCGA-24-1471-01A-01D-0501-05 TCGA-24-1471-01A-21-1562-20 TCGA-24-1471-01A-01D-0497-01 TCGA-24-1471-01 f9ddc125-66a3-4277-ac22-1b3b2acced36 TCGA-24-1471-01A-01D-0497-01 TCGA-24-1471-01A-01W-0551-08 TCGA-24-1471-01 TCGA-24-1471-01A-01W-0551-08 TCGA-24-1471-01A-01R-0504-07 +TCGA-24-1474-01 TCGA-24-1474-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1474 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Left TCGA-24-1474-F26073 TCGA-24-1474 TCGA-24-1474-01A Stage IIIC -20902 676 0 676 332 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G3 Recurrence TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7.pdf 1474 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.7 24 1-10 mm Ovary A DECEASED 2000 TCGA-24-1474-01 TCGA-24-1474-01 c6e04760-3285-42ad-b307-cb00ffbe2e9e TCGA-24-1474-01 TCGA-24-1474-01A-01D-0501-05 TCGA-24-1474-01A-21-1562-20 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01D-0497-01 TCGA-24-1474-01 e5f26e9b-2fc8-4514-a028-cd97c5390b0a TCGA-24-1474-01A-01D-0497-01 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01W-0551-08 TCGA-24-1474-01 TCGA-24-1474-01 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01W-0551-08 TCGA-24-1474-01A-01R-0504-07 +TCGA-24-1544-01 TCGA-24-1544-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation c1uster 9 TCGA-24-1544 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-24-1544-F26080 TCGA-24-1544 TCGA-24-1544-01A Stage IIIC -26141 820 0 820 643 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.4 G3 Progression of Disease TCGA-24-1544.2fd78a14-cc3f-4920-9c50-6051579b6ad4.pdf 1544 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 2000 TCGA-24-1544-01 TCGA-24-1544-01 TCGA-24-1544-01A-01W-0615-10 d403d7b8-d8d8-47ba-9821-a314704866bb TCGA-24-1544-01 TCGA-24-1544-01A-01W-0615-10 TCGA-24-1544-01A-01D-0536-05 TCGA-24-1544-01A-21-1558-20 83333a5a-de0b-4d72-b886-e5488c619827 TCGA-24-1544-01A-01D-0533-01 TCGA-24-1544-01 9653a9c6-37fa-4e38-9c7e-c48ae95933ec TCGA-24-1544-01A-01D-0533-01 83333a5a-de0b-4d72-b886-e5488c619827 83333a5a-de0b-4d72-b886-e5488c619827 TCGA-24-1544-01 TCGA-24-1544-01 83333a5a-de0b-4d72-b886-e5488c619827 TCGA-24-1544-01A-01W-0615-10 TCGA-24-1544-01A-01R-0540-07 +TCGA-24-1545-01 TCGA-24-1545-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1545 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-24-1545-F26088 TCGA-24-1545 TCGA-24-1545-01A Stage IIIC -25460 1746 0 1746 861 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.8 G3 Recurrence TCGA-24-1545.0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975.pdf 1545 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 >20 mm Ovary A DECEASED 1997 TCGA-24-1545-01 TCGA-24-1545-01 TCGA-24-1545-01A-01W-0615-10 3ed80032-69ae-4f21-8e60-8f177787e9f0 TCGA-24-1545-01 TCGA-24-1545-01A-01W-0615-10 TCGA-24-1545-01A-01D-0536-05 TCGA-24-1545-01A-21-1558-20 e2fcba09-755d-425d-ab4d-cede8ef86e48 TCGA-24-1545-01A-01D-0533-01 TCGA-24-1545-01 f3a3c3dc-4069-4c53-9017-c6dc610240e4 TCGA-24-1545-01A-01D-0533-01 e2fcba09-755d-425d-ab4d-cede8ef86e48 e2fcba09-755d-425d-ab4d-cede8ef86e48 TCGA-24-1545-01 TCGA-24-1545-01 e2fcba09-755d-425d-ab4d-cede8ef86e48 TCGA-24-1545-01A-01W-0615-10 TCGA-24-1545-01A-01R-0540-07 +TCGA-24-1546-01 TCGA-24-1546-01 High Low purity c2 OV-like c4 miRNA cluster 3 cluster 6 TCGA-24-1546 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Bilateral TCGA-24-1546-F26097 TCGA-24-1546 TCGA-24-1546-01A Stage IIIC -17130 1955 0 1955 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1.5 G3 TCGA-24-1546.d6eec9a6-7bfd-40e2-891e-0a3cd7759ace.pdf 1546 YES Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1546-01 TCGA-24-1546-01 TCGA-24-1546-01A-01W-0615-10 67d70140-fcb4-4b5b-9821-498cbd5d53c2 TCGA-24-1546-01 TCGA-24-1546-01A-01W-0615-10 TCGA-24-1546-01A-01D-0536-05 TCGA-24-1546-01A-21-1563-20 9984be2d-c37f-44cd-9eb8-61b65efcf8cb TCGA-24-1546-01A-01D-0533-01 TCGA-24-1546-01 9cdbc7ad-cffd-4f34-b805-47e7c57d9978 TCGA-24-1546-01A-01D-0533-01 9984be2d-c37f-44cd-9eb8-61b65efcf8cb 9984be2d-c37f-44cd-9eb8-61b65efcf8cb TCGA-24-1546-01 TCGA-24-1546-01 9984be2d-c37f-44cd-9eb8-61b65efcf8cb TCGA-24-1546-01A-01R-0540-07 +TCGA-24-1548-01 TCGA-24-1548-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-1548 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-24-1548-F26101 TCGA-24-1548 TCGA-24-1548-01A Stage IIIC -20945 493 0 493 207 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 G3 Recurrence TCGA-24-1548.d7b9bc71-e243-478f-a116-7e9371b87327.pdf 1548 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1548-01 TCGA-24-1548-01 TCGA-24-1548-01A-01W-0615-10 45cc6ed6-17ea-4291-8654-2b5b30c5a5e1 TCGA-24-1548-01 TCGA-24-1548-01A-01W-0615-10 TCGA-24-1548-01A-01D-0536-05 TCGA-24-1548-01A-21-1558-20 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf TCGA-24-1548-01A-01D-0533-01 TCGA-24-1548-01 adc1690a-194c-44ea-8344-7bac461ab669 TCGA-24-1548-01A-01D-0533-01 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf TCGA-24-1548-01 TCGA-24-1548-01 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf TCGA-24-1548-01A-01W-0615-10 TCGA-24-1548-01A-01R-0540-07 +TCGA-24-1549-01 TCGA-24-1549-01 Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1549 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-24-1549-F26113 TCGA-24-1549 Stage IIIB -21432 1721 0 1721 1042 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1549 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 24 Ovary DECEASED 1997 TCGA-24-1549-01 TCGA-24-1549-01 f0c19024-16a9-4bc1-af8a-5f55326a22d4 TCGA-24-1549-01 TCGA-24-1549-01A-01D-0501-05 TCGA-24-1549-01A-01W-0553-09 TCGA-24-1549-01A-21-1558-20 TCGA-24-1549-01A-01W-0553-09 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f TCGA-24-1549-01A-01D-0497-01 TCGA-24-1549-01 b18db100-89ea-409a-841a-e90e9e9b65b2 TCGA-24-1549-01A-01D-0497-01 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f f8ead0c8-9072-4a1d-9e07-f724a0d74a0f TCGA-24-1549-01 TCGA-24-1549-01 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f TCGA-24-1549-01A-01W-0553-09 TCGA-24-1549-01A-01R-0504-07 +TCGA-24-1550-01 TCGA-24-1550-01 High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 1 TCGA-24-1550 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Left TCGA-24-1550-F26130 TCGA-24-1550 TCGA-24-1550-01A Stage IIIC -18049 1249 0 1249 892 1 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-24-1550.7ebd8d19-0a81-4623-8127-f225ad650d46.pdf 1550 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.7 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1550-01 TCGA-24-1550-01 d5e13008-a81c-4dc5-b621-6d11b492883b TCGA-24-1550-01 TCGA-24-1550-01A-01D-0501-05 TCGA-24-1550-01A-21-1558-20 648cb96f-df1c-48c1-bb15-c37a2784a9db TCGA-24-1550-01A-01D-0497-01 TCGA-24-1550-01 907ac822-b65b-45f3-87ea-fc78f06bab60 TCGA-24-1550-01A-01D-0497-01 648cb96f-df1c-48c1-bb15-c37a2784a9db 648cb96f-df1c-48c1-bb15-c37a2784a9db TCGA-24-1550-01 TCGA-24-1550-01 648cb96f-df1c-48c1-bb15-c37a2784a9db TCGA-24-1550-01A-01R-0504-07 +TCGA-24-1551-01 TCGA-24-1551-01 Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1551 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1551-F26139 TCGA-24-1551 TCGA-24-1551-01A Stage IIIC -19661 1579 0 1579 764 1 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 G3 Recurrence TCGA-24-1551.474ac527-45a2-4258-bec4-0a48a3b80742.pdf 1551 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1551-01 TCGA-24-1551-01 6e9136b5-6f84-4b3d-9586-257b42d3d8e2 TCGA-24-1551-01 TCGA-24-1551-01A-01D-0501-05 TCGA-24-1551-01A-21-1558-20 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01D-0497-01 TCGA-24-1551-01 48b26794-efa4-4e9a-b3c0-5a5391b17b03 TCGA-24-1551-01A-01D-0497-01 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01W-0551-08 TCGA-24-1551-01 TCGA-24-1551-01 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01W-0551-08 TCGA-24-1551-01A-01R-0504-07 +TCGA-24-1552-01 TCGA-24-1552-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1552 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Left TCGA-24-1552-F26148 TCGA-24-1552 TCGA-24-1552-01A Stage IIIC -28129 1259 0 1259 403 0 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.9 YES G3 Recurrence TCGA-24-1552.FF7B6D0B-D13B-473E-A924-C63CB0B46511.pdf 1552 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.8 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1552-01 TCGA-24-1552-01 62b27771-c8c0-41f8-852f-07b188f7b8e3 TCGA-24-1552-01 TCGA-24-1552-01A-01D-0501-05 TCGA-24-1552-01A-21-1558-20 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01D-0497-01 TCGA-24-1552-01 ce833a2e-7c81-4720-baa7-49cf52f4f0bd TCGA-24-1552-01A-01D-0497-01 990bcb1f-7269-4020-8ea5-8ba338b390b8 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01W-0551-08 TCGA-24-1552-01 TCGA-24-1552-01 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01W-0551-08 TCGA-24-1552-01A-01R-0504-07 +TCGA-24-1553-01 TCGA-24-1553-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1553 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1553-F26157 TCGA-24-1553 TCGA-24-1553-01A Stage IIIB -19393 1767 0 1767 553 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.3 G3 Recurrence TCGA-24-1553.5abe7782-ca53-4add-9a9a-01955859420b.pdf 1553 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1553-01 TCGA-24-1553-01 TCGA-24-1553-01A-01W-0552-10 6007eb37-11b8-4127-b498-f3ada326b0e1 TCGA-24-1553-01 TCGA-24-1553-01A-01W-0552-10 TCGA-24-1553-01A-01D-0501-05 TCGA-24-1553-01A-21-1558-20 7c607e77-a353-4995-855b-36ccaaf3bde6 TCGA-24-1553-01A-01D-0497-01 TCGA-24-1553-01 64c63ba8-750c-4ac7-a0e9-57044507a0a4 TCGA-24-1553-01A-01D-0497-01 7c607e77-a353-4995-855b-36ccaaf3bde6 7c607e77-a353-4995-855b-36ccaaf3bde6 TCGA-24-1553-01 TCGA-24-1553-01 7c607e77-a353-4995-855b-36ccaaf3bde6 TCGA-24-1553-01A-01W-0552-10 TCGA-24-1553-01A-01R-0504-07 +TCGA-24-1555-01 TCGA-24-1555-01 Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-24-1555 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-24-1555-F26171 TCGA-24-1555 TCGA-24-1555-01A Stage IIIC -18404 2692 0 2692 1577 0 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G3 Recurrence TCGA-24-1555.b7b2f370-207a-4849-b7a0-528789363a02.pdf 1555 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 Ovary A DECEASED 1997 TCGA-24-1555-01 TCGA-24-1555-01 TCGA-24-1555-01A-01W-0552-10 b3e00fd1-65a1-4254-ac59-1d56b879c253 TCGA-24-1555-01 TCGA-24-1555-01A-01W-0552-10 TCGA-24-1555-01A-01D-0501-05 TCGA-24-1555-01A-21-1558-20 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 TCGA-24-1555-01A-01D-0497-01 TCGA-24-1555-01 10cb1259-03bf-4d9e-946e-bea05e4f23bd TCGA-24-1555-01A-01D-0497-01 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 TCGA-24-1555-01 TCGA-24-1555-01 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 TCGA-24-1555-01A-01W-0552-10 TCGA-24-1555-01A-01R-0504-07 +TCGA-24-1556-01 TCGA-24-1556-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1556 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 50 Left TCGA-24-1556-F26184 TCGA-24-1556 TCGA-24-1556-01A Stage IIB -18517 2148 0 2148 539 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.9 G3 Recurrence TCGA-24-1556.75c91323-45a7-4629-b014-f7eda2f1075e.pdf 1556 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 1-10 mm Ovary A DECEASED 2000 TCGA-24-1556-01 TCGA-24-1556-01 TCGA-24-1556-01A-01W-0615-10 3602ad67-bdfb-48a8-8a58-8019bee04630 TCGA-24-1556-01 TCGA-24-1556-01A-01W-0615-10 TCGA-24-1556-01A-01D-0536-05 TCGA-24-1556-01A-21-1558-20 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd TCGA-24-1556-01A-01D-0533-01 TCGA-24-1556-01 7c4dcb9c-346b-4b52-9b64-f835ebc85dba TCGA-24-1556-01A-01D-0533-01 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd TCGA-24-1556-01 TCGA-24-1556-01 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd TCGA-24-1556-01A-01W-0615-10 TCGA-24-1556-01A-01R-0540-07 +TCGA-24-1557-01 TCGA-24-1557-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-24-1557 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-24-1557-F26194 TCGA-24-1557 Stage IIIC -17943 1213 0 1213 447 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Progression of Disease 1557 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 24 >20 mm Ovary DECEASED 2000 TCGA-24-1557-01 TCGA-24-1557-01 TCGA-24-1557-01A-01W-0615-10 e9f05aba-2e25-44c7-b49f-9300cb5c61e1 TCGA-24-1557-01 TCGA-24-1557-01A-01W-0615-10 TCGA-24-1557-01A-01D-0536-05 TCGA-24-1557-01A-21-1558-20 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 TCGA-24-1557-01A-01D-0533-01 TCGA-24-1557-01 d534bbdd-5827-426e-ad74-9346b06716f5 TCGA-24-1557-01A-01D-0533-01 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 TCGA-24-1557-01 TCGA-24-1557-01 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 TCGA-24-1557-01A-01W-0615-10 TCGA-24-1557-01A-01R-0540-07 +TCGA-24-1558-01 TCGA-24-1558-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 2 TCGA-24-1558 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-24-1558-F26212 TCGA-24-1558 TCGA-24-1558-01A Stage IIIC -27004 594 0 594 273 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.9 G3 Recurrence TCGA-24-1558.62143e5f-4452-47ca-a67c-cd87036424b1.pdf 1558 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.9 24 1-10 mm Ovary A DECEASED 2000 TCGA-24-1558-01 TCGA-24-1558-01 TCGA-24-1558-01A-01W-0615-10 beca71a6-9c32-4f27-9419-32d96cafed27 TCGA-24-1558-01 TCGA-24-1558-01A-01W-0615-10 TCGA-24-1558-01A-01D-0536-05 TCGA-24-1558-01A-21-1558-20 1b8d5b5e-f671-419a-844a-6640fe5a896d TCGA-24-1558-01A-01D-0533-01 TCGA-24-1558-01 b37713e8-e63a-4dba-b7fb-aebc5914676d TCGA-24-1558-01A-01D-0533-01 1b8d5b5e-f671-419a-844a-6640fe5a896d 1b8d5b5e-f671-419a-844a-6640fe5a896d TCGA-24-1558-01 TCGA-24-1558-01 1b8d5b5e-f671-419a-844a-6640fe5a896d TCGA-24-1558-01A-01W-0615-10 TCGA-24-1558-01A-01R-0540-07 +TCGA-24-1560-01 TCGA-24-1560-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1560 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Left TCGA-24-1560-F26221 TCGA-24-1560 TCGA-24-1560-01A Stage IIIC -18671 1341 0 1341 143 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G4 Recurrence TCGA-24-1560.464e1a20-b2d1-49c4-8da5-11b8c0f96b4e.pdf 1560 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1560-01 TCGA-24-1560-01 TCGA-24-1560-01A-01W-0615-10 5b6e5bbe-fe20-4613-b55c-2e544ea51a2b TCGA-24-1560-01 TCGA-24-1560-01A-01W-0615-10 TCGA-24-1560-01A-01D-0536-05 TCGA-24-1560-01A-21-1558-20 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 TCGA-24-1560-01A-01D-0533-01 TCGA-24-1560-01 15295f32-7794-43cb-a943-03a38d4b6016 TCGA-24-1560-01A-01D-0533-01 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 TCGA-24-1560-01 TCGA-24-1560-01 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 TCGA-24-1560-01A-01W-0615-10 TCGA-24-1560-01A-01R-0540-07 +TCGA-24-1562-01 TCGA-24-1562-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1562 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-1562-F26237 TCGA-24-1562 TCGA-24-1562-01A Stage IIIC -24747 1384 0 1384 229 0 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1 G3 Recurrence TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a.pdf 1562 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1562-01 TCGA-24-1562-01 f36d78a7-5e27-4a7a-8055-a7ca51b8c371 TCGA-24-1562-01 TCGA-24-1562-01A-01D-0501-05 TCGA-24-1562-01A-01W-0553-09 TCGA-24-1562-01A-21-1558-20 TCGA-24-1562-01A-01W-0553-09 eb8cb3b3-d1b1-4d2d-b048-7394931040bd TCGA-24-1562-01A-01D-0497-01 TCGA-24-1562-01 9082bc34-1aa2-4e77-bb64-22778ee28635 TCGA-24-1562-01A-01D-0497-01 eb8cb3b3-d1b1-4d2d-b048-7394931040bd eb8cb3b3-d1b1-4d2d-b048-7394931040bd TCGA-24-1562-01 TCGA-24-1562-01 eb8cb3b3-d1b1-4d2d-b048-7394931040bd TCGA-24-1562-01A-01W-0553-09 TCGA-24-1562-01A-01R-0504-07 +TCGA-24-1563-01 TCGA-24-1563-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1563 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Left TCGA-24-1563-F26248 TCGA-24-1563 TCGA-24-1563-01A Stage IIIC -24274 1451 0 1451 396 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.1 G3 Recurrence TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba.pdf 1563 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1563-01 TCGA-24-1563-01 70951f22-8982-42be-bf1e-15f24b415708 TCGA-24-1563-01 TCGA-24-1563-01A-01D-0501-05 TCGA-24-1563-01A-01W-0553-09 TCGA-24-1563-01A-21-1558-20 TCGA-24-1563-01A-01W-0553-09 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a TCGA-24-1563-01A-01D-0497-01 TCGA-24-1563-01 e52eaae7-ae99-43fe-a752-89045be81447 TCGA-24-1563-01A-01D-0497-01 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a a9c4a08c-1db7-49eb-8685-b5ca442c3e7a TCGA-24-1563-01 TCGA-24-1563-01 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a TCGA-24-1563-01A-01W-0553-09 TCGA-24-1563-01A-01R-0504-07 +TCGA-24-1564-01 TCGA-24-1564-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1564 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 67 Bilateral TCGA-24-1564-F26260 TCGA-24-1564 TCGA-24-1564-01A Stage IIIC -24668 787 0 787 221 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 G3 Recurrence TCGA-24-1564.fa1c8286-2e55-4137-93ae-c19d470ce2e4.pdf 1564 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1564-01 TCGA-24-1564-01 3b4f61f1-616b-4995-bcb6-6eb2e11be681 TCGA-24-1564-01 TCGA-24-1564-01A-01D-0501-05 TCGA-24-1564-01A-21-1558-20 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01D-0497-01 TCGA-24-1564-01 b6e7fde5-418d-4848-a99e-6fc8c943bd7b TCGA-24-1564-01A-01D-0497-01 03b8480f-d19e-43e4-8a09-f9230c525c1e 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01W-0551-08 TCGA-24-1564-01 TCGA-24-1564-01 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01W-0551-08 TCGA-24-1564-01A-01R-0504-07 +TCGA-24-1565-01 TCGA-24-1565-01 Iq C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation c1uster 9 TCGA-24-1565 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-1565-F26274 TCGA-24-1565 TCGA-24-1565-01A Stage IIIC -27048 312 0 312 145 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 YES G3 Recurrence TCGA-24-1565.f424905e-3dc2-4e37-b6c4-8a77c7ce817b.pdf 1565 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 TCGA-24-1565-01 8c0e5f5a-fd1e-40de-9746-1b22572df7b8 TCGA-24-1565-01 TCGA-24-1565-01A-01D-0501-05 TCGA-24-1565-01A-21-1558-20 TCGA-24-1565-01A-01D-0497-01 TCGA-24-1565-01 bd856415-5235-4086-a72f-9d0a65b8867b TCGA-24-1565-01A-01D-0497-01 TCGA-24-1565-01A-01W-0551-08 TCGA-24-1565-01 TCGA-24-1565-01A-01W-0551-08 TCGA-24-1565-01A-01R-0504-07 +TCGA-24-1567-01 TCGA-24-1567-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1567 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-24-1567-F26279 TCGA-24-1567 TCGA-24-1567-01A Stage IIIB -19843 524 0 524 319 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.3 NO 1.1 G3 Recurrence TCGA-24-1567.90910bbc-49e1-495b-9b06-11056ff401df.pdf 1567 WITH TUMOR YES Molecular Markers NO Primary Tumor 01 0.3 24 1-10 mm Ovary A DECEASED 1999 TCGA-24-1567-01 TCGA-24-1567-01 TCGA-24-1567-01A-01W-0615-10 b39f67ca-abb2-4f96-a0c4-79ea6cbe523e TCGA-24-1567-01 TCGA-24-1567-01A-01W-0615-10 TCGA-24-1567-01A-01D-0536-05 TCGA-24-1567-01A-21-1558-20 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 TCGA-24-1567-01A-01D-0533-01 TCGA-24-1567-01 e4b66de6-faab-41b2-af46-ad0f9f81bed7 TCGA-24-1567-01A-01D-0533-01 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 TCGA-24-1567-01 TCGA-24-1567-01 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 TCGA-24-1567-01A-01W-0615-10 TCGA-24-1567-01A-01R-0540-07 +TCGA-24-1603-01 TCGA-24-1603-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1603 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1603-F26284 TCGA-24-1603 TCGA-24-1603-01A Stage IIIB -19681 2742 0 2742 992 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G3 Recurrence TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9.pdf 1603 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.7 24 Ovary A DECEASED 1996 TCGA-24-1603-01 TCGA-24-1603-01 74a46153-942a-42e8-b6a0-ac066c006e5d TCGA-24-1603-01 TCGA-24-1603-01A-01D-0501-05 TCGA-24-1603-01A-21-1558-20 f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01D-0497-01 TCGA-24-1603-01 eecacbb1-98ef-4194-957d-5a49f9548657 TCGA-24-1603-01A-01D-0497-01 f4187f4f-9c52-4065-818b-c884183a5a70 f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01W-0551-08 TCGA-24-1603-01 TCGA-24-1603-01 f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01W-0551-08 TCGA-24-1603-01A-01R-0504-07 +TCGA-24-1604-01 TCGA-24-1604-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1604 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Bilateral TCGA-24-1604-F26299 TCGA-24-1604 TCGA-24-1604-01A Stage IIIC -24471 2688 0 2688 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.4 G3 TCGA-24-1604.de978a3d-92f9-4bd8-98f4-f8a3ec09b362.pdf 1604 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.6 24 Ovary A DECEASED 1996 TCGA-24-1604-01 TCGA-24-1604-01 TCGA-24-1604-01A-01W-0552-10 08109bba-5c11-4400-a968-c858329cbedf TCGA-24-1604-01 TCGA-24-1604-01A-01W-0552-10 TCGA-24-1604-01A-01D-0501-05 TCGA-24-1604-01A-21-1558-20 a658045c-93a6-4aac-abbb-1cd6093b7735 TCGA-24-1604-01A-01D-0497-01 TCGA-24-1604-01 2350016d-f638-4c02-a24b-76f1df75cb69 TCGA-24-1604-01A-01D-0497-01 a658045c-93a6-4aac-abbb-1cd6093b7735 a658045c-93a6-4aac-abbb-1cd6093b7735 TCGA-24-1604-01 TCGA-24-1604-01 a658045c-93a6-4aac-abbb-1cd6093b7735 TCGA-24-1604-01A-01W-0552-10 TCGA-24-1604-01A-01R-0504-07 +TCGA-24-1614-01 TCGA-24-1614-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-1614 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Right TCGA-24-1614-F26306 TCGA-24-1614 TCGA-24-1614-01A Stage IIIC -20993 1470 0 1470 644 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 100 1.2 G3 Recurrence TCGA-24-1614.4e371c15-c0d1-454a-997d-dfbe98b02f7e.pdf 1614 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1614-01 TCGA-24-1614-01A-01W-0552-10 a85349ef-886c-4d39-8c23-ff13b920059a TCGA-24-1614-01 TCGA-24-1614-01A-01W-0552-10 TCGA-24-1614-01A-01D-0501-05 TCGA-24-1614-01A-21-1558-20 TCGA-24-1614-01A-01D-0497-01 TCGA-24-1614-01 6ceece0c-56d0-41e6-93e9-12e2a4fdb4c4 TCGA-24-1614-01A-01D-0497-01 TCGA-24-1614-01 TCGA-24-1614-01A-01W-0552-10 TCGA-24-1614-01A-01R-0504-07 +TCGA-24-1616-01 TCGA-24-1616-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1616 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-24-1616-F26315 TCGA-24-1616 TCGA-24-1616-01A Stage IIIC -20785 1163 0 1163 405 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.9 G3 Recurrence TCGA-24-1616.d8c764d9-0fe8-488e-8aa1-da73a8c10b01.pdf 1616 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1616-01 TCGA-24-1616-01 e40e646a-09da-49ad-bcca-1e56df395a36 TCGA-24-1616-01 TCGA-24-1616-01A-01D-0501-05 TCGA-24-1616-01A-01W-0553-09 TCGA-24-1616-01A-21-1558-20 TCGA-24-1616-01A-01W-0553-09 c334b353-0652-49fb-8cd6-5bcf8485e5d0 TCGA-24-1616-01A-01D-0497-01 TCGA-24-1616-01 3e449bae-1749-47d9-adc1-6e70b0c829dc TCGA-24-1616-01A-01D-0497-01 c334b353-0652-49fb-8cd6-5bcf8485e5d0 c334b353-0652-49fb-8cd6-5bcf8485e5d0 TCGA-24-1616-01 TCGA-24-1616-01 c334b353-0652-49fb-8cd6-5bcf8485e5d0 TCGA-24-1616-01A-01W-0553-09 TCGA-24-1616-01A-01R-0504-07 +TCGA-24-1842-01 TCGA-24-1842-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-1842 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-24-1842-F26325 TCGA-24-1842 TCGA-24-1842-01A Stage IIIC -18227 0 253 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 YES G3 TCGA-24-1842.3465aae7-0664-44e5-a27f-c02fd73526a1.pdf 1842 Other TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.7 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1842-01 TCGA-24-1842-01 af43832d-2996-4a7f-8e5c-6bd2ec938cfe TCGA-24-1842-01 TCGA-24-1842-01A-01D-0581-05 TCGA-24-1842-01A-21-1559-20 TCGA-24-1842-01A-01W-0639-09 6cb78602-e09f-4dbc-b3e5-684ebe77bddc TCGA-24-1842-01A-01D-0577-01 TCGA-24-1842-01 5dcf27b7-8966-4c46-a0f6-5a1450f60d1d TCGA-24-1842-01A-01D-0577-01 6cb78602-e09f-4dbc-b3e5-684ebe77bddc 6cb78602-e09f-4dbc-b3e5-684ebe77bddc TCGA-24-1842-01 TCGA-24-1842-01 6cb78602-e09f-4dbc-b3e5-684ebe77bddc TCGA-24-1842-01A-01R-0584-07 +TCGA-24-1843-01 TCGA-24-1843-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-1843 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Right TCGA-24-1843-F26330 TCGA-24-1843 TCGA-24-1843-01A Stage IIIC -24469 0 106 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 YES G3 TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb.pdf 1843 YES Complete Remission/Response NO Primary Tumor 01 0.4 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1843-01 TCGA-24-1843-01 51ac296a-c599-47db-9a67-5aacf572efab TCGA-24-1843-01 TCGA-24-1843-01A-01D-0581-05 TCGA-24-1843-01A-01W-0639-09 c50cf5af-3375-4748-9894-1f9521f746da TCGA-24-1843-01A-01D-0577-01 TCGA-24-1843-01 TCGA-24-1843-01A-01D-0577-01 c50cf5af-3375-4748-9894-1f9521f746da c50cf5af-3375-4748-9894-1f9521f746da TCGA-24-1843-01 TCGA-24-1843-01 c50cf5af-3375-4748-9894-1f9521f746da TCGA-24-1843-01A-01R-0584-07 +TCGA-24-1844-01 TCGA-24-1844-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-1844 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Bilateral TCGA-24-1844-F26335 TCGA-24-1844 TCGA-24-1844-01A Stage IIIC -23542 0 113 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G3 TCGA-24-1844.5fd30c3c-9734-40dd-b81e-ae3f364c8fa8.pdf 1844 YES NO Primary Tumor 01 0.4 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1844-01 TCGA-24-1844-01 5f13ef2d-8e72-4552-8ace-f089597b1131 TCGA-24-1844-01 TCGA-24-1844-01A-01D-0581-05 TCGA-24-1844-01A-21-1559-20 TCGA-24-1844-01A-01W-0639-09 53a60e9f-3541-4fe7-a7ea-87ee888c0446 TCGA-24-1844-01A-01D-0577-01 TCGA-24-1844-01 d95c8065-b35e-47b0-899a-305b14ed2a56 TCGA-24-1844-01A-01D-0577-01 53a60e9f-3541-4fe7-a7ea-87ee888c0446 53a60e9f-3541-4fe7-a7ea-87ee888c0446 TCGA-24-1844-01 TCGA-24-1844-01 53a60e9f-3541-4fe7-a7ea-87ee888c0446 TCGA-24-1844-01A-01R-0584-07 +TCGA-24-1845-01 TCGA-24-1845-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 TCGA-24-1845 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 42 Bilateral TCGA-24-1845-F26340 TCGA-24-1845 TCGA-24-1845-01A Stage IIIC -15599 0 116 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.8 G3 TCGA-24-1845.1fda446a-e0d2-422a-a023-57ec5bfae62b.pdf 1845 YES NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1845-01 24d1e3ea-44ad-4bb9-8aa7-cd448b8bec21 TCGA-24-1845-01 TCGA-24-1845-01A-01D-0581-05 TCGA-24-1845-01A-21-1559-20 TCGA-24-1845-01A-01W-0639-09 TCGA-24-1845-01A-01D-0577-01 TCGA-24-1845-01 cd017460-81cb-4e71-b352-42612cae745e TCGA-24-1845-01A-01D-0577-01 TCGA-24-1845-01 TCGA-24-1845-01A-01R-0584-07 +TCGA-24-1846-01 TCGA-24-1846-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-1846 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-24-1846-F26346 TCGA-24-1846 TCGA-24-1846-01A Stage IIIC -16534 0 133 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.1 YES G3 TCGA-24-1846.fb12e5b3-1529-4873-90fd-7ba0a78dd9f4.pdf 1846 Other YES NO Primary Tumor 01 0.6 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1846-01 TCGA-24-1846-01 50b9dcb5-0fb8-4be7-97ce-5cd477d6c351 TCGA-24-1846-01 TCGA-24-1846-01A-01D-0581-05 TCGA-24-1846-01A-21-1559-20 TCGA-24-1846-01A-01W-0639-09 4b073708-9525-4340-90dc-ede08ee24977 TCGA-24-1846-01A-01D-0577-01 TCGA-24-1846-01 15134c0c-7253-481e-83e3-7d1c57bc521d TCGA-24-1846-01A-01D-0577-01 4b073708-9525-4340-90dc-ede08ee24977 4b073708-9525-4340-90dc-ede08ee24977 TCGA-24-1846-01 TCGA-24-1846-01 4b073708-9525-4340-90dc-ede08ee24977 TCGA-24-1846-01A-01R-0584-07 +TCGA-24-1847-01 TCGA-24-1847-01 High OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 TCGA-24-1847 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-24-1847-F26350 TCGA-24-1847 TCGA-24-1847-01A Stage IV -16529 0 343 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy 0.9 NO 1 YES G3 TCGA-24-1847.20d96d45-40d3-44ad-a9e8-fdc7e545ed5d.pdf 1847 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1847-01 TCGA-24-1847-01 74b939d6-c502-4edf-a412-df6dc9484eb6 TCGA-24-1847-01 TCGA-24-1847-01A-01D-0563-05 TCGA-24-1847-01A-01W-0633-09 83354694-078e-411e-89d2-029649708528 TCGA-24-1847-01A-01D-0559-01 TCGA-24-1847-01 TCGA-24-1847-01A-01D-0559-01 83354694-078e-411e-89d2-029649708528 83354694-078e-411e-89d2-029649708528 TCGA-24-1847-01 TCGA-24-1847-01 83354694-078e-411e-89d2-029649708528 TCGA-24-1847-01A-01R-0566-07 +TCGA-24-1849-01 TCGA-24-1849-01 Squamous OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 TCGA-24-1849 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 80 Bilateral TCGA-24-1849-F26355 TCGA-24-1849 TCGA-24-1849-01A Stage IIIC -29555 0 176 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.8 YES G3 TCGA-24-1849.a2181913-086c-42a2-99fd-057b17025deb.pdf 1849 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1849-01 TCGA-24-1849-01 36592a9b-a440-4741-95bc-51e700d14b52 TCGA-24-1849-01 TCGA-24-1849-01A-01D-0581-05 TCGA-24-1849-01A-21-1562-20 TCGA-24-1849-01A-01W-0639-09 58f3764a-4651-4c26-a667-74aef5c5679c TCGA-24-1849-01A-01D-0577-01 TCGA-24-1849-01 66dc2c60-9fa1-4fb7-8bd4-76da1e11229a TCGA-24-1849-01A-01D-0577-01 58f3764a-4651-4c26-a667-74aef5c5679c 58f3764a-4651-4c26-a667-74aef5c5679c TCGA-24-1849-01 TCGA-24-1849-01 58f3764a-4651-4c26-a667-74aef5c5679c TCGA-24-1849-01A-01R-0584-07 +TCGA-24-1850-01 TCGA-24-1850-01 High C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-24-1850 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 72 Bilateral TCGA-24-1850-F26359 TCGA-24-1850 TCGA-24-1850-01A Stage IIIC -26369 0 168 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2 YES G3 TCGA-24-1850.a8c2f09f-6971-48e1-b890-f1d63611cdbd.pdf 1850 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1850-01 TCGA-24-1850-01 717a05a3-2930-4f69-a497-d884d493edaa TCGA-24-1850-01 TCGA-24-1850-01A-01D-0581-05 TCGA-24-1850-01A-21-1559-20 TCGA-24-1850-01A-01W-0639-09 9d88c064-c348-4f3f-a1f1-5884e0b66d9e TCGA-24-1850-01A-01D-0577-01 TCGA-24-1850-01 eacc0479-97ed-45f6-a4cb-9cca12252bd2 TCGA-24-1850-01A-01D-0577-01 9d88c064-c348-4f3f-a1f1-5884e0b66d9e 9d88c064-c348-4f3f-a1f1-5884e0b66d9e TCGA-24-1850-01 TCGA-24-1850-01 9d88c064-c348-4f3f-a1f1-5884e0b66d9e TCGA-24-1850-01A-01R-0584-07 +TCGA-24-1852-01 TCGA-24-1852-01 High OV-like c1 OV-like c4 TCGA-24-1852 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-1852-F26363 TCGA-24-1852 TCGA-24-1852-01A Stage IIIC -20390 2201 0 2201 1009 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Tumor resection 0.5 NO 1.4 G3 Recurrence TCGA-24-1852.FC6FD336-EB96-40CD-91FB-9371A305EF76.pdf 1852 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1997 8bc4b5b7-b987-475b-90f7-28c8bd19a0fa TCGA-24-1852-01A-01D-0807-05 TCGA-24-1852-01A-21-1559-20 TCGA-24-1852-01A-01D-0803-01 TCGA-24-1852-01 6800890d-adf7-4831-8a21-68fc3b583fe6,b2810bf7-eaed-4955-b0da-e6ea3c65a9a7 TCGA-24-1852-01A-01D-0803-01 TCGA-24-1852-01 TCGA-24-1852-01A-01R-0810-07 +TCGA-24-1852-02 TCGA-24-1852-02 OV-like c1 TCGA-24-1852 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-1852-F26363 TCGA-24-1852 TCGA-24-1852-02A Stage IIIC -20390 2201 0 2201 1009 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Tumor resection 0.9 NO 1.2 G3 Recurrence TCGA-24-1852.FC644609-4B3F-41A5-9164-BC024C95DAB0.pdf 1852 WITH TUMOR YES Complete Remission/Response Imaging Study NO Recurrent Tumor 02 0.3 24 1-10 mm Ovary A DECEASED 1997 7c459b65-7eca-4081-83f0-ff67f0410a9b TCGA-24-1852-02A-01D-0807-05 8e296930-ef86-4ff6-ac5c-11ef322d0dc2 TCGA-24-1852-02A-01R-0810-07 +TCGA-24-1920-01 TCGA-24-1920-01 High OV-like c1 BRCA basal-like c6 miRNA cluster 1 cluster 3 TCGA-24-1920 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Right TCGA-24-1920-F26373 TCGA-24-1920 TCGA-24-1920-01A Stage IIIC -27042 0 298 0 2010-2-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 2 G3 TCGA-24-1920.292d7fe5-e949-458b-b7da-cc55009b1c06.pdf 1920 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 24 1-10 mm Ovary A LIVING 2009 TCGA-24-1920-01 678cbaa5-cd2a-4cf5-a7e5-34b3db7281cc TCGA-24-1920-01 TCGA-24-1920-01A-01D-0652-05 TCGA-24-1920-01A-21-1559-20 TCGA-24-1920-01A-01D-0648-01 TCGA-24-1920-01 300fb12e-d372-4a03-ae7f-95d0cef8027a TCGA-24-1920-01A-01D-0648-01 TCGA-24-1920-01 TCGA-24-1920-01A-01R-0655-07 +TCGA-24-1923-01 TCGA-24-1923-01 Squamous Low purity c2 OV-like c4 miRNA cluster 3 cluster 6 TCGA-24-1923 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-24-1923-F26379 TCGA-24-1923 TCGA-24-1923-01A Stage IIIC -18628 690 0 690 343 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 0.6 NO 1.3 YES G3 Recurrence TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7.pdf 1923 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1923-01 fde22a7e-62c4-4c20-ac40-ac1b873edf9a TCGA-24-1923-01 TCGA-24-1923-01A-01D-0652-05 TCGA-24-1923-01A-21-1559-20 TCGA-24-1923-01A-01D-0648-01 TCGA-24-1923-01 9c88c21f-4bb9-41cc-b942-9c6e73a46511 TCGA-24-1923-01A-01D-0648-01 TCGA-24-1923-01 TCGA-24-1923-01A-01R-0655-07 +TCGA-24-1924-01 TCGA-24-1924-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-24-1924 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-24-1924-F26386 TCGA-24-1924 TCGA-24-1924-01A Stage IIIC -23801 919 0 919 320 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 YES G3 Recurrence TCGA-24-1924.4199b57a-81f5-4d5f-9f4c-1e514dcd26dc.pdf 1924 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 2001 TCGA-24-1924-01 TCGA-24-1924-01 16cd57f0-1334-447e-828e-989c2339c282 TCGA-24-1924-01 TCGA-24-1924-01A-01D-0652-05 TCGA-24-1924-01A-21-1559-20 2592f314-cc0a-4d00-bdcf-6376afd32bb7 TCGA-24-1924-01A-01D-0648-01 TCGA-24-1924-01 d4067ae4-665b-4539-938c-e86a08523d3f TCGA-24-1924-01A-01D-0648-01 2592f314-cc0a-4d00-bdcf-6376afd32bb7 2592f314-cc0a-4d00-bdcf-6376afd32bb7 TCGA-24-1924-01 TCGA-24-1924-01 2592f314-cc0a-4d00-bdcf-6376afd32bb7 TCGA-24-1924-01A-01R-0655-07 +TCGA-24-1927-01 TCGA-24-1927-01 Squamous OV-like c1 OV-like c4 TCGA-24-1927 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-24-1927-F26396 TCGA-24-1927 Stage IIIC -21719 500 0 500 290 2010-3-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1927 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 24 1-10 mm Ovary DECEASED 1999 TCGA-24-1927-01A-01D-0652-05 TCGA-24-1927-01A-21-1559-20 TCGA-24-1927-01A-01D-0648-01 TCGA-24-1927-01 f9b9b275-8678-4ff8-95fe-dd804f20713d TCGA-24-1927-01A-01D-0648-01 TCGA-24-1927-01 TCGA-24-1927-01A-01R-0655-07 +TCGA-24-1928-01 TCGA-24-1928-01 High OV-like c1 miRNA cluster 2 cluster 2 TCGA-24-1928 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-24-1928-F26403 TCGA-24-1928 TCGA-24-1928-01A Stage IIIC -28126 336 0 336 70 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.5 NO 1.5 G3 Recurrence TCGA-24-1928.dc4407fb-d15b-44d5-9c3b-129cca67d8f1.pdf 1928 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.3 24 11-20 mm Ovary A DECEASED 1998 TCGA-24-1928-01 TCGA-24-1928-01 681d19fb-e521-4105-8d76-275624c1d3b0 TCGA-24-1928-01 TCGA-24-1928-01A-01D-0652-05 433d642a-06fe-454f-a2bf-3e0afb3dd23b TCGA-24-1928-01A-01D-0648-01 TCGA-24-1928-01 TCGA-24-1928-01A-01D-0648-01 433d642a-06fe-454f-a2bf-3e0afb3dd23b 433d642a-06fe-454f-a2bf-3e0afb3dd23b TCGA-24-1928-01 TCGA-24-1928-01 433d642a-06fe-454f-a2bf-3e0afb3dd23b TCGA-24-1928-01A-01R-0655-07 +TCGA-24-1930-01 TCGA-24-1930-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-24-1930 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Bilateral TCGA-24-1930-F26410 TCGA-24-1930 TCGA-24-1930-01A Stage IIIC -19387 2467 0 2467 544 0 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 100 1 G3 Recurrence TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c.pdf 1930 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 1-10 mm Ovary A DECEASED 1998 TCGA-24-1930-01 TCGA-24-1930-01 3412c513-36c6-459c-9f66-3dd15d0d8e72 TCGA-24-1930-01 TCGA-24-1930-01A-01D-0652-05 TCGA-24-1930-01A-21-1559-20 d85ca8ac-9458-4f3a-b2ef-db4df852f75e TCGA-24-1930-01A-01D-0648-01 TCGA-24-1930-01 bf3c2d8b-6072-4f59-8f19-128cfff7314e TCGA-24-1930-01A-01D-0648-01 d85ca8ac-9458-4f3a-b2ef-db4df852f75e d85ca8ac-9458-4f3a-b2ef-db4df852f75e TCGA-24-1930-01 TCGA-24-1930-01 d85ca8ac-9458-4f3a-b2ef-db4df852f75e TCGA-24-1930-01A-01R-0655-07 +TCGA-24-2019-01 TCGA-24-2019-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-24-2019 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Bilateral TCGA-24-2019-F26429 TCGA-24-2019 TCGA-24-2019-01A Stage IIIC -17009 0 148 1 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1.pdf 2019 Other YES NO Primary Tumor 01 0.3 24 1-10 mm Ovary A LIVING 2009 TCGA-24-2019-01 TCGA-24-2019-01 437a6ae6-ad96-446e-ad48-d2d8f608e915 TCGA-24-2019-01 TCGA-24-2019-01A-02D-0667-05 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02D-0663-01 TCGA-24-2019-01 TCGA-24-2019-01A-02D-0663-01 52908652-f29a-4517-8ff6-6f4cd31c691b 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02W-0722-08 TCGA-24-2019-01 TCGA-24-2019-01 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02W-0722-08 TCGA-24-2019-01A-02R-0670-07 +TCGA-24-2020-01 TCGA-24-2020-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-24-2020 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-2020-F26431 TCGA-24-2020 TCGA-24-2020-01A Stage IIIC -24682 4624 0 4624 723 2010-3-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.1 G3 Recurrence TCGA-24-2020.4f529d42-acb0-4c02-bd0f-d4a650655df8.pdf 2020 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1994 TCGA-24-2020-01 TCGA-24-2020-01 dfccfa2b-c85a-4ef7-815f-75d1042b5c6d TCGA-24-2020-01 TCGA-24-2020-01A-01D-0652-05 TCGA-24-2020-01A-21-1560-20 19765b4f-458e-4f02-bf96-01498d80ac83 TCGA-24-2020-01A-01D-0648-01 TCGA-24-2020-01 809ac07d-5244-462e-a41e-531eeb193296 TCGA-24-2020-01A-01D-0648-01 19765b4f-458e-4f02-bf96-01498d80ac83 19765b4f-458e-4f02-bf96-01498d80ac83 TCGA-24-2020-01 TCGA-24-2020-01 19765b4f-458e-4f02-bf96-01498d80ac83 TCGA-24-2020-01A-01R-0655-07 +TCGA-24-2023-01 TCGA-24-2023-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-24-2023 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-24-2023-F26442 TCGA-24-2023 TCGA-24-2023-01A Stage IIIA -19901 1364 0 1364 1069 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G3 Recurrence TCGA-24-2023.2a255fa6-65cd-4fb7-9d08-1b6aadd6682b.pdf 2023 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1994 TCGA-24-2023-01 TCGA-24-2023-01 feeee3cc-2213-4b46-b985-4575d7dcbf23 TCGA-24-2023-01 TCGA-24-2023-01A-01D-0652-05 TCGA-24-2023-01A-21-1560-20 11fd4bb1-0f8d-4830-a7f0-83897a5df11d TCGA-24-2023-01A-01D-0648-01 TCGA-24-2023-01 53cd60af-85e4-468e-a6f8-f21be9631a23 TCGA-24-2023-01A-01D-0648-01 11fd4bb1-0f8d-4830-a7f0-83897a5df11d 11fd4bb1-0f8d-4830-a7f0-83897a5df11d TCGA-24-2023-01 TCGA-24-2023-01 11fd4bb1-0f8d-4830-a7f0-83897a5df11d TCGA-24-2023-01A-01R-0655-07 +TCGA-24-2024-01 TCGA-24-2024-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2024 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Bilateral TCGA-24-2024-F26450 TCGA-24-2024 TCGA-24-2024-01A Stage IIIC -26476 1769 0 1769 421 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G3 Recurrence TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061.pdf 2024 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1994 TCGA-24-2024-01 TCGA-24-2024-01 3f66920b-c10b-4768-a706-c8a6cef1c149 TCGA-24-2024-01 TCGA-24-2024-01A-02D-0667-05 TCGA-24-2024-01A-03-1563-20 bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02D-0663-01 TCGA-24-2024-01 c3771a58-897b-4427-8dbb-70214f74dc03 TCGA-24-2024-01A-02D-0663-01 bdd5afb1-a251-4541-bbbe-0fcd1126a3ce bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02W-0722-08 TCGA-24-2024-01 TCGA-24-2024-01 bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02W-0722-08 TCGA-24-2024-01A-02R-0670-07 +TCGA-24-2026-01 TCGA-24-2026-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-2026 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 79 Bilateral TCGA-24-2026-F26456 TCGA-24-2026 Stage IIIC -29050 1059 0 1059 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 2026 YES NO Primary Tumor 01 24 >20 mm Ovary DECEASED 1995 TCGA-24-2026-01 TCGA-24-2026-01 ccb2b163-3da6-4594-b55b-c63221fc8ad5 TCGA-24-2026-01 TCGA-24-2026-01A-01D-0652-05 TCGA-24-2026-01A-21-1560-20 ce0fd762-e18f-4cca-a4c4-c064dca62e60 TCGA-24-2026-01A-01D-0648-01 TCGA-24-2026-01 f68086f7-8d41-4631-9346-849088f1f577 TCGA-24-2026-01A-01D-0648-01 ce0fd762-e18f-4cca-a4c4-c064dca62e60 ce0fd762-e18f-4cca-a4c4-c064dca62e60 TCGA-24-2026-01 TCGA-24-2026-01 ce0fd762-e18f-4cca-a4c4-c064dca62e60 TCGA-24-2026-01A-01R-0655-07 +TCGA-24-2027-01 TCGA-24-2027-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-24-2027 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-24-2027-F26460 TCGA-24-2027 TCGA-24-2027-01A Stage IV -18835 3337 0 3337 617 0 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.6 G3 Recurrence TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6.pdf 2027 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 24 >20 mm Ovary A DECEASED 1995 TCGA-24-2027-01 TCGA-24-2027-01 e9c0e81a-4be2-4ab2-a0fe-33ea200f4047 TCGA-24-2027-01 TCGA-24-2027-01A-01D-0652-05 TCGA-24-2027-01A-21-1560-20 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 TCGA-24-2027-01A-01D-0648-01 TCGA-24-2027-01 55afc19d-b001-47f3-9d3d-9bc9a8681031 TCGA-24-2027-01A-01D-0648-01 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 TCGA-24-2027-01 TCGA-24-2027-01 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 TCGA-24-2027-01A-01R-0655-07 +TCGA-24-2029-01 TCGA-24-2029-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 TCGA-24-2029 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 75 Bilateral TCGA-24-2029-F26476 TCGA-24-2029 Stage IIIC -27527 439 0 439 372 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 2029 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 24 >20 mm Ovary DECEASED 1995 TCGA-24-2029-01 fc252b6a-222d-4529-a609-012e71c0b436 TCGA-24-2029-01 TCGA-24-2029-01A-01D-0652-05 TCGA-24-2029-01A-21-1560-20 TCGA-24-2029-01A-01D-0648-01 TCGA-24-2029-01 c10a5aef-aa73-4f20-acef-a5bd42e29fca TCGA-24-2029-01A-01D-0648-01 TCGA-24-2029-01 TCGA-24-2029-01A-01R-0655-07 +TCGA-24-2030-01 TCGA-24-2030-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-24-2030 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Left TCGA-24-2030-F26480 TCGA-24-2030 TCGA-24-2030-01A Stage IIIC -31900 1701 0 1641 646 2010-2-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.5 G3 Recurrence TCGA-24-2030.bb1b63ab-1e13-4401-ab6a-0325da96b17f.pdf 2030 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 24 >20 mm Ovary A DECEASED 1995 TCGA-24-2030-01 07894e29-8a70-415e-a10d-389d652f11a5 TCGA-24-2030-01 TCGA-24-2030-01A-01D-0667-05 TCGA-24-2030-01A-21-1560-20 TCGA-24-2030-01A-01D-0663-01 TCGA-24-2030-01 827506c7-c89c-4301-971d-b42ace20769e TCGA-24-2030-01A-01D-0663-01 TCGA-24-2030-01A-01W-0722-08 TCGA-24-2030-01 TCGA-24-2030-01A-01W-0722-08 TCGA-24-2030-01A-01R-0670-07 +TCGA-24-2033-01 TCGA-24-2033-01 High C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 3 TCGA-24-2033 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Bilateral TCGA-24-2033-F26490 TCGA-24-2033 Stage IIIC -31977 562 0 562 351 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 2033 WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 24 >20 mm Ovary DECEASED 1995 TCGA-24-2033-01 TCGA-24-2033-01 a735c975-e05c-4389-a39d-80c25462dfe6 TCGA-24-2033-01 TCGA-24-2033-01A-01D-0667-05 TCGA-24-2033-01A-21-1560-20 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 TCGA-24-2033-01A-01D-0663-01 TCGA-24-2033-01 d671c1b8-d45e-4d50-bf32-458677874c49 TCGA-24-2033-01A-01D-0663-01 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 TCGA-24-2033-01 TCGA-24-2033-01 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 TCGA-24-2033-01A-01R-0670-07 +TCGA-24-2035-01 TCGA-24-2035-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-2035 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Left TCGA-24-2035-F26496 TCGA-24-2035 Stage IIIC -23855 857 0 857 287 0 2010-3-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 2035 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 24 1-10 mm Ovary DECEASED 1996 TCGA-24-2035-01 TCGA-24-2035-01 ede49e4b-e555-4d20-99cb-e98ea98ddec2 TCGA-24-2035-01 TCGA-24-2035-01A-01D-0667-05 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01D-0663-01 TCGA-24-2035-01 TCGA-24-2035-01A-01D-0663-01 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01W-0722-08 TCGA-24-2035-01 TCGA-24-2035-01 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01W-0722-08 TCGA-24-2035-01A-01R-0670-07 +TCGA-24-2036-01 TCGA-24-2036-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-24-2036 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 50 TCGA-24-2036-F26505 TCGA-24-2036 TCGA-24-2036-01A Stage IIIA -18582 1947 0 1947 914 0 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.1 G3 Recurrence TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e.pdf 2036 Other WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1996 TCGA-24-2036-01 b7b09d06-e228-4549-b19a-99561867345b TCGA-24-2036-01A-01D-0667-05 TCGA-24-2036-01A-21-1560-20 788ade22-382b-49ca-b2b1-447a2072d0ea TCGA-24-2036-01A-01D-0663-01 TCGA-24-2036-01 bcde7ed3-4bc7-41c7-99af-f132bda4a6ef TCGA-24-2036-01A-01D-0663-01 788ade22-382b-49ca-b2b1-447a2072d0ea 788ade22-382b-49ca-b2b1-447a2072d0ea TCGA-24-2036-01 TCGA-24-2036-01 788ade22-382b-49ca-b2b1-447a2072d0ea TCGA-24-2036-01A-01R-0670-07 +TCGA-24-2038-01 TCGA-24-2038-01 Iq C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 12 TCGA-24-2038 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Right TCGA-24-2038-F26518 TCGA-24-2038 TCGA-24-2038-01A Stage IIIA -24957 1354 0 1354 1169 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 GB Recurrence TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81.pdf 2038 WITH TUMOR NO Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 2000 TCGA-24-2038-01 TCGA-24-2038-01 05783372-9fc0-426a-a1ea-203af160b5b6 TCGA-24-2038-01 TCGA-24-2038-01A-01D-0667-05 TCGA-24-2038-01A-21-1560-20 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01D-0663-01 TCGA-24-2038-01 b9526a72-d01f-46bc-896d-4798319abebf TCGA-24-2038-01A-01D-0663-01 372a8471-dff3-44c0-9393-94ad511a7374 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01W-0722-08 TCGA-24-2038-01 TCGA-24-2038-01 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01W-0722-08 TCGA-24-2038-01A-01R-0670-07 +TCGA-24-2254-01 TCGA-24-2254-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 2 TCGA-24-2254 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-24-2254-F26523 TCGA-24-2254 TCGA-24-2254-01A Stage IIIC -24407 1736 0 1736 606 0 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 YES G3 Recurrence TCGA-24-2254.3788629f-17da-4075-af61-cf124bdfb48e.pdf 2254 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 2003 TCGA-24-2254-01 TCGA-24-2254-01 b8cac420-a963-4be2-9ecf-dd92700477e1 TCGA-24-2254-01 TCGA-24-2254-01A-01D-0667-05 TCGA-24-2254-01A-21-1560-20 e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01D-0663-01 TCGA-24-2254-01 9525da91-59ae-487e-b9cb-925f263dfcb6 TCGA-24-2254-01A-01D-0663-01 e496319b-df71-44a0-bfa6-90f50ae54654 e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01W-0722-08 TCGA-24-2254-01 TCGA-24-2254-01 e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01W-0722-08 TCGA-24-2254-01A-01R-0670-07 +TCGA-24-2260-01 TCGA-24-2260-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2260 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-2260-F26532 TCGA-24-2260 TCGA-24-2260-01A Stage IIIB -27112 1100 0 1100 667 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1 NO 1.7 G3 Recurrence TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8.pdf 2260 WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 0.5 24 1-10 mm Ovary A DECEASED 1992 TCGA-24-2260-01 0bfc4955-78bd-4883-b7b0-a262b6c1594f TCGA-24-2260-01 TCGA-24-2260-01A-01D-0667-05 TCGA-24-2260-01A-21-1560-20 TCGA-24-2260-01A-01D-0663-01 TCGA-24-2260-01 34ce0e32-d482-45e5-8663-edf50b16309a TCGA-24-2260-01A-01D-0663-01 TCGA-24-2260-01A-01W-0722-08 TCGA-24-2260-01 TCGA-24-2260-01A-01W-0722-08 TCGA-24-2260-01A-01R-0670-07 +TCGA-24-2261-01 TCGA-24-2261-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-2261 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 76 Left TCGA-24-2261-F26540 TCGA-24-2261 TCGA-24-2261-01A Stage IIIC -27897 24 0 24 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.7 YES G3 TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86.pdf 2261 WITH TUMOR NO NO Primary Tumor 01 0.4 24 11-20 mm Ovary A DECEASED 1992 TCGA-24-2261-01 TCGA-24-2261-01 8c41ba6a-3315-4903-9cd5-ac3f82576008 TCGA-24-2261-01 TCGA-24-2261-01A-01D-0667-05 TCGA-24-2261-01A-21-1560-20 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01D-0663-01 TCGA-24-2261-01 cbbb0190-5bfe-4a4f-aabe-63d68021b388 TCGA-24-2261-01A-01D-0663-01 75e9506a-d007-4fb2-8bdd-7e7780653a63 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01W-0722-08 TCGA-24-2261-01 TCGA-24-2261-01 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01W-0722-08 TCGA-24-2261-01A-01R-0670-07 +TCGA-24-2262-01 TCGA-24-2262-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2262 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Right TCGA-24-2262-F26542 TCGA-24-2262 TCGA-24-2262-01A Stage IIIC -20861 11 0 11 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G3 TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff.pdf 2262 WITH TUMOR NO NO Primary Tumor 01 0.4 24 1-10 mm Ovary A DECEASED 1992 TCGA-24-2262-01 TCGA-24-2262-01 8462f214-6bf7-4018-b40b-f9a3f3847542 TCGA-24-2262-01 TCGA-24-2262-01A-01D-0708-05 TCGA-24-2262-01A-21-1560-20 efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01D-0704-01 TCGA-24-2262-01 5d31db74-24ef-4322-9880-5189dee10ccb TCGA-24-2262-01A-01D-0704-01 efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01W-0799-08 TCGA-24-2262-01 TCGA-24-2262-01 efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01W-0799-08 TCGA-24-2262-01A-01R-0711-07 +TCGA-24-2267-01 TCGA-24-2267-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2267 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-24-2267-F26544 TCGA-24-2267 TCGA-24-2267-01A Stage IIB -21293 1446 0 1446 512 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.5 YES G3 Recurrence TCGA-24-2267.24844312-f32c-4366-945e-96d9a923f82a.pdf 2267 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 24 No Macroscopic disease Ovary A DECEASED 1993 TCGA-24-2267-01 TCGA-24-2267-01 7d6e82dd-4715-42df-8325-444be465aa24 TCGA-24-2267-01 TCGA-24-2267-01A-01D-0708-05 TCGA-24-2267-01A-21-1560-20 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01D-0704-01 TCGA-24-2267-01 25f1b635-6318-41d5-a0c8-37e8d263dddd TCGA-24-2267-01A-01D-0704-01 9ebb3535-6536-49fc-a88b-473235972378 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01W-0799-08 TCGA-24-2267-01 TCGA-24-2267-01 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01W-0799-08 TCGA-24-2267-01A-01R-0711-07 +TCGA-24-2271-01 TCGA-24-2271-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2271 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-2271-F26557 TCGA-24-2271 TCGA-24-2271-01A Stage IIIC -20399 962 0 962 827 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.6 YES G3 Recurrence TCGA-24-2271.87d64a93-9b08-48a5-a26e-1cc4b5ac8bde.pdf 2271 WITH TUMOR YES Physical Examination NO Primary Tumor 01 0.5 24 >20 mm Ovary YES A DECEASED 1999 TCGA-24-2271-01 TCGA-24-2271-01 3f1bd8a1-5a33-4c68-9d62-a65289c677dd TCGA-24-2271-01 TCGA-24-2271-01A-01D-0708-05 TCGA-24-2271-01A-21-1560-20 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01D-0704-01 TCGA-24-2271-01 9651ae11-92cc-4085-b9f5-b141eff0fb99 TCGA-24-2271-01A-01D-0704-01 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01W-0799-08 TCGA-24-2271-01 TCGA-24-2271-01 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01W-0799-08 TCGA-24-2271-01A-01R-0711-07 +TCGA-24-2280-01 TCGA-24-2280-01 Squamous OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-2280 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-2280-F26561 TCGA-24-2280 TCGA-24-2280-01A Stage IIIC -27356 0 2143 535 0 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.5 G3 Recurrence TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192.pdf 2280 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 1-10 mm Ovary A LIVING 2004 TCGA-24-2280-01 964fcf21-982e-474f-ab2d-cfcb0bbd0e15 TCGA-24-2280-01 TCGA-24-2280-01A-01D-0708-05 TCGA-24-2280-01A-01D-0704-01 TCGA-24-2280-01 TCGA-24-2280-01A-01D-0704-01 TCGA-24-2280-01A-01W-0799-08 TCGA-24-2280-01 TCGA-24-2280-01A-01W-0799-08 TCGA-24-2280-01A-01R-0711-07 +TCGA-24-2281-01 TCGA-24-2281-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2281 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 68 Bilateral TCGA-24-2281-F26570 TCGA-24-2281 TCGA-24-2281-01A Stage IIA -25019 0 1357 0 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.5 YES G3 TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8.pdf 2281 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.2 24 1-10 mm Ovary A LIVING 2006 TCGA-24-2281-01 TCGA-24-2281-01 0ca4dc50-aee3-49e2-b327-b86ddfce658f TCGA-24-2281-01 TCGA-24-2281-01A-01D-0708-05 TCGA-24-2281-01A-21-1560-20 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01D-0704-01 TCGA-24-2281-01 e83257be-084b-405a-8098-b10055d1ad85 TCGA-24-2281-01A-01D-0704-01 44948279-405d-42f6-ad29-465150ee6d85 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01W-0799-08 TCGA-24-2281-01 TCGA-24-2281-01 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01W-0799-08 TCGA-24-2281-01A-01R-0711-07 +TCGA-24-2288-01 TCGA-24-2288-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 8 TCGA-24-2288 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 70 Bilateral TCGA-24-2288-F26574 TCGA-24-2288 TCGA-24-2288-01A Stage IIIC -25831 25 0 25 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.2 YES G3 TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45.pdf 2288 WITH TUMOR YES NO Primary Tumor 01 0.5 24 >20 mm Ovary A DECEASED 1999 TCGA-24-2288-01 TCGA-24-2288-01 bea203c5-e349-4941-aa28-d3b9372ad7a2 TCGA-24-2288-01 TCGA-24-2288-01A-01D-0708-05 TCGA-24-2288-01A-21-1560-20 dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01D-0704-01 TCGA-24-2288-01 7c143023-df5b-42cb-958b-962d6f607e92 TCGA-24-2288-01A-01D-0704-01 dbc2cfac-df65-4750-af39-37760bad1057 dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01W-0799-08 TCGA-24-2288-01 TCGA-24-2288-01 dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01W-0799-08 TCGA-24-2288-01A-01R-0711-07 +TCGA-24-2289-01 TCGA-24-2289-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 mutation cluster 8 TCGA-24-2289 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-24-2289-F26578 TCGA-24-2289 TCGA-24-2289-01A Stage IV -25191 2049 0 2049 568 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 1.5 G3 Recurrence TCGA-24-2289.3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d.pdf 2289 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 0.4 24 >20 mm Ovary A DECEASED 1997 TCGA-24-2289-01 TCGA-24-2289-01 9ef0fcf7-e7c3-4c19-ab2b-185392963182 TCGA-24-2289-01 TCGA-24-2289-01A-01D-0708-05 TCGA-24-2289-01A-21-1560-20 bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01D-0704-01 TCGA-24-2289-01 992227e4-86a6-4703-ac81-cae8ea4a5dac TCGA-24-2289-01A-01D-0704-01 bdc4400c-c552-450b-a806-2ae10f61cca8 bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01W-0799-08 TCGA-24-2289-01 TCGA-24-2289-01 bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01W-0799-08 TCGA-24-2289-01A-01R-0711-07 +TCGA-24-2290-01 TCGA-24-2290-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2290 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 TCGA-24-2290-F26583 TCGA-24-2290 TCGA-24-2290-01A Stage IIIC -20530 1102 0 1102 324 0 2010-2-19 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d.pdf 2290 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 24 1-10 mm Omentum A DECEASED 1997 TCGA-24-2290-01 TCGA-24-2290-01 ad9e04b7-2000-411e-81bd-d1d22381d5c8 TCGA-24-2290-01 TCGA-24-2290-01A-01D-0708-05 TCGA-24-2290-01A-21-1560-20 a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01D-0704-01 TCGA-24-2290-01 7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9 TCGA-24-2290-01A-01D-0704-01 a3173b33-aa16-48a2-b733-0345aad49755 a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01W-0799-08 TCGA-24-2290-01 TCGA-24-2290-01 a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01W-0799-08 TCGA-24-2290-01A-01R-0711-07 +TCGA-24-2293-01 TCGA-24-2293-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 mutation c1uster 9 TCGA-24-2293 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 47 Right TCGA-24-2293-F26598 TCGA-24-2293 TCGA-24-2293-01A -17235 506 0 506 2010-2-26 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection 1.1 NO 1.3 G3 TCGA-24-2293.caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7.pdf 2293 YES Partial Remission/Response NO Primary Tumor 01 0.3 24 >20 mm Omentum A DECEASED 1995 TCGA-24-2293-01 TCGA-24-2293-01 87480009-8495-4826-9d10-dbe6dc6281f1 TCGA-24-2293-01 TCGA-24-2293-01A-01D-0708-05 TCGA-24-2293-01A-21-1560-20 d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01D-0704-01 TCGA-24-2293-01 a40fdeac-ebb6-4f9f-9f90-837deef5095e TCGA-24-2293-01A-01D-0704-01 d554a1f1-3e8a-4b8c-a458-36e6550905dd d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01W-0799-08 TCGA-24-2293-01 TCGA-24-2293-01 d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01W-0799-08 TCGA-24-2293-01A-01R-0711-07 +TCGA-24-2295-01 TCGA-24-2295-01 High OV-like c1 OV-like c4 TCGA-24-2295 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Right TCGA-24-2295-F26605 TCGA-24-2295 TCGA-24-2295-01A Stage IIIC -25416 1007 0 1007 281 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.1 YES G3 Recurrence TCGA-24-2295.44d946e9-12ae-437b-9211-1be42b4d6439.pdf 2295 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.4 24 >20 mm Ovary A DECEASED 1995 8a525a38-29e3-457d-a665-e05297e6b07a TCGA-24-2295-01A-01D-0708-05 TCGA-24-2295-01A-21-1560-20 TCGA-24-2295-01A-01D-0704-01 TCGA-24-2295-01 eb245ed7-60fc-47eb-9d75-4704c337b943 TCGA-24-2295-01A-01D-0704-01 TCGA-24-2295-01 TCGA-24-2295-01A-01R-0711-07 +TCGA-24-2297-01 TCGA-24-2297-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-24-2297 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 Bilateral TCGA-24-2297-F26612 TCGA-24-2297 TCGA-24-2297-01A Stage IIIC -20487 1699 0 1699 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G3 TCGA-24-2297.12b02227-4050-4d02-bdb8-939d348a4c19.pdf 2297 YES Complete Remission/Response NO Primary Tumor 01 0.3 24 >20 mm Ovary A DECEASED 1993 TCGA-24-2297-01 TCGA-24-2297-01 971a0b51-b807-436b-ac4c-ef9cc2e2038d TCGA-24-2297-01 TCGA-24-2297-01A-01D-0708-05 TCGA-24-2297-01A-21-1560-20 2b0089bc-b493-4179-bf5c-e58550e1ee5b TCGA-24-2297-01A-01D-0704-01 TCGA-24-2297-01 f700e3e2-462f-4889-82fa-ac614983d642 TCGA-24-2297-01A-01D-0704-01 2b0089bc-b493-4179-bf5c-e58550e1ee5b 2b0089bc-b493-4179-bf5c-e58550e1ee5b TCGA-24-2297-01 TCGA-24-2297-01 2b0089bc-b493-4179-bf5c-e58550e1ee5b TCGA-24-2297-01A-01R-0711-07 +TCGA-24-2298-01 TCGA-24-2298-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-2298 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-2298-F26616 TCGA-24-2298 TCGA-24-2298-01A Stage IIIC -20453 1620 0 1620 469 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1 G3 Recurrence TCGA-24-2298.fe9d7bf4-a278-4842-b911-018d0127ef20.pdf 2298 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 24 >20 mm Ovary A DECEASED 1993 TCGA-24-2298-01 TCGA-24-2298-01 9c71ce7f-4e80-46bc-b66c-c893614dd207 TCGA-24-2298-01 TCGA-24-2298-01A-01D-0708-05 TCGA-24-2298-01A-21-1560-20 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01D-0704-01 TCGA-24-2298-01 a99356d2-7d94-4274-9720-3defe513159a TCGA-24-2298-01A-01D-0704-01 7b39cb0a-7152-4037-9989-57545a1df980 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01W-0799-08 TCGA-24-2298-01 TCGA-24-2298-01 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01W-0799-08 TCGA-24-2298-01A-01R-0711-07 +TCGA-25-1312-01 TCGA-25-1312-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-25-1312 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 69 Left TCGA-25-1312-F26626 TCGA-25-1312 TCGA-25-1312-01A Stage IV -25537 31 0 31 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2.5 NO 3 G3 TCGA-25-1312.9AD5ADDB-713E-4FF7-97F1-123FA771AC5B.pdf 1312 NO Primary Tumor 01 1 25 1-10 mm Ovary A DECEASED 2001 TCGA-25-1312-01 TCGA-25-1312-01 c31a0d45-5e8c-4fcb-b773-1bd3744b5eea TCGA-25-1312-01 TCGA-25-1312-01A-01D-0460-05 TCGA-25-1312-01A-11-1562-20 0d7561dc-7069-41df-ba49-8fcd4df52efb TCGA-25-1312-01A-01D-0452-01 TCGA-25-1312-01 43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b TCGA-25-1312-01A-01D-0452-01 0d7561dc-7069-41df-ba49-8fcd4df52efb 0d7561dc-7069-41df-ba49-8fcd4df52efb TCGA-25-1312-01 TCGA-25-1312-01 0d7561dc-7069-41df-ba49-8fcd4df52efb TCGA-25-1312-01A-01R-0456-07 +TCGA-25-1313-01 TCGA-25-1313-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-25-1313 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-25-1313-F26628 TCGA-25-1313 TCGA-25-1313-01A Stage IV -22982 820 0 820 394 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2 G3 Recurrence TCGA-25-1313.3F5AAE21-3694-4AC2-8A18-4970090A08F4.pdf 1313 WITH TUMOR YES Complete Remission/Response Molecular Markers Primary Tumor 01 1.5 25 1-10 mm Ovary A DECEASED 2000 TCGA-25-1313-01 TCGA-25-1313-01 5e71901f-ac21-4d6d-8705-ab20c65ec0f0 TCGA-25-1313-01 TCGA-25-1313-01A-01D-0460-05 TCGA-25-1313-01A-21-1562-20 ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01D-0452-01 TCGA-25-1313-01 291a8a6a-23e2-42c9-a260-8696b9795cf2 TCGA-25-1313-01A-01D-0452-01 ab99683f-6116-463d-8bf6-5782809d4729 ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01W-0492-08 TCGA-25-1313-01 TCGA-25-1313-01 ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01W-0492-08 TCGA-25-1313-01A-01R-0456-07 +TCGA-25-1314-01 TCGA-25-1314-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-25-1314 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-25-1314-F26633 TCGA-25-1314 Stage IV -15462 1004 0 974 274 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Progression of Disease 1314 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 25 1-10 mm Ovary DECEASED 2000 TCGA-25-1314-01 TCGA-25-1314-01 da862d11-c970-44ee-af78-1179902f9310 TCGA-25-1314-01 TCGA-25-1314-01A-01D-0460-05 TCGA-25-1314-01A-21-1562-20 b571f7cf-e9b8-493f-822b-a489f114420b TCGA-25-1314-01A-01D-0452-01 TCGA-25-1314-01 b17945ba-39d6-400d-8e3e-e81123595c51 TCGA-25-1314-01A-01D-0452-01 b571f7cf-e9b8-493f-822b-a489f114420b b571f7cf-e9b8-493f-822b-a489f114420b TCGA-25-1314-01 TCGA-25-1314-01 b571f7cf-e9b8-493f-822b-a489f114420b TCGA-25-1314-01A-01R-0456-07 +TCGA-25-1315-01 TCGA-25-1315-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1315 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-25-1315-F26639 TCGA-25-1315 TCGA-25-1315-01A Stage IIIC -18263 1583 0 1553 153 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 3.5 G3 Progression of Disease TCGA-25-1315.486E22A0-A224-4471-BA52-9F52E021B131.pdf 1315 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.9 25 1-10 mm Ovary A DECEASED 2000 TCGA-25-1315-01 TCGA-25-1315-01 6f8cdfc3-aada-43e2-a9ce-9d8d437b9442 TCGA-25-1315-01 TCGA-25-1315-01A-01D-0460-05 TCGA-25-1315-01A-01W-0494-09 TCGA-25-1315-01A-21-1562-20 TCGA-25-1315-01A-01W-0494-09 b6908d33-80c8-4fc0-bd1d-829ec3161527 TCGA-25-1315-01A-01D-0452-01 TCGA-25-1315-01 1ecf4db0-2d32-4ad5-a14a-ce5065f7fb01 TCGA-25-1315-01A-01D-0452-01 b6908d33-80c8-4fc0-bd1d-829ec3161527 b6908d33-80c8-4fc0-bd1d-829ec3161527 TCGA-25-1315-01 TCGA-25-1315-01 b6908d33-80c8-4fc0-bd1d-829ec3161527 TCGA-25-1315-01A-01W-0494-09 TCGA-25-1315-01A-01R-0456-07 +TCGA-25-1316-01 TCGA-25-1316-01 BRCA-LUAD+ C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 12 TCGA-25-1316 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Right TCGA-25-1316-F26646 TCGA-25-1316 TCGA-25-1316-01A Stage IIIC -20331 1279 0 1126 276 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2.5 NO 3 G3 Progression of Disease TCGA-25-1316.B766CB7E-C4EC-489C-AEF0-BE28132D5BA5.pdf 1316 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 1.5 25 1-10 mm Ovary A DECEASED 2000 TCGA-25-1316-01 TCGA-25-1316-01 5c167e3e-7757-4a02-b218-81c2ba107bfa TCGA-25-1316-01 TCGA-25-1316-01A-01D-0460-05 TCGA-25-1316-01A-01W-0494-09 TCGA-25-1316-01A-21-20 TCGA-25-1316-01A-01W-0494-09 6cb5e275-1284-482b-a4e9-933acf9aad44 TCGA-25-1316-01A-01D-0452-01 TCGA-25-1316-01 4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4 TCGA-25-1316-01A-01D-0452-01 6cb5e275-1284-482b-a4e9-933acf9aad44 6cb5e275-1284-482b-a4e9-933acf9aad44 TCGA-25-1316-01 TCGA-25-1316-01 6cb5e275-1284-482b-a4e9-933acf9aad44 TCGA-25-1316-01A-01W-0494-09 TCGA-25-1316-01A-01R-0456-07 +TCGA-25-1317-01 TCGA-25-1317-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-1317 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Bilateral TCGA-25-1317-F26651 TCGA-25-1317 TCGA-25-1317-01A Stage IIIC -24199 61 0 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.5 G3 TCGA-25-1317.5DC53520-0991-42B6-B10D-0D62C3F92BAD.pdf 1317 YES NO Primary Tumor 01 0.5 25 Ovary A DECEASED 2000 TCGA-25-1317-01 TCGA-25-1317-01 TCGA-25-1317-01A-01W-0490-10 5b49f5cc-28fd-4b1e-ae8e-6391f99ccb46 TCGA-25-1317-01 TCGA-25-1317-01A-01W-0490-10 TCGA-25-1317-01A-01D-0460-05 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf TCGA-25-1317-01A-01D-0452-01 TCGA-25-1317-01 TCGA-25-1317-01A-01D-0452-01 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf TCGA-25-1317-01 TCGA-25-1317-01 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf TCGA-25-1317-01A-01W-0490-10 TCGA-25-1317-01A-01R-0456-07 +TCGA-25-1318-01 TCGA-25-1318-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1318 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-25-1318-F26655 TCGA-25-1318 TCGA-25-1318-01A Stage IIIC -19755 1064 0 1064 185 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 4.5 G3 Recurrence TCGA-25-1318.D9B9F69A-265C-42F4-BCD2-4B136A7FE935.pdf 1318 WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.8 25 1-10 mm Ovary A DECEASED 2000 TCGA-25-1318-01 TCGA-25-1318-01 TCGA-25-1318-01A-01W-0490-10 f912d9b2-2f49-4c3f-aed0-3edc0065d54b TCGA-25-1318-01 TCGA-25-1318-01A-01W-0490-10 TCGA-25-1318-01A-01D-0460-05 TCGA-25-1318-01A-21-1562-20 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 TCGA-25-1318-01A-01D-0452-01 TCGA-25-1318-01 2f954b2b-ab8d-4f81-8717-e85d500987ee TCGA-25-1318-01A-01D-0452-01 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 TCGA-25-1318-01 TCGA-25-1318-01 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 TCGA-25-1318-01A-01W-0490-10 TCGA-25-1318-01A-01R-0456-07 +TCGA-25-1319-01 TCGA-25-1319-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1319 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-25-1319-F26660 TCGA-25-1319 TCGA-25-1319-01A Stage IIIC -26786 1977 0 1977 730 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2.5 NO 3 G3 Recurrence TCGA-25-1319.62BFD64E-1C60-49A8-BAD0-B173DD22C951.pdf 1319 YES NO Primary Tumor 01 1 25 11-20 mm Ovary A DECEASED 2000 TCGA-25-1319-01 TCGA-25-1319-01 7f028062-e863-4f7d-8ec6-8e91da60fc74 TCGA-25-1319-01 TCGA-25-1319-01A-01D-0460-05 TCGA-25-1319-01A-21-1562-20 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01D-0452-01 TCGA-25-1319-01 09ef1041-497f-409f-9892-b5a1631a647f TCGA-25-1319-01A-01D-0452-01 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01W-0492-08 TCGA-25-1319-01 TCGA-25-1319-01 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01W-0492-08 TCGA-25-1319-01A-01R-0456-07 +TCGA-25-1320-01 TCGA-25-1320-01 High C9-OV OV-like c1 BRCA basal-like c6 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-1320 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-25-1320-F26664 TCGA-25-1320 TCGA-25-1320-01A Stage IIIC -24018 1155 0 1124 424 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 3 NO 3.4 G3 Recurrence TCGA-25-1320.AF68EF8D-A31D-453B-8083-CF6B9EE4E838.pdf 1320 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 1 25 1-10 mm Ovary A DECEASED 2001 TCGA-25-1320-01 TCGA-25-1320-01 7a1cfa3d-a19e-42b1-91b5-485891ff2d34 TCGA-25-1320-01 TCGA-25-1320-01A-01D-0460-05 TCGA-25-1320-01A-21-1562-20 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01D-0452-01 TCGA-25-1320-01 d1b3fd86-d1f2-4621-980a-19f3d9ee76f4 TCGA-25-1320-01A-01D-0452-01 52697815-ede2-4ce3-a6d0-2680f6b9bb73 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01W-0492-08 TCGA-25-1320-01 TCGA-25-1320-01 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01W-0492-08 TCGA-25-1320-01A-01R-0456-07 +TCGA-25-1321-01 TCGA-25-1321-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1321 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-25-1321-F26670 TCGA-25-1321 TCGA-25-1321-01A Stage IIIC -23987 1033 0 1033 454 0 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.6 NO 3 G3 Recurrence TCGA-25-1321.5D309784-AED1-4946-817D-37AC8969315C.pdf 1321 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.8 25 No Macroscopic disease Ovary A DECEASED 2001 TCGA-25-1321-01 TCGA-25-1321-01 8f9bea4f-6738-429b-8ebb-8ae8cf65d294 TCGA-25-1321-01 TCGA-25-1321-01A-01D-0460-05 TCGA-25-1321-01A-21-1562-20 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01D-0452-01 TCGA-25-1321-01 9790631d-f673-415e-8644-5419b2b956b2 TCGA-25-1321-01A-01D-0452-01 74ad9d3e-97a9-419d-8842-3fb37d3f099a 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01W-0492-08 TCGA-25-1321-01 TCGA-25-1321-01 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01W-0492-08 TCGA-25-1321-01A-01R-0456-07 +TCGA-25-1322-01 TCGA-25-1322-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1322 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-25-1322-F26676 TCGA-25-1322 TCGA-25-1322-01A Stage IV -22646 91 0 91 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.8 NO 2.6 G3 TCGA-25-1322.6EAF4358-51F9-4999-A219-39178418CC9C.pdf 1322 WITH TUMOR YES NO Primary Tumor 01 0.8 25 >20 mm Ovary A DECEASED 2001 TCGA-25-1322-01 TCGA-25-1322-01 34a7dcf3-fc87-4334-8ee0-77166a5398fa TCGA-25-1322-01 TCGA-25-1322-01A-01D-0460-05 TCGA-25-1322-01A-01W-0494-09 TCGA-25-1322-01A-21-20 TCGA-25-1322-01A-01W-0494-09 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 TCGA-25-1322-01A-01D-0452-01 TCGA-25-1322-01 90cba3ae-e75e-4a1e-bc31-293ac260cf96 TCGA-25-1322-01A-01D-0452-01 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 TCGA-25-1322-01 TCGA-25-1322-01 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 TCGA-25-1322-01A-01W-0494-09 TCGA-25-1322-01A-01R-0456-07 +TCGA-25-1323-01 TCGA-25-1323-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 TCGA-25-1323 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Bilateral TCGA-25-1323-F26680 TCGA-25-1323 TCGA-25-1323-01A Stage IIIC -26602 395 0 365 365 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2.5 G3 Progression of Disease TCGA-25-1323.AFE55BB2-F0FC-4B39-A61A-2287B62354AD.pdf 1323 WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 0.6 25 1-10 mm Ovary A DECEASED 2001 TCGA-25-1323-01 TCGA-25-1323-01 61b1bbe5-434f-4d88-aadb-a42344b0e0fb TCGA-25-1323-01 TCGA-25-1323-01A-01D-0460-05 TCGA-25-1323-01A-21-1562-20 cd401b89-ae05-4775-94b0-6800f88652b0 TCGA-25-1323-01A-01D-0452-01 TCGA-25-1323-01 e89ce7f4-4c3f-4c48-a222-506d3806ad33 TCGA-25-1323-01A-01D-0452-01 cd401b89-ae05-4775-94b0-6800f88652b0 cd401b89-ae05-4775-94b0-6800f88652b0 TCGA-25-1323-01 TCGA-25-1323-01 cd401b89-ae05-4775-94b0-6800f88652b0 TCGA-25-1323-01A-01R-0456-07 +TCGA-25-1324-01 TCGA-25-1324-01 OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 11 TCGA-25-1324 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Bilateral TCGA-25-1324-F26685 TCGA-25-1324 TCGA-25-1324-01A Stage IIIC -27090 1035 0 1035 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-25-1324.53AE406F-E6E6-4137-A7B3-01DAFAEDE783.pdf 1324 YES NO Primary Tumor 01 0.8 25 1-10 mm Ovary A DECEASED 2001 TCGA-25-1324-01 TCGA-25-1324-01 TCGA-25-1324-01A-01W-0490-10 dadc9a44-fbec-4109-b5e5-4a21ad28eb63 TCGA-25-1324-01 TCGA-25-1324-01A-01W-0490-10 TCGA-25-1324-01A-01D-0460-05 790c6d79-9f7d-4e9a-89db-43b26fe16816 TCGA-25-1324-01 790c6d79-9f7d-4e9a-89db-43b26fe16816 790c6d79-9f7d-4e9a-89db-43b26fe16816 790c6d79-9f7d-4e9a-89db-43b26fe16816 TCGA-25-1324-01A-01W-0490-10 TCGA-25-1324-01A-01R-0456-07 +TCGA-25-1325-01 TCGA-25-1325-01 OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 TCGA-25-1325 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 77 Left TCGA-25-1325-F26689 TCGA-25-1325 TCGA-25-1325-01A Stage IV -28183 976 0 976 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 5 G3 TCGA-25-1325.E9315413-584C-4F29-B05D-657DB9A0B4F5.pdf 1325 NO Primary Tumor 01 1.3 25 >20 mm Ovary A DECEASED 2002 TCGA-25-1325-01 TCGA-25-1325-01A-01W-0490-10 7d8ca51a-3995-47a6-89ad-63ffd81e32a0 TCGA-25-1325-01 TCGA-25-1325-01A-01W-0490-10 TCGA-25-1325-01A-01D-0460-05 TCGA-25-1325-01A-21-1562-20 TCGA-25-1325-01 8896ef4e-3809-4ed8-befa-a014b7b81da1 TCGA-25-1325-01A-01R-0456-07 +TCGA-25-1326-01 TCGA-25-1326-01 C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1326 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-25-1326-F26691 TCGA-25-1326 TCGA-25-1326-01A Stage IIIC -22339 1249 0 945 396 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2.5 NO 3 G3 Recurrence TCGA-25-1326.B17E5B27-48DB-4E64-A1C3-CAE4921C14DF.pdf 1326 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 1.2 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1326-01 TCGA-25-1326-01 f01d69dc-1d50-4afb-83de-8124b93685a9 TCGA-25-1326-01 TCGA-25-1326-01A-01D-0460-05 TCGA-25-1326-01A-21-1562-20 b29bd766-95b1-46fa-a070-d2206cd5722a TCGA-25-1326-01 6e7bb043-ec9a-4648-9acd-14526dca800e b29bd766-95b1-46fa-a070-d2206cd5722a b29bd766-95b1-46fa-a070-d2206cd5722a TCGA-25-1326-01A-01W-0492-08 b29bd766-95b1-46fa-a070-d2206cd5722a TCGA-25-1326-01A-01W-0492-08 TCGA-25-1326-01A-01R-0456-07 +TCGA-25-1328-01 TCGA-25-1328-01 C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-25-1328 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-25-1328-F26698 TCGA-25-1328 TCGA-25-1328-01A Stage IIIC -13911 2009 0 1979 244 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.8 NO 2.8 G3 Recurrence TCGA-25-1328.A2DA7EB3-8E42-4E86-9352-99673F51AEFF.pdf 1328 WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO Primary Tumor 01 1 25 1-10 mm Ovary A DECEASED 2001 TCGA-25-1328-01 TCGA-25-1328-01 73b10e0b-cb82-49ec-8bdd-07d79bc2b8d6 TCGA-25-1328-01 TCGA-25-1328-01A-01D-0460-05 TCGA-25-1328-01A-21-1562-20 9ba8d6bf-1541-4127-bc60-73091d2d81c7 TCGA-25-1328-01 d064cdc4-ad95-4e85-b9b0-6871d9c2698d 9ba8d6bf-1541-4127-bc60-73091d2d81c7 9ba8d6bf-1541-4127-bc60-73091d2d81c7 TCGA-25-1328-01A-01W-0492-08 9ba8d6bf-1541-4127-bc60-73091d2d81c7 TCGA-25-1328-01A-01W-0492-08 TCGA-25-1328-01A-01R-0456-07 +TCGA-25-1329-01 TCGA-25-1329-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1329 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 76 Bilateral TCGA-25-1329-F26705 TCGA-25-1329 TCGA-25-1329-01A Stage IIIC -28093 457 0 90 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2.6 NO 3 G3 TCGA-25-1329.857409C6-75EC-4935-85BC-6D5F66AF4DB3.pdf 1329 YES Primary Tumor 01 0.6 25 11-20 mm Ovary A DECEASED 2002 TCGA-25-1329-01 TCGA-25-1329-01 3bd2e158-9743-44cd-a5c3-0ba7179b8660 TCGA-25-1329-01 TCGA-25-1329-01A-01D-0460-05 TCGA-25-1329-01A-21-1562-20 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01D-0452-01 TCGA-25-1329-01 299168d0-39ac-4d64-9345-88fe0f6746ee TCGA-25-1329-01A-01D-0452-01 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01W-0492-08 TCGA-25-1329-01 TCGA-25-1329-01 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01W-0492-08 TCGA-25-1329-01A-01R-0456-07 +TCGA-25-1623-01 TCGA-25-1623-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1623 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-1623-F26707 TCGA-25-1623 TCGA-25-1623-01A Stage IV -26060 565 0 565 342 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.8 G3 Recurrence TCGA-25-1623.A57CB221-076A-4EE5-8C77-D1E33070597C.pdf 1623 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 25 No Macroscopic disease Ovary A DECEASED 2006 TCGA-25-1623-01 TCGA-25-1623-01 TCGA-25-1623-01A-01W-0615-10 47640c72-6c10-4956-8a89-0c5f0b12cc49 TCGA-25-1623-01 TCGA-25-1623-01A-01W-0615-10 TCGA-25-1623-01A-01D-0536-05 TCGA-25-1623-01A-21-1558-20 3e4f0ca7-8428-47df-80a3-3bc9153aedfa TCGA-25-1623-01A-01D-0533-01 TCGA-25-1623-01 ef62a625-cf2c-45d1-aa59-9d44e16a37fa TCGA-25-1623-01A-01D-0533-01 3e4f0ca7-8428-47df-80a3-3bc9153aedfa 3e4f0ca7-8428-47df-80a3-3bc9153aedfa TCGA-25-1623-01 TCGA-25-1623-01 3e4f0ca7-8428-47df-80a3-3bc9153aedfa TCGA-25-1623-01A-01W-0615-10 TCGA-25-1623-01A-01R-0540-07 +TCGA-25-1625-01 TCGA-25-1625-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1625 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-25-1625-F26712 TCGA-25-1625 TCGA-25-1625-01A Stage IIIC -24298 840 0 548 526 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.5 G3 Recurrence TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf 1625 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2006 TCGA-25-1625-01 TCGA-25-1625-01 TCGA-25-1625-01A-01W-0615-10 b176a30a-0977-46e6-b577-a421ca9bb340 TCGA-25-1625-01 TCGA-25-1625-01A-01W-0615-10 TCGA-25-1625-01A-01D-0536-05 TCGA-25-1625-01A-21-1558-20 921fab94-5522-4c08-8e02-13fb6ea2d388 TCGA-25-1625-01A-01D-0533-01 TCGA-25-1625-01 ffb78d5c-46f5-4f3a-8572-55df5db80a1d TCGA-25-1625-01A-01D-0533-01 921fab94-5522-4c08-8e02-13fb6ea2d388 921fab94-5522-4c08-8e02-13fb6ea2d388 TCGA-25-1625-01 TCGA-25-1625-01 921fab94-5522-4c08-8e02-13fb6ea2d388 TCGA-25-1625-01A-01W-0615-10 TCGA-25-1625-01A-01R-0540-07 +TCGA-25-1626-01 TCGA-25-1626-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1626 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-25-1626-F26716 TCGA-25-1626 TCGA-25-1626-01A Stage IIIC -23932 518 0 481 318 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.4 G3 Recurrence TCGA-25-1626.4B54A1C9-6F08-435B-B85F-736D4278EA82.pdf 1626 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 25 >20 mm Ovary A DECEASED 2006 TCGA-25-1626-01 TCGA-25-1626-01 TCGA-25-1626-01A-01W-0615-10 a1ed5a8a-8ac2-4d94-96e0-92bb4dcc8af6 TCGA-25-1626-01 TCGA-25-1626-01A-01W-0615-10 TCGA-25-1626-01A-01D-0536-05 TCGA-25-1626-01A-21-1558-20 daaba89d-acd3-4670-a618-89e5973b03f4 TCGA-25-1626-01A-01D-0533-01 TCGA-25-1626-01 7a9090de-0e14-4fc3-a2d7-c42629b3afd7 TCGA-25-1626-01A-01D-0533-01 daaba89d-acd3-4670-a618-89e5973b03f4 daaba89d-acd3-4670-a618-89e5973b03f4 TCGA-25-1626-01 TCGA-25-1626-01 daaba89d-acd3-4670-a618-89e5973b03f4 TCGA-25-1626-01A-01W-0615-10 TCGA-25-1626-01A-01R-0540-07 +TCGA-25-1627-01 TCGA-25-1627-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1627 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-25-1627-F26722 TCGA-25-1627 TCGA-25-1627-01A Stage IIIC -26784 394 0 11 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-25-1627.FB36B0F9-6519-4CF5-9A74-F7015FD405FF.pdf 1627 YES NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2003 TCGA-25-1627-01 TCGA-25-1627-01 TCGA-25-1627-01A-01W-0615-10 d1eafd5b-5036-44dd-b902-92951e9d31c5 TCGA-25-1627-01 TCGA-25-1627-01A-01W-0615-10 TCGA-25-1627-01A-01D-0536-05 TCGA-25-1627-01A-21-1558-20 0fc68715-c7fc-4481-a5bf-68a281f5ec64 TCGA-25-1627-01A-01D-0533-01 TCGA-25-1627-01 a2210172-a1e0-4bbf-a38a-363571251f90 TCGA-25-1627-01A-01D-0533-01 0fc68715-c7fc-4481-a5bf-68a281f5ec64 0fc68715-c7fc-4481-a5bf-68a281f5ec64 TCGA-25-1627-01 TCGA-25-1627-01 0fc68715-c7fc-4481-a5bf-68a281f5ec64 TCGA-25-1627-01A-01W-0615-10 TCGA-25-1627-01A-01R-0540-07 +TCGA-25-1628-01 TCGA-25-1628-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1628 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 TCGA-25-1628-F26724 TCGA-25-1628 TCGA-25-1628-01A Stage IIIC -24488 627 0 627 287 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 2 G3 Recurrence TCGA-25-1628.790D6E48-15D0-45F9-B6DD-182787298EBA.pdf 1628 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 0.4 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1628-01 TCGA-25-1628-01 TCGA-25-1628-01A-01W-0615-10 7db7c522-1983-4b98-b630-2ddbd5d4aefa TCGA-25-1628-01 TCGA-25-1628-01A-01W-0615-10 TCGA-25-1628-01A-01D-0536-05 TCGA-25-1628-01A-21-1558-20 a3083fd8-f5d0-486b-bf3d-31ae094b1cbf TCGA-25-1628-01A-01D-0533-01 TCGA-25-1628-01 f7ac6f1b-7ee1-4536-84ae-48d20a61df99 TCGA-25-1628-01A-01D-0533-01 a3083fd8-f5d0-486b-bf3d-31ae094b1cbf a3083fd8-f5d0-486b-bf3d-31ae094b1cbf TCGA-25-1628-01 TCGA-25-1628-01 a3083fd8-f5d0-486b-bf3d-31ae094b1cbf TCGA-25-1628-01A-01W-0615-10 TCGA-25-1628-01A-01R-0540-07 +TCGA-25-1630-01 TCGA-25-1630-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1630 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-25-1630-F26729 TCGA-25-1630 Stage IIIC -27006 1162 0 239 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 1630 YES Complete Remission/Response NO Primary Tumor 01 25 1-10 mm Ovary DECEASED 2002 TCGA-25-1630-01 TCGA-25-1630-01 TCGA-25-1630-01A-01W-0615-10 f497f9fd-9a0e-446e-98fa-265e325e194e TCGA-25-1630-01 TCGA-25-1630-01A-01W-0615-10 TCGA-25-1630-01A-01D-0536-05 TCGA-25-1630-01A-21-1558-20 c5a82b6e-048d-4377-9b6c-4417ba1876fe TCGA-25-1630-01A-01D-0533-01 TCGA-25-1630-01 c0b3ff41-c34a-4f86-b029-5a761ff85b2e TCGA-25-1630-01A-01D-0533-01 c5a82b6e-048d-4377-9b6c-4417ba1876fe c5a82b6e-048d-4377-9b6c-4417ba1876fe TCGA-25-1630-01 TCGA-25-1630-01 c5a82b6e-048d-4377-9b6c-4417ba1876fe TCGA-25-1630-01A-01W-0615-10 TCGA-25-1630-01A-01R-0540-07 +TCGA-25-1631-01 TCGA-25-1631-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1631 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-25-1631-F26733 TCGA-25-1631 TCGA-25-1631-01A Stage IIIC -26687 9 0 9 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2 G3 TCGA-25-1631.1C74F61E-1131-4782-8117-20C59B86D845.pdf 1631 TUMOR FREE NO NO Primary Tumor 01 0.4 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1631-01 TCGA-25-1631-01 TCGA-25-1631-01A-01W-0615-10 2fab3946-dfac-449c-971a-9312801bbe51 TCGA-25-1631-01 TCGA-25-1631-01A-01W-0615-10 TCGA-25-1631-01A-01D-0536-05 TCGA-25-1631-01A-21-1558-20 29c4cab9-c19e-4416-ad88-484cc02a980f TCGA-25-1631-01A-01D-0533-01 TCGA-25-1631-01 51225525-5680-46ab-8e00-f35ed4df6470 TCGA-25-1631-01A-01D-0533-01 29c4cab9-c19e-4416-ad88-484cc02a980f 29c4cab9-c19e-4416-ad88-484cc02a980f TCGA-25-1631-01 TCGA-25-1631-01 29c4cab9-c19e-4416-ad88-484cc02a980f TCGA-25-1631-01A-01W-0615-10 TCGA-25-1631-01A-01R-0540-07 +TCGA-25-1632-01 TCGA-25-1632-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 8 TCGA-25-1632 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-25-1632-F26735 TCGA-25-1632 TCGA-25-1632-01A Stage IV -24993 1799 0 1732 537 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.4 G3 Recurrence TCGA-25-1632.F083C2B4-20DE-440F-B6A8-2F332346CECA.pdf 1632 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1632-01 TCGA-25-1632-01 TCGA-25-1632-01A-01W-0615-10 8736b37d-cdc1-4e9e-8215-edb675c8a072 TCGA-25-1632-01 TCGA-25-1632-01A-01W-0615-10 TCGA-25-1632-01A-01D-0536-05 TCGA-25-1632-01A-21-1558-20 12c78d62-6045-4f77-bd84-9ab5a38f4635 TCGA-25-1632-01A-01D-0533-01 TCGA-25-1632-01 105464b7-4efd-4ed6-a906-2dab64b49ad0 TCGA-25-1632-01A-01D-0533-01 12c78d62-6045-4f77-bd84-9ab5a38f4635 12c78d62-6045-4f77-bd84-9ab5a38f4635 TCGA-25-1632-01 TCGA-25-1632-01 12c78d62-6045-4f77-bd84-9ab5a38f4635 TCGA-25-1632-01A-01W-0615-10 TCGA-25-1632-01A-01R-0540-07 +TCGA-25-1633-01 TCGA-25-1633-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1633 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Bilateral TCGA-25-1633-F26742 TCGA-25-1633 TCGA-25-1633-01A Stage IIIC -23407 1891 0 1843 616 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.3 G3 Recurrence TCGA-25-1633.B3B45EA2-B154-45DC-B49D-422500EA1D9C.pdf 1633 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.2 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1633-01 TCGA-25-1633-01 TCGA-25-1633-01A-01W-0615-10 9f229f84-97c9-4684-8eb7-f2af666e3399 TCGA-25-1633-01 TCGA-25-1633-01A-01W-0615-10 TCGA-25-1633-01A-01D-0536-05 TCGA-25-1633-01A-21-1558-20 7517c446-401d-4501-bf27-916e0835deac TCGA-25-1633-01A-01D-0533-01 TCGA-25-1633-01 a9062738-4ec8-464c-b5c9-abd82bf322bc TCGA-25-1633-01A-01D-0533-01 7517c446-401d-4501-bf27-916e0835deac 7517c446-401d-4501-bf27-916e0835deac TCGA-25-1633-01 TCGA-25-1633-01 7517c446-401d-4501-bf27-916e0835deac TCGA-25-1633-01A-01W-0615-10 TCGA-25-1633-01A-01R-0540-07 +TCGA-25-1634-01 TCGA-25-1634-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-25-1634 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Bilateral TCGA-25-1634-F26749 TCGA-25-1634 Stage IIIC -27749 1091 0 1081 380 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1634 WITH TUMOR YES Complete Remission/Response Other Method NO Primary Tumor 01 25 No Macroscopic disease Ovary DECEASED 2002 TCGA-25-1634-01 TCGA-25-1634-01 TCGA-25-1634-01A-01W-0615-10 e3aae8d6-511b-40ce-8ade-6208c6fcdb9f TCGA-25-1634-01 TCGA-25-1634-01A-01W-0615-10 TCGA-25-1634-01A-01D-0536-05 d10f0cee-d755-43cc-8d3d-8974cea0defb TCGA-25-1634-01A-01D-0533-01 TCGA-25-1634-01 TCGA-25-1634-01A-01D-0533-01 d10f0cee-d755-43cc-8d3d-8974cea0defb d10f0cee-d755-43cc-8d3d-8974cea0defb TCGA-25-1634-01 TCGA-25-1634-01 d10f0cee-d755-43cc-8d3d-8974cea0defb TCGA-25-1634-01A-01W-0615-10 TCGA-25-1634-01A-01R-0540-07 +TCGA-25-1635-01 TCGA-25-1635-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1635 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-1635-F26756 TCGA-25-1635 TCGA-25-1635-01A Stage IIIC -26200 1583 0 1558 614 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.7 G3 Recurrence TCGA-25-1635.28168C52-FD75-4B43-918B-C48CC8DA9C66.pdf 1635 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2002 TCGA-25-1635-01 TCGA-25-1635-01 TCGA-25-1635-01A-01W-0615-10 2fc96f18-9f32-4d5f-b768-587981329254 TCGA-25-1635-01 TCGA-25-1635-01A-01W-0615-10 TCGA-25-1635-01A-01D-0536-05 TCGA-25-1635-01A-21-1558-20 877d96a2-6e5c-472c-b190-59fcfd1febb4 TCGA-25-1635-01A-01D-0533-01 TCGA-25-1635-01 e22c9a04-50e5-40e2-9df0-66c86b6f3b38 TCGA-25-1635-01A-01D-0533-01 877d96a2-6e5c-472c-b190-59fcfd1febb4 877d96a2-6e5c-472c-b190-59fcfd1febb4 TCGA-25-1635-01 TCGA-25-1635-01 877d96a2-6e5c-472c-b190-59fcfd1febb4 TCGA-25-1635-01A-01W-0615-10 TCGA-25-1635-01A-01R-0540-07 +TCGA-25-1870-01 TCGA-25-1870-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-25-1870 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-25-1870-F26763 TCGA-25-1870 Stage IIIC -21550 455 0 455 243 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1870 WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO Primary Tumor 01 25 11-20 mm Ovary DECEASED 1994 TCGA-25-1870-01 TCGA-25-1870-01 fc0c9f6b-6603-4200-9190-25422af07078 TCGA-25-1870-01 TCGA-25-1870-01A-01D-0652-05 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 TCGA-25-1870-01A-01D-0648-01 TCGA-25-1870-01 TCGA-25-1870-01A-01D-0648-01 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 TCGA-25-1870-01 TCGA-25-1870-01 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 TCGA-25-1870-01A-01R-0655-07 +TCGA-25-1871-01 TCGA-25-1871-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 TCGA-25-1871 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-25-1871-F26769 TCGA-25-1871 TCGA-25-1871-01A Stage IIIC -25627 760 0 760 230 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.7 G3 Recurrence TCGA-25-1871.737827A6-C99E-49BE-90AD-004FE8DF11F1.pdf 1871 WITH TUMOR YES Progressive Disease Physical Examination NO Primary Tumor 01 0.1 25 11-20 mm Ovary A DECEASED 1993 TCGA-25-1871-01 TCGA-25-1871-01 2ee780b4-d0ac-4d56-9120-fdf5e98b4249 TCGA-25-1871-01 TCGA-25-1871-01A-01D-0652-05 efcc36b2-e351-4875-b743-df58480bc9fb TCGA-25-1871-01A-01D-0648-01 TCGA-25-1871-01 TCGA-25-1871-01A-01D-0648-01 efcc36b2-e351-4875-b743-df58480bc9fb efcc36b2-e351-4875-b743-df58480bc9fb TCGA-25-1871-01 TCGA-25-1871-01 efcc36b2-e351-4875-b743-df58480bc9fb TCGA-25-1871-01A-01R-0655-07 +TCGA-25-1877-01 TCGA-25-1877-01 High OV-like c1 miRNA cluster 1 cluster 3 TCGA-25-1877 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Left TCGA-25-1877-F26774 TCGA-25-1877 TCGA-25-1877-01A Stage IIIC -29615 730 0 549 549 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.7 G3 Recurrence TCGA-25-1877.D98B5A1F-DF34-43E7-826F-BCB45DEC582D.pdf 1877 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.4 25 1-10 mm Ovary A DECEASED 1993 TCGA-25-1877-01 8918bbfe-a867-41ea-a137-46e704232e6d TCGA-25-1877-01 TCGA-25-1877-01A-01D-0652-05 TCGA-25-1877-01A-01D-0648-01 TCGA-25-1877-01 TCGA-25-1877-01A-01D-0648-01 TCGA-25-1877-01 TCGA-25-1877-01A-01R-0655-07 +TCGA-25-1878-01 TCGA-25-1878-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-25-1878 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-25-1878-F26779 TCGA-25-1878 Stage IIIC -22035 2587 0 2587 971 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1878 WITH TUMOR YES Complete Remission/Response Molecular Markers NO Primary Tumor 01 25 1-10 mm Ovary DECEASED 1994 TCGA-25-1878-01 f38efeef-0f8b-48f8-8ad9-caaaad82eecc TCGA-25-1878-01 TCGA-25-1878-01A-01D-0652-05 TCGA-25-1878-01A-21-1559-20 TCGA-25-1878-01A-01D-0648-01 TCGA-25-1878-01 c747a216-2d46-4b01-a34d-651fa616109a TCGA-25-1878-01A-01D-0648-01 TCGA-25-1878-01 TCGA-25-1878-01A-01R-0655-07 +TCGA-25-2042-01 TCGA-25-2042-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation c1uster 9 TCGA-25-2042 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-25-2042-F26785 TCGA-25-2042 TCGA-25-2042-01A Stage IIIC -22127 396 0 396 123 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.4 G3 Metastatic YES TCGA-25-2042.4D14A408-E3F6-47EB-A67C-0606450DB0C5.pdf 2042 WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO Primary Tumor 01 0.3 25 >20 mm Ovary A DECEASED 2006 TCGA-25-2042-01 TCGA-25-2042-01 4873bfbf-079c-407d-9d8f-5bab18d1c3a0 TCGA-25-2042-01 TCGA-25-2042-01A-01D-0708-05 TCGA-25-2042-01A-21-1560-20 ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01D-0704-01 TCGA-25-2042-01 59676524-6b40-4bcc-b488-120781e23d22 TCGA-25-2042-01A-01D-0704-01 ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01W-0799-08 TCGA-25-2042-01 TCGA-25-2042-01 ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01W-0799-08 TCGA-25-2042-01A-01R-0711-07 +TCGA-25-2390-01 TCGA-25-2390-01 OV-like c1 OV-like c4 TCGA-25-2390 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 80 TCGA-25-2390 TCGA-25-2390-01A -29257 0 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES 0.6 NO 1.6 TCGA-25-2390.B57A7111-209E-4FD3-8E2E-868B70BFF806.pdf 2390 Primary Tumor 01 0.3 25 Ovary A 2003 TCGA-25-2390-01A-01D-0708-05 TCGA-25-2390-01A-21-1560-20 29f6e462-4410-445e-8777-3402fc8488be TCGA-25-2390-01A-01R-0711-07 +TCGA-25-2391-01 TCGA-25-2391-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2391 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Bilateral TCGA-25-2391-F26796 TCGA-25-2391 TCGA-25-2391-01A Stage IIIC -20939 1492 0 1492 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-25-2391.32AC761D-67A0-46C5-AB01-AE9BBE7307CA.pdf 2391 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 25 >20 mm Ovary A DECEASED 2003 TCGA-25-2391-01 TCGA-25-2391-01 bf367755-354c-4d12-a8a8-7a1373b8d397 TCGA-25-2391-01 TCGA-25-2391-01A-01D-0708-05 TCGA-25-2391-01A-21-1560-20 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01D-0704-01 TCGA-25-2391-01 53220d7f-967c-4101-82ce-24495a3e2b9a TCGA-25-2391-01A-01D-0704-01 0ee0c708-77c4-4ac3-be13-0d08e6444003 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01W-0799-08 TCGA-25-2391-01 TCGA-25-2391-01 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01W-0799-08 TCGA-25-2391-01A-01R-0711-07 +TCGA-25-2392-01 TCGA-25-2392-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 2 TCGA-25-2392 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 75 Bilateral TCGA-25-2392-F26801 TCGA-25-2392 TCGA-25-2392-01A Stage IV -27667 31 0 31 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-25-2392.C520D0D6-F104-492C-A4C2-844390F55570.pdf 2392 NO NO Primary Tumor 01 0.3 25 11-20 mm Ovary A DECEASED 2003 TCGA-25-2392-01 TCGA-25-2392-01 62414e51-fd9a-4ed8-bc34-c4d194fdc884 TCGA-25-2392-01 TCGA-25-2392-01A-01D-0708-05 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01D-0704-01 TCGA-25-2392-01 TCGA-25-2392-01A-01D-0704-01 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01W-0799-08 TCGA-25-2392-01 TCGA-25-2392-01 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01W-0799-08 TCGA-25-2392-01A-01R-0711-07 +TCGA-25-2393-01 TCGA-25-2393-01 High C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2393 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Left TCGA-25-2393-F26803 TCGA-25-2393 TCGA-25-2393-01A Stage IIIC -29585 1157 0 1157 305 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.3 G3 Recurrence TCGA-25-2393.0B780E04-2DE3-4C56-9B93-1919F4BBE5D4.pdf 2393 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 25 11-20 mm Ovary A DECEASED 2003 TCGA-25-2393-01 TCGA-25-2393-01 93d53663-d5fc-4a27-8844-d58f09f47c64 TCGA-25-2393-01 TCGA-25-2393-01A-01D-0708-05 TCGA-25-2393-01A-21-1560-20 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01D-0704-01 TCGA-25-2393-01 7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5 TCGA-25-2393-01A-01D-0704-01 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01W-0799-08 TCGA-25-2393-01 TCGA-25-2393-01 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01W-0799-08 TCGA-25-2393-01A-01R-0711-07 +TCGA-25-2396-01 TCGA-25-2396-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2396 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Bilateral TCGA-25-2396-F26808 TCGA-25-2396 TCGA-25-2396-01A Stage IIIC -26145 92 0 92 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G3 TCGA-25-2396.5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF.pdf 2396 NO Primary Tumor 01 1 25 No Macroscopic disease Ovary A DECEASED 2004 TCGA-25-2396-01 TCGA-25-2396-01 5cbceba0-c820-45dc-926d-ee4893659503 TCGA-25-2396-01 TCGA-25-2396-01A-01D-0708-05 TCGA-25-2396-01A-21-1560-20 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01D-0704-01 TCGA-25-2396-01 abf3ad2e-f8d1-4a58-a48b-eaf3b553e793 TCGA-25-2396-01A-01D-0704-01 43352a4d-f866-4ed7-81f5-5dc478c10992 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01W-0799-08 TCGA-25-2396-01 TCGA-25-2396-01 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01W-0799-08 TCGA-25-2396-01A-01R-0711-07 +TCGA-25-2397-01 TCGA-25-2397-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-25-2397 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-25-2397-F26810 TCGA-25-2397 TCGA-25-2397-01A Stage IV -21581 365 0 365 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 2.2 G3 TCGA-25-2397.D67C4E1F-6A68-4EE6-B143-22038C05C926.pdf 2397 NO Primary Tumor 01 0.7 25 No Macroscopic disease Ovary A DECEASED 2004 TCGA-25-2397-01 TCGA-25-2397-01 3faab68c-41ef-4eef-8ed1-1d5c7c5b9a8b TCGA-25-2397-01 TCGA-25-2397-01A-01D-0708-05 TCGA-25-2397-01A-21-1560-20 7ad7080c-730b-4a5d-a8c1-f6387fbee72e TCGA-25-2397-01A-01D-0704-01 TCGA-25-2397-01 eac7612a-49d6-4b40-84b7-c68db54e56c1 TCGA-25-2397-01A-01D-0704-01 7ad7080c-730b-4a5d-a8c1-f6387fbee72e 7ad7080c-730b-4a5d-a8c1-f6387fbee72e TCGA-25-2397-01 TCGA-25-2397-01 7ad7080c-730b-4a5d-a8c1-f6387fbee72e TCGA-25-2397-01A-01R-0711-07 +TCGA-25-2398-01 TCGA-25-2398-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2398 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-2398-F26812 TCGA-25-2398 TCGA-25-2398-01A Stage IIIC -26267 1369 0 1369 577 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.5 G3 Recurrence TCGA-25-2398.CFF4E9E3-AC10-4A50-BE90-5A12822FEF42.pdf 2398 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.5 25 1-10 mm Ovary A DECEASED 2004 TCGA-25-2398-01 TCGA-25-2398-01 bcdd8efe-1f50-4bb6-904a-b8bdfd32dfbd TCGA-25-2398-01 TCGA-25-2398-01A-01D-0708-05 TCGA-25-2398-01A-21-1563-20 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01D-0704-01 TCGA-25-2398-01 b081cedd-6727-478d-9ebf-22ad78c34b27 TCGA-25-2398-01A-01D-0704-01 3a080008-8266-4e2d-a143-adac14991b22 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01W-0799-08 TCGA-25-2398-01 TCGA-25-2398-01 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01W-0799-08 TCGA-25-2398-01A-01R-0711-07 +TCGA-25-2399-01 TCGA-25-2399-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2399 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 80 Bilateral TCGA-25-2399-F26818 TCGA-25-2399 TCGA-25-2399-01A Stage IIIC -29373 608 0 608 243 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.6 G3 Recurrence TCGA-25-2399.38AEA3BF-A853-4719-B308-63884A6F8F13.pdf 2399 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 25 >20 mm Ovary A DECEASED 2004 TCGA-25-2399-01 TCGA-25-2399-01 a05df1ef-35d1-4fe3-a944-ab5c6b52d468 TCGA-25-2399-01 TCGA-25-2399-01A-01D-0708-05 TCGA-25-2399-01A-21-1560-20 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01D-0704-01 TCGA-25-2399-01 27dde0e4-5be8-4045-910b-24c0535a4623 TCGA-25-2399-01A-01D-0704-01 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01W-0799-08 TCGA-25-2399-01 TCGA-25-2399-01 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01W-0799-08 TCGA-25-2399-01A-01R-0711-07 +TCGA-25-2400-01 TCGA-25-2400-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2400 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-25-2400-F26823 TCGA-25-2400 TCGA-25-2400-01A Stage IIIC -27789 1278 0 1278 577 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.1 G3 Recurrence TCGA-25-2400.0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C.pdf 2400 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 25 No Macroscopic disease Ovary A DECEASED 2004 TCGA-25-2400-01 TCGA-25-2400-01 1dab017a-bf35-4cec-9bef-f03b5c5b363c TCGA-25-2400-01 TCGA-25-2400-01A-01D-0708-05 TCGA-25-2400-01A-21-1560-20 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01D-0704-01 TCGA-25-2400-01 ab4e5114-ba2a-4706-8be1-a359c4e5b547 TCGA-25-2400-01A-01D-0704-01 5c98c2c5-806f-4562-ad57-e152ea8388ab 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01W-0799-08 TCGA-25-2400-01 TCGA-25-2400-01 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01W-0799-08 TCGA-25-2400-01A-01R-0711-07 +TCGA-25-2401-01 TCGA-25-2401-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-25-2401 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Bilateral TCGA-25-2401-F26829 TCGA-25-2401 TCGA-25-2401-01A Stage IIIC -23711 90 0 90 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.8 G3 TCGA-25-2401.5B192072-1F11-4316-AC39-81085F7E425D.pdf 2401 NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2004 TCGA-25-2401-01 TCGA-25-2401-01 d34e80bb-5261-478c-9aa8-6732cc107f9f TCGA-25-2401-01 TCGA-25-2401-01A-01D-0708-05 TCGA-25-2401-01A-21-1560-20 c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01D-0704-01 TCGA-25-2401-01 8b55fa70-3074-4209-ab77-4634075aa0d1 TCGA-25-2401-01A-01D-0704-01 c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01W-0799-08 TCGA-25-2401-01 TCGA-25-2401-01 c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01W-0799-08 TCGA-25-2401-01A-01R-0711-07 +TCGA-25-2404-01 TCGA-25-2404-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2404 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-25-2404-F26831 TCGA-25-2404 TCGA-25-2404-01A Stage IIIC -14184 883 0 883 426 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 2 G3 Recurrence TCGA-25-2404.7B13E549-204D-47F8-93EB-D8C5C8D259FA.pdf 2404 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.6 25 No Macroscopic disease Ovary A DECEASED 2005 TCGA-25-2404-01 TCGA-25-2404-01 df215206-d33b-40b7-94dc-86d5a3cfbc87 TCGA-25-2404-01 TCGA-25-2404-01A-01D-0708-05 TCGA-25-2404-01A-21-1560-20 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01D-0704-01 TCGA-25-2404-01 2300785c-d77b-4d40-94e5-7947b18f9c24 TCGA-25-2404-01A-01D-0704-01 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01W-0799-08 TCGA-25-2404-01 TCGA-25-2404-01 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01W-0799-08 TCGA-25-2404-01A-01R-0711-07 +TCGA-25-2408-01 TCGA-25-2408-01 Iq C9-OV Low purity c2 OV-like c4 miRNA cluster 1 cluster 6 mutation c1uster 9 TCGA-25-2408 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NO 37 Bilateral TCGA-25-2408-F26837 TCGA-25-2408 TCGA-25-2408-01A Stage IV -13606 943 0 943 334 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G2 Recurrence TCGA-25-2408.2A91BE69-31C8-456E-8EBB-8AD08AAAB3A9.pdf 2408 WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.3 25 1-10 mm Ovary A DECEASED 2005 TCGA-25-2408-01 a693a4be-bb91-4608-bacb-4ffa101e413a TCGA-25-2408-01 TCGA-25-2408-01A-01D-0708-05 TCGA-25-2408-01A-21-1562-20 TCGA-25-2408-01A-01D-0704-01 TCGA-25-2408-01 19590adb-d236-4acf-a78f-275de0e8f0e1 TCGA-25-2408-01A-01D-0704-01 TCGA-25-2408-01A-01W-0799-08 TCGA-25-2408-01 TCGA-25-2408-01A-01W-0799-08 TCGA-25-2408-01A-01R-0711-07 +TCGA-25-2409-01 TCGA-25-2409-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-2409 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-2409-F26841 TCGA-25-2409 TCGA-25-2409-01A Stage IV -26267 821 0 821 304 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 1.5 G3 Recurrence TCGA-25-2409.89A631C6-5000-4A96-B752-879EAA7231CB.pdf 2409 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 25 1-10 mm Ovary A DECEASED 2005 TCGA-25-2409-01 TCGA-25-2409-01 71b8d6ab-57cb-411e-89f3-9ea82e67abff TCGA-25-2409-01 TCGA-25-2409-01A-01D-0708-05 TCGA-25-2409-01A-21-1560-20 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01D-0704-01 TCGA-25-2409-01 bfaa6831-b085-4b98-90a5-fef72266d642 TCGA-25-2409-01A-01D-0704-01 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01W-0799-08 TCGA-25-2409-01 TCGA-25-2409-01 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01W-0799-08 TCGA-25-2409-01A-01R-0711-07 +TCGA-29-1688-01 TCGA-29-1688-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 TCGA-29-1688 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 39 Bilateral TCGA-29-1688-F27124 TCGA-29-1688 TCGA-29-1688-01A Stage IIIC -14574 2400 0 2400 184 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2.5 G2 Recurrence TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3.pdf 1688 WITH TUMOR YES Stable Disease First Seen At Further Surgery NO Primary Tumor 01 0.5 29 Ovary YES A DECEASED 1992 TCGA-29-1688-01 TCGA-29-1688-01 065ec84d-9986-4b99-8c58-3d0a578cd8fb TCGA-29-1688-01 TCGA-29-1688-01A-01D-0563-05 TCGA-29-1688-01A-21-1558-20 TCGA-29-1688-01A-01W-0633-09 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf TCGA-29-1688-01A-01D-0559-01 TCGA-29-1688-01 46d8cea8-b5a2-4136-bfeb-4969e3ccbd85 TCGA-29-1688-01A-01D-0559-01 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf TCGA-29-1688-01 TCGA-29-1688-01 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf TCGA-29-1688-01A-01R-0566-07 +TCGA-29-1690-01 TCGA-29-1690-01 Iq C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 TCGA-29-1690 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 66 Bilateral TCGA-29-1690-F27142 TCGA-29-1690 TCGA-29-1690-01A Stage IIIC -24319 1448 0 1360 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.3 NO 1.4 G2 TCGA-29-1690.a44f0507-fc95-410a-a6b2-b66caacee30e.pdf 1690 WITH TUMOR YES NO Primary Tumor 01 0.7 29 11-20 mm Ovary A DECEASED 1993 TCGA-29-1690-01 TCGA-29-1690-01 21ed8b03-3122-4467-8542-a90a261e9934 TCGA-29-1690-01 TCGA-29-1690-01A-01D-0563-05 TCGA-29-1690-01A-21-1558-20 TCGA-29-1690-01A-01W-0633-09 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 TCGA-29-1690-01A-01D-0559-01 TCGA-29-1690-01 865fd9bb-d8c0-43d0-874c-ce6e69ce93be TCGA-29-1690-01A-01D-0559-01 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 TCGA-29-1690-01 TCGA-29-1690-01 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 TCGA-29-1690-01A-01R-0566-07 +TCGA-29-1691-01 TCGA-29-1691-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-29-1691 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-29-1691-F27148 TCGA-29-1691 Stage IIIC -18664 1470 0 1435 613 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G2 Recurrence 1691 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 29 1-10 mm Ovary DECEASED 1995 TCGA-29-1691-01 TCGA-29-1691-01 cbacc51e-d8b4-4dab-8ba8-7e769d19c26a TCGA-29-1691-01 TCGA-29-1691-01A-01D-0563-05 TCGA-29-1691-01A-21-1558-20 TCGA-29-1691-01A-01W-0633-09 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 TCGA-29-1691-01A-01D-0559-01 TCGA-29-1691-01 e634e64b-7b5c-4d33-88f9-c5c83442fdc1 TCGA-29-1691-01A-01D-0559-01 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 TCGA-29-1691-01 TCGA-29-1691-01 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 TCGA-29-1691-01A-01R-0566-07 +TCGA-29-1692-01 TCGA-29-1692-01 High OV-like c1 TCGA-29-1692 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-29-1692-F27159 TCGA-29-1692 TCGA-29-1692-01B Stage IIIC -21193 2872 0 2872 544 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.7 G2 Recurrence TCGA-29-1692.522E504C-7F53-4E91-A684-FD7B3C54CF06.pdf 1692 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response NO R1 Primary Tumor 01 0.2 29 11-20 mm Ovary B DECEASED 1997 2ecbe10e-1afc-4a38-91ee-cb0cc670f254 TCGA-29-1692-01B-01D-0807-05 TCGA-29-1692-01B-01D-2069-01 TCGA-29-1692-01 TCGA-29-1692-01B-01D-2069-01 TCGA-29-1692-01 TCGA-29-1692-01B-01R-0810-07 +TCGA-29-1692-02 TCGA-29-1692-02 OV-like c1 TCGA-29-1692 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-29-1692-F27159 TCGA-29-1692 TCGA-29-1692-02A Stage IIIC -21193 2872 0 2872 544 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 G2 Recurrence TCGA-29-1692.FF9EECFF-66C4-440F-91AB-42ACCEED0A3B.pdf 1692 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response NO R1 Recurrent Tumor 02 0.6 29 11-20 mm Ovary A DECEASED 1997 4001650f-30d3-46dd-8ba2-7f148afe4ba7 TCGA-29-1692-02A-01D-0807-05 fb710151-c817-4915-90d2-2997726ceccd TCGA-29-1692-02A-01R-0810-07 +TCGA-29-1693-01 TCGA-29-1693-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1693 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 72 Left TCGA-29-1693-F27174 TCGA-29-1693 TCGA-29-1693-01A Stage IIIC -26300 0 3096 694 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.7 YES G3 Recurrence TCGA-29-1693.90087244-634d-45eb-a877-ff7cc6bd2282.pdf 1693 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary YES A LIVING 2001 TCGA-29-1693-01 TCGA-29-1693-01 111c7bf6-d79d-48e4-adf8-94bc0c538ab5 TCGA-29-1693-01 TCGA-29-1693-01A-01D-0563-05 TCGA-29-1693-01A-21-1558-20 TCGA-29-1693-01A-01W-0633-09 7e5d2390-1e04-4e46-aa48-4b0131076007 TCGA-29-1693-01A-01D-0559-01 TCGA-29-1693-01 75dd78d6-cd26-476f-927f-ddb0d4a9c66f TCGA-29-1693-01A-01D-0559-01 7e5d2390-1e04-4e46-aa48-4b0131076007 7e5d2390-1e04-4e46-aa48-4b0131076007 TCGA-29-1693-01 TCGA-29-1693-01 7e5d2390-1e04-4e46-aa48-4b0131076007 TCGA-29-1693-01A-01R-0566-07 +TCGA-29-1694-01 TCGA-29-1694-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1694 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 45 Bilateral TCGA-29-1694-F27192 TCGA-29-1694 TCGA-29-1694-01A Stage IIIC -16523 1187 0 [Discrepancy] 206 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 GX Locoregional Disease YES TCGA-29-1694.ccfb9f1d-1779-4fae-a34f-c46a19d4b095.pdf 1694 Other WITH TUMOR YES Stable Disease First Seen At Further Surgery NO Primary Tumor 01 0.3 29 11-20 mm Ovary A DECEASED 2002 TCGA-29-1694-01 TCGA-29-1694-01 57cead11-58b6-4d8e-ab66-b742de63ae1d TCGA-29-1694-01 TCGA-29-1694-01A-01D-0563-05 TCGA-29-1694-01A-21-1558-20 TCGA-29-1694-01A-01W-0633-09 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 TCGA-29-1694-01A-01D-0559-01 TCGA-29-1694-01 463fec61-5758-4225-b43e-b77f36ece717 TCGA-29-1694-01A-01D-0559-01 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 TCGA-29-1694-01 TCGA-29-1694-01 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 TCGA-29-1694-01A-01R-0566-07 +TCGA-29-1695-01 TCGA-29-1695-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-29-1695 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Left TCGA-29-1695-F27204 TCGA-29-1695 TCGA-29-1695-01A Stage IIIC -22895 1229 0 24 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G2 TCGA-29-1695.136a4380-2a2a-489f-8675-886e876f17f7.pdf 1695 NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 2003 TCGA-29-1695-01 TCGA-29-1695-01 43c657df-dd50-4c53-a5de-e73d3a5e1b0c TCGA-29-1695-01 TCGA-29-1695-01A-01D-0563-05 TCGA-29-1695-01A-21-1558-20 TCGA-29-1695-01A-01W-0633-09 33f1dda6-7601-48c6-b46d-f0ba759e4048 TCGA-29-1695-01A-01D-0559-01 TCGA-29-1695-01 997dba94-b0d4-4872-b93b-d561f71f6ba3 TCGA-29-1695-01A-01D-0559-01 33f1dda6-7601-48c6-b46d-f0ba759e4048 33f1dda6-7601-48c6-b46d-f0ba759e4048 TCGA-29-1695-01 TCGA-29-1695-01 33f1dda6-7601-48c6-b46d-f0ba759e4048 TCGA-29-1695-01A-01R-0566-07 +TCGA-29-1696-01 TCGA-29-1696-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1696 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 43 Right TCGA-29-1696-F27206 TCGA-29-1696 TCGA-29-1696-01A Stage IIIC -15818 1032 0 1025 342 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 0.8 NO G2 Recurrence TCGA-29-1696.5e817943-3108-4838-bf8c-85c4507eb873.pdf 1696 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 29 1-10 mm Ovary A DECEASED 2003 TCGA-29-1696-01 TCGA-29-1696-01 fea497c6-293b-49aa-9d5f-021f2f89913e TCGA-29-1696-01 TCGA-29-1696-01A-01D-0563-05 TCGA-29-1696-01A-21-1558-20 TCGA-29-1696-01A-01W-0633-09 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef TCGA-29-1696-01A-01D-0559-01 TCGA-29-1696-01 93ea52c3-dc03-4845-9493-f1ecdd9e9124 TCGA-29-1696-01A-01D-0559-01 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef TCGA-29-1696-01 TCGA-29-1696-01 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef TCGA-29-1696-01A-01R-0566-07 +TCGA-29-1697-01 TCGA-29-1697-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 12 cluster 5 TCGA-29-1697 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-29-1697-F27216 TCGA-29-1697 TCGA-29-1697-01A Stage IIIC -22933 949 0 949 500 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.9 G3 Recurrence TCGA-29-1697.294ba09f-347a-4129-847d-211cdf73ca99.pdf 1697 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 2003 TCGA-29-1697-01 TCGA-29-1697-01 bd90331c-acc6-49f5-8943-065fbfb16519 TCGA-29-1697-01 TCGA-29-1697-01A-01D-0563-05 TCGA-29-1697-01A-21-1558-20 TCGA-29-1697-01A-01W-0633-09 75435634-4311-49d8-8e42-ae1069c1e2ef TCGA-29-1697-01A-01D-0559-01 TCGA-29-1697-01 9efe9dcc-44d7-47ae-b404-d324e821910e TCGA-29-1697-01A-01D-0559-01 75435634-4311-49d8-8e42-ae1069c1e2ef 75435634-4311-49d8-8e42-ae1069c1e2ef TCGA-29-1697-01 TCGA-29-1697-01 75435634-4311-49d8-8e42-ae1069c1e2ef TCGA-29-1697-01A-01R-0566-07 +TCGA-29-1698-01 TCGA-29-1698-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-29-1698 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-29-1698-F27227 TCGA-29-1698 TCGA-29-1698-01A Stage IIIC -19611 0 2078 181 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.4 G3 Recurrence TCGA-29-1698.133f2df5-6c22-4653-9d2e-f3d5971502b0.pdf 1698 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.3 29 1-10 mm Ovary A LIVING 2004 TCGA-29-1698-01 TCGA-29-1698-01 86e20816-f37a-4686-876b-3ef6f0be521a TCGA-29-1698-01 TCGA-29-1698-01A-01D-0563-05 TCGA-29-1698-01A-21-1558-20 TCGA-29-1698-01A-01W-0633-09 74970c45-4cc5-4952-9846-ce2d959437ea TCGA-29-1698-01A-01D-0559-01 TCGA-29-1698-01 a40be7ea-f682-4d3e-a749-74aec6961b88 TCGA-29-1698-01A-01D-0559-01 74970c45-4cc5-4952-9846-ce2d959437ea 74970c45-4cc5-4952-9846-ce2d959437ea TCGA-29-1698-01 TCGA-29-1698-01 74970c45-4cc5-4952-9846-ce2d959437ea TCGA-29-1698-01A-01R-0566-07 +TCGA-29-1699-01 TCGA-29-1699-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-29-1699 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Bilateral TCGA-29-1699-F41729 TCGA-29-1699 TCGA-29-1699-01A Stage IIIC -21130 1106 0 16 1 Progressive Disease 2013-8-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.5 YES G3 NO TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036.pdf 1699 Preoperative Primary Tumor 01 0.6 29 1-10 mm Ovary A DECEASED 2004 TCGA-29-1699-01 TCGA-29-1699-01 036b4d31-1291-4092-9442-9950564a6699 TCGA-29-1699-01 TCGA-29-1699-01A-01D-0563-05 TCGA-29-1699-01A-21-1558-20 TCGA-29-1699-01A-01W-0633-09 6d1d8c8a-fea0-4a47-bd2a-124270561406 TCGA-29-1699-01A-01D-0559-01 TCGA-29-1699-01 21c96f53-087e-42c2-86ce-ea45cf876627 TCGA-29-1699-01A-01D-0559-01 6d1d8c8a-fea0-4a47-bd2a-124270561406 6d1d8c8a-fea0-4a47-bd2a-124270561406 TCGA-29-1699-01 TCGA-29-1699-01 6d1d8c8a-fea0-4a47-bd2a-124270561406 TCGA-29-1699-01A-01R-0566-07 +TCGA-29-1701-01 TCGA-29-1701-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-29-1701 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-29-1701-F27243 TCGA-29-1701 TCGA-29-1701-01A Stage IIIC -20737 515 0 514 298 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.3 YES G3 Recurrence TCGA-29-1701.f7568046-b77a-4654-9f94-8978bd3e22c4.pdf 1701 Post-Adjuvant Therapy WITH TUMOR NO Partial Remission/Response Imaging Study NO Primary Tumor 01 0.6 29 Ovary YES A DECEASED 2004 TCGA-29-1701-01 TCGA-29-1701-01 9ffceda1-d2ab-4689-baee-eab0b133ded9 TCGA-29-1701-01 TCGA-29-1701-01A-01D-0563-05 TCGA-29-1701-01A-21-1558-20 TCGA-29-1701-01A-01W-0633-09 e5e6f25b-d641-4598-8bb1-0850750ef048 TCGA-29-1701-01A-01D-0559-01 TCGA-29-1701-01 d770980a-b6ef-4e85-8ed6-a22702326573 TCGA-29-1701-01A-01D-0559-01 e5e6f25b-d641-4598-8bb1-0850750ef048 e5e6f25b-d641-4598-8bb1-0850750ef048 TCGA-29-1701-01 TCGA-29-1701-01 e5e6f25b-d641-4598-8bb1-0850750ef048 TCGA-29-1701-01A-01R-0566-07 +TCGA-29-1702-01 TCGA-29-1702-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-29-1702 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 84 Right TCGA-29-1702-F27249 TCGA-29-1702 TCGA-29-1702-01A Stage IIIC -30910 728 0 568 286 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 G3 Recurrence TCGA-29-1702.f825bb6c-afc2-48ea-9286-09c09c7e9918.pdf 1702 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 29 1-10 mm Ovary A DECEASED 2005 TCGA-29-1702-01 TCGA-29-1702-01 3a13cc49-5376-4695-9e64-45b457b9d36b TCGA-29-1702-01 TCGA-29-1702-01A-01D-0563-05 TCGA-29-1702-01A-21-1558-20 TCGA-29-1702-01A-01W-0633-09 c317689f-a405-4486-9a22-ff6eadd2d5b8 TCGA-29-1702-01A-01D-0559-01 TCGA-29-1702-01 0160cfab-a19a-415e-a418-5679ae8d6779 TCGA-29-1702-01A-01D-0559-01 c317689f-a405-4486-9a22-ff6eadd2d5b8 c317689f-a405-4486-9a22-ff6eadd2d5b8 TCGA-29-1702-01 TCGA-29-1702-01 c317689f-a405-4486-9a22-ff6eadd2d5b8 TCGA-29-1702-01A-01R-0566-07 +TCGA-29-1703-01 TCGA-29-1703-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-29-1703 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-29-1703-F27255 TCGA-29-1703 TCGA-29-1703-01A Stage IIIC -20622 1815 0 1815 324 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 G2 Recurrence TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953.pdf 1703 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 1-10 mm Ovary A DECEASED 2005 TCGA-29-1703-01 TCGA-29-1703-01 059bf2b5-7752-44aa-935c-8b9c482e29e2 TCGA-29-1703-01 TCGA-29-1703-01A-01D-0563-05 TCGA-29-1703-01A-21-1558-20 TCGA-29-1703-01A-01W-0633-09 64e3f978-d213-45e2-bb52-e9b9a2032dc0 TCGA-29-1703-01A-01D-0559-01 TCGA-29-1703-01 13530c03-540d-4e0d-a760-c0f6946f0480 TCGA-29-1703-01A-01D-0559-01 64e3f978-d213-45e2-bb52-e9b9a2032dc0 64e3f978-d213-45e2-bb52-e9b9a2032dc0 TCGA-29-1703-01 TCGA-29-1703-01 64e3f978-d213-45e2-bb52-e9b9a2032dc0 TCGA-29-1703-01A-01R-0566-07 +TCGA-29-1704-01 TCGA-29-1704-01 High OV-like c1 TCGA-29-1704 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-29-1704-F27269 TCGA-29-1704 Stage IIIC -22511 0 1587 568 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1704 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Other Method NO R1 Primary Tumor 01 29 11-20 mm Ovary LIVING 2005 bbc42149-d2c4-44f9-a59f-bd9397bc96e8 TCGA-29-1704-01B-01D-0807-05 TCGA-29-1704-01B-01D-0803-01 TCGA-29-1704-01 TCGA-29-1704-01B-01D-0803-01 TCGA-29-1704-01 TCGA-29-1704-01B-01R-0810-07 +TCGA-29-1704-02 TCGA-29-1704-02 OV-like c1 TCGA-29-1704 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-29-1704-F27269 TCGA-29-1704 TCGA-29-1704-02A Stage IIIC -22511 0 1587 568 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.6 G3 Recurrence TCGA-29-1704.4C689C80-12E5-4E40-8A12-910D07C8C084.pdf 1704 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Other Method NO R1 Recurrent Tumor 02 0.2 29 11-20 mm Ovary A LIVING 2005 TCGA-29-1704-02A-01D-0807-05 +TCGA-29-1705-01 TCGA-29-1705-01 BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 TCGA-29-1705 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-29-1705-F27279 TCGA-29-1705 TCGA-29-1705-01A Stage IIIC -17530 555 0 555 283 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.8 G2 Recurrence TCGA-29-1705.e7a899e9-2c61-4bda-874c-0f1b456e5dfc.pdf 1705 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.7 29 >20 mm Ovary A DECEASED 2005 TCGA-29-1705-01 TCGA-29-1705-01 3d4c3c05-1760-43b8-9a4d-e66ebfaf9533 TCGA-29-1705-01 TCGA-29-1705-01A-01D-0563-05 TCGA-29-1705-01A-21-1558-20 TCGA-29-1705-01A-01W-0633-09 d1603029-2b45-4c5c-b313-8846d0ebdbdb TCGA-29-1705-01A-01D-0559-01 TCGA-29-1705-01 94faea93-a4a5-45c7-9b05-b342bec4e176,daae8ca1-a6fd-43cc-a82e-32ffe02803c7 TCGA-29-1705-01A-01D-0559-01 d1603029-2b45-4c5c-b313-8846d0ebdbdb d1603029-2b45-4c5c-b313-8846d0ebdbdb TCGA-29-1705-01 TCGA-29-1705-01 d1603029-2b45-4c5c-b313-8846d0ebdbdb TCGA-29-1705-01A-01R-0566-07 +TCGA-29-1705-02 TCGA-29-1705-02 C9-OV OV-like c1 miRNA cluster 3 TCGA-29-1705 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-29-1705-F27279 TCGA-29-1705 TCGA-29-1705-02A Stage IIIC -17530 555 0 555 283 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.3 G2 Recurrence TCGA-29-1705.EADA1E69-0CAB-4521-ABE4-035F73ABB54A.pdf 1705 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Recurrent Tumor 02 0.4 29 >20 mm Ovary A DECEASED 2005 TCGA-29-1705-02 83b8567f-7316-4c8b-877d-b5db5bf8c9da TCGA-29-1705-02 TCGA-29-1705-02A-01D-0807-05 032aec92-5009-4a62-94cf-7dca39023322 TCGA-29-1705-02A-01R-0810-07 +TCGA-29-1707-01 TCGA-29-1707-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-29-1707 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Left TCGA-29-1707-F27288 TCGA-29-1707 TCGA-29-1707-01A Stage IIC -15017 0 1277 1201 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 NO G3 Recurrence TCGA-29-1707.da725324-2b94-47d4-a35c-a5f2233a024f.pdf 1707 Post-Adjuvant Therapy YES Complete Remission/Response Other Method NO Primary Tumor 01 0.5 29 No Macroscopic disease Ovary A LIVING 2006 TCGA-29-1707-01 5a0fb2e7-59de-4180-9b11-456580ad1d78 TCGA-29-1707-01 TCGA-29-1707-01A-01D-0563-05 TCGA-29-1707-01A-21-1559-20 TCGA-29-1707-01A-01W-0633-09 TCGA-29-1707-01A-01D-0559-01 TCGA-29-1707-01 c7511c99-d363-45ed-9d27-cff988927e46,26e9028d-8002-4408-82e8-68bf43f27fec TCGA-29-1707-01A-01D-0559-01 TCGA-29-1707-01 TCGA-29-1707-01A-01R-0566-07 +TCGA-29-1707-02 TCGA-29-1707-02 OV-like c1 miRNA cluster 1 TCGA-29-1707 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Left TCGA-29-1707-F27288 TCGA-29-1707 TCGA-29-1707-02A Stage IIC -15017 0 1277 1201 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 NO G3 Recurrence TCGA-29-1707.264DFD3E-7413-4DEA-A115-14887718139D.pdf 1707 Post-Adjuvant Therapy YES Complete Remission/Response Other Method NO Recurrent Tumor 02 0.5 29 No Macroscopic disease Ovary A LIVING 2006 TCGA-29-1707-02 ef4e079b-c946-4598-a7dd-575e48a4a133 TCGA-29-1707-02 TCGA-29-1707-02A-01D-0807-05 08fc3ec8-3c83-4ffc-bd91-67e6b162790b TCGA-29-1707-02A-01R-0810-07 +TCGA-29-1710-01 TCGA-29-1710-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 TCGA-29-1710 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1710-F27294 TCGA-29-1710 TCGA-29-1710-01A Stage IIIC -19969 951 0 889 315 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.8 G2 Recurrence TCGA-29-1710.52a0d2ae-7467-40f0-b8f3-59812cfac52a.pdf 1710 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 1-10 mm Ovary A DECEASED 2006 TCGA-29-1710-01 TCGA-29-1710-01 31aaa27c-8eaf-4030-9067-d505d9abf983 TCGA-29-1710-01 TCGA-29-1710-01A-02D-0563-05 TCGA-29-1710-01A-02W-0633-09 3bf24456-4b70-4313-a04d-19aba239108d TCGA-29-1710-01A-02D-0559-01 TCGA-29-1710-01 34b987ae-5e5a-435b-b1f3-0cf9623f1337 TCGA-29-1710-01A-02D-0559-01 3bf24456-4b70-4313-a04d-19aba239108d 3bf24456-4b70-4313-a04d-19aba239108d TCGA-29-1710-01 TCGA-29-1710-01 3bf24456-4b70-4313-a04d-19aba239108d TCGA-29-1710-01A-02R-0566-07 +TCGA-29-1710-02 TCGA-29-1710-02 OV-like c1 TCGA-29-1710 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1710-F27294 TCGA-29-1710 TCGA-29-1710-02A Stage IIIC -19969 951 0 889 315 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G2 Recurrence TCGA-29-1710.4FD493D6-DAA8-497E-8EB2-ED2A97034B23.pdf 1710 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Recurrent Tumor 02 0.3 29 1-10 mm Ovary A DECEASED 2006 4a8f0084-d5a6-4f5b-bc46-8494a2bfe6b1 TCGA-29-1710-02A-01D-0807-05 8fdfe883-7ce3-46b5-a3c7-e34b59a5557c TCGA-29-1710-02A-01R-0810-07 +TCGA-29-1711-01 TCGA-29-1711-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-29-1711 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 45 Bilateral TCGA-29-1711-F27307 TCGA-29-1711 TCGA-29-1711-01A Stage IIIC -16485 0 1053 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.2 G2 TCGA-29-1711.e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d.pdf 1711 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 29 No Macroscopic disease Ovary A LIVING 2006 TCGA-29-1711-01 TCGA-29-1711-01 299a04e7-e90f-4a24-a211-7f0bd18b3ea0 TCGA-29-1711-01 TCGA-29-1711-01A-01D-0563-05 TCGA-29-1711-01A-21-1559-20 TCGA-29-1711-01A-01W-0633-09 c512a6e3-8bc8-4188-b264-89b2fe02baa8 TCGA-29-1711-01A-01D-0559-01 TCGA-29-1711-01 8aedfe25-9010-4502-a25c-88ed899eeb22 TCGA-29-1711-01A-01D-0559-01 c512a6e3-8bc8-4188-b264-89b2fe02baa8 c512a6e3-8bc8-4188-b264-89b2fe02baa8 TCGA-29-1711-01 TCGA-29-1711-01 c512a6e3-8bc8-4188-b264-89b2fe02baa8 TCGA-29-1711-01A-01R-0566-07 +TCGA-29-1761-01 TCGA-29-1761-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1761 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 80 Bilateral TCGA-29-1761-F27312 TCGA-29-1761 TCGA-29-1761-01A Stage IIIC -29337 528 0 517 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.9 G3 TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854.pdf 1761 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 1998 TCGA-29-1761-01 TCGA-29-1761-01 288d1cec-45f2-448c-8bf1-ce001420d126 TCGA-29-1761-01 TCGA-29-1761-01A-01D-0563-05 TCGA-29-1761-01A-21-1559-20 TCGA-29-1761-01A-01W-0633-09 c4446f6f-fae9-414c-8bae-7c78bb894982 TCGA-29-1761-01A-01D-0559-01 TCGA-29-1761-01 1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8 TCGA-29-1761-01A-01D-0559-01 c4446f6f-fae9-414c-8bae-7c78bb894982 c4446f6f-fae9-414c-8bae-7c78bb894982 TCGA-29-1761-01 TCGA-29-1761-01 c4446f6f-fae9-414c-8bae-7c78bb894982 TCGA-29-1761-01A-01R-0566-07 +TCGA-29-1762-01 TCGA-29-1762-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-29-1762 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-29-1762-F27316 TCGA-29-1762 TCGA-29-1762-01A Stage IV -21879 2634 0 2606 1375 2 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 0.9 G2 Recurrence TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e.pdf 1762 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 1998 TCGA-29-1762-01 TCGA-29-1762-01 49c0d36f-14fc-49f0-90a0-57cfbd8ec25b TCGA-29-1762-01 TCGA-29-1762-01A-01D-0563-05 TCGA-29-1762-01A-21-1559-20 TCGA-29-1762-01A-01W-0633-09 c3559ae3-3355-4f38-9c07-e557e435fcbd TCGA-29-1762-01A-01D-0559-01 TCGA-29-1762-01 a8bcbfb3-7a83-4170-8b2c-fa5447b5abce TCGA-29-1762-01A-01D-0559-01 c3559ae3-3355-4f38-9c07-e557e435fcbd c3559ae3-3355-4f38-9c07-e557e435fcbd TCGA-29-1762-01 TCGA-29-1762-01 c3559ae3-3355-4f38-9c07-e557e435fcbd TCGA-29-1762-01A-01R-0566-07 +TCGA-29-1763-01 TCGA-29-1763-01 High Low purity c2 OV-like c16 miRNA cluster 1 cluster 2 TCGA-29-1763 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 43 Bilateral TCGA-29-1763-F27325 TCGA-29-1763 Stage IIC -16021 0 2032 428 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G2 Recurrence 1763 Other WITH TUMOR YES Complete Remission/Response Other Method NO Primary Tumor 01 29 1-10 mm Ovary LIVING 2004 TCGA-29-1763-01 TCGA-29-1763-01 afc40d40-daf1-4bb5-8813-017913722541 TCGA-29-1763-01 TCGA-29-1763-01A-02D-0563-05 TCGA-29-1763-01A-02W-0633-09 af63aa43-ab5f-44c5-85cf-01d84be261a3 TCGA-29-1763-01A-02D-0559-01 TCGA-29-1763-01 TCGA-29-1763-01A-02D-0559-01 af63aa43-ab5f-44c5-85cf-01d84be261a3 af63aa43-ab5f-44c5-85cf-01d84be261a3 TCGA-29-1763-01 TCGA-29-1763-01 af63aa43-ab5f-44c5-85cf-01d84be261a3 TCGA-29-1763-01A-02R-0566-07 +TCGA-29-1764-01 TCGA-29-1764-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-29-1764 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-29-1764-F27338 TCGA-29-1764 TCGA-29-1764-01A Stage IIIC -18012 0 1914 792 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.6 G2 Recurrence TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17.pdf 1764 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary A LIVING 2004 TCGA-29-1764-01 523d9b2a-4c0b-479c-917c-2086480c8558 TCGA-29-1764-01 TCGA-29-1764-01A-01D-0563-05 TCGA-29-1764-01A-21-1559-20 TCGA-29-1764-01A-01W-0633-09 TCGA-29-1764-01A-01D-0559-01 TCGA-29-1764-01 3c3a33be-9e62-4a32-946a-15f32661e2a1 TCGA-29-1764-01A-01D-0559-01 TCGA-29-1764-01 TCGA-29-1764-01A-01R-0566-07 +TCGA-29-1766-01 TCGA-29-1766-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 TCGA-29-1766 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Right TCGA-29-1766-F27350 TCGA-29-1766 Stage IIIC -27359 1199 0 1190 672 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C48.2 8441/3 C48.2 YES Tumor resection G2 Recurrence 1766 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 29 11-20 mm Peritoneum ovary DECEASED 2006 TCGA-29-1766-01 a7005558-9983-48f6-8252-943b8a9dd384 TCGA-29-1766-01 TCGA-29-1766-01A-01D-0563-05 TCGA-29-1766-01A-21-1559-20 TCGA-29-1766-01A-01W-0633-09 TCGA-29-1766-01A-01D-0559-01 TCGA-29-1766-01 dd8951d2-5b83-4b78-9b04-52d474639e2f TCGA-29-1766-01A-01D-0559-01 TCGA-29-1766-01 TCGA-29-1766-01A-01R-0566-07 +TCGA-29-1768-01 TCGA-29-1768-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-29-1768 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-29-1768-F27358 TCGA-29-1768 TCGA-29-1768-01A Stage IV -18396 952 0 950 547 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 G3 Recurrence TCGA-29-1768.12d9b343-a52d-4a36-ba7b-31bfeb66da50.pdf 1768 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 2006 TCGA-29-1768-01 83edce75-1b96-4e56-8042-76fc6e87f25f TCGA-29-1768-01 TCGA-29-1768-01A-01D-0563-05 TCGA-29-1768-01A-21-1559-20 TCGA-29-1768-01A-01W-0633-09 TCGA-29-1768-01A-01D-0559-01 TCGA-29-1768-01 f70a1542-3bd5-4ebe-880a-e8f7c75faaba TCGA-29-1768-01A-01D-0559-01 TCGA-29-1768-01 TCGA-29-1768-01A-01R-0566-07 +TCGA-29-1769-01 TCGA-29-1769-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 TCGA-29-1769 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 40 Bilateral TCGA-29-1769-F27366 TCGA-29-1769 TCGA-29-1769-01A Stage IIIC -14754 0 699 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.1 NO G3 TCGA-29-1769.67f144b3-c10b-4f96-a70b-6794d817170f.pdf 1769 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 29 1-10 mm Ovary A LIVING 2007 TCGA-29-1769-01 8e7a34f7-d49b-46c8-8b74-374232c60b71 TCGA-29-1769-01 TCGA-29-1769-01A-01D-0581-05 TCGA-29-1769-01A-21-1559-20 TCGA-29-1769-01A-01W-0639-09 TCGA-29-1769-01A-01D-0577-01 TCGA-29-1769-01 161fd24e-ed8c-41ef-8f00-000b3554d9e8 TCGA-29-1769-01A-01D-0577-01 TCGA-29-1769-01 TCGA-29-1769-01A-01R-0584-07 +TCGA-29-1770-01 TCGA-29-1770-01 High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 TCGA-29-1770 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1770-F27373 TCGA-29-1770 TCGA-29-1770-01A Stage IIIC -20015 0 741 377 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.2 G2 Recurrence TCGA-29-1770.05816aac-55d2-4604-9300-e268f73338fe.pdf 1770 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.5 29 1-10 mm Ovary A LIVING 2007 TCGA-29-1770-01 TCGA-29-1770-01 17024b36-bf59-4753-bcb3-7ddda14f1556 TCGA-29-1770-01 TCGA-29-1770-01A-01D-0563-05 TCGA-29-1770-01A-21-1559-20 TCGA-29-1770-01A-01W-0633-09 5ba75bb8-6229-4d6a-80e5-9a79a548e167 TCGA-29-1770-01A-01D-0559-01 TCGA-29-1770-01 1577dc3d-937d-4fbb-b280-25f969e43f81 TCGA-29-1770-01A-01D-0559-01 5ba75bb8-6229-4d6a-80e5-9a79a548e167 5ba75bb8-6229-4d6a-80e5-9a79a548e167 TCGA-29-1770-01 TCGA-29-1770-01 5ba75bb8-6229-4d6a-80e5-9a79a548e167 TCGA-29-1770-01A-01R-0566-07 +TCGA-29-1770-02 TCGA-29-1770-02 C9-OV Low purity c2 OV-like c16 miRNA cluster 3 TCGA-29-1770 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1770-F27373 TCGA-29-1770 TCGA-29-1770-02A Stage IIIC -20015 0 741 377 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.4 G2 Recurrence TCGA-29-1770.49220236-FBFE-44AA-89BC-FC4E7CBC94FA.pdf 1770 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Recurrent Tumor 02 0.2 29 1-10 mm Ovary A LIVING 2007 TCGA-29-1770-02 4ccece6b-c6cf-4921-81e5-af3780afffbc TCGA-29-1770-02 TCGA-29-1770-02A-01D-0807-05 ea119111-5217-4b8a-88e0-36dc77782241 ea119111-5217-4b8a-88e0-36dc77782241 ea119111-5217-4b8a-88e0-36dc77782241 ea119111-5217-4b8a-88e0-36dc77782241 TCGA-29-1770-02A-01R-0810-07 +TCGA-29-1771-01 TCGA-29-1771-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-29-1771 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-29-1771-F27383 TCGA-29-1771 Stage IIIC -28093 0 686 595 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G2 Recurrence 1771 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 29 >20 mm Ovary LIVING 2007 TCGA-29-1771-01 d95ccef1-6cfa-4bda-ab09-c931f8c7a344 TCGA-29-1771-01 TCGA-29-1771-01A-01D-0563-05 TCGA-29-1771-01A-21-1559-20 TCGA-29-1771-01A-01W-0633-09 TCGA-29-1771-01A-01D-0559-01 TCGA-29-1771-01 b69387b5-4b22-4ef1-8711-d1e406c1afdc TCGA-29-1771-01A-01D-0559-01 TCGA-29-1771-01 TCGA-29-1771-01A-01R-0566-07 +TCGA-29-1774-01 TCGA-29-1774-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-29-1774 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 82 Bilateral TCGA-29-1774-F27391 TCGA-29-1774 Stage IIIC -29991 0 527 234 2 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1774 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 29 >20 mm Ovary LIVING 2008 TCGA-29-1774-01 d9a5abd2-9d18-48b7-a38a-c69c134e6086 TCGA-29-1774-01 TCGA-29-1774-01A-01D-0581-05 TCGA-29-1774-01A-21-1559-20 TCGA-29-1774-01A-01W-0639-09 TCGA-29-1774-01A-01D-0577-01 TCGA-29-1774-01 eed4cd8b-16bc-419f-8474-248270a93780 TCGA-29-1774-01A-01D-0577-01 TCGA-29-1774-01 TCGA-29-1774-01A-01R-0584-07 +TCGA-29-1775-01 TCGA-29-1775-01 High OV-like c1 OV-like c4 TCGA-29-1775 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-29-1775-F27398 TCGA-29-1775 TCGA-29-1775-01A Stage IIIC -18943 0 376 341 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy 0.7 NO 1.1 G2 Recurrence TCGA-29-1775.8f5dd3e0-b6c8-443e-88d9-c9d02a531f60.pdf 1775 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.5 29 1-10 mm Ovary A LIVING 2008 8ead8627-a2d2-4952-9d59-cb15c2ae2021 TCGA-29-1775-01A-01D-0581-05 TCGA-29-1775-01A-21-1559-20 TCGA-29-1775-01A-01W-0639-09 TCGA-29-1775-01A-01D-0577-01 TCGA-29-1775-01 8a55a793-3d3c-455f-a342-3c5cbd01f849 TCGA-29-1775-01A-01D-0577-01 TCGA-29-1775-01 TCGA-29-1775-01A-01R-0584-07 +TCGA-29-1776-01 TCGA-29-1776-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 TCGA-29-1776 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-29-1776-F27409 TCGA-29-1776 TCGA-29-1776-01A Stage IIIC -23016 0 360 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.9 G3 TCGA-29-1776.eb6df66e-c6ee-4c63-889d-9f4b6ca170c7.pdf 1776 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.4 29 >20 mm Ovary A LIVING 2008 TCGA-29-1776-01 TCGA-29-1776-01 1549eee5-f999-4053-b926-baae183792f1 TCGA-29-1776-01 TCGA-29-1776-01A-01D-0581-05 TCGA-29-1776-01A-21-1559-20 TCGA-29-1776-01A-01W-0639-09 50867fed-2fda-4c45-aa08-042087e7daa9 TCGA-29-1776-01A-01D-0577-01 TCGA-29-1776-01 3da0c471-ede3-480f-b692-f94939ed8ac3 TCGA-29-1776-01A-01D-0577-01 50867fed-2fda-4c45-aa08-042087e7daa9 50867fed-2fda-4c45-aa08-042087e7daa9 TCGA-29-1776-01 TCGA-29-1776-01 50867fed-2fda-4c45-aa08-042087e7daa9 TCGA-29-1776-01A-01R-0584-07 +TCGA-29-1777-01 TCGA-29-1777-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 TCGA-29-1777 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 47 Bilateral TCGA-29-1777-F27415 TCGA-29-1777 TCGA-29-1777-01A Stage IIIC -17356 0 374 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.3 G2 TCGA-29-1777.bfd59906-509b-4ca3-9282-c881f9962e15.pdf 1777 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.5 29 >20 mm Ovary A LIVING 2008 TCGA-29-1777-01 79992944-6a6c-4f97-baf4-132689a69fff TCGA-29-1777-01 TCGA-29-1777-01A-01D-0581-05 TCGA-29-1777-01A-21-1559-20 TCGA-29-1777-01A-01W-0639-09 TCGA-29-1777-01A-01D-0577-01 TCGA-29-1777-01 9b5e802b-56e7-4f93-8869-2db3170006bc TCGA-29-1777-01A-01D-0577-01 TCGA-29-1777-01 TCGA-29-1777-01A-01R-0584-07 +TCGA-29-1778-01 TCGA-29-1778-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1778 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 77 Right TCGA-29-1778-F27420 TCGA-29-1778 TCGA-29-1778-01A Stage IIIC -28147 0 454 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 G3 TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701.pdf 1778 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 29 No Macroscopic disease Ovary A LIVING 2008 TCGA-29-1778-01 TCGA-29-1778-01 0654179f-2887-47e8-b4f4-051312a4907c TCGA-29-1778-01 TCGA-29-1778-01A-01D-0581-05 TCGA-29-1778-01A-21-1559-20 TCGA-29-1778-01A-01W-0639-09 7ecd0f7a-d186-422b-a2e1-833dfc400e39 TCGA-29-1778-01A-01D-0577-01 TCGA-29-1778-01 9a724a0a-6807-4995-889b-4b80a32e280d TCGA-29-1778-01A-01D-0577-01 7ecd0f7a-d186-422b-a2e1-833dfc400e39 7ecd0f7a-d186-422b-a2e1-833dfc400e39 TCGA-29-1778-01 TCGA-29-1778-01 7ecd0f7a-d186-422b-a2e1-833dfc400e39 TCGA-29-1778-01A-01R-0584-07 +TCGA-29-1781-01 TCGA-29-1781-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 TCGA-29-1781 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 69 Bilateral TCGA-29-1781-F27427 TCGA-29-1781 TCGA-29-1781-01A Stage IIIC -25404 0 255 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G3 TCGA-29-1781.959c11fe-f170-49bc-a1fe-73b799741b93.pdf 1781 Pre-Adjuvant Therapy TUMOR FREE NO Complete Remission/Response NO Primary Tumor 01 0.4 29 No Macroscopic disease Ovary A LIVING 2009 TCGA-29-1781-01 TCGA-29-1781-01 b87d2ec7-4fbf-4ecd-99fd-4983eb2fb7d8 TCGA-29-1781-01 TCGA-29-1781-01A-01D-0563-05 TCGA-29-1781-01A-21-1559-20 TCGA-29-1781-01A-01W-0633-09 5fd66773-ed5a-438c-a7c1-d029f05798e5 TCGA-29-1781-01A-01D-0559-01 TCGA-29-1781-01 7b26743c-756e-45d0-8eaa-cffb1c11fef1 TCGA-29-1781-01A-01D-0559-01 5fd66773-ed5a-438c-a7c1-d029f05798e5 5fd66773-ed5a-438c-a7c1-d029f05798e5 TCGA-29-1781-01 TCGA-29-1781-01 5fd66773-ed5a-438c-a7c1-d029f05798e5 TCGA-29-1781-01A-01R-0566-07 +TCGA-29-1783-01 TCGA-29-1783-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1783 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Right TCGA-29-1783-F27431 TCGA-29-1783 TCGA-29-1783-01A Stage IIIC -21284 0 220 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G3 TCGA-29-1783.6ebf4763-bb2a-4ef5-ab22-23460980df1c.pdf 1783 Post-Adjuvant Therapy TUMOR FREE YES NO Primary Tumor 01 0.4 29 1-10 mm Ovary A LIVING 2009 TCGA-29-1783-01 TCGA-29-1783-01 2981b53e-f39a-4c5e-9254-dd1a6bf6c4e6 TCGA-29-1783-01 TCGA-29-1783-01A-01D-0563-05 TCGA-29-1783-01A-21-1559-20 TCGA-29-1783-01A-01W-0633-09 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 TCGA-29-1783-01A-01D-0559-01 TCGA-29-1783-01 82dd8748-e0c5-4030-bf40-fe5d229adeae TCGA-29-1783-01A-01D-0559-01 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 TCGA-29-1783-01 TCGA-29-1783-01 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 TCGA-29-1783-01A-01R-0566-07 +TCGA-29-1784-01 TCGA-29-1784-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1784 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Right TCGA-29-1784-F27436 TCGA-29-1784 TCGA-29-1784-01A Stage IIIC -20210 0 163 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 YES G3 TCGA-29-1784.e4614e5d-eb1f-4ac7-a17f-105936745e80.pdf 1784 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 29 No Macroscopic disease Ovary A LIVING 2009 TCGA-29-1784-01 TCGA-29-1784-01 3720cc8a-5b9c-44cb-ba9d-5540f1ece950 TCGA-29-1784-01 TCGA-29-1784-01A-02D-0563-05 TCGA-29-1784-01A-02W-0633-09 c72e442b-36f5-4ea6-a893-505b5ccd8c4f TCGA-29-1784-01A-02D-0559-01 TCGA-29-1784-01 TCGA-29-1784-01A-02D-0559-01 c72e442b-36f5-4ea6-a893-505b5ccd8c4f c72e442b-36f5-4ea6-a893-505b5ccd8c4f TCGA-29-1784-01 TCGA-29-1784-01 c72e442b-36f5-4ea6-a893-505b5ccd8c4f TCGA-29-1784-01A-02R-0566-07 +TCGA-29-1785-01 TCGA-29-1785-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 TCGA-29-1785 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Right TCGA-29-1785-F27442 TCGA-29-1785 TCGA-29-1785-01A Stage IIIC -20417 1104 0 1053 473 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 YES G3 Recurrence TCGA-29-1785.b520ed75-17dd-420f-b444-4436bb03f40f.pdf 1785 Post-Adjuvant Therapy YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 29 >20 mm Ovary A DECEASED 2006 TCGA-29-1785-01 TCGA-29-1785-01 89db2b71-04a7-42f7-8480-a8ba3f118bcc TCGA-29-1785-01 TCGA-29-1785-01A-01D-0563-05 TCGA-29-1785-01A-21-1559-20 TCGA-29-1785-01A-01W-0633-09 dcff1416-56fd-4d8e-a472-a40a00ef3066 TCGA-29-1785-01A-01D-0559-01 TCGA-29-1785-01 c7002a87-0a3e-4ffb-b976-b1d7f768dd30 TCGA-29-1785-01A-01D-0559-01 dcff1416-56fd-4d8e-a472-a40a00ef3066 dcff1416-56fd-4d8e-a472-a40a00ef3066 TCGA-29-1785-01 TCGA-29-1785-01 dcff1416-56fd-4d8e-a472-a40a00ef3066 TCGA-29-1785-01A-01R-0566-07 +TCGA-29-2414-01 TCGA-29-2414-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 TCGA-29-2414 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Left TCGA-29-2414-F27451 TCGA-29-2414 TCGA-29-2414-01A Stage IIIC -27417 2621 0 2621 552 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 G2 Recurrence TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf 2414 WITH TUMOR YES Complete Remission/Response Other Method NO R1 Primary Tumor 01 0.5 29 11-20 mm Ovary NO A DECEASED 1998 TCGA-29-2414-01 TCGA-29-2414-01 9d580db8-ad4f-4ecb-affd-e9ae032e8ebb TCGA-29-2414-01 TCGA-29-2414-01A-02D-0708-05 ecbadb01-01ec-4d9f-877c-75709d6f5914 TCGA-29-2414-01A-02D-2069-01 TCGA-29-2414-01 2433c714-344b-4fa6-91a4-2cab830a4485 TCGA-29-2414-01A-02D-2069-01 ecbadb01-01ec-4d9f-877c-75709d6f5914 ecbadb01-01ec-4d9f-877c-75709d6f5914 TCGA-29-2414-01 TCGA-29-2414-01 ecbadb01-01ec-4d9f-877c-75709d6f5914 TCGA-29-2414-01A-02R-0711-07 +TCGA-29-2414-02 TCGA-29-2414-02 OV-like c1 OV-like c16 miRNA cluster 1 TCGA-29-2414 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Left TCGA-29-2414-F27451 TCGA-29-2414 TCGA-29-2414-02A Stage IIIC -27417 2621 0 2621 552 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 G2 Recurrence TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf 2414 WITH TUMOR YES Complete Remission/Response Other Method NO R1 Recurrent Tumor 02 0.3 29 11-20 mm Ovary NO A DECEASED 1998 TCGA-29-2414-02 4e488bb5-78b0-4a28-b276-109b203230d4 TCGA-29-2414-02 TCGA-29-2414-02A-01D-0807-05 1558c0c4-6bd2-482d-9c4e-2430a402dacc 754eb22a-d0a5-4ea9-9fee-685e6d2cad7f 1558c0c4-6bd2-482d-9c4e-2430a402dacc 1558c0c4-6bd2-482d-9c4e-2430a402dacc 1558c0c4-6bd2-482d-9c4e-2430a402dacc TCGA-29-2414-02A-01R-0810-07 +TCGA-29-2425-01 TCGA-29-2425-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-29-2425 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 TCGA-29-2425-F27462 TCGA-29-2425 TCGA-29-2425-01A Stage IIIC -22089 0 1977 1577 0 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 NO G2 Progression of Disease TCGA-29-2425.ec04e6ae-ae66-4fc2-b77b-485f77ce39bc.pdf 2425 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 29 >20 mm Ovary A LIVING 2004 TCGA-29-2425-01 TCGA-29-2425-01 572ffa30-3fd6-49b7-a250-f8505555bde9 TCGA-29-2425-01 TCGA-29-2425-01A-01D-0708-05 TCGA-29-2425-01A-21-1560-20 3ce6b8c4-7020-447a-8eb8-5370eef05344 TCGA-29-2425-01A-01D-0704-01 TCGA-29-2425-01 8d87815d-6b5a-4713-9f0b-0ca8609996f2 TCGA-29-2425-01A-01D-0704-01 3ce6b8c4-7020-447a-8eb8-5370eef05344 3ce6b8c4-7020-447a-8eb8-5370eef05344 TCGA-29-2425-01 TCGA-29-2425-01 3ce6b8c4-7020-447a-8eb8-5370eef05344 TCGA-29-2425-01A-01R-0711-07 +TCGA-29-2427-01 TCGA-29-2427-01 BRCA-LUAD+ C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-29-2427 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Left TCGA-29-2427-F27470 TCGA-29-2427 TCGA-29-2427-01A Stage IIIC -21940 0 1900 1582 0 2010-2-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 Recurrence TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf 2427 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 29 >20 mm Ovary A LIVING 2004 TCGA-29-2427-01 TCGA-29-2427-01 68e99d72-4df2-4d2d-9e24-b8fc81942a46 TCGA-29-2427-01 TCGA-29-2427-01A-01D-0708-05 TCGA-29-2427-01A-21-1560-20 f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01D-0704-01 TCGA-29-2427-01 596d6d8e-d15c-442b-bcd4-ed2dec59aef2 TCGA-29-2427-01A-01D-0704-01 f1579d6e-6efd-47b5-b2b4-a97e1480ce0a f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01W-0799-08 TCGA-29-2427-01 TCGA-29-2427-01 f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01W-0799-08 TCGA-29-2427-01A-01R-0711-07 +TCGA-29-2428-01 TCGA-29-2428-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-29-2428 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Left TCGA-29-2428-F27478 TCGA-29-2428 TCGA-29-2428-01A Stage IIIC -21392 0 1372 0 2010-2-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.7 YES G3 TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb.pdf 2428 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO R1 Primary Tumor 01 0.4 29 >20 mm Ovary A LIVING 2005 TCGA-29-2428-01 TCGA-29-2428-01 b7c8f2a5-de96-4a38-bfa4-2a6c1b8ea1e2 TCGA-29-2428-01 TCGA-29-2428-01A-01D-0708-05 TCGA-29-2428-01A-21-1560-20 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b TCGA-29-2428-01A-01D-0704-01 TCGA-29-2428-01 364ced0b-2737-4f70-a7bb-a5a9171e4ef8 TCGA-29-2428-01A-01D-0704-01 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b TCGA-29-2428-01 TCGA-29-2428-01 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b TCGA-29-2428-01A-01R-0711-07 +TCGA-29-2429-01 TCGA-29-2429-01 High OV-like c1 OV-like c4 TCGA-29-2429 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 79 Right TCGA-29-2429-F44633 TCGA-29-2429 TCGA-29-2429-01A Stage IIIC -29156 421 0 2013-8-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.1 YES G3 NO TCGA-29-2429.09804c6e-b6f3-482f-a23e-a4efa84f2ab7.pdf 2429 WITH TUMOR R1 Primary Tumor 01 0.3 29 >20 mm Ovary A DECEASED 2005 1142b276-1e85-4021-8fa7-85e562b6c747 TCGA-29-2429-01A-01D-1047-05 TCGA-29-2429-01A-21-1560-20 TCGA-29-2429-01A-01D-1526-09 TCGA-29-2429-01A-01D-1043-01 TCGA-29-2429-01 3ba731e2-2840-44c0-aa48-541f8f9e4d29 TCGA-29-2429-01A-01D-1043-01 TCGA-29-2429-01 TCGA-29-2429-01A-01R-1050-07 +TCGA-29-2431-01 TCGA-29-2431-01 High OV-like c1 OV-like c4 TCGA-29-2431 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-29-2431-F27485 TCGA-29-2431 TCGA-29-2431-01A Stage IIIC -21833 0 1285 960 0 2010-6-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.5 G2 Recurrence TCGA-29-2431.cbd3ddd8-b431-4852-b4db-b4be535115d6.pdf 2431 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO R0 Primary Tumor 01 0.3 29 1-10 mm Ovary A LIVING 2006 88be95fd-3aa9-4279-91ff-e705db3e187c TCGA-29-2431-01A-01D-1047-05 TCGA-29-2431-01A-21-1560-20 TCGA-29-2431-01A-01D-1526-09 TCGA-29-2431-01A-01D-1043-01 TCGA-29-2431-01 f02341bc-10e3-4bbf-98c8-0604616796ea TCGA-29-2431-01A-01D-1043-01 TCGA-29-2431-01 TCGA-29-2431-01A-01R-1050-07 +TCGA-29-2432-01 TCGA-29-2432-01 High OV-like c1 OV-like c4 TCGA-29-2432 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-29-2432-F27492 TCGA-29-2432 TCGA-29-2432-01A Stage IIIC -22605 653 0 360 174 2010-6-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.3 G3 Recurrence TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f.pdf 2432 WITH TUMOR YES Progressive Disease NO R1 Primary Tumor 01 0.5 29 11-20 mm Ovary A DECEASED 2008 6fcda1cc-9224-452c-8fda-369e73f2f05e TCGA-29-2432-01A-01D-1047-05 TCGA-29-2432-01A-21-1560-20 TCGA-29-2432-01A-01D-1526-09 TCGA-29-2432-01A-01D-1043-01 TCGA-29-2432-01 a835eb6a-c37b-49de-bea5-9f9251f817a5 TCGA-29-2432-01A-01D-1043-01 TCGA-29-2432-01 TCGA-29-2432-01A-01R-1050-07 +TCGA-29-2434-01 TCGA-29-2434-01 High OV-like c1 OV-like c4 TCGA-29-2434 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Left TCGA-29-2434-F27505 TCGA-29-2434 TCGA-29-2434-01A Stage IIIC -18997 0 349 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G3 TCGA-29-2434.0891ac31-d9ed-4cb3-82ae-8499fb4c29ea.pdf 2434 TUMOR FREE YES Complete Remission/Response NO R0 Primary Tumor 01 0.4 29 No Macroscopic disease Ovary A LIVING 2009 7b45cfcd-a37c-4f92-b35f-e75ac6b1d000 TCGA-29-2434-01A-01D-1047-05 TCGA-29-2434-01A-21-1560-20 TCGA-29-2434-01A-01D-1526-09 TCGA-29-2434-01A-01D-1043-01 TCGA-29-2434-01 9eb175cd-3311-4f57-a37a-7a2463bc58fb TCGA-29-2434-01A-01D-1043-01 TCGA-29-2434-01 TCGA-29-2434-01A-01R-1050-07 +TCGA-29-2435-01 TCGA-29-2435-01 OV-like c4 TCGA-29-2435 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Left TCGA-29-2435-F27510 TCGA-29-2435 TCGA-29-2435-01A Stage IV -28779 0 34 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.5 G3 TCGA-29-2435.6EF128AE-31B6-483A-B0DD-9626CEEC278E.pdf 2435 YES R1 Primary Tumor 01 0.3 29 11-20 mm Ovary A LIVING 2009 TCGA-29-2435-01A-21-1560-20 84e1540d-c756-414e-92c9-3e0d5f45cd48 +TCGA-29-2436-01 TCGA-29-2436-01 COAD-READ Low purity c2 OV-like c4 TCGA-29-2436 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 36 Bilateral TCGA-29-2436-F27514 TCGA-29-2436 TCGA-29-2436-01A Stage IIIC -13346 0 297 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.3 G2 TCGA-29-2436.0caa891b-3d47-44c1-bc75-0468afc11495.pdf 2436 TUMOR FREE YES Complete Remission/Response NO R0 Primary Tumor 01 0.4 29 1-10 mm Ovary YES A LIVING 2009 e467e3e0-9311-48ff-8da8-f3b9118011e7 TCGA-29-2436-01A-01D-1047-05 TCGA-29-2436-01A-21-1560-20 TCGA-29-2436-01A-01D-1526-09 TCGA-29-2436-01A-01D-1043-01 TCGA-29-2436-01 851a2dc8-da35-4a80-bcd1-1ed74ee459c7 TCGA-29-2436-01A-01D-1043-01 TCGA-29-2436-01 TCGA-29-2436-01A-01R-1050-07 +TCGA-29-A5NZ-01 TCGA-29-A5NZ-01 TCGA-29-A5NZ TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 TCGA-29-A5NZ-F59530 TCGA-29-A5NZ TCGA-29-A5NZ-01A Stage IIIC -24161 515 1088 0 984 879 Additional New Tumor Event 2014-5-14 FEMALE Serous Cystadenocarcinoma No C48.1 8460/3 C48.1 YES 1040 NO NO G3 Progression of Disease YES true No TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864.pdf A5NZ WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 29 Omentum A LIVING 2011 TCGA-29-A5NZ-01 TCGA-29-A5NZ-01 TCGA-29-A5NZ-01A-11D-A409-05 TCGA-29-A5NZ-01 ea715147-2b94-4bed-9531-ba91c13630fe TCGA-29-A5NZ-01A-11D-A402-01 8E54518A-2DD5-448F-AFA2-C23D91E0290D TCGA-29-A5NZ-01A-11R-A406-31 TCGA-29-A5NZ-01A-11D-A402-01 ea715147-2b94-4bed-9531-ba91c13630fe TCGA-29-A5NZ-01A-11R-A406-31 ea715147-2b94-4bed-9531-ba91c13630fe TCGA-29-A5NZ-01 ea715147-2b94-4bed-9531-ba91c13630fe +TCGA-30-1714-01 TCGA-30-1714-01 High OV-like c1 miRNA cluster 1 cluster 3 TCGA-30-1714 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 68 Bilateral TCGA-30-1714-F27518 TCGA-30-1714 TCGA-30-1714-01A Stage IV -25032 1158 0 1158 241 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.6 YES G3 Recurrence TCGA-30-1714.7bec7160-e40c-4b47-b0d6-93652c5e27f2.pdf 1714 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 30 1-10 mm Ovary NO A DECEASED 2001 TCGA-30-1714-01 9b91d688-3f05-43a9-8900-57027113b885 TCGA-30-1714-01 TCGA-30-1714-01A-02D-0563-05 TCGA-30-1714-01A-02W-0633-09 TCGA-30-1714-01A-02D-0559-01 TCGA-30-1714-01 TCGA-30-1714-01A-02D-0559-01 TCGA-30-1714-01 TCGA-30-1714-01A-02R-0566-07 +TCGA-30-1718-01 TCGA-30-1718-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 TCGA-30-1718 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-30-1718-F27534 TCGA-30-1718 TCGA-30-1718-01A Stage IIIC -16400 1579 0 1579 896 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.3 NO G3 Recurrence TCGA-30-1718.078da76a-b9f5-40d0-9a57-04c306ade36a.pdf 1718 WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.4 30 1-10 mm Ovary NO A DECEASED 2002 TCGA-30-1718-01 TCGA-30-1718-01 f9ba9bc4-5591-4a79-b8ad-fee2f83ea724 TCGA-30-1718-01 TCGA-30-1718-01A-01D-0563-05 TCGA-30-1718-01A-21-1559-20 TCGA-30-1718-01A-01W-0633-09 5abce979-686d-40c4-acd7-ef9cc5acf26f TCGA-30-1718-01A-01D-0559-01 TCGA-30-1718-01 bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370 TCGA-30-1718-01A-01D-0559-01 5abce979-686d-40c4-acd7-ef9cc5acf26f 5abce979-686d-40c4-acd7-ef9cc5acf26f TCGA-30-1718-01 TCGA-30-1718-01 5abce979-686d-40c4-acd7-ef9cc5acf26f TCGA-30-1718-01A-01R-0566-07 +TCGA-30-1853-01 TCGA-30-1853-01 High OV-like c1 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-30-1853 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-30-1853-F27542 TCGA-30-1853 TCGA-30-1853-01A Stage IIIC -21404 1103 0 1103 634 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 NO G3 Recurrence TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288.pdf 1853 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 30 1-10 mm Ovary A DECEASED 2000 TCGA-30-1853-01 549e923d-4430-4b66-8378-af96f66646b7 TCGA-30-1853-01 TCGA-30-1853-01A-02D-0652-05 TCGA-30-1853-01A-02D-0648-01 TCGA-30-1853-01 TCGA-30-1853-01A-02D-0648-01 TCGA-30-1853-01A-02W-0699-08 TCGA-30-1853-01 TCGA-30-1853-01A-02W-0699-08 TCGA-30-1853-01A-02R-0655-07 +TCGA-30-1855-01 TCGA-30-1855-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-30-1855 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 61 TCGA-30-1855-F27550 TCGA-30-1855 TCGA-30-1855-01A Stage IIIC -22394 75 0 75 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 NO G3 TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3.pdf 1855 WITH TUMOR NO NO Primary Tumor 01 0.4 30 1-10 mm Ovary NO A DECEASED 2001 TCGA-30-1855-01 TCGA-30-1855-01 b47399a9-31a2-4721-8da0-63bf21c6fcae TCGA-30-1855-01 TCGA-30-1855-01A-01D-0581-05 TCGA-30-1855-01A-21-1559-20 TCGA-30-1855-01A-01W-0639-09 732d0664-c343-4a63-9dc3-40985e540a59 TCGA-30-1855-01A-01D-0577-01 TCGA-30-1855-01 6b1438ab-2904-4d21-865d-f14c76777f62 TCGA-30-1855-01A-01D-0577-01 732d0664-c343-4a63-9dc3-40985e540a59 732d0664-c343-4a63-9dc3-40985e540a59 TCGA-30-1855-01 TCGA-30-1855-01 732d0664-c343-4a63-9dc3-40985e540a59 TCGA-30-1855-01A-01R-0584-07 +TCGA-30-1856-01 TCGA-30-1856-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 TCGA-30-1856 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1856-F27552 TCGA-30-1856 TCGA-30-1856-01A Stage IIIC -20626 477 0 477 220 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 NO G3 Recurrence TCGA-30-1856.281005d7-4231-467c-9c6c-43f536fcebe1.pdf 1856 WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO Primary Tumor 01 0.4 30 1-10 mm Ovary NO A DECEASED 2001 TCGA-30-1856-01 73874ff9-38f8-4a31-9ac1-923793b88b91 TCGA-30-1856-01 TCGA-30-1856-01A-01D-0581-05 TCGA-30-1856-01A-21-1559-20 TCGA-30-1856-01A-01W-0639-09 TCGA-30-1856-01A-01D-0577-01 TCGA-30-1856-01 60d477e5-467d-4be3-b495-ed511519e4fa TCGA-30-1856-01A-01D-0577-01 TCGA-30-1856-01 TCGA-30-1856-01A-01R-0584-07 +TCGA-30-1857-01 TCGA-30-1857-01 Squamous OV-like c1 miRNA cluster 3 cluster 6 TCGA-30-1857 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Right TCGA-30-1857-F27564 TCGA-30-1857 TCGA-30-1857-01A Stage IV -23689 8 0 8 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 G3 TCGA-30-1857.e3d84909-0149-4691-a398-1a6b272dde60.pdf 1857 WITH TUMOR NO NO Primary Tumor 01 0.4 30 Ovary A DECEASED 2001 TCGA-30-1857-01 TCGA-30-1857-01 bffff720-6d86-4661-9ae9-85605520064f TCGA-30-1857-01 TCGA-30-1857-01A-02D-0581-05 TCGA-30-1857-01A-02W-0639-09 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01A-02D-0577-01 TCGA-30-1857-01 TCGA-30-1857-01A-02R-1569-13 TCGA-30-1857-01A-02D-0577-01 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01A-02R-1569-13 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01 TCGA-30-1857-01 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01A-02R-0584-07 +TCGA-30-1859-01 TCGA-30-1859-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 TCGA-30-1859 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1859-F27566 TCGA-30-1859 TCGA-30-1859-01A -20498 1463 0 1463 210 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.3 NO 1 G3 Locoregional Disease YES TCGA-30-1859.6c4d66bc-361f-465f-b18a-7bb1a0fc7752.pdf 1859 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.3 30 1-10 mm Ovary A DECEASED 2002 TCGA-30-1859-01 4618e0b6-9a8d-4843-a67f-a0b0de96b4ec TCGA-30-1859-01 TCGA-30-1859-01A-01D-0652-05 TCGA-30-1859-01A-21-1559-20 TCGA-30-1859-01A-01D-0648-01 TCGA-30-1859-01 063c9971-7f3f-45f5-8f42-11b3eca461fa TCGA-30-1859-01A-01D-0648-01 TCGA-30-1859-01 TCGA-30-1859-01A-01R-0655-07 +TCGA-30-1860-01 TCGA-30-1860-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 TCGA-30-1860 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 58 Bilateral TCGA-30-1860-F27580 TCGA-30-1860 TCGA-30-1860-01A Stage IIIC -21406 1366 0 1366 397 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.5 NO G3 Recurrence TCGA-30-1860.d5b8e59f-1ae5-4e22-b933-48e48a364788.pdf 1860 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 30 >20 mm Ovary NO A DECEASED 2002 TCGA-30-1860-01 TCGA-30-1860-01 713acb94-3fd4-444d-ae04-e79c1ee73b3a TCGA-30-1860-01 TCGA-30-1860-01A-01D-0652-05 TCGA-30-1860-01A-21-1559-20 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 TCGA-30-1860-01A-01D-0648-01 TCGA-30-1860-01 5c4486d9-1d91-4f42-83fd-85526c4f0836 TCGA-30-1860-01A-01D-0648-01 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 TCGA-30-1860-01 TCGA-30-1860-01 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 TCGA-30-1860-01A-01R-0655-07 +TCGA-30-1861-01 TCGA-30-1861-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 TCGA-30-1861 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Bilateral TCGA-30-1861 TCGA-30-1861-01A Stage IIIC -27103 1058 0 1058 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.8 G3 TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe.pdf 1861 Primary Tumor 01 0.4 30 1-10 mm Ovary A DECEASED 2002 TCGA-30-1861-01 TCGA-30-1861-01 617ac2af-9b70-4c2b-b659-02436e604267 TCGA-30-1861-01 TCGA-30-1861-01A-01D-0652-05 TCGA-30-1861-01A-21-1559-20 32a58029-c8aa-4647-a932-bbf57e82fc48 TCGA-30-1861-01A-01D-0648-01 TCGA-30-1861-01 7e253248-d889-4b00-a098-55cfcb18758b TCGA-30-1861-01A-01D-0648-01 32a58029-c8aa-4647-a932-bbf57e82fc48 32a58029-c8aa-4647-a932-bbf57e82fc48 TCGA-30-1861-01 TCGA-30-1861-01 32a58029-c8aa-4647-a932-bbf57e82fc48 TCGA-30-1861-01A-01R-0655-07 +TCGA-30-1862-01 TCGA-30-1862-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-30-1862 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 65 TCGA-30-1862-F27593 TCGA-30-1862 Stage IV -23895 186 0 186 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G2 1862 WITH TUMOR NO NO Primary Tumor 01 30 >20 mm Ovary DECEASED 2003 TCGA-30-1862-01 TCGA-30-1862-01 b1c27950-57b3-4a9e-96f6-5c7232951f1c TCGA-30-1862-01 TCGA-30-1862-01A-02D-0652-05 ab0701bc-0bc5-4008-a75b-5f665ef9c14a TCGA-30-1862-01A-02D-0648-01 TCGA-30-1862-01 TCGA-30-1862-01A-02D-0648-01 ab0701bc-0bc5-4008-a75b-5f665ef9c14a ab0701bc-0bc5-4008-a75b-5f665ef9c14a TCGA-30-1862-01 TCGA-30-1862-01 ab0701bc-0bc5-4008-a75b-5f665ef9c14a TCGA-30-1862-01A-02W-0699-08 TCGA-30-1862-01A-02R-0655-07 +TCGA-30-1866-01 TCGA-30-1866-01 High OV-like c1 miRNA cluster 2 cluster 1 TCGA-30-1866 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-30-1866-F27595 TCGA-30-1866 Stage IV -22562 1114 0 1114 285 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G2 Recurrence 1866 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 30 1-10 mm Ovary DECEASED 2003 TCGA-30-1866-01 a334b0fd-05cc-4aa3-bbff-4439e2807085 TCGA-30-1866-01 TCGA-30-1866-01A-02D-0652-05 TCGA-30-1866-01A-02D-0648-01 TCGA-30-1866-01 TCGA-30-1866-01A-02D-0648-01 TCGA-30-1866-01 TCGA-30-1866-01A-02R-0655-07 +TCGA-30-1867-01 TCGA-30-1867-01 High OV-like c1 miRNA cluster 1 cluster 6 TCGA-30-1867 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 TCGA-30-1867-F27605 TCGA-30-1867 TCGA-30-1867-01A Stage IV -17159 37 0 37 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.3 NO 0.3 GX TCGA-30-1867.420a6b8c-33b8-4b1e-8bba-e299c20611c7.pdf 1867 WITH TUMOR NO NO Primary Tumor 01 0.3 30 Ovary A DECEASED 2004 TCGA-30-1867-01 105890a2-5198-4ecf-af7f-6538542dc162 TCGA-30-1867-01 TCGA-30-1867-01A-01D-0652-05 TCGA-30-1867-01A-01D-0648-01 TCGA-30-1867-01 TCGA-30-1867-01A-01D-0648-01 TCGA-30-1867-01 TCGA-30-1867-01A-01R-0655-07 +TCGA-30-1869-01 TCGA-30-1869-01 OV-like c1 OV-like c4 TCGA-30-1869 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-30-1869-F27607 TCGA-30-1869 TCGA-30-1869-01A Stage IV -18398 1563 0 1563 767 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO NO G3 Recurrence TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c.pdf 1869 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 30 1-10 mm Ovary A DECEASED 2004 TCGA-30-1869-01A-01D-0652-05 TCGA-30-1869-01A-21-1559-20 014cbeef-19c7-4ac9-b9a0-5f95e07c5d45 +TCGA-30-1880-01 TCGA-30-1880-01 Squamous Low purity c2 miRNA cluster 1 cluster 3 TCGA-30-1880 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1880-F27620 TCGA-30-1880 TCGA-30-1880-01A Stage IIIC -20525 1751 0 1751 348 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1 NO G3 Recurrence TCGA-30-1880.D23622FE-9648-422D-AE92-B21F9B6E5A51.pdf 1880 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.2 30 No Macroscopic disease Ovary A DECEASED 2001 TCGA-30-1880-01 2d39ca81-8c8c-43ab-b065-38627152d132 TCGA-30-1880-01 TCGA-30-1880-01A-01D-0652-05 TCGA-30-1880-01A-01D-0648-01 TCGA-30-1880-01 TCGA-30-1880-01A-01D-0648-01 TCGA-30-1880-01 TCGA-30-1880-01A-01R-0655-07 +TCGA-30-1887-01 TCGA-30-1887-01 High OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 TCGA-30-1887 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-30-1887-F27633 TCGA-30-1887 TCGA-30-1887-01A Stage IIIC -24495 738 0 738 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 YES G2 TCGA-30-1887.a074363f-dd94-4193-b583-70885400ff2f.pdf 1887 WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.5 30 1-10 mm Ovary YES A DECEASED 2005 TCGA-30-1887-01 1065d480-5815-40a4-93c6-faa8712a1e94 TCGA-30-1887-01 TCGA-30-1887-01A-01D-0652-05 TCGA-30-1887-01A-21-1559-20 TCGA-30-1887-01A-01D-0648-01 TCGA-30-1887-01 e26411ea-dc83-4441-a0f4-84fd52798fdd TCGA-30-1887-01A-01D-0648-01 TCGA-30-1887-01 TCGA-30-1887-01A-01R-0655-07 +TCGA-30-1891-01 TCGA-30-1891-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-30-1891 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-30-1891-F27640 TCGA-30-1891 TCGA-30-1891-01A Stage IIIC -22344 914 0 914 181 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.2 NO G2 Recurrence TCGA-30-1891.F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B.pdf 1891 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.4 30 1-10 mm Ovary NO A DECEASED 2004 TCGA-30-1891-01 TCGA-30-1891-01 d97a0c15-2c1d-4af3-9e62-ff67cbf7b700 TCGA-30-1891-01 TCGA-30-1891-01A-01D-0652-05 TCGA-30-1891-01A-21-1559-20 690d1437-2a05-4263-8fa7-8f4481893b83 TCGA-30-1891-01A-01D-0648-01 TCGA-30-1891-01 7f8386ef-cf19-4207-86ae-13029c49d944 TCGA-30-1891-01A-01D-0648-01 690d1437-2a05-4263-8fa7-8f4481893b83 690d1437-2a05-4263-8fa7-8f4481893b83 TCGA-30-1891-01 TCGA-30-1891-01 690d1437-2a05-4263-8fa7-8f4481893b83 TCGA-30-1891-01A-01W-0699-08 TCGA-30-1891-01A-01R-0655-07 +TCGA-30-1892-01 TCGA-30-1892-01 Squamous OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 TCGA-30-1892 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Left TCGA-30-1892-F27654 TCGA-30-1892 TCGA-30-1892-01A Stage IIIC -19256 1484 0 1484 253 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 G3 Recurrence TCGA-30-1892.fb7c966c-9b16-4781-9c01-2db480c88d63.pdf 1892 WITH TUMOR YES Complete Remission/Response Physical Examination NO Primary Tumor 01 0.3 30 1-10 mm Ovary A DECEASED 2004 TCGA-30-1892-01 e969eb72-cef5-4c16-b1fd-8a97324ce3e4 TCGA-30-1892-01 TCGA-30-1892-01A-01D-0652-05 TCGA-30-1892-01A-21-1559-20 TCGA-30-1892-01A-01D-0648-01 TCGA-30-1892-01 3c68d944-a329-44c2-8697-2f8c50a8b38c TCGA-30-1892-01A-01D-0648-01 TCGA-30-1892-01 TCGA-30-1892-01A-01R-0655-07 +TCGA-31-1944-01 TCGA-31-1944-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-31-1944 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-31-1944-F27668 TCGA-31-1944 TCGA-31-1944-01A Stage IIIC -17207 0 1386 678 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 YES G3 Recurrence TCGA-31-1944.bd7361f7-07c1-4be8-92c6-4f0a3dea99b2.pdf 1944 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 31 No Macroscopic disease Ovary YES A LIVING 2005 TCGA-31-1944-01 TCGA-31-1944-01 b9b5c6a5-cbc8-4645-9ce1-131c26e36683 TCGA-31-1944-01 TCGA-31-1944-01A-01D-0652-05 TCGA-31-1944-01A-21-1559-20 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 TCGA-31-1944-01A-01D-0648-01 TCGA-31-1944-01 332735d2-c077-400a-b011-1f0984b07339 TCGA-31-1944-01A-01D-0648-01 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 TCGA-31-1944-01 TCGA-31-1944-01 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 TCGA-31-1944-01A-01R-0655-07 +TCGA-31-1946-01 TCGA-31-1946-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-31-1946 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 30 Bilateral TCGA-31-1946-F27679 TCGA-31-1946 TCGA-31-1946-01A Stage IIIC -11146 0 918 664 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1 NO G3 Recurrence TCGA-31-1946.5ef31a8f-38e7-486b-8efc-99cd8c1ec06d.pdf 1946 WITH TUMOR YES Physical Examination NO Primary Tumor 01 0.3 31 No Macroscopic disease Ovary YES A LIVING 2006 TCGA-31-1946-01 TCGA-31-1946-01 fb4cc131-9ac0-4615-b8c1-802273c4c6cf TCGA-31-1946-01 TCGA-31-1946-01A-01D-0652-05 TCGA-31-1946-01A-21-1559-20 05abb2f5-07c3-42da-92d9-0b4560fb6f09 TCGA-31-1946-01A-01D-0648-01 TCGA-31-1946-01 fb44d557-9e0a-40d5-83c3-3b9431e72d9d TCGA-31-1946-01A-01D-0648-01 05abb2f5-07c3-42da-92d9-0b4560fb6f09 05abb2f5-07c3-42da-92d9-0b4560fb6f09 TCGA-31-1946-01 TCGA-31-1946-01 05abb2f5-07c3-42da-92d9-0b4560fb6f09 TCGA-31-1946-01A-01R-0655-07 +TCGA-31-1950-01 TCGA-31-1950-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-31-1950 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-31-1950-F27688 TCGA-31-1950 TCGA-31-1950-01A Stage IIIC -28100 0 571 349 1 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.2 NO G2 Recurrence TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73.pdf 1950 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.2 31 1-10 mm Ovary NO A LIVING 2007 TCGA-31-1950-01 72689370-cb7a-4e3b-8964-2dcde6633902 TCGA-31-1950-01 TCGA-31-1950-01A-01D-0652-05 TCGA-31-1950-01A-21-1559-20 a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01D-0648-01 TCGA-31-1950-01 6f927c4d-19b8-4bc9-92eb-da2402ed6e31 TCGA-31-1950-01A-01D-0648-01 a32eba80-dbe9-464e-8102-5f77a3c7e177 a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01W-0699-08 TCGA-31-1950-01 a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01W-0699-08 TCGA-31-1950-01A-01R-0655-07 +TCGA-31-1951-01 TCGA-31-1951-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 TCGA-31-1951 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Left TCGA-31-1951-F27692 TCGA-31-1951 TCGA-31-1951-01A Stage IIIC -21352 0 684 659 2010-1-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.7 YES G3 Recurrence TCGA-31-1951.b10efe75-1420-47d2-9c5b-202b09099357.pdf 1951 WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.3 31 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-31-1951-01 TCGA-31-1951-01 c9806ee2-6323-4078-bfc0-6fc773a7f66e TCGA-31-1951-01 TCGA-31-1951-01A-01D-0652-05 TCGA-31-1951-01A-21-1559-20 197ea6b5-5716-4e5c-9c7f-92ed4521682a TCGA-31-1951-01A-01D-0648-01 TCGA-31-1951-01 a6bb52ad-58cf-4ee0-ae89-9615811f4de6 TCGA-31-1951-01A-01D-0648-01 197ea6b5-5716-4e5c-9c7f-92ed4521682a 197ea6b5-5716-4e5c-9c7f-92ed4521682a TCGA-31-1951-01 TCGA-31-1951-01 197ea6b5-5716-4e5c-9c7f-92ed4521682a TCGA-31-1951-01A-01R-0655-07 +TCGA-31-1953-01 TCGA-31-1953-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-31-1953 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-31-1953-F27698 TCGA-31-1953 TCGA-31-1953-01A Stage IIIC -19064 0 204 70 1 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 NO G3 Recurrence TCGA-31-1953.c824400d-b062-4a04-b805-f717426d688e.pdf 1953 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.1 31 Ovary NO A LIVING 2008 TCGA-31-1953-01 TCGA-31-1953-01 b3f75e69-3519-46eb-821c-773c2506d7fd TCGA-31-1953-01 TCGA-31-1953-01A-01D-0652-05 7b31fc47-0299-4449-aa5b-622ba549371f TCGA-31-1953-01A-01D-0648-01 TCGA-31-1953-01 TCGA-31-1953-01A-01D-0648-01 7b31fc47-0299-4449-aa5b-622ba549371f 7b31fc47-0299-4449-aa5b-622ba549371f TCGA-31-1953-01 TCGA-31-1953-01 7b31fc47-0299-4449-aa5b-622ba549371f TCGA-31-1953-01A-01W-0699-08 TCGA-31-1953-01A-01R-0655-07 +TCGA-31-1955-01 TCGA-31-1955-01 Squamous OV-like c1 OV-like c4 TCGA-31-1955 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 43 Bilateral TCGA-31-1955-F27704 TCGA-31-1955 TCGA-31-1955-01A Stage IIIC -15926 0 1293 918 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.4 NO G3 Recurrence TCGA-31-1955.16f5a24e-2c57-42fe-bd79-ef174d44b8b1.pdf 1955 WITH TUMOR YES Physical Examination YES Primary Tumor 01 0.4 31 No Macroscopic disease Ovary YES A LIVING 2005 TCGA-31-1955-01A-01D-0652-05 TCGA-31-1955-01A-21-1559-20 TCGA-31-1955-01A-01D-0648-01 TCGA-31-1955-01 47461ed4-1491-4f27-bd9c-cbd1ee184f5a TCGA-31-1955-01A-01D-0648-01 TCGA-31-1955-01 TCGA-31-1955-01A-01R-0655-07 +TCGA-31-1956-01 TCGA-31-1956-01 Squamous OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 TCGA-31-1956 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Left TCGA-31-1956-F27711 TCGA-31-1956 TCGA-31-1956-01A Stage IIIB -22100 0 1342 119 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.3 YES G3 Locoregional Disease YES TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c.pdf 1956 WITH TUMOR YES NO Primary Tumor 01 0.2 31 Ovary NO A LIVING 2005 TCGA-31-1956-01 TCGA-31-1956-01 c6dcadc5-be05-4d61-b82a-bc5111fb2634 TCGA-31-1956-01 TCGA-31-1956-01A-01D-0652-05 24cfcfd9-ce30-4e24-9470-60265efd6721 TCGA-31-1956-01A-01D-0648-01 TCGA-31-1956-01 TCGA-31-1956-01A-01D-0648-01 24cfcfd9-ce30-4e24-9470-60265efd6721 24cfcfd9-ce30-4e24-9470-60265efd6721 TCGA-31-1956-01 TCGA-31-1956-01 24cfcfd9-ce30-4e24-9470-60265efd6721 TCGA-31-1956-01A-01R-0655-07 +TCGA-31-1959-01 TCGA-31-1959-01 High OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-31-1959 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Bilateral TCGA-31-1959-F27715 TCGA-31-1959 TCGA-31-1959-01A Stage IV -18247 0 67 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy 0.7 NO 1.1 YES G2 TCGA-31-1959.c78c6998-1f86-4dd2-bf41-78f12d43c33a.pdf 1959 WITH TUMOR YES NO Primary Tumor 01 0.2 31 Ovary YES A LIVING 2009 TCGA-31-1959-01 TCGA-31-1959-01 427e1629-b22d-4421-b6f5-ffbd672fd164 TCGA-31-1959-01 TCGA-31-1959-01A-01D-0652-05 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 TCGA-31-1959-01A-01D-0648-01 TCGA-31-1959-01 TCGA-31-1959-01A-01D-0648-01 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 TCGA-31-1959-01 TCGA-31-1959-01 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 TCGA-31-1959-01A-01W-0699-08 TCGA-31-1959-01A-01R-0655-07 +TCGA-36-1568-01 TCGA-36-1568-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-36-1568 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-36-1568-F27850 TCGA-36-1568 TCGA-36-1568-01A Stage IIIC -19311 0 875 548 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.6 NO G3 Recurrence TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3.pdf 1568 WITH TUMOR YES Partial Remission/Response Imaging Study NO Primary Tumor 01 0.3 36 Ovary A LIVING 2007 TCGA-36-1568-01 TCGA-36-1568-01 TCGA-36-1568-01A-01W-0615-10 cde7f1d6-c4c9-4fc3-a6cf-696addee91d6 TCGA-36-1568-01 TCGA-36-1568-01A-01W-0615-10 TCGA-36-1568-01A-01D-0536-05 TCGA-36-1568-01A-21-1558-20 4e539c62-454a-4b1c-bde1-6951ee12d109 TCGA-36-1568-01A-01D-0533-01 TCGA-36-1568-01 b9598717-cdb9-49e1-a8d5-49ec5189cb31 TCGA-36-1568-01A-01D-0533-01 4e539c62-454a-4b1c-bde1-6951ee12d109 4e539c62-454a-4b1c-bde1-6951ee12d109 TCGA-36-1568-01 TCGA-36-1568-01 4e539c62-454a-4b1c-bde1-6951ee12d109 TCGA-36-1568-01A-01W-0615-10 TCGA-36-1568-01A-01R-0540-07 +TCGA-36-1569-01 TCGA-36-1569-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-36-1569 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-36-1569-F27855 TCGA-36-1569 TCGA-36-1569-01A Stage IIIC -19151 0 885 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.9 NO 1.6 YES G3 TCGA-36-1569.52192360-2ACE-401C-9642-B3D6F677362D.pdf 1569 Preoperative YES Partial Remission/Response NO Primary Tumor 01 0.4 36 1-10 mm Ovary A LIVING 2007 TCGA-36-1569-01 TCGA-36-1569-01 TCGA-36-1569-01A-01W-0615-10 3ae2deaa-bc6d-4b38-b9ea-56e91c83b53a TCGA-36-1569-01 TCGA-36-1569-01A-01W-0615-10 TCGA-36-1569-01A-01D-0536-05 TCGA-36-1569-01A-21-1558-20 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 TCGA-36-1569-01A-01D-0533-01 TCGA-36-1569-01 44783ce8-15cb-45b3-9a4f-e45925356334 TCGA-36-1569-01A-01D-0533-01 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 TCGA-36-1569-01 TCGA-36-1569-01 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 TCGA-36-1569-01A-01W-0615-10 TCGA-36-1569-01A-01R-0540-07 +TCGA-36-1570-01 TCGA-36-1570-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-36-1570 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-36-1570-F27857 TCGA-36-1570 TCGA-36-1570-01A Stage IIIC -17956 0 655 375 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.3 YES G3 Recurrence TCGA-36-1570.f83833f4-a820-4fb9-a040-c238084976c3.pdf 1570 Preoperative WITH TUMOR YES Partial Remission/Response Physical Examination NO Primary Tumor 01 0.7 36 >20 mm Ovary YES A LIVING 2007 TCGA-36-1570-01 TCGA-36-1570-01 TCGA-36-1570-01A-01W-0615-10 2893bba4-3d68-4a21-97d6-51342437a657 TCGA-36-1570-01 TCGA-36-1570-01A-01W-0615-10 TCGA-36-1570-01A-01D-0536-05 TCGA-36-1570-01A-21-1558-20 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 TCGA-36-1570-01A-01D-0533-01 TCGA-36-1570-01 0bd6d1dc-2f53-479b-bbaa-ef70250341a2 TCGA-36-1570-01A-01D-0533-01 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 TCGA-36-1570-01 TCGA-36-1570-01 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 TCGA-36-1570-01A-01W-0615-10 TCGA-36-1570-01A-01R-0540-07 +TCGA-36-1571-01 TCGA-36-1571-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-36-1571 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-36-1571-F27862 TCGA-36-1571 TCGA-36-1571-01A Stage IIIB -19608 695 0 695 375 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.3 NO G3 Recurrence TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481.pdf 1571 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.9 36 No Macroscopic disease Ovary NO A DECEASED 2007 TCGA-36-1571-01 TCGA-36-1571-01 TCGA-36-1571-01A-01W-0615-10 62f86b95-1bfe-4123-8f09-311c9c826de0 TCGA-36-1571-01 TCGA-36-1571-01A-01W-0615-10 TCGA-36-1571-01A-01D-0536-05 TCGA-36-1571-01A-21-1558-20 55c68aef-938c-4f68-a74d-f408673fff9c TCGA-36-1571-01A-01D-0533-01 TCGA-36-1571-01 8add1736-9ac5-4d0e-9969-7ea6ffaf635c TCGA-36-1571-01A-01D-0533-01 55c68aef-938c-4f68-a74d-f408673fff9c 55c68aef-938c-4f68-a74d-f408673fff9c TCGA-36-1571-01 TCGA-36-1571-01 55c68aef-938c-4f68-a74d-f408673fff9c TCGA-36-1571-01A-01W-0615-10 TCGA-36-1571-01A-01R-0540-07 +TCGA-36-1574-01 TCGA-36-1574-01 Squamous C9-OV Low purity c2 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-36-1574 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-36-1574-F27868 TCGA-36-1574 Stage IIIC -17847 0 686 648 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Recurrence 1574 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 36 >20 mm Ovary LIVING 2007 TCGA-36-1574-01 TCGA-36-1574-01 TCGA-36-1574-01A-01W-0615-10 d83bcf90-4a10-4318-ac80-4ae41ea88894 TCGA-36-1574-01 TCGA-36-1574-01A-01W-0615-10 TCGA-36-1574-01A-01D-0536-05 ff781a4f-7281-4195-880f-3df099a401cc TCGA-36-1574-01A-01D-0533-01 TCGA-36-1574-01 TCGA-36-1574-01A-01D-0533-01 ff781a4f-7281-4195-880f-3df099a401cc ff781a4f-7281-4195-880f-3df099a401cc TCGA-36-1574-01 TCGA-36-1574-01 ff781a4f-7281-4195-880f-3df099a401cc TCGA-36-1574-01A-01W-0615-10 TCGA-36-1574-01A-01R-0540-07 +TCGA-36-1575-01 TCGA-36-1575-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-36-1575 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 83 TCGA-36-1575-F27872 TCGA-36-1575 Stage IIIB -30592 0 260 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 1575 TUMOR FREE YES NO Primary Tumor 01 36 No Macroscopic disease Ovary NO LIVING 2006 TCGA-36-1575-01 TCGA-36-1575-01 TCGA-36-1575-01A-01W-0615-10 fb275fb0-6793-4401-99a0-5d3bdf2a7ac0 TCGA-36-1575-01 TCGA-36-1575-01A-01W-0615-10 TCGA-36-1575-01A-01D-0536-05 TCGA-36-1575-01A-21-1558-20 a28ef775-c78b-416f-afeb-89ba265440f0 TCGA-36-1575-01A-01D-0533-01 TCGA-36-1575-01 ba2a2d99-a0a6-4d8d-a207-d1a82501f18d TCGA-36-1575-01A-01D-0533-01 a28ef775-c78b-416f-afeb-89ba265440f0 a28ef775-c78b-416f-afeb-89ba265440f0 TCGA-36-1575-01 TCGA-36-1575-01 a28ef775-c78b-416f-afeb-89ba265440f0 TCGA-36-1575-01A-01W-0615-10 TCGA-36-1575-01A-01R-0540-07 +TCGA-36-1576-01 TCGA-36-1576-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-36-1576 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 TCGA-36-1576-F27874 TCGA-36-1576 TCGA-36-1576-01A Stage IIIC -27778 0 915 817 2 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 2.6 YES G3 Recurrence TCGA-36-1576.2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f.pdf 1576 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 36 >20 mm Ovary YES A LIVING 2006 TCGA-36-1576-01 TCGA-36-1576-01 TCGA-36-1576-01A-01W-0615-10 15528051-b343-4e7d-9433-b9fc052e7d77 TCGA-36-1576-01 TCGA-36-1576-01A-01W-0615-10 TCGA-36-1576-01A-01D-0536-05 TCGA-36-1576-01A-21-1558-20 55b6bd7c-e77d-4019-93e9-b5410e4807b2 TCGA-36-1576-01A-01D-0533-01 TCGA-36-1576-01 e1158086-b305-4b38-8ebe-43bd33c73952 TCGA-36-1576-01A-01D-0533-01 55b6bd7c-e77d-4019-93e9-b5410e4807b2 55b6bd7c-e77d-4019-93e9-b5410e4807b2 TCGA-36-1576-01 TCGA-36-1576-01 55b6bd7c-e77d-4019-93e9-b5410e4807b2 TCGA-36-1576-01A-01W-0615-10 TCGA-36-1576-01A-01R-0540-07 +TCGA-36-1577-01 TCGA-36-1577-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-36-1577 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 43 Bilateral TCGA-36-1577-F27878 TCGA-36-1577 TCGA-36-1577-01A Stage IIC -15804 0 783 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 1.7 G2 TCGA-36-1577.0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc.pdf 1577 TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 0.6 36 No Macroscopic disease Ovary A LIVING 2007 TCGA-36-1577-01 TCGA-36-1577-01 TCGA-36-1577-01A-01W-0615-10 ea44120c-4ba1-426a-a989-11ce1ca54e15 TCGA-36-1577-01 TCGA-36-1577-01A-01W-0615-10 TCGA-36-1577-01A-01D-0536-05 TCGA-36-1577-01A-21-1558-20 9ec93bbd-5c62-4974-984f-f86301f0d27e TCGA-36-1577-01A-01D-0533-01 TCGA-36-1577-01 ec733c30-ab8b-454e-88f9-8ee34bcf0416 TCGA-36-1577-01A-01D-0533-01 9ec93bbd-5c62-4974-984f-f86301f0d27e 9ec93bbd-5c62-4974-984f-f86301f0d27e TCGA-36-1577-01 TCGA-36-1577-01 9ec93bbd-5c62-4974-984f-f86301f0d27e TCGA-36-1577-01A-01W-0615-10 TCGA-36-1577-01A-01R-0540-07 +TCGA-36-1578-01 TCGA-36-1578-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-36-1578 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 TCGA-36-1578-F27884 TCGA-36-1578 TCGA-36-1578-01A Stage IV -23329 0 847 310 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 0.6 G3 Recurrence TCGA-36-1578.6BD44F43-7D75-4DF3-891D-7E08291F020C.pdf 1578 Preoperative WITH TUMOR YES Imaging Study NO Primary Tumor 01 0.5 36 >20 mm Ovary NO A LIVING 2007 TCGA-36-1578-01 TCGA-36-1578-01 TCGA-36-1578-01A-01W-0615-10 644de2b8-bb23-4161-b6dc-dbb926d573f0 TCGA-36-1578-01 TCGA-36-1578-01A-01W-0615-10 TCGA-36-1578-01A-01D-0536-05 TCGA-36-1578-01A-21-1558-20 7ecb58fe-e2fe-4dc8-996b-2b959da43566 TCGA-36-1578-01A-01D-0533-01 TCGA-36-1578-01 cb41005f-cf76-417e-9ce8-8b5d3047609c TCGA-36-1578-01A-01D-0533-01 7ecb58fe-e2fe-4dc8-996b-2b959da43566 7ecb58fe-e2fe-4dc8-996b-2b959da43566 TCGA-36-1578-01 TCGA-36-1578-01 7ecb58fe-e2fe-4dc8-996b-2b959da43566 TCGA-36-1578-01A-01W-0615-10 TCGA-36-1578-01A-01R-0540-07 +TCGA-36-1580-01 TCGA-36-1580-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-36-1580 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 82 TCGA-36-1580-F27889 TCGA-36-1580 TCGA-36-1580-01A Stage IIIC -29992 737 0 737 440 1 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1 NO 2 G3 Recurrence TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98.pdf 1580 Preoperative WITH TUMOR YES Physical Examination NO Primary Tumor 01 0.4 36 >20 mm Ovary A DECEASED 2007 TCGA-36-1580-01 TCGA-36-1580-01 TCGA-36-1580-01A-01W-0615-10 2b7461a0-84ad-4a91-b136-395c33f059fc TCGA-36-1580-01 TCGA-36-1580-01A-01W-0615-10 TCGA-36-1580-01A-01D-0536-05 TCGA-36-1580-01A-21-1558-20 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 TCGA-36-1580-01A-01D-0533-01 TCGA-36-1580-01 1d325272-4508-4a42-97ba-9e59edf59993 TCGA-36-1580-01A-01D-0533-01 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 TCGA-36-1580-01 TCGA-36-1580-01 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 TCGA-36-1580-01A-01W-0615-10 TCGA-36-1580-01A-01R-0540-07 +TCGA-36-1581-01 TCGA-36-1581-01 High C1-LUAD-enriched Cluster 5 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 6 TCGA-36-1581 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Left TCGA-36-1581-F27893 TCGA-36-1581 Stage IIC -23272 0 751 702 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 Recurrence 1581 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 36 No Macroscopic disease Ovary LIVING 2007 TCGA-36-1581-01 TCGA-36-1581-01 ba4c8ab9-f8ee-48ab-a513-ab43f71b8723 TCGA-36-1581-01 TCGA-36-1581-01A-01D-0536-05 TCGA-36-1581-01A-03-1563-20 d84c76a9-dbee-4720-8639-91382101b27a TCGA-36-1581-01A-01D-0533-01 TCGA-36-1581-01 c3ce568b-8558-45db-97b4-23882e482cbf TCGA-36-1581-01A-01D-0533-01 d84c76a9-dbee-4720-8639-91382101b27a d84c76a9-dbee-4720-8639-91382101b27a TCGA-36-1581-01 TCGA-36-1581-01 d84c76a9-dbee-4720-8639-91382101b27a TCGA-36-1581-01A-01R-0540-07 +TCGA-36-2529-01 TCGA-36-2529-01 High OV-like c1 OV-like c4 TCGA-36-2529 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-36-2529-F27897 TCGA-36-2529 Stage IIIC -26092 0 1066 567 0 2010-8-17 FEMALE Serous Cystadenocarcinoma No C48.2 8441/3 C48.2 YES Tumor resection G3 Recurrence 2529 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Physical Examination NO R1 Primary Tumor 01 36 >20 mm Peritoneum ovary LIVING 2007 d63b58d4-56b8-4879-b103-74cb3f92c242 TCGA-36-2529-01A-01D-1047-05 TCGA-36-2529-01A-21-1560-20 TCGA-36-2529-01A-01D-1043-01 TCGA-36-2529-01 a954f069-3088-49e6-839f-d823017cfa40 TCGA-36-2529-01A-01D-1043-01 TCGA-36-2529-01 TCGA-36-2529-01A-01R-1050-07 +TCGA-36-2530-01 TCGA-36-2530-01 Squamous OV-like c4 TCGA-36-2530 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-36-2530-F27906 TCGA-36-2530 Stage IIIC -13885 0 1004 630 2010-8-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NO G3 Recurrence 2530 WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 36 11-20 mm Ovary LIVING 2007 f4fa786b-3eaf-45ab-9d3e-4cf7ec61de3c TCGA-36-2530-01A-21-1560-20 TCGA-36-2530-01A-01D-1526-09 TCGA-36-2530-01A-01D-1043-01 TCGA-36-2530-01 ae583504-181e-4199-a79c-8fd11d3c99af TCGA-36-2530-01A-01D-1043-01 TCGA-36-2530-01 TCGA-36-2530-01A-01R-1050-07 +TCGA-36-2532-01 TCGA-36-2532-01 Squamous OV-like c1 OV-like c4 TCGA-36-2532 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 61 Bilateral TCGA-36-2532-F27913 TCGA-36-2532 TCGA-36-2532-01A Stage IIIC -22333 0 897 2010-8-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy 0.9 NO 2.7 YES G3 TCGA-36-2532.d99b756c-2a3c-48cd-844e-ce61f811c3a0.pdf 2532 WITH TUMOR YES NO R0 Primary Tumor 01 0.7 36 No Macroscopic disease Ovary YES A LIVING 2007 0830b9f6-0220-4c58-9c8b-58478ac2f49e TCGA-36-2532-01A-01D-1047-05 TCGA-36-2532-01A-21-1560-20 TCGA-36-2532-01A-01D-1526-09 TCGA-36-2532-01A-01D-1043-01 TCGA-36-2532-01 0ee5a901-a30a-493d-895a-6e674967a5eb TCGA-36-2532-01A-01D-1043-01 TCGA-36-2532-01 TCGA-36-2532-01A-01R-1050-07 +TCGA-36-2533-01 TCGA-36-2533-01 Squamous OV-like c1 OV-like c4 TCGA-36-2533 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Right TCGA-36-2533 TCGA-36-2533-01A Stage IIIC -20187 0 0 2010-9-14 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1 YES G3 TCGA-36-2533.ebe9dfc0-28ac-4d22-a18b-b910aa2814e0.pdf 2533 Primary Tumor 01 0.4 36 Ovary A 2007 06bf48f2-1c9a-42eb-bf68-505501a4c354 TCGA-36-2533-01A-01D-1047-05 TCGA-36-2533-01A-21-1560-20 TCGA-36-2533-01A-01D-1526-09 TCGA-36-2533-01A-01D-1043-01 TCGA-36-2533-01 6b83e35e-5d42-43db-a0cc-a5979af12af3 TCGA-36-2533-01A-01D-1043-01 TCGA-36-2533-01 TCGA-36-2533-01A-01R-1050-07 +TCGA-36-2534-01 TCGA-36-2534-01 Squamous OV-like c1 OV-like c4 TCGA-36-2534 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Right TCGA-36-2534-F27918 TCGA-36-2534 TCGA-36-2534-01A Stage IIIC -26621 0 907 383 1 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.5 G3 Progression of Disease TCGA-36-2534.b62a4922-ad09-4422-8cb2-bea80a0fe533.pdf 2534 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 36 >20 mm Ovary A LIVING 2007 39d1a308-db4f-4161-ad51-7cb9ccb4d059 TCGA-36-2534-01A-01D-1047-05 TCGA-36-2534-01A-21-1560-20 TCGA-36-2534-01A-01D-1526-09 TCGA-36-2534-01A-01D-1043-01 TCGA-36-2534-01 d32b063f-7dc4-4081-8ba5-301ea0f98089 TCGA-36-2534-01A-01D-1043-01 TCGA-36-2534-01 TCGA-36-2534-01A-01R-1050-07 +TCGA-36-2537-01 TCGA-36-2537-01 Squamous OV-like c1 OV-like c4 TCGA-36-2537 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 39 Bilateral TCGA-36-2537-F27923 TCGA-36-2537 TCGA-36-2537-01A Stage IIIC -14595 0 788 431 2 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.2 G3 Progression of Disease TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905.pdf 2537 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.8 36 >20 mm Ovary A LIVING 2008 74f16c9d-4f75-4307-a243-35a387eb20db TCGA-36-2537-01A-01D-1047-05 TCGA-36-2537-01A-21-1560-20 TCGA-36-2537-01A-01D-1526-09 TCGA-36-2537-01A-01D-1043-01 TCGA-36-2537-01 dab8df2a-7a8a-4735-9548-ebac64341b3a TCGA-36-2537-01A-01D-1043-01 TCGA-36-2537-01 TCGA-36-2537-01A-01R-1050-07 +TCGA-36-2538-01 TCGA-36-2538-01 Squamous OV-like c1 OV-like c4 TCGA-36-2538 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 37 Right TCGA-36-2538-F27930 TCGA-36-2538 TCGA-36-2538-01A Stage IIIB -13681 0 763 523 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.7 NO 1 NO G3 Recurrence TCGA-36-2538.e78dd67e-58f2-4b75-b3a5-1ca9ee6e01e5.pdf 2538 WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.3 36 11-20 mm Ovary NO A LIVING 2008 8e5e1961-d950-4ae8-9f07-1c5a10c82ad4 TCGA-36-2538-01A-01D-1047-05 TCGA-36-2538-01A-21-20 TCGA-36-2538-01A-01D-1526-09 TCGA-36-2538-01A-01D-1043-01 TCGA-36-2538-01 da67724e-5273-48f5-8545-56c9a944c0a8 TCGA-36-2538-01A-01D-1043-01 TCGA-36-2538-01 TCGA-36-2538-01A-01R-1050-07 +TCGA-36-2539-01 TCGA-36-2539-01 Squamous OV-like c1 OV-like c4 TCGA-36-2539 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-36-2539-01A 0.6 NO 1.3 TCGA-36-2539.c388f1d4-53dd-4e8b-bc68-ded38c816530.pdf Primary Tumor 01 0.4 A f335ca72-d387-445f-a46c-542b608b2646 TCGA-36-2539-01A-01D-1047-05 TCGA-36-2539-01A-21-20 TCGA-36-2539-01A-01D-1526-09 TCGA-36-2539-01A-01D-1043-01 22ebbb58-a3c5-4473-82e6-4c4e0a5995e5 TCGA-36-2539-01A-01D-1043-01 TCGA-36-2539-01A-01R-1050-07 +TCGA-36-2540-01 TCGA-36-2540-01 Kirc+ Low purity c2 OV-like c4 TCGA-36-2540 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 26 Bilateral TCGA-36-2540-F27936 TCGA-36-2540 TCGA-36-2540-01A Stage IIIC -9760 0 724 665 0 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.3 YES G1 Recurrence TCGA-36-2540.d66d4750-20f9-4e75-bdb7-b48de6dbc449.pdf 2540 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.2 36 >20 mm Ovary YES A LIVING 2008 75cee431-5541-49ea-a935-5e3b287f367b TCGA-36-2540-01A-01D-1047-05 TCGA-36-2540-01A-21-20 TCGA-36-2540-01A-01D-1526-09 TCGA-36-2540-01A-01D-1043-01 TCGA-36-2540-01 72b43e39-cb64-4610-b39e-02cc4b39c541 TCGA-36-2540-01A-01D-1043-01 TCGA-36-2540-01 TCGA-36-2540-01A-01R-1050-07 +TCGA-36-2542-01 TCGA-36-2542-01 Squamous OV-like c1 OV-like c4 TCGA-36-2542 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-36-2542-F27942 TCGA-36-2542 Stage IIIB -21902 0 657 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G3 2542 TUMOR FREE YES Complete Remission/Response NO R1 Primary Tumor 01 36 1-10 mm Ovary LIVING 2008 e4d9b54f-bf90-484f-9f85-06cd87712fd7 TCGA-36-2542-01A-01D-1047-05 TCGA-36-2542-01A-21-20 TCGA-36-2542-01A-01D-1526-09 TCGA-36-2542-01A-01D-1043-01 TCGA-36-2542-01 e58dd1a4-afb0-40c4-a0b2-aad520bcd0c9 TCGA-36-2542-01A-01D-1043-01 TCGA-36-2542-01 TCGA-36-2542-01A-01R-1050-07 +TCGA-36-2543-01 TCGA-36-2543-01 High OV-like c1 OV-like c4 TCGA-36-2543 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 85 Bilateral TCGA-36-2543-F27946 TCGA-36-2543 TCGA-36-2543-01A Stage IIIC -31211 68 0 68 27 3 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.5 NO 1.6 G3 Progression of Disease TCGA-36-2543.ec25ac8e-1a07-459b-a986-c78edfff88c0.pdf 2543 Other WITH TUMOR NO Progressive Disease NO R1 Primary Tumor 01 0.4 36 >20 mm Ovary A DECEASED 2008 c25023f6-f376-41b0-8346-3f898a11fd1f TCGA-36-2543-01A-01D-1047-05 TCGA-36-2543-01A-21-20 TCGA-36-2543-01A-01D-1526-09 TCGA-36-2543-01A-01D-1043-01 TCGA-36-2543-01 2146a3b5-3eb9-47be-9143-3a5de8c4a0d5 TCGA-36-2543-01A-01D-1043-01 TCGA-36-2543-01 TCGA-36-2543-01A-01R-1050-07 +TCGA-36-2544-01 TCGA-36-2544-01 Squamous OV-like c1 OV-like c4 TCGA-36-2544 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-36-2544-F27948 TCGA-36-2544 TCGA-36-2544-01A Stage IIIC -21384 0 638 325 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 2.3 G3 Progression of Disease TCGA-36-2544.87f69148-d6fb-4b70-8404-c24b106b6195.pdf 2544 WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.7 36 >20 mm Ovary A LIVING 2008 7f53f5f6-c900-4ebb-87d8-9e1edcbe1de5 TCGA-36-2544-01A-01D-1047-05 TCGA-36-2544-01A-21-20 TCGA-36-2544-01A-01D-1526-09 TCGA-36-2544-01A-01D-1043-01 TCGA-36-2544-01 5ef7b46e-b379-4137-a5ab-91c9d6de74a3 TCGA-36-2544-01A-01D-1043-01 TCGA-36-2544-01 TCGA-36-2544-01A-01R-1050-07 +TCGA-36-2545-01 TCGA-36-2545-01 Squamous OV-like c1 OV-like c4 TCGA-36-2545 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 42 Bilateral TCGA-36-2545-F27954 TCGA-36-2545 TCGA-36-2545-01A Stage IIIA -15444 0 557 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 2 G3 TCGA-36-2545.e8e6f050-7372-41f3-b198-72ddb241fb08.pdf 2545 TUMOR FREE YES NO R0 Primary Tumor 01 0.8 36 No Macroscopic disease Ovary A LIVING 2008 625f1165-c70d-4a7f-be3b-ff55aca5ca12 TCGA-36-2545-01A-01D-1047-05 TCGA-36-2545-01A-21-20 TCGA-36-2545-01A-01D-1526-09 TCGA-36-2545-01A-01D-1043-01 TCGA-36-2545-01 ecfb4f91-8c7a-465b-86f0-054855f71fe5 TCGA-36-2545-01A-01D-1043-01 TCGA-36-2545-01 TCGA-36-2545-01A-01R-1050-07 +TCGA-36-2547-01 TCGA-36-2547-01 High OV-like c1 OV-like c4 TCGA-36-2547 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Left TCGA-36-2547-F27958 TCGA-36-2547 TCGA-36-2547-01A Stage IIIC -23706 0 624 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.7 G3 TCGA-36-2547.f615f400-96c3-42f3-bee9-c273b1a16b63.pdf 2547 YES NO R0 Primary Tumor 01 0.7 36 No Macroscopic disease Ovary A LIVING 2008 40ca7354-e907-4a61-853e-c1d66651f9a3 TCGA-36-2547-01A-01D-1047-05 TCGA-36-2547-01A-21-20 TCGA-36-2547-01A-01D-1526-09 TCGA-36-2547-01A-01D-1043-01 TCGA-36-2547-01 48b9af43-88a1-46c9-b6c7-ec1d1ac9e5f9 TCGA-36-2547-01A-01D-1043-01 TCGA-36-2547-01 TCGA-36-2547-01A-01R-1050-07 +TCGA-36-2548-01 TCGA-36-2548-01 High OV-like c1 OV-like c4 TCGA-36-2548 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Right TCGA-36-2548-F27962 TCGA-36-2548 TCGA-36-2548-01A Stage IIIC -20897 0 431 395 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Other method, specify: 0.7 NO 1.3 G3 Recurrence TCGA-36-2548.68bf291c-3320-46f9-8e5f-7de81f0c6964.pdf 2548 WITH TUMOR YES Imaging Study NO R1 Primary Tumor 01 0.7 36 >20 mm Ovary A LIVING 2008 abe78829-2661-4c6e-ba83-03e06963d9aa TCGA-36-2548-01A-01D-1047-05 TCGA-36-2548-01A-21-20 TCGA-36-2548-01A-01D-1526-09 TCGA-36-2548-01A-01D-1043-01 TCGA-36-2548-01 4794aace-89fb-4e9e-b117-3234ef1fc792 TCGA-36-2548-01A-01D-1043-01 TCGA-36-2548-01 TCGA-36-2548-01A-01R-1050-07 +TCGA-36-2549-01 TCGA-36-2549-01 BRCA-LUAD+ OV-like c1 OV-like c4 TCGA-36-2549 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 54 Bilateral TCGA-36-2549-F27966 TCGA-36-2549 TCGA-36-2549-01A Stage IIC -20076 0 184 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.4 G3 TCGA-36-2549.42b18428-81f6-48d0-8a5f-fd08926128b1.pdf 2549 TUMOR FREE YES NO R0 Primary Tumor 01 0.6 36 No Macroscopic disease Ovary A LIVING 2008 3dac49f4-f485-4050-93d1-cbc22eef91d9 TCGA-36-2549-01A-01D-1047-05 TCGA-36-2549-01A-21-20 TCGA-36-2549-01A-01D-1043-01 TCGA-36-2549-01 0b81fd60-103b-484a-a954-839f7941bf98 TCGA-36-2549-01A-01D-1043-01 TCGA-36-2549-01 TCGA-36-2549-01A-01R-1050-07 +TCGA-36-2551-01 TCGA-36-2551-01 High OV-like c1 OV-like c4 TCGA-36-2551 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-36-2551-F27970 TCGA-36-2551 TCGA-36-2551-01A Stage IIIC -21045 0 492 338 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.7 NO 1 NO G3 Recurrence TCGA-36-2551.c3e022a3-b58d-437b-a990-691730e9daf1.pdf 2551 WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.3 36 >20 mm Ovary A LIVING 2009 543cc9e3-5fb6-4229-aedb-a55273230b98 TCGA-36-2551-01A-01D-1047-05 TCGA-36-2551-01A-21-20 TCGA-36-2551-01A-01D-1526-09 TCGA-36-2551-01A-01D-1043-01 TCGA-36-2551-01 ceb02af7-9228-4bfa-812b-f1d88482c383 TCGA-36-2551-01A-01D-1043-01 TCGA-36-2551-01 TCGA-36-2551-01A-01R-1050-07 +TCGA-36-2552-01 TCGA-36-2552-01 High OV-like c1 OV-like c4 TCGA-36-2552 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 64 Bilateral TCGA-36-2552-F27976 TCGA-36-2552 TCGA-36-2552-01A Stage IIC -23379 0 349 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.3 G3 TCGA-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf 2552 TUMOR FREE YES NO R0 Primary Tumor 01 0.8 36 No Macroscopic disease Ovary A LIVING 2009 4f0b1c4b-e033-4679-a32a-9bf80ff6d42d TCGA-36-2552-01A-01D-1047-05 TCGA-36-2552-01A-21-20 TCGA-36-2552-01A-01D-1526-09 TCGA-36-2552-01A-01D-1043-01 TCGA-36-2552-01 984b6351-1d3e-4ef1-99c4-d99895a3a49b TCGA-36-2552-01A-01D-1043-01 TCGA-36-2552-01 TCGA-36-2552-01A-01R-1050-07 +TCGA-3P-A9WA-01 TCGA-3P-A9WA-01 TCGA-3P-A9WA TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Left TCGA-3P-A9WA-F67273 TCGA-3P-A9WA TCGA-3P-A9WA-01A Stage IIB -20211 126 0 420 Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 FEMALE Serous Cystadenocarcinoma No C56.9 8440/3 C56.9 YES Other method, specify: 660 NO 100 NO G3 NO false Yes, History of Synchronous/Bilateral Malignancy TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16.pdf A9WA Pre-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO RX Primary Tumor 01 YES NO 3P Ovary A LIVING 2013 TCGA-3P-A9WA-01 TCGA-3P-A9WA-01 TCGA-3P-A9WA-01A-11D-A409-05 TCGA-3P-A9WA-01 94e91d8c-244a-48cf-af09-9412659e6759 TCGA-3P-A9WA-01A-11D-A402-01 7C867DDB-C776-4764-8E77-F2CE4D474116 TCGA-3P-A9WA-01A-11R-A406-31 TCGA-3P-A9WA-01A-11D-A402-01 94e91d8c-244a-48cf-af09-9412659e6759 TCGA-3P-A9WA-01A-11R-A406-31 94e91d8c-244a-48cf-af09-9412659e6759 TCGA-3P-A9WA-01 94e91d8c-244a-48cf-af09-9412659e6759 +TCGA-42-2582-01 TCGA-42-2582-01 High OV-like c1 OV-like c4 TCGA-42-2582 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 49 Bilateral TCGA-42-2582-F34657 TCGA-42-2582 TCGA-42-2582-01A Stage IIIC -17961 1447 0 435 1179 1 Additional New Tumor Event Progressive Disease 2013-3-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.3 NO YES G3 Progression of Disease YES TCGA-42-2582.04201F3C-F4FF-4F85-8C14-F1D754DAFDD6.pdf 2582 WITH TUMOR YES Stable Disease Imaging Study NO R0 Primary Tumor 01 0.2 42 No Macroscopic disease Ovary A DECEASED 2009 7f63006e-7016-483d-9a09-7d535a342d3a TCGA-42-2582-01A-01D-1047-05 TCGA-42-2582-01A-21-20 TCGA-42-2582-01A-01D-1526-09 TCGA-42-2582-01A-01D-1043-01 TCGA-42-2582-01 61f8ad02-1fe9-48ca-b317-c573aba61c08 TCGA-42-2582-01A-01D-1043-01 TCGA-42-2582-01 TCGA-42-2582-01A-01R-1231-07 +TCGA-42-2587-01 TCGA-42-2587-01 Squamous OV-like c1 OV-like c4 TCGA-42-2587 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 75 Bilateral TCGA-42-2587-F28795 TCGA-42-2587 TCGA-42-2587-01A Stage IIIC -27510 0 722 2011-8-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.4 YES G3 TCGA-42-2587.dc4896ef-1797-4796-8869-e9f5d19456d2.pdf 2587 TUMOR FREE YES Complete Remission/Response NO R1 Primary Tumor 01 0.6 42 >20 mm Ovary YES A LIVING 2009 e8013ca8-18e0-42ee-aa94-b7171902da03 TCGA-42-2587-01A-01D-1047-05 TCGA-42-2587-01A-21-1563-20 TCGA-42-2587-01A-01D-1526-09 TCGA-42-2587-01A-01D-1043-01 TCGA-42-2587-01 934207be-d750-48bc-a51a-c6740d415d56 TCGA-42-2587-01A-01D-1043-01 TCGA-42-2587-01 TCGA-42-2587-01A-01R-1050-07 +TCGA-42-2588-01 TCGA-42-2588-01 High OV-like c1 OV-like c4 TCGA-42-2588 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-42-2588-F28821 TCGA-42-2588 Stage IV -22377 880 0 287 267 2 2012-1-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) YES G3 Progression of Disease 2588 Preoperative WITH TUMOR YES Progressive Disease NO R2 Primary Tumor 01 42 >20 mm Ovary DECEASED 2009 fd52301b-6882-4868-95e8-501ec794f7a8 TCGA-42-2588-01A-01D-1047-05 TCGA-42-2588-01A-21-20 TCGA-42-2588-01A-01D-1526-09 TCGA-42-2588-01A-01D-1043-01 TCGA-42-2588-01 ba162045-6055-466e-bf4d-ff04006919db TCGA-42-2588-01A-01D-1043-01 TCGA-42-2588-01 TCGA-42-2588-01A-01R-1050-07 +TCGA-42-2589-01 TCGA-42-2589-01 High OV-like c1 OV-like c4 TCGA-42-2589 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 54 Bilateral TCGA-42-2589-F41366 TCGA-42-2589 TCGA-42-2589-01A Stage IIIC -19852 0 1278 1274 Additional New Tumor Event Progressive Disease 2013-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy 1 NO 1 NO YES G3 YES TCGA-42-2589.07cceb21-4aca-4343-965e-81960a40cff2.pdf 2589 WITH TUMOR YES Complete Remission/Response NO R0 Primary Tumor 01 0.5 42 1-10 mm Ovary A LIVING 2009 9add86b7-a9d7-41ea-8536-41a204c97ae1 TCGA-42-2589-01A-01D-1047-05 TCGA-42-2589-01A-21-20 TCGA-42-2589-01A-01D-1526-09 TCGA-42-2589-01A-01D-1043-01 TCGA-42-2589-01 77d0cab8-5a58-4fed-ac41-68dff4f946cd TCGA-42-2589-01A-01D-1043-01 TCGA-42-2589-01 TCGA-42-2589-01A-01R-1050-07 +TCGA-42-2590-01 TCGA-42-2590-01 High OV-like c1 OV-like c4 TCGA-42-2590 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-42-2590-F28809 TCGA-42-2590 TCGA-42-2590-01A Stage IV -20965 317 0 227 226 1 2011-5-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 2.2 G2 Progression of Disease TCGA-42-2590.9c7c0209-b1d6-4174-b57e-e8bcd3e5d766.pdf 2590 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO R1 Primary Tumor 01 0.4 42 >20 mm Ovary A DECEASED 2009 919946b9-3135-45fd-9fdd-b2d40c8bc3ba TCGA-42-2590-01A-01D-1047-05 TCGA-42-2590-01A-21-20 TCGA-42-2590-01A-01D-1526-09 TCGA-42-2590-01A-01D-1043-01 TCGA-42-2590-01 043ea617-6eec-43ae-a45c-b5cffacc7695 TCGA-42-2590-01A-01D-1043-01 TCGA-42-2590-01 TCGA-42-2590-01A-01R-1050-07 +TCGA-42-2591-01 TCGA-42-2591-01 Squamous OV-like c1 OV-like c4 TCGA-42-2591 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-42-2591-F41420 TCGA-42-2591 TCGA-42-2591-01A Stage IIIC -18654 0 1240 Scheduled Follow-up Submission Complete Remission/Response 2013-3-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.5 NO YES GX NO TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097.pdf 2591 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.6 42 No Macroscopic disease Ovary A LIVING 2009 5c6e2798-32a6-4fb9-b246-c6267f7dfc51 TCGA-42-2591-01A-01D-1047-05 TCGA-42-2591-01A-21-20 TCGA-42-2591-01A-01D-1526-09 TCGA-42-2591-01A-01D-1043-01 TCGA-42-2591-01 0a1bb74b-fa00-4320-b966-ea146e76c9fa TCGA-42-2591-01A-01D-1043-01 TCGA-42-2591-01 TCGA-42-2591-01A-01R-1050-07 +TCGA-42-2593-01 TCGA-42-2593-01 High OV-like c1 OV-like c4 TCGA-42-2593 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 67 Bilateral TCGA-42-2593-F39341 TCGA-42-2593 TCGA-42-2593-01A Stage IIIC -24823 45 0 4 Scheduled Follow-up Submission 2013-1-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.9 NO YES G3 NO TCGA-42-2593.302c2898-9b19-494b-86a5-f0ff3cab7163.pdf 2593 Other WITH TUMOR NO NO R2 Primary Tumor 01 0.4 YES NO 42 >20 mm Ovary YES A DECEASED 2009 f5e8a865-c4eb-4043-9a8f-7979d3fe6532 TCGA-42-2593-01A-01D-1047-05 TCGA-42-2593-01A-21-20 TCGA-42-2593-01A-01D-1043-01 8ae9695c-082b-4011-b078-f55aa285fa11 TCGA-42-2593-01A-01D-1043-01 TCGA-42-2593-01A-01R-1050-07 +TCGA-57-1582-01 TCGA-57-1582-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-57-1582 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Left TCGA-57-1582-F28059 TCGA-57-1582 TCGA-57-1582-01A Stage IIIC 731 0 731 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 2 YES G3 TCGA-57-1582.0ed35510-c6ad-416b-8b57-e97005471dc1.pdf 1582 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.6 57 1-10 mm Ovary YES A DECEASED 2006 TCGA-57-1582-01 TCGA-57-1582-01 TCGA-57-1582-01A-01W-0615-10 18e8fac4-913e-4c0f-bb6e-3d19b58518cc TCGA-57-1582-01 TCGA-57-1582-01A-01W-0615-10 TCGA-57-1582-01A-01D-0536-05 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 TCGA-57-1582-01A-01D-0533-01 TCGA-57-1582-01 TCGA-57-1582-01A-01D-0533-01 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 TCGA-57-1582-01 TCGA-57-1582-01 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 TCGA-57-1582-01A-01W-0615-10 TCGA-57-1582-01A-01R-0540-07 +TCGA-57-1583-01 TCGA-57-1583-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-57-1583 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Left TCGA-57-1583-F28068 TCGA-57-1583 TCGA-57-1583-01A Stage IIIC -21167 346 0 346 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 NO G3 TCGA-57-1583.b899b485-621f-46df-8bda-97b0fbe10b6d.pdf 1583 WITH TUMOR YES NO Primary Tumor 01 0.4 57 No Macroscopic disease Ovary NO A DECEASED 2006 TCGA-57-1583-01 TCGA-57-1583-01 TCGA-57-1583-01A-01W-0615-10 bb6bfbc9-0379-4f74-8720-186fa0a165b9 TCGA-57-1583-01 TCGA-57-1583-01A-01W-0615-10 TCGA-57-1583-01A-01D-0536-05 3a37e320-0301-4f2b-bf09-f102c12502b1 TCGA-57-1583-01A-01D-0533-01 TCGA-57-1583-01 TCGA-57-1583-01A-01D-0533-01 3a37e320-0301-4f2b-bf09-f102c12502b1 3a37e320-0301-4f2b-bf09-f102c12502b1 TCGA-57-1583-01 TCGA-57-1583-01 3a37e320-0301-4f2b-bf09-f102c12502b1 TCGA-57-1583-01A-01W-0615-10 TCGA-57-1583-01A-01R-0540-07 +TCGA-57-1584-01 TCGA-57-1584-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 3 TCGA-57-1584 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-57-1584-F28072 TCGA-57-1584 Stage IIIC -17263 0 643 530 0 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1584 Pre-Adjuvant Therapy WITH TUMOR NO Imaging Study NO Primary Tumor 01 57 1-10 mm Ovary YES LIVING 2007 TCGA-57-1584-01 TCGA-57-1584-01 TCGA-57-1584-01A-01W-0615-10 e10d4b1f-cba8-4e34-af2e-331949b18dba TCGA-57-1584-01 TCGA-57-1584-01A-01W-0615-10 TCGA-57-1584-01A-01D-0536-05 e92b95df-bacb-4083-b2de-78e540ec0e68 TCGA-57-1584-01A-01D-0533-01 TCGA-57-1584-01 TCGA-57-1584-01A-01D-0533-01 e92b95df-bacb-4083-b2de-78e540ec0e68 e92b95df-bacb-4083-b2de-78e540ec0e68 TCGA-57-1584-01 TCGA-57-1584-01 e92b95df-bacb-4083-b2de-78e540ec0e68 TCGA-57-1584-01A-01W-0615-10 TCGA-57-1584-01A-01R-0540-07 +TCGA-57-1585-01 TCGA-57-1585-01 Squamous OV-like c1 miRNA cluster 3 cluster 6 TCGA-57-1585 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Bilateral TCGA-57-1585-F28076 TCGA-57-1585 TCGA-57-1585-01A Stage IIIC -20862 53 0 53 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 0.8 YES G3 TCGA-57-1585.2c748aca-e5b2-4418-9820-1343293d379f.pdf 1585 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.3 57 11-20 mm Ovary YES A DECEASED 2007 TCGA-57-1585-01 TCGA-57-1585-01 9485c5c9-3fa8-48a3-bb75-a152f1547ae3 TCGA-57-1585-01 TCGA-57-1585-01A-01D-0536-05 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 TCGA-57-1585-01A-01D-0533-01 TCGA-57-1585-01 TCGA-57-1585-01A-01D-0533-01 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 TCGA-57-1585-01 TCGA-57-1585-01 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 TCGA-57-1585-01A-01R-0540-07 +TCGA-57-1586-01 TCGA-57-1586-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-57-1586 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-57-1586-F28080 TCGA-57-1586 Stage IIIC -24304 0 679 259 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Recurrence 1586 WITH TUMOR YES Molecular Markers NO Primary Tumor 01 57 11-20 mm Ovary YES LIVING 2007 TCGA-57-1586-01 ec771953-9297-4d7d-aa29-531499b3e2eb TCGA-57-1586-01 TCGA-57-1586-01A-02D-0563-05 TCGA-57-1586-01A-03-1563-20 TCGA-57-1586-01A-02W-0633-09 TCGA-57-1586-01A-02D-0559-01 TCGA-57-1586-01 a93a15b9-aef1-403b-85c4-1d5203e6d9dc TCGA-57-1586-01A-02D-0559-01 TCGA-57-1586-01 TCGA-57-1586-01A-02R-0566-07 +TCGA-57-1992-01 TCGA-57-1992-01 High OV-like c1 TCGA-57-1992 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Left TCGA-57-1992-F28090 TCGA-57-1992 TCGA-57-1992-01A Stage IC 0 882 2009-12-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.3 YES G3 TCGA-57-1992.77c742d8-bb0b-4ea9-9f61-9606c78c438e.pdf 1992 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 57 No Macroscopic disease Ovary YES A LIVING 2006 6fcb27b1-5f0d-4c30-b9a4-205f60bc880b TCGA-57-1992-01A-01D-0652-05 TCGA-57-1992-01A-01D-0648-01 TCGA-57-1992-01 TCGA-57-1992-01A-01D-0648-01 TCGA-57-1992-01 TCGA-57-1992-01A-01R-0655-07 +TCGA-57-1993-01 TCGA-57-1993-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-57-1993 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 Bilateral TCGA-57-1993-F28092 TCGA-57-1993 TCGA-57-1993-01A Stage IIIC -20498 0 763 2010-1-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.5 YES G3 TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea.pdf 1993 TUMOR FREE YES NO R0 Primary Tumor 01 0.5 57 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-57-1993-01 TCGA-57-1993-01 f8c91078-d156-4ee9-96c9-7ec6937c40b3 TCGA-57-1993-01 TCGA-57-1993-01A-01D-0652-05 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01D-0648-01 TCGA-57-1993-01 TCGA-57-1993-01A-01D-0648-01 55f9061c-54e7-465c-af61-21d8bc8ecbe0 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01W-0699-08 TCGA-57-1993-01 TCGA-57-1993-01 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01W-0699-08 TCGA-57-1993-01A-01R-0655-07 +TCGA-57-1994-01 TCGA-57-1994-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 TCGA-57-1994 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 TCGA-57-1994-F28096 TCGA-57-1994 TCGA-57-1994-01A -23062 0 761 2011-6-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.5 TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb.pdf 1994 NO NO Primary Tumor 01 0.4 57 Ovary A LIVING 2004 TCGA-57-1994-01 TCGA-57-1994-01 24fbfb49-2a8c-40af-b607-577cc3001b2d TCGA-57-1994-01 TCGA-57-1994-01A-01D-0652-05 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 TCGA-57-1994-01A-01D-0648-01 TCGA-57-1994-01 TCGA-57-1994-01A-01D-0648-01 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 TCGA-57-1994-01 TCGA-57-1994-01 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 TCGA-57-1994-01A-01R-0655-07 +TCGA-59-2348-01 TCGA-59-2348-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2348 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 59 Bilateral TCGA-59-2348-F28098 TCGA-59-2348 TCGA-59-2348-01A Stage IIIC 0 5481 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 2 G3 TCGA-59-2348.ffb300e9-cb06-4162-a751-f079fec57153.pdf 2348 TUMOR FREE Complete Remission/Response Primary Tumor 01 0.4 59 Ovary A LIVING 1994 TCGA-59-2348-01 TCGA-59-2348-01 139d2d19-f3e9-46fc-bd88-b57709af9ec5 TCGA-59-2348-01 TCGA-59-2348-01A-01D-0708-05 TCGA-59-2348-01A-21-1560-20 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01D-0704-01 TCGA-59-2348-01 c37d3098-f79e-4ce7-9ed5-884d82725dff TCGA-59-2348-01A-01D-0704-01 7162d809-ff1a-4346-bb00-c8086386ec46 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01W-0799-08 TCGA-59-2348-01 TCGA-59-2348-01 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01W-0799-08 TCGA-59-2348-01A-01R-0711-07 +TCGA-59-2349-01 TCGA-59-2349-01 Kirc+ Cluster 5 BRCA basal-like c6 TCGA-59-2349 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Left TCGA-59-2349-F28100 TCGA-59-2349 TCGA-59-2349-01A Stage IA 2437 0 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.3 G3 TCGA-59-2349.a56064eb-651a-4a7d-b32c-5c890821e338.pdf 2349 Complete Remission/Response Primary Tumor 01 0.3 NO YES 59 No Macroscopic disease Ovary A DECEASED 1994 7557f686-ae87-4ab8-b7df-b1f1b0850e51 TCGA-59-2349-01A-01D-0708-05 TCGA-59-2349-01A-21-1560-20 TCGA-59-2349-01A-01D-0704-01 TCGA-59-2349-01 96c57593-695a-4b64-997b-b465ed28917c TCGA-59-2349-01A-01D-0704-01 TCGA-59-2349-01 TCGA-59-2349-01A-01R-0711-07 +TCGA-59-2350-01 TCGA-59-2350-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-59-2350 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 44 Bilateral TCGA-59-2350-F28102 TCGA-59-2350 Stage IV 679 0 211 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection G3 Progression of Disease 2350 WITH TUMOR Partial Remission/Response Primary Tumor 01 NO YES 59 1-10 mm Ovary DECEASED 1995 TCGA-59-2350-01 TCGA-59-2350-01 e5b094fc-335d-4a9e-9ead-d0bda9695e33 TCGA-59-2350-01 TCGA-59-2350-01A-01D-0708-05 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01D-0704-01 TCGA-59-2350-01 TCGA-59-2350-01A-01D-0704-01 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01W-0799-08 TCGA-59-2350-01 TCGA-59-2350-01 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01W-0799-08 TCGA-59-2350-01A-01R-0711-07 +TCGA-59-2351-01 TCGA-59-2351-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-59-2351 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-59-2351-F28104 TCGA-59-2351 TCGA-59-2351-01A Stage IIIC 0 3532 2139 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 2 G3 Progression of Disease TCGA-59-2351.6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad.pdf 2351 TUMOR FREE Complete Remission/Response Imaging Study Primary Tumor 01 0.4 NO YES 59 1-10 mm Ovary A LIVING 1999 TCGA-59-2351-01 TCGA-59-2351-01 2c72e167-d9b6-47e2-ae10-3183a6d13e7a TCGA-59-2351-01 TCGA-59-2351-01A-01D-0708-05 TCGA-59-2351-01A-21-1560-20 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01D-0704-01 TCGA-59-2351-01 2cdeaf4d-f2c6-44fd-872e-965ef80e505b TCGA-59-2351-01A-01D-0704-01 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01W-0799-08 TCGA-59-2351-01 TCGA-59-2351-01 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01W-0799-08 TCGA-59-2351-01A-01R-0711-07 +TCGA-59-2352-01 TCGA-59-2352-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-59-2352 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Right TCGA-59-2352 TCGA-59-2352-01A Stage IIIC 286 0 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.2 NO 2 G3 TCGA-59-2352.15f65643-b84c-4239-bc14-0ddacdfe0425.pdf 2352 WITH TUMOR Primary Tumor 01 0.4 NO YES 59 Ovary A DECEASED 2002 TCGA-59-2352-01 TCGA-59-2352-01 87ec1cd8-27d3-4cde-a59b-58c82ab8cbbe TCGA-59-2352-01 TCGA-59-2352-01A-01D-0708-05 TCGA-59-2352-01A-21-1560-20 a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01D-0704-01 TCGA-59-2352-01 d9066d98-0039-4956-9e7e-9931b8c28379 TCGA-59-2352-01A-01D-0704-01 a209a8f4-9462-4ade-be57-caaec54999cb a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01W-0799-08 TCGA-59-2352-01 TCGA-59-2352-01 a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01W-0799-08 TCGA-59-2352-01A-01R-0711-07 +TCGA-59-2354-01 TCGA-59-2354-01 Squamous C9-OV OV-like c1 OV-like c4 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2354 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Left TCGA-59-2354-F28107 TCGA-59-2354 TCGA-59-2354-01A Stage IIIC 1046 0 462 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 2.4 YES G3 Progression of Disease TCGA-59-2354.cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc.pdf 2354 WITH TUMOR YES Stable Disease Imaging Study Primary Tumor 01 0.3 59 1-10 mm Ovary A DECEASED 2005 TCGA-59-2354-01 TCGA-59-2354-01 e0e3aedf-ace3-4525-83c2-887b517837c0 TCGA-59-2354-01 TCGA-59-2354-01A-01D-0708-05 TCGA-59-2354-01A-21-1560-20 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01D-0704-01 TCGA-59-2354-01 d80db939-9815-4d8b-8d3d-927a54355003 TCGA-59-2354-01A-01D-0704-01 33367eb6-4ca9-4daf-9e47-30a47a78e144 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01W-0799-08 TCGA-59-2354-01 TCGA-59-2354-01 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01W-0799-08 TCGA-59-2354-01A-01R-0711-07 +TCGA-59-2355-01 TCGA-59-2355-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-59-2355 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 58 Right TCGA-59-2355-F28111 TCGA-59-2355 TCGA-59-2355-01A Stage IV 65 0 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.6 YES G3 TCGA-59-2355.322bedf6-e6b5-4275-a186-0075a2ec271e.pdf 2355 WITH TUMOR YES Primary Tumor 01 0.2 59 >20 mm Ovary A DECEASED 2006 TCGA-59-2355-01 TCGA-59-2355-01 9c18086a-f203-48f5-af4c-d756fe1b266b TCGA-59-2355-01 TCGA-59-2355-01A-01D-0708-05 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01D-0704-01 TCGA-59-2355-01 TCGA-59-2355-01A-01D-0704-01 866c7355-e2ec-4816-953f-7bf791033283 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01W-0799-08 TCGA-59-2355-01 TCGA-59-2355-01 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01W-0799-08 TCGA-59-2355-01A-01R-0711-07 +TCGA-59-2363-01 TCGA-59-2363-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2363 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 40 Bilateral TCGA-59-2363-F28115 TCGA-59-2363 TCGA-59-2363-01A Stage IIIA 0 165 2010-2-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 NO G3 TCGA-59-2363.9b047485-eb2b-4fc1-a22a-d96046b63bf2.pdf 2363 TUMOR FREE YES Complete Remission/Response NO R0 Primary Tumor 01 0.4 59 No Macroscopic disease Ovary NO A LIVING 2007 TCGA-59-2363-01 TCGA-59-2363-01 0ef0c1bf-9885-4be9-85b1-ed400a1a940f TCGA-59-2363-01 TCGA-59-2363-01A-01D-0708-05 TCGA-59-2363-01A-21-1560-20 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01D-0704-01 TCGA-59-2363-01 abdc5a45-9e20-4c0e-b854-9a2ec535245a TCGA-59-2363-01A-01D-0704-01 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01W-0799-08 TCGA-59-2363-01 TCGA-59-2363-01 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01W-0799-08 TCGA-59-2363-01A-01R-0711-07 +TCGA-59-2372-01 TCGA-59-2372-01 High OV-like c1 OV-like c4 TCGA-59-2372 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 73 Bilateral TCGA-59-2372-F28119 TCGA-59-2372 TCGA-59-2372-01A Stage IIIC 1363 0 2010-2-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 NO G2 TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09.pdf 2372 YES NO R0 Primary Tumor 01 0.5 59 No Macroscopic disease Ovary NO A DECEASED 2005 b368a37f-fa86-47ae-9a1c-d1038f19a663 TCGA-59-2372-01A-01D-1047-05 TCGA-59-2372-01A-21-1560-20 TCGA-59-2372-01A-01D-1526-09 TCGA-59-2372-01A-01D-1043-01 TCGA-59-2372-01 7d66df01-e224-4584-8c36-f54735a2fc53 TCGA-59-2372-01A-01D-1043-01 TCGA-59-2372-01 TCGA-59-2372-01A-01R-1050-07 +TCGA-59-A5PD-01 TCGA-59-A5PD-01 TCGA-59-A5PD TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Right TCGA-59-A5PD TCGA-59-A5PD-01A Stage IC -20263 730 624 0 0 2013-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 130 NO 100 YES G3 YES false Yes, History of Synchronous/Bilateral Malignancy TCGA-59-A5PD.9A3CB382-654F-4DFD-BF41-7615710D2825.pdf A5PD Preoperative WITH TUMOR NO Complete Remission/Response NO Primary Tumor 01 NO YES 59 Ovary YES A DECEASED 2011 TCGA-59-A5PD-01 TCGA-59-A5PD-01 TCGA-59-A5PD-01A-11D-A409-05 TCGA-59-A5PD-01 356a00a0-d19a-498c-8ed7-20ce89cd21eb TCGA-59-A5PD-01A-11D-A402-01 8E787AAF-9659-4F93-97F9-CD58BD1FEC1D TCGA-59-A5PD-01A-11R-A406-31 TCGA-59-A5PD-01A-11D-A402-01 356a00a0-d19a-498c-8ed7-20ce89cd21eb TCGA-59-A5PD-01A-11R-A406-31 356a00a0-d19a-498c-8ed7-20ce89cd21eb TCGA-59-A5PD-01 356a00a0-d19a-498c-8ed7-20ce89cd21eb +TCGA-5X-AA5U-01 TCGA-5X-AA5U-01 TCGA-5X-AA5U TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 61 Right TCGA-5X-AA5U-F69358 TCGA-5X-AA5U TCGA-5X-AA5U-01A Stage IIC -22438 11 0 361 0 Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Tumor resection 230 NO 100 NO NO GX NO true Yes, History of Synchronous/Bilateral Malignancy TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE.pdf AA5U Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NO R0 Primary Tumor 01 YES NO 5X Ovary NO A LIVING 2013 TCGA-5X-AA5U-01 TCGA-5X-AA5U-01 TCGA-5X-AA5U-01A-11D-A409-05 TCGA-5X-AA5U-01 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 TCGA-5X-AA5U-01A-11D-A402-01 3372257B-B9F7-42AF-8EC4-AC69618A0A35 TCGA-5X-AA5U-01A-11R-A406-31 TCGA-5X-AA5U-01A-11D-A402-01 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 TCGA-5X-AA5U-01A-11R-A406-31 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 TCGA-5X-AA5U-01 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 +TCGA-61-1721-01 TCGA-61-1721-01 Quiet C5-KIRC Low purity c2 OV-like c4 GBM-like c6 miRNA cluster 3 cluster 6 TCGA-61-1721 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 38 Bilateral TCGA-61-1721-F28123 TCGA-61-1721 TCGA-61-1721-01A Stage IV -13894 0 338 2009-6-2 FEMALE Serous Cystadenocarcinoma Yes C56.9 8441/3 C56.9 YES Excisional Biopsy 0.9 NO 1 YES G1 TCGA-61-1721.f44d906c-f069-45e6-9cc4-49eb0da74226.pdf 1721 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 61 Ovary YES A LIVING 2008 TCGA-61-1721-01 TCGA-61-1721-01 13cc06b1-0e57-4cfe-bfe1-b6ec96321199 TCGA-61-1721-01 TCGA-61-1721-01A-01D-0652-05 TCGA-61-1721-01A-21-1559-20 226f9774-e22b-4b8b-8259-934edb649fc3 TCGA-61-1721-01A-01D-0648-01 TCGA-61-1721-01 0479fc63-879d-4b50-b014-20d276a2d13d TCGA-61-1721-01A-01D-0648-01 226f9774-e22b-4b8b-8259-934edb649fc3 226f9774-e22b-4b8b-8259-934edb649fc3 TCGA-61-1721-01 TCGA-61-1721-01 226f9774-e22b-4b8b-8259-934edb649fc3 TCGA-61-1721-01A-01R-0655-07 +TCGA-61-1722-01 TCGA-61-1722-01 High OV-like c1 OV-like c4 TCGA-61-1722 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 89 Bilateral TCGA-61-1722-F28129 TCGA-61-1722 TCGA-61-1722-01A Stage IB -32853 0 246 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc.pdf 1722 WITH TUMOR NO Stable Disease NO Primary Tumor 01 0.2 61 No Macroscopic disease Ovary NO A LIVING 2008 79b7ffda-716b-4253-a580-4b1372a8f152 TCGA-61-1722-01A-01D-0581-05 TCGA-61-1722-01A-21-1559-20 TCGA-61-1722-01A-01D-1556-09 TCGA-61-1722-01A-01D-0577-01 TCGA-61-1722-01 b17eace3-8ff6-4e2c-abd1-81f67343d8d1 TCGA-61-1722-01A-01D-0577-01 TCGA-61-1722-01 TCGA-61-1722-01A-01R-0584-07 +TCGA-61-1724-01 TCGA-61-1724-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 5 TCGA-61-1724 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-61-1724-F28135 TCGA-61-1724 Stage IIIC -17168 637 0 637 187 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G3 Locoregional Disease YES 1724 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 61 No Macroscopic disease Ovary YES DECEASED 2007 TCGA-61-1724-01 TCGA-61-1724-01 af7c2e4b-c7c1-46d1-854e-c75365f3c967 TCGA-61-1724-01 TCGA-61-1724-01A-01D-0652-05 TCGA-61-1724-01A-21-1559-20 faab5b85-3c69-4c64-bba0-a8d5404939a2 TCGA-61-1724-01A-01D-0648-01 TCGA-61-1724-01 eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd TCGA-61-1724-01A-01D-0648-01 faab5b85-3c69-4c64-bba0-a8d5404939a2 faab5b85-3c69-4c64-bba0-a8d5404939a2 TCGA-61-1724-01 TCGA-61-1724-01 faab5b85-3c69-4c64-bba0-a8d5404939a2 TCGA-61-1724-01A-01R-0655-07 +TCGA-61-1725-01 TCGA-61-1725-01 Squamous OV-like c1 OV-like c16 miRNA cluster 1 cluster 2 TCGA-61-1725 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-1725-F28143 TCGA-61-1725 TCGA-61-1725-01A Stage IIIC -14782 0 956 844 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1 YES G3 Recurrence TCGA-61-1725.8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04.pdf 1725 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 0.4 61 11-20 mm Ovary YES A LIVING 2007 TCGA-61-1725-01 TCGA-61-1725-01 be16e66f-a839-44c7-b700-4a95d366435f TCGA-61-1725-01 TCGA-61-1725-01A-01D-0581-05 TCGA-61-1725-01A-01W-0639-09 748ff969-cb49-4f22-994f-6debe734c38f TCGA-61-1725-01A-01D-0577-01 TCGA-61-1725-01 TCGA-61-1725-01A-01D-0577-01 748ff969-cb49-4f22-994f-6debe734c38f 748ff969-cb49-4f22-994f-6debe734c38f TCGA-61-1725-01 TCGA-61-1725-01 748ff969-cb49-4f22-994f-6debe734c38f TCGA-61-1725-01A-01R-0584-07 +TCGA-61-1727-01 TCGA-61-1727-01 Squamous OV-like c1 OV-like c4 TCGA-61-1727 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Right TCGA-61-1727-F28152 TCGA-61-1727 TCGA-61-1727-01A Stage IC -27203 0 564 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.1 G3 TCGA-61-1727.f8e2cbf2-911a-48a7-ad80-c23124af44fe.pdf 1727 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary NO A LIVING 2007 ea305cbb-1171-49bd-be79-debefe08023f TCGA-61-1727-01A-01D-0581-05 TCGA-61-1727-01A-21-1559-20 TCGA-61-1727-01A-01W-0639-09 TCGA-61-1727-01A-01D-0577-01 TCGA-61-1727-01 3d14831f-1ab6-43e9-bd15-0c6e930304e8 TCGA-61-1727-01A-01D-0577-01 TCGA-61-1727-01 TCGA-61-1727-01A-01R-0584-07 +TCGA-61-1728-01 TCGA-61-1728-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-1728 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-61-1728-F28156 TCGA-61-1728 TCGA-61-1728-01A Stage IV -21582 0 848 533 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.1 NO G3 Recurrence TCGA-61-1728.7611c4d4-f58b-404e-93f1-949c865c9e12.pdf 1728 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.2 61 1-10 mm Ovary NO A LIVING 2007 TCGA-61-1728-01 TCGA-61-1728-01 54635249-84d5-466b-b956-e125a7113132 TCGA-61-1728-01 TCGA-61-1728-01A-01D-0652-05 bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01D-0648-01 TCGA-61-1728-01 TCGA-61-1728-01A-01D-0648-01 bf909020-d6a1-49f1-8007-4192d39abd04 bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01W-0699-08 TCGA-61-1728-01 TCGA-61-1728-01 bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01W-0699-08 TCGA-61-1728-01A-01R-0655-07 +TCGA-61-1730-01 TCGA-61-1730-01 High OV-like c1 OV-like c4 TCGA-61-1730 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Left TCGA-61-1730-F28161 TCGA-61-1730 TCGA-61-1730-01A Stage IC -28508 132 0 132 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.2 NO G3 TCGA-61-1730.4624968a-27c1-4f4f-b9f1-3e6997c15a21.pdf 1730 WITH TUMOR NO NO Primary Tumor 01 0.4 61 1-10 mm Ovary NO A DECEASED 2007 59246787-027e-4aea-8a7e-04521b0f96a6 TCGA-61-1730-01A-01D-0581-05 TCGA-61-1730-01A-21-1559-20 TCGA-61-1730-01A-01W-0639-09 TCGA-61-1730-01A-01D-0577-01 TCGA-61-1730-01 1a49f3dd-f92d-4206-bce7-05a2ff6df71e TCGA-61-1730-01A-01D-0577-01 TCGA-61-1730-01 TCGA-61-1730-01A-01R-0584-07 +TCGA-61-1733-01 TCGA-61-1733-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-61-1733 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-61-1733-F28163 TCGA-61-1733 TCGA-61-1733-01A Stage IIIC -26180 0 967 175 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 YES G3 Recurrence TCGA-61-1733.bc4e6e92-d716-4ab3-8459-4f339caecffd.pdf 1733 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.2 61 No Macroscopic disease Ovary YES A LIVING 2006 TCGA-61-1733-01 TCGA-61-1733-01 dd206c0f-dd03-40ee-ad76-e6b3bf84ffc8 TCGA-61-1733-01 TCGA-61-1733-01A-01D-0581-05 TCGA-61-1733-01A-21-1559-20 TCGA-61-1733-01A-01W-0639-09 e6f856bf-0694-4c21-aecc-0d8dd54761f1 TCGA-61-1733-01A-01D-0577-01 TCGA-61-1733-01 1b2390f5-f59e-4c94-8586-35b620e0dc4d TCGA-61-1733-01A-01D-0577-01 e6f856bf-0694-4c21-aecc-0d8dd54761f1 e6f856bf-0694-4c21-aecc-0d8dd54761f1 TCGA-61-1733-01 TCGA-61-1733-01 e6f856bf-0694-4c21-aecc-0d8dd54761f1 TCGA-61-1733-01A-01R-0584-07 +TCGA-61-1734-01 TCGA-61-1734-01 Squamous OV-like c1 OV-like c4 TCGA-61-1734 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-61-1734-F28171 TCGA-61-1734 TCGA-61-1734-01B Stage IC -19026 0 866 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 YES G3 TCGA-61-1734.32d02aa2-1c81-417b-87a8-a5ed4035f5c0.pdf 1734 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 61 Ovary YES B LIVING 2006 b3b6480c-a96b-44c5-9590-e0659b2fc9ad TCGA-61-1734-01B-01D-0667-05 TCGA-61-1734-01B-21-1559-20 TCGA-61-1734-01B-01D-0663-01 TCGA-61-1734-01 8d84c559-ee21-4b79-a879-99d3bc6a624e TCGA-61-1734-01B-01D-0663-01 TCGA-61-1734-01 TCGA-61-1734-01B-01R-0670-07 +TCGA-61-1736-01 TCGA-61-1736-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-1736 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-61-1736-F28175 TCGA-61-1736 TCGA-61-1736-01B Stage IIIC -16613 1484 0 1484 764 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy 0.8 NO 1 YES G3 Recurrence TCGA-61-1736.c034e484-683b-463c-999d-eb1fd9741292.pdf 1736 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 Ovary YES B DECEASED 2005 TCGA-61-1736-01 TCGA-61-1736-01 4f3d65e1-2001-48dc-bded-b8dd0a949c2c TCGA-61-1736-01 TCGA-61-1736-01B-01D-0667-05 TCGA-61-1736-01B-21-1559-20 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01D-0663-01 TCGA-61-1736-01 de7da1bd-3d13-495a-a931-5ae952aa5ea3 TCGA-61-1736-01B-01D-0663-01 89f1ae39-c387-4dff-be38-e3b7265222bb 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01W-0722-08 TCGA-61-1736-01 TCGA-61-1736-01 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01W-0722-08 TCGA-61-1736-01B-01R-0670-07 +TCGA-61-1737-01 TCGA-61-1737-01 High OV-like c1 miRNA cluster 1 cluster 5 TCGA-61-1737 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 42 Bilateral TCGA-61-1737-F28182 TCGA-61-1737 TCGA-61-1737-01A Stage IV -15515 0 1364 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.3 NO 0.7 YES G3 TCGA-61-1737.2fa09bf8-8be5-411c-a9cf-16c12ed1390f.pdf 1737 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.2 61 1-10 mm Ovary YES A LIVING 2005 TCGA-61-1737-01 TCGA-61-1737-01 478e4825-4983-4315-aeda-12145a87f92b TCGA-61-1737-01 TCGA-61-1737-01A-01D-0581-05 TCGA-61-1737-01A-01W-0639-09 b442230a-d330-45da-adf7-76873d18645c TCGA-61-1737-01A-01D-0577-01 TCGA-61-1737-01 TCGA-61-1737-01A-01D-0577-01 b442230a-d330-45da-adf7-76873d18645c b442230a-d330-45da-adf7-76873d18645c TCGA-61-1737-01 TCGA-61-1737-01 b442230a-d330-45da-adf7-76873d18645c TCGA-61-1737-01A-01R-0584-07 +TCGA-61-1738-01 TCGA-61-1738-01 High C9-OV UCEC Serous c4 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 5 TCGA-61-1738 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Right TCGA-61-1738-F28190 TCGA-61-1738 TCGA-61-1738-01A Stage IIIC -21965 1089 0 1089 276 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.2 YES G3 Recurrence TCGA-61-1738.05898c76-9832-4724-ada5-ff47eb3838b5.pdf 1738 WITH TUMOR YES Progressive Disease Imaging Study NO Primary Tumor 01 0.2 61 1-10 mm Ovary YES A DECEASED 2005 TCGA-61-1738-01 TCGA-61-1738-01 4c4af8bd-a614-4875-bdb5-4e8c64c4d134 TCGA-61-1738-01 TCGA-61-1738-01A-01D-0581-05 TCGA-61-1738-01A-21-1559-20 TCGA-61-1738-01A-01W-0639-09 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 TCGA-61-1738-01A-01D-0577-01 TCGA-61-1738-01 3fed489e-8243-43c5-8ca2-37979d540d22 TCGA-61-1738-01A-01D-0577-01 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 TCGA-61-1738-01 TCGA-61-1738-01 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 TCGA-61-1738-01A-01R-0584-07 +TCGA-61-1740-01 TCGA-61-1740-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 TCGA-61-1740 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Right TCGA-61-1740-F28198 TCGA-61-1740 TCGA-61-1740-01A Stage IIIC -26169 74 0 74 3 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.6 YES G3 TCGA-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf 1740 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.3 61 >20 mm Ovary YES A DECEASED 2005 TCGA-61-1740-01 TCGA-61-1740-01 7e650317-6bd3-4ad9-b4ad-47178983707c TCGA-61-1740-01 TCGA-61-1740-01A-01D-0581-05 TCGA-61-1740-01A-21-1559-20 TCGA-61-1740-01A-01W-0639-09 e7825482-380d-4323-a4fb-d11b365c7073 TCGA-61-1740-01A-01D-0577-01 TCGA-61-1740-01 3349b819-24fe-404f-a480-0e94ed56a1cd TCGA-61-1740-01A-01D-0577-01 e7825482-380d-4323-a4fb-d11b365c7073 e7825482-380d-4323-a4fb-d11b365c7073 TCGA-61-1740-01 TCGA-61-1740-01 e7825482-380d-4323-a4fb-d11b365c7073 TCGA-61-1740-01A-01R-0584-07 +TCGA-61-1741-01 TCGA-61-1741-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 TCGA-61-1741 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-61-1741-F28201 TCGA-61-1741 TCGA-61-1741-01A Stage IIIB -27762 1024 0 1024 488 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G3 Recurrence TCGA-61-1741.e2d0ec41-559c-48d4-8c4d-59e0f9d48823.pdf 1741 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 >20 mm Ovary NO A DECEASED 2004 TCGA-61-1741-01 TCGA-61-1741-01 fba783f9-28fc-41c2-b82a-1fcc55d19941 TCGA-61-1741-01 TCGA-61-1741-01A-02D-0581-05 TCGA-61-1741-01A-11-1563-20 TCGA-61-1741-01A-02W-0639-09 92d5764e-c576-47cd-a6bd-68ed0365c213 TCGA-61-1741-01A-02D-0577-01 TCGA-61-1741-01 4da87c92-0d8f-4475-b5c8-332329e3d7b2 TCGA-61-1741-01A-02D-0577-01 92d5764e-c576-47cd-a6bd-68ed0365c213 92d5764e-c576-47cd-a6bd-68ed0365c213 TCGA-61-1741-01 TCGA-61-1741-01 92d5764e-c576-47cd-a6bd-68ed0365c213 TCGA-61-1741-01A-02R-0584-07 +TCGA-61-1743-01 TCGA-61-1743-01 High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 1 TCGA-61-1743 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NO 53 Bilateral TCGA-61-1743-F28209 TCGA-61-1743 TCGA-61-1743-01A Stage IIC -19365 1329 0 1329 809 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G2 Recurrence TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1.pdf 1743 WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 0.3 61 No Macroscopic disease Ovary A DECEASED 2004 TCGA-61-1743-01 TCGA-61-1743-01 5e99b999-2c02-4a1b-97b6-176afa3edfb3 TCGA-61-1743-01 TCGA-61-1743-01A-01D-0652-05 TCGA-61-1743-01A-21-1559-20 f3277084-b0a8-43df-946e-dc792bbb8cdb TCGA-61-1743-01A-01D-0648-01 TCGA-61-1743-01 a6fffcf6-69f4-4c40-b183-a0345dacff1a TCGA-61-1743-01A-01D-0648-01 f3277084-b0a8-43df-946e-dc792bbb8cdb f3277084-b0a8-43df-946e-dc792bbb8cdb TCGA-61-1743-01 TCGA-61-1743-01 f3277084-b0a8-43df-946e-dc792bbb8cdb TCGA-61-1743-01A-01R-0655-07 +TCGA-61-1895-01 TCGA-61-1895-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-61-1895 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 52 Bilateral TCGA-61-1895-F28213 TCGA-61-1895 TCGA-61-1895-01A Stage IIIB -19060 0 44 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.1 YES G3 TCGA-61-1895.b33d3a26-d864-4669-b06e-1335be4e9e3a.pdf 1895 TUMOR FREE YES Stable Disease NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary YES A LIVING 2009 TCGA-61-1895-01 7ca1db65-98e8-471a-81d5-063d6c3c3a0c TCGA-61-1895-01 TCGA-61-1895-01A-01D-0581-05 TCGA-61-1895-01A-21-1559-20 TCGA-61-1895-01A-01W-0639-09 TCGA-61-1895-01A-01D-0577-01 TCGA-61-1895-01 9525c377-b25f-422f-8da7-60319fc43d79 TCGA-61-1895-01A-01D-0577-01 TCGA-61-1895-01 TCGA-61-1895-01A-01R-0584-07 +TCGA-61-1899-01 TCGA-61-1899-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-61-1899 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 81 Left TCGA-61-1899-F28217 TCGA-61-1899 TCGA-61-1899-01A Stage IIIC -29692 0 256 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 G3 TCGA-61-1899.0b416e24-55c4-4235-b56b-9dc1507ee5ef.pdf 1899 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary NO A LIVING 2008 TCGA-61-1899-01 06aa647b-fe58-4a63-976b-9bd171297b87 TCGA-61-1899-01 TCGA-61-1899-01A-01D-0581-05 TCGA-61-1899-01A-21-1559-20 TCGA-61-1899-01A-01W-0639-09 TCGA-61-1899-01A-01D-0577-01 TCGA-61-1899-01 fdb5929a-eedd-48b3-9938-5d08ac8ba4fc TCGA-61-1899-01A-01D-0577-01 TCGA-61-1899-01 TCGA-61-1899-01A-01R-0584-07 +TCGA-61-1900-01 TCGA-61-1900-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-61-1900 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-61-1900-F28221 TCGA-61-1900 TCGA-61-1900-01A Stage IIIB -18963 0 176 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.9 NO 1.5 NO G3 TCGA-61-1900.b0dd202d-16dc-42ec-ad83-6f02b37b919f.pdf 1900 TUMOR FREE YES Stable Disease NO Primary Tumor 01 0.6 61 No Macroscopic disease Ovary NO A LIVING 2008 TCGA-61-1900-01 TCGA-61-1900-01 c5d1eb0e-d7a4-49e1-9a07-1abe99e33881 TCGA-61-1900-01 TCGA-61-1900-01A-01D-0581-05 TCGA-61-1900-01A-21-1559-20 TCGA-61-1900-01A-01W-0639-09 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 TCGA-61-1900-01A-01D-0577-01 TCGA-61-1900-01 c3a92cba-410a-4853-8bae-4bec74b693d7 TCGA-61-1900-01A-01D-0577-01 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 TCGA-61-1900-01 TCGA-61-1900-01 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 TCGA-61-1900-01A-01R-0584-07 +TCGA-61-1901-01 TCGA-61-1901-01 Squamous OV-like c1 miRNA cluster 1 cluster 6 TCGA-61-1901 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 65 Bilateral TCGA-61-1901-F28226 TCGA-61-1901 Stage IV -24042 347 0 347 329 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) YES G3 Progression of Disease 1901 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 61 Ovary YES DECEASED 2008 TCGA-61-1901-01 e34c17f8-b6a2-4c24-bba7-d9548a0cca89 TCGA-61-1901-01 TCGA-61-1901-01A-01D-0581-05 TCGA-61-1901-01A-01W-0639-09 TCGA-61-1901-01A-01D-0577-01 TCGA-61-1901-01 TCGA-61-1901-01A-01D-0577-01 TCGA-61-1901-01 TCGA-61-1901-01A-01R-0584-07 +TCGA-61-1903-01 TCGA-61-1903-01 High OV-like c1 OV-like c4 TCGA-61-1903 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Bilateral TCGA-61-1903-F28231 TCGA-61-1903 TCGA-61-1903-01A Stage IB -20381 0 396 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 NO G3 TCGA-61-1903.879ac4e3-cb0d-4fcb-a51d-8cbc6ad0c4a0.pdf 1903 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 Ovary NO A LIVING 2007 9bcc6171-29ca-40b3-880a-2e3e95a95f94 TCGA-61-1903-01A-01D-0581-05 TCGA-61-1903-01A-21-1559-20 TCGA-61-1903-01A-01W-0639-09 TCGA-61-1903-01A-01D-0577-01 TCGA-61-1903-01 57c3b3e8-b200-43e1-9f63-f7e0f872ca8c TCGA-61-1903-01A-01D-0577-01 TCGA-61-1903-01 TCGA-61-1903-01A-01R-0584-07 +TCGA-61-1904-01 TCGA-61-1904-01 High OV-like c1 TCGA-61-1904 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-61-1904-F28236 TCGA-61-1904 Stage IIIC -22009 0 276 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 1904 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 61 1-10 mm Ovary NO LIVING 2007 ac3f73b4-4953-4836-8834-43729c647ac3 TCGA-61-1904-01A-01D-0581-05 TCGA-61-1904-01A-01W-0639-09 TCGA-61-1904-01A-01D-0577-01 TCGA-61-1904-01 TCGA-61-1904-01A-01D-0577-01 TCGA-61-1904-01 TCGA-61-1904-01A-01R-0584-07 +TCGA-61-1906-01 TCGA-61-1906-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 TCGA-61-1906 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-61-1906-F28240 TCGA-61-1906 TCGA-61-1906-01A Stage IIIC -20378 1038 0 1038 236 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 YES G3 Recurrence TCGA-61-1906.a540b6e3-4a34-4546-a91a-a6bcd09921bd.pdf 1906 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 61 11-20 mm Ovary YES A DECEASED 2006 TCGA-61-1906-01 9e164e07-0887-4e9d-8e54-92e2b9621257 TCGA-61-1906-01 TCGA-61-1906-01A-01D-0581-05 TCGA-61-1906-01A-21-1559-20 TCGA-61-1906-01A-01W-0639-09 TCGA-61-1906-01A-01D-0577-01 TCGA-61-1906-01 f3b04ec3-bd80-437b-be87-aa7b75249821 TCGA-61-1906-01A-01D-0577-01 TCGA-61-1906-01 TCGA-61-1906-01A-01R-0584-07 +TCGA-61-1907-01 TCGA-61-1907-01 Squamous C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 4 TCGA-61-1907 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-61-1907-F28250 TCGA-61-1907 TCGA-61-1907-01A Stage IIIC -23204 0 952 743 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.9 NO 1.6 G3 Recurrence TCGA-61-1907.ae7e4795-496e-47d0-ad60-cec04e5876b0.pdf 1907 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.4 61 11-20 mm Ovary YES A LIVING 2006 TCGA-61-1907-01 TCGA-61-1907-01 429e7e1a-3ded-46a3-9eee-aa048cbfade2 TCGA-61-1907-01 TCGA-61-1907-01A-01D-0581-05 TCGA-61-1907-01A-21-1559-20 TCGA-61-1907-01A-01W-0639-09 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed TCGA-61-1907-01A-01D-0577-01 TCGA-61-1907-01 2356261e-fe60-47da-9f8e-c06bfe510a03 TCGA-61-1907-01A-01D-0577-01 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed TCGA-61-1907-01 TCGA-61-1907-01 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed TCGA-61-1907-01A-01R-0584-07 +TCGA-61-1910-01 TCGA-61-1910-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 TCGA-61-1910 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 56 Bilateral TCGA-61-1910-F28256 TCGA-61-1910 TCGA-61-1910-01A Stage IIC -20779 0 1127 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.5 YES G3 TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40.pdf 1910 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 1-10 mm Ovary YES A LIVING 2006 TCGA-61-1910-01 TCGA-61-1910-01 e61d1b4c-7a8a-431c-bef5-1be42deda0c1 TCGA-61-1910-01 TCGA-61-1910-01A-01D-0581-05 TCGA-61-1910-01A-21-1559-20 TCGA-61-1910-01A-01W-0639-09 65e4e40b-f27f-4b84-9979-af659564363d TCGA-61-1910-01A-01D-0577-01 TCGA-61-1910-01 18b958a6-f51e-4fb3-a240-cfe22c05d967 TCGA-61-1910-01A-01D-0577-01 65e4e40b-f27f-4b84-9979-af659564363d 65e4e40b-f27f-4b84-9979-af659564363d TCGA-61-1910-01 TCGA-61-1910-01 65e4e40b-f27f-4b84-9979-af659564363d TCGA-61-1910-01A-01R-0584-07 +TCGA-61-1911-01 TCGA-61-1911-01 High OV-like c1 OV-like c4 miRNA cluster 1 cluster 2 TCGA-61-1911 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Left TCGA-61-1911-F28260 TCGA-61-1911 TCGA-61-1911-01A Stage IIA -20144 0 1293 844 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 2 YES G3 Recurrence TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8.pdf 1911 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 Ovary YES A LIVING 2005 TCGA-61-1911-01 70685d12-f206-43bd-bc6d-1954ffa1b600 TCGA-61-1911-01 TCGA-61-1911-01A-01D-0581-05 TCGA-61-1911-01A-21-1559-20 TCGA-61-1911-01A-01W-0639-09 TCGA-61-1911-01A-01D-0577-01 TCGA-61-1911-01 18959b13-60ff-43b5-8f53-acee023d775a TCGA-61-1911-01A-01D-0577-01 TCGA-61-1911-01 TCGA-61-1911-01A-01R-0584-07 +TCGA-61-1913-01 TCGA-61-1913-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-61-1913 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Right TCGA-61-1913-F28269 TCGA-61-1913 TCGA-61-1913-01A Stage IIIB -17575 0 1488 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.1 G3 TCGA-61-1913.b789ee6d-d1e2-4836-8bdc-3c59b0729ee1.pdf 1913 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 61 1-10 mm Ovary YES A LIVING 2005 TCGA-61-1913-01 7b569b43-ae4c-4611-8852-1e8213c1d7ae TCGA-61-1913-01 TCGA-61-1913-01A-01D-0581-05 TCGA-61-1913-01A-21-1559-20 TCGA-61-1913-01A-01W-0639-09 TCGA-61-1913-01A-01D-0577-01 TCGA-61-1913-01 a97ee569-979a-4d19-bf30-61dd734ed78d TCGA-61-1913-01A-01D-0577-01 TCGA-61-1913-01 TCGA-61-1913-01A-01R-0584-07 +TCGA-61-1914-01 TCGA-61-1914-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 TCGA-61-1914 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-61-1914-F28273 TCGA-61-1914 TCGA-61-1914-01A Stage IIIC -23850 0 1722 1674 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 YES G3 Recurrence TCGA-61-1914.b634b2cf-9e8d-4dd4-8442-337c22522a43.pdf 1914 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 >20 mm Ovary YES A LIVING 2003 TCGA-61-1914-01 TCGA-61-1914-01 32a0bd09-8cc4-46e6-a36d-67478fab51fc TCGA-61-1914-01 TCGA-61-1914-01A-01D-0581-05 TCGA-61-1914-01A-21-1559-20 TCGA-61-1914-01A-01W-0639-09 0d75483f-eab3-41c8-b2cc-453af29b6f44 TCGA-61-1914-01A-01D-0577-01 TCGA-61-1914-01 7497a274-7ee4-423f-a0bd-59afb02a305e TCGA-61-1914-01A-01D-0577-01 0d75483f-eab3-41c8-b2cc-453af29b6f44 0d75483f-eab3-41c8-b2cc-453af29b6f44 TCGA-61-1914-01 TCGA-61-1914-01 0d75483f-eab3-41c8-b2cc-453af29b6f44 TCGA-61-1914-01A-01R-0584-07 +TCGA-61-1915-01 TCGA-61-1915-01 Squamous OV-like c1 OV-like c4 miRNA cluster 1 cluster 4 TCGA-61-1915 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 50 Bilateral TCGA-61-1915-F28280 TCGA-61-1915 TCGA-61-1915-01A Stage IIC -18424 0 2061 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1 G3 TCGA-61-1915.1c305700-d86f-449a-a556-02f32484dda1.pdf 1915 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 Ovary YES A LIVING 2003 TCGA-61-1915-01 4c9b5377-7e2c-4a97-9663-3ff18822053c TCGA-61-1915-01 TCGA-61-1915-01A-01D-0581-05 TCGA-61-1915-01A-21-1559-20 TCGA-61-1915-01A-01W-0639-09 TCGA-61-1915-01A-01D-0577-01 TCGA-61-1915-01 407fd5a4-3e13-42c6-9f10-424562adfee5 TCGA-61-1915-01A-01D-0577-01 TCGA-61-1915-01 TCGA-61-1915-01A-01R-0584-07 +TCGA-61-1916-01 TCGA-61-1916-01 Quiet OV-like c1 OV-like c4 TCGA-61-1916 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 53 Bilateral TCGA-61-1916-F28284 TCGA-61-1916 Stage IIIC -19463 475 0 475 326 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) G2 Recurrence 1916 YES NO R1 Primary Tumor 01 61 1-10 mm Ovary YES DECEASED 2002 aab4f5cd-7169-41e6-ae24-2bddbd752f62 TCGA-61-1916-01A-01D-0807-05 TCGA-61-1916-01A-21-1559-20 TCGA-61-1916-01 e7b8ce5d-a28b-44c9-8b3a-d52882fce319 TCGA-61-1916-01A-01R-0810-07 +TCGA-61-1916-02 TCGA-61-1916-02 OV-like c1 TCGA-61-1916 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 53 Bilateral TCGA-61-1916-F28284 TCGA-61-1916 TCGA-61-1916-02A Stage IIIC -19463 475 0 475 326 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.3 NO 1.8 G2 Recurrence TCGA-61-1916.C85D2BF7-498B-4E17-9F13-899AC8D6EC88.pdf 1916 YES NO R1 Recurrent Tumor 02 0.3 61 1-10 mm Ovary YES A DECEASED 2002 6490d8bc-620c-45d2-9314-97ec1b52e4d0 TCGA-61-1916-02A-01D-0807-05 TCGA-61-1916-02A-01R-0810-07 +TCGA-61-1917-01 TCGA-61-1917-01 High OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 TCGA-61-1917 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 60 Bilateral TCGA-61-1917-F28290 TCGA-61-1917 TCGA-61-1917-01A Stage IIIB -21972 1321 0 1321 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 2 G3 TCGA-61-1917.ebb81051-f181-4878-85ac-7e00ad6aca85.pdf 1917 YES Complete Remission/Response NO Primary Tumor 01 0.1 61 Ovary NO A DECEASED 2002 TCGA-61-1917-01 TCGA-61-1917-01 5005b439-42ac-4dc7-aa13-3817d6091536 TCGA-61-1917-01 TCGA-61-1917-01A-01D-0652-05 519aea8b-5e08-47b2-bb98-b311f2dba540 TCGA-61-1917-01A-01D-0648-01 TCGA-61-1917-01 TCGA-61-1917-01A-01D-0648-01 519aea8b-5e08-47b2-bb98-b311f2dba540 519aea8b-5e08-47b2-bb98-b311f2dba540 TCGA-61-1917-01 TCGA-61-1917-01 519aea8b-5e08-47b2-bb98-b311f2dba540 TCGA-61-1917-01A-01R-0655-07 +TCGA-61-1918-01 TCGA-61-1918-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 TCGA-61-1918 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-61-1918-F28295 TCGA-61-1918 TCGA-61-1918-01A Stage IV -16689 479 0 479 413 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1 G3 Recurrence TCGA-61-1918.6c95bd12-e871-4e4e-961f-09a64c1fe2de.pdf 1918 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary YES A DECEASED 2002 TCGA-61-1918-01 TCGA-61-1918-01 5f2955fc-dc80-4ce8-93d6-6db708af6ea4 TCGA-61-1918-01 TCGA-61-1918-01A-01D-0652-05 TCGA-61-1918-01A-21-1559-20 62f75d97-ea9e-4694-8c83-1a0e6d137a02 TCGA-61-1918-01A-01D-0648-01 TCGA-61-1918-01 8c7cf533-1039-4e1a-9a0a-83c8d8c2e597 TCGA-61-1918-01A-01D-0648-01 62f75d97-ea9e-4694-8c83-1a0e6d137a02 62f75d97-ea9e-4694-8c83-1a0e6d137a02 TCGA-61-1918-01 TCGA-61-1918-01 62f75d97-ea9e-4694-8c83-1a0e6d137a02 TCGA-61-1918-01A-01R-0655-07 +TCGA-61-1919-01 TCGA-61-1919-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-1919 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-61-1919-F28300 TCGA-61-1919 TCGA-61-1919-01A Stage IIIC -21199 1161 0 1161 439 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.5 G2 Recurrence TCGA-61-1919.240a49a3-b611-4949-b3b9-3799d8c0dc46.pdf 1919 YES Complete Remission/Response NO Primary Tumor 01 0.4 61 Ovary A DECEASED 2001 TCGA-61-1919-01 TCGA-61-1919-01 e2935fb6-7c83-4691-b144-029cd17eadac TCGA-61-1919-01 TCGA-61-1919-01A-01D-0652-05 TCGA-61-1919-01A-21-1559-20 056cca38-92df-42ff-b064-b0c243f8a82f TCGA-61-1919-01A-01D-0648-01 TCGA-61-1919-01 278e1675-c8e6-4578-b83d-4cd82de93d4b TCGA-61-1919-01A-01D-0648-01 056cca38-92df-42ff-b064-b0c243f8a82f 056cca38-92df-42ff-b064-b0c243f8a82f TCGA-61-1919-01 TCGA-61-1919-01 056cca38-92df-42ff-b064-b0c243f8a82f TCGA-61-1919-01A-01W-0699-08 TCGA-61-1919-01A-01R-0655-07 +TCGA-61-1995-01 TCGA-61-1995-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-61-1995 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 43 Bilateral TCGA-61-1995-F28302 TCGA-61-1995 TCGA-61-1995-01A Stage IIIC -16016 0 61 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 1.1 YES G3 TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d.pdf 1995 WITH TUMOR YES Stable Disease NO Primary Tumor 01 0.2 61 1-10 mm Ovary YES A LIVING 2009 TCGA-61-1995-01 TCGA-61-1995-01 180584fa-7aa6-4182-b57b-4e02365663e1 TCGA-61-1995-01 TCGA-61-1995-01A-01D-0667-05 TCGA-61-1995-01A-21-1559-20 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01D-0663-01 TCGA-61-1995-01 1bdc5555-06ec-496c-ac44-b8847ca95fb5 TCGA-61-1995-01A-01D-0663-01 13b2c972-c6ef-4d1f-8ada-f831d2606023 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01W-0722-08 TCGA-61-1995-01 TCGA-61-1995-01 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01W-0722-08 TCGA-61-1995-01A-01R-0670-07 +TCGA-61-1998-01 TCGA-61-1998-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-1998 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Bilateral TCGA-61-1998-F28306 TCGA-61-1998 TCGA-61-1998-01A Stage IIIC -17855 0 168 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1 YES G3 TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a.pdf 1998 WITH TUMOR YES NO Primary Tumor 01 0.1 61 1-10 mm Ovary YES A LIVING 2009 TCGA-61-1998-01 TCGA-61-1998-01 03f33fd8-fd9b-46b0-8291-ba92d1d32102 TCGA-61-1998-01 TCGA-61-1998-01A-01D-0667-05 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01D-0663-01 TCGA-61-1998-01 TCGA-61-1998-01A-01D-0663-01 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01W-0722-08 TCGA-61-1998-01 TCGA-61-1998-01 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01W-0722-08 TCGA-61-1998-01A-01R-0670-07 +TCGA-61-2000-01 TCGA-61-2000-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-2000 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-61-2000-F28311 TCGA-61-2000 TCGA-61-2000-01A Stage IIIC -24723 0 441 339 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 YES G3 Recurrence TCGA-61-2000.4e13b897-c34a-4422-9c66-7ca8b2734ef2.pdf 2000 WITH TUMOR YES Stable Disease Imaging Study NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary YES A LIVING 2008 TCGA-61-2000-01 TCGA-61-2000-01 4150fb96-e722-40db-a6d0-d55e60cc30f6 TCGA-61-2000-01 TCGA-61-2000-01A-01D-0667-05 TCGA-61-2000-01A-21-1559-20 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01D-0663-01 TCGA-61-2000-01 c7083eed-998f-456d-b294-5fbcf50eff88 TCGA-61-2000-01A-01D-0663-01 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01W-0722-08 TCGA-61-2000-01 TCGA-61-2000-01 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01W-0722-08 TCGA-61-2000-01A-01R-0670-07 +TCGA-61-2002-01 TCGA-61-2002-01 High OV-like c1 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2002 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 46 Bilateral TCGA-61-2002-F28321 TCGA-61-2002 TCGA-61-2002-01A Stage IIIC -17115 0 547 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1.2 YES G3 TCGA-61-2002.8030b8aa-9686-45b3-bf39-1889a6b8b36f.pdf 2002 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.2 61 11-20 mm Ovary YES A LIVING 2008 TCGA-61-2002-01 TCGA-61-2002-01 a31ab004-2dce-4cd6-a015-88c43ca44086 TCGA-61-2002-01 TCGA-61-2002-01A-01D-0667-05 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01D-0663-01 TCGA-61-2002-01 TCGA-61-2002-01A-01D-0663-01 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01W-0722-08 TCGA-61-2002-01 TCGA-61-2002-01 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01W-0722-08 TCGA-61-2002-01A-01R-0670-07 +TCGA-61-2003-01 TCGA-61-2003-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-2003 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 53 Bilateral TCGA-61-2003-F28327 TCGA-61-2003 TCGA-61-2003-01A Stage IIIC -19605 0 122 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1.4 NO 1.5 YES G2 TCGA-61-2003.79c66510-6e38-470f-9e91-d774665d39a6.pdf 2003 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.2 61 1-10 mm Ovary YES A LIVING 2008 TCGA-61-2003-01 TCGA-61-2003-01 a878c841-59fa-4ef2-af20-dc8937f92b9b TCGA-61-2003-01 TCGA-61-2003-01A-01D-0667-05 TCGA-61-2003-01A-21-1559-20 bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01D-0663-01 TCGA-61-2003-01 379f3f36-fb28-4eb4-8c56-24c0382bf38f TCGA-61-2003-01A-01D-0663-01 bc200f3a-6d31-4480-8785-987f14cfa319 bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01W-0722-08 TCGA-61-2003-01 TCGA-61-2003-01 bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01W-0722-08 TCGA-61-2003-01A-01R-0670-07 +TCGA-61-2008-01 TCGA-61-2008-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-2008 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2008-F28334 TCGA-61-2008 TCGA-61-2008-01A Stage IIC -14791 0 932 818 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 1.2 YES G2 Recurrence TCGA-61-2008.25448427-9a2c-4c36-bc9d-40a82d6e3710.pdf 2008 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-61-2008-01 TCGA-61-2008-01 5df0fa21-8263-4992-a797-44e2a1981b93 TCGA-61-2008-01 TCGA-61-2008-01A-02D-0667-05 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02D-0663-01 TCGA-61-2008-01 53527bf6-168b-469b-bbb3-d5e7640ee38a TCGA-61-2008-01A-02D-0663-01 10271f7f-cce6-44fd-8754-7a4beabfb394 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02W-0722-08 TCGA-61-2008-01 TCGA-61-2008-01 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02W-0722-08 TCGA-61-2008-01A-02R-0670-07 +TCGA-61-2008-02 TCGA-61-2008-02 C9-OV OV-like c1 OV-like c16 miRNA cluster 1 mutation cluster 5 TCGA-61-2008 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2008-F28334 TCGA-61-2008 TCGA-61-2008-02A Stage IIC -14791 0 932 818 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.5 NO 2 YES G2 Recurrence TCGA-61-2008.614D7B6A-B3B4-4F1B-9762-0749D559247F.pdf 2008 WITH TUMOR YES Complete Remission/Response Imaging Study NO Recurrent Tumor 02 0.3 61 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-61-2008-02 0d478984-a92d-491d-88e6-4a7621463012 TCGA-61-2008-02 TCGA-61-2008-02A-01D-0807-05 b90a4b33-cb6f-4c75-bc26-ff316ea81cce 540b245e-be19-4b26-a9fa-a4b3dd9a2975 b90a4b33-cb6f-4c75-bc26-ff316ea81cce b90a4b33-cb6f-4c75-bc26-ff316ea81cce b90a4b33-cb6f-4c75-bc26-ff316ea81cce TCGA-61-2008-02A-01R-0810-07 +TCGA-61-2009-01 TCGA-61-2009-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 2 TCGA-61-2009 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-61-2009-F28341 TCGA-61-2009 TCGA-61-2009-01A Stage IIIC -23772 0 1212 101 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2 YES G3 Recurrence TCGA-61-2009.39de8c59-e593-47d3-932d-575a4537b4dc.pdf 2009 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.2 61 11-20 mm Ovary YES A LIVING 2006 TCGA-61-2009-01 TCGA-61-2009-01 c8e01e3b-9789-4216-b771-18ac3b062a4c TCGA-61-2009-01 TCGA-61-2009-01A-01D-0667-05 TCGA-61-2009-01A-21-1559-20 b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01D-0663-01 TCGA-61-2009-01 8e12e5af-19de-4c90-a0b6-da67eeb438f4 TCGA-61-2009-01A-01D-0663-01 b6ed2184-0885-49ba-8b00-a3e57e4e5500 b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01W-0722-08 TCGA-61-2009-01 TCGA-61-2009-01 b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01W-0722-08 TCGA-61-2009-01A-01R-0670-07 +TCGA-61-2012-01 TCGA-61-2012-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 8 TCGA-61-2012 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 81 Left TCGA-61-2012-F28352 TCGA-61-2012 TCGA-61-2012-01A Stage IIC -29830 0 932 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.6 YES G2 TCGA-61-2012.534e3236-b9e7-4b0b-a2a3-2fc3a96fac81.pdf 2012 YES YES Primary Tumor 01 0.4 61 Ovary YES A LIVING 2006 TCGA-61-2012-01 TCGA-61-2012-01 12b5e477-31d5-4ec1-ac90-989ce781c36a TCGA-61-2012-01 TCGA-61-2012-01A-01D-0667-05 TCGA-61-2012-01A-21-1559-20 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01D-0663-01 TCGA-61-2012-01 6eb6997b-a982-44b0-ab5a-5faaa1b0c2be TCGA-61-2012-01A-01D-0663-01 929c2bc4-4cee-4f82-b336-918fe041a588 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01W-0722-08 TCGA-61-2012-01 TCGA-61-2012-01 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01W-0722-08 TCGA-61-2012-01A-01R-0670-07 +TCGA-61-2016-01 TCGA-61-2016-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2016 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-61-2016-F28357 TCGA-61-2016 TCGA-61-2016-01A Stage IIIC -18788 36 0 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 YES G3 TCGA-61-2016.1bb87fde-9ff0-4c33-a388-b655f9647407.pdf 2016 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 0.1 61 No Macroscopic disease Ovary YES A DECEASED 2006 TCGA-61-2016-01 TCGA-61-2016-01 4e470958-8a7a-4a48-a609-2d7f49b49bbf TCGA-61-2016-01 TCGA-61-2016-01A-01D-0667-05 a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01D-0663-01 TCGA-61-2016-01 TCGA-61-2016-01A-01D-0663-01 a391b870-b6fb-4ca8-b425-2331fceae442 a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01W-0722-08 TCGA-61-2016-01 TCGA-61-2016-01 a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01W-0722-08 TCGA-61-2016-01A-01R-0670-07 +TCGA-61-2017-01 TCGA-61-2017-01 Squamous OV-like c1 OV-like c4 TCGA-61-2017 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Bilateral TCGA-61-2017-F28359 TCGA-61-2017 TCGA-61-2017-01A Stage IIIC -23509 0 1398 1006 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 0.8 NO G1 Recurrence TCGA-61-2017.b24757fc-4585-496e-b89e-f3dafac36b8b.pdf 2017 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.3 61 1-10 mm Ovary NO A LIVING 2005 7cfe4d7d-392d-4612-a29a-80ddafdfcbd0 TCGA-61-2017-01A-01D-0667-05 TCGA-61-2017-01A-21-1559-20 TCGA-61-2017-01A-01D-0663-01 TCGA-61-2017-01 62d181c0-c0fb-44b3-9837-040f5780c2ff TCGA-61-2017-01A-01D-0663-01 TCGA-61-2017-01 TCGA-61-2017-01A-01R-0670-07 +TCGA-61-2018-01 TCGA-61-2018-01 High OV-like c1 OV-like c4 TCGA-61-2018 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-61-2018-F28366 TCGA-61-2018 TCGA-61-2018-01A Stage IC -22929 0 1381 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.9 NO G3 TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7.pdf 2018 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 61 No Macroscopic disease Ovary NO A LIVING 2005 a13bb1ee-868f-4891-921f-d0005ebe1ab8 TCGA-61-2018-01A-01D-0667-05 TCGA-61-2018-01A-21-1559-20 TCGA-61-2018-01A-01D-0663-01 TCGA-61-2018-01 99bf9379-737b-4b8c-9196-2c1fa0148eae TCGA-61-2018-01A-01D-0663-01 TCGA-61-2018-01 TCGA-61-2018-01A-01R-0670-07 +TCGA-61-2087-01 TCGA-61-2087-01 High OV-like c1 OV-like c4 TCGA-61-2087 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 49 Left TCGA-61-2087-F28372 TCGA-61-2087 Stage IC -18182 0 146 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NO G3 2087 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 61 No Macroscopic disease Ovary NO LIVING 2009 a60b189b-6316-4098-adc7-fefca69b803b TCGA-61-2087-01A-01D-0667-05 TCGA-61-2087-01A-21-1560-20 TCGA-61-2087-01A-01D-0663-01 TCGA-61-2087-01 b59fdd2e-4ec7-4e64-95fd-f5777ecdc89b TCGA-61-2087-01A-01D-0663-01 TCGA-61-2087-01 TCGA-61-2087-01A-01R-0670-07 +TCGA-61-2088-01 TCGA-61-2088-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-61-2088 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 51 Bilateral TCGA-61-2088-F28377 TCGA-61-2088 TCGA-61-2088-01A Stage IIIC -18770 0 145 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.4 NO G3 TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3.pdf 2088 TUMOR FREE YES NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary NO A LIVING 2009 TCGA-61-2088-01 TCGA-61-2088-01 9959458a-de14-4d2d-b13f-9ab2f0c88bf1 TCGA-61-2088-01 TCGA-61-2088-01A-01D-0667-05 TCGA-61-2088-01A-21-1560-20 62fdea50-f152-4f43-9130-a93079b5e61f TCGA-61-2088-01A-01D-0663-01 TCGA-61-2088-01 2b716c21-1692-4b95-9363-0c6a23de28d6 TCGA-61-2088-01A-01D-0663-01 62fdea50-f152-4f43-9130-a93079b5e61f 62fdea50-f152-4f43-9130-a93079b5e61f TCGA-61-2088-01 TCGA-61-2088-01 62fdea50-f152-4f43-9130-a93079b5e61f TCGA-61-2088-01A-01W-0722-08 TCGA-61-2088-01A-01R-0670-07 +TCGA-61-2092-01 TCGA-61-2092-01 BRCA-LUAD+ C9-OV UCEC non-CIMP c3 OV-like c4 COADREAD-like c15 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2092 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 57 Bilateral TCGA-61-2092-F28381 TCGA-61-2092 TCGA-61-2092-01A Stage IIIC -21072 0 1573 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.2 NO 1.3 NO G3 TCGA-61-2092.35b4bfa3-e6a5-4b55-a7f1-bc39953422c0.pdf 2092 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary NO A LIVING 2004 TCGA-61-2092-01 TCGA-61-2092-01 cf1288eb-e5c8-4c90-9f83-f3bdcbd94a96 TCGA-61-2092-01 TCGA-61-2092-01A-01D-0667-05 TCGA-61-2092-01A-21-1560-20 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01D-0663-01 TCGA-61-2092-01 94487130-5cc1-4f68-beab-57c211204449 TCGA-61-2092-01A-01D-0663-01 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01W-0722-08 TCGA-61-2092-01 TCGA-61-2092-01 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01W-0722-08 TCGA-61-2092-01A-01R-0670-07 +TCGA-61-2094-01 TCGA-61-2094-01 Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-2094 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 63 Bilateral TCGA-61-2094-F28385 TCGA-61-2094 TCGA-61-2094-01A Stage IIIC -23273 0 2182 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.1 NO 2 G3 TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75.pdf 2094 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.3 61 Ovary A LIVING 2003 TCGA-61-2094-01 TCGA-61-2094-01 1429ef11-964e-4e8b-afbb-8f38b75ad39f TCGA-61-2094-01 TCGA-61-2094-01A-01D-0667-05 TCGA-61-2094-01A-21-1560-20 c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01D-0663-01 TCGA-61-2094-01 1ac0ed16-0e91-4c45-9b9d-b68ceb9940da TCGA-61-2094-01A-01D-0663-01 c6e1c591-3225-482a-8350-112b664a37e6 c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01W-0722-08 TCGA-61-2094-01 TCGA-61-2094-01 c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01W-0722-08 TCGA-61-2094-01A-01R-0670-07 +TCGA-61-2095-01 TCGA-61-2095-01 Kirc+ C9-OV OV-like c1 OV-like c4 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-61-2095 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-61-2095-F28389 TCGA-61-2095 TCGA-61-2095-01A Stage IIIC -19797 1875 0 445 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1.2 G2 Recurrence TCGA-61-2095.3e08408b-b76a-4a32-b3f1-4590459f4af8.pdf 2095 WITH TUMOR YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary YES A DECEASED 2003 TCGA-61-2095-01 TCGA-61-2095-01 5229ff68-9cae-49dc-aba8-757026e6e452 TCGA-61-2095-01 TCGA-61-2095-01A-01D-0667-05 TCGA-61-2095-01A-21-1560-20 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01D-0663-01 TCGA-61-2095-01 74a1f15a-05c4-4d85-a731-9a4e5281f644 TCGA-61-2095-01A-01D-0663-01 15a11ef0-5e18-44d0-ba50-73cf356b8408 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01W-0722-08 TCGA-61-2095-01 TCGA-61-2095-01 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01W-0722-08 TCGA-61-2095-01A-01R-0670-07 +TCGA-61-2095-02 TCGA-61-2095-02 C9-OV OV-like c1 mutation c1uster 9 TCGA-61-2095 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-61-2095-F28389 TCGA-61-2095 TCGA-61-2095-02A Stage IIIC -19797 1875 0 445 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.6 G2 Recurrence TCGA-61-2095.309AA9DC-F958-45C3-B596-362ADA553B8C.pdf 2095 WITH TUMOR YES Complete Remission/Response Imaging Study NO Recurrent Tumor 02 0.3 61 No Macroscopic disease Ovary YES A DECEASED 2003 9105d49a-b3ca-4453-95c7-3bb78b3e9e80 TCGA-61-2095-02A-01D-0807-05 TCGA-61-2095-02A-01R-0810-07 +TCGA-61-2096-01 TCGA-61-2096-01 Squamous OV-like c1 OV-like c4 TCGA-61-2096 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Right TCGA-61-2096-F28398 TCGA-61-2096 TCGA-61-2096-01A Stage IC -20663 0 1776 421 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G2 Recurrence TCGA-61-2096.9f95fe7d-4865-4ca5-bb57-9d47c388a7ed.pdf 2096 TUMOR FREE YES Progressive Disease Imaging Study NO Primary Tumor 01 0.5 61 No Macroscopic disease Ovary A LIVING 2003 9497f7ac-b177-401b-a063-6297f90f009c TCGA-61-2096-01A-01D-0667-05 TCGA-61-2096-01A-21-1560-20 TCGA-61-2096-01A-01D-0663-01 TCGA-61-2096-01 91b0b079-17b3-4c29-9ebd-1781ae28c86a TCGA-61-2096-01A-01D-0663-01 TCGA-61-2096-01 TCGA-61-2096-01A-01R-0670-07 +TCGA-61-2097-01 TCGA-61-2097-01 High C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2097 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 71 Bilateral TCGA-61-2097-F28413 TCGA-61-2097 Stage IIC -25961 0 1844 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection YES G2 2097 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 61 1-10 mm Ovary YES LIVING 2003 TCGA-61-2097-01 TCGA-61-2097-01 c1da73c7-9f61-41b6-90a1-fdc7bbf4ecd3 TCGA-61-2097-01 TCGA-61-2097-01A-02D-0667-05 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02D-0663-01 TCGA-61-2097-01 TCGA-61-2097-01A-02D-0663-01 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02W-0722-08 TCGA-61-2097-01 TCGA-61-2097-01 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02W-0722-08 TCGA-61-2097-01A-02R-0670-07 +TCGA-61-2098-01 TCGA-61-2098-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 TCGA-61-2098 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 62 Bilateral TCGA-61-2098-F28418 TCGA-61-2098 TCGA-61-2098-01A Stage IIIC -22876 0 1993 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.7 NO 2 G2 TCGA-61-2098.d1c8ab49-5ba0-46c3-8205-53b4e39808b3.pdf 2098 TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 0.5 61 11-20 mm Ovary NO A LIVING 2003 TCGA-61-2098-01 TCGA-61-2098-01 0a007e29-e769-44ca-b0a8-465df5d46f4e TCGA-61-2098-01 TCGA-61-2098-01A-01D-0667-05 TCGA-61-2098-01A-21-1560-20 d855f86a-f302-47fb-aa9f-5977632c695a TCGA-61-2098-01A-01D-0663-01 TCGA-61-2098-01 f69ce3d8-2a32-4048-a786-50d7e153c051 TCGA-61-2098-01A-01D-0663-01 d855f86a-f302-47fb-aa9f-5977632c695a d855f86a-f302-47fb-aa9f-5977632c695a TCGA-61-2098-01 TCGA-61-2098-01 d855f86a-f302-47fb-aa9f-5977632c695a TCGA-61-2098-01A-01R-0670-07 +TCGA-61-2101-01 TCGA-61-2101-01 High C9-OV OV-like c1 OV-like c4 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2101 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Bilateral TCGA-61-2101-F28422 TCGA-61-2101 TCGA-61-2101-01A Stage IIIC -20287 1688 0 0 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 100 1.5 G2 TCGA-61-2101.b9d85995-85dd-4b00-b93f-3387cd018475.pdf 2101 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NO Primary Tumor 01 0.4 61 11-20 mm Ovary A DECEASED 1999 TCGA-61-2101-01 TCGA-61-2101-01 504e1539-a518-4ef6-90b0-4ec6cd2ffbe8 TCGA-61-2101-01 TCGA-61-2101-01A-01D-0667-05 TCGA-61-2101-01A-21-1560-20 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01D-0663-01 TCGA-61-2101-01 c33bc4d6-607a-425b-bffd-e818b69949f8 TCGA-61-2101-01A-01D-0663-01 95970bdb-e1f2-49dc-903b-c30088cef71d 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01W-0722-08 TCGA-61-2101-01 TCGA-61-2101-01 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01W-0722-08 TCGA-61-2101-01A-01R-0670-07 +TCGA-61-2102-01 TCGA-61-2102-01 High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-61-2102 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 74 Right TCGA-61-2102-F28438 TCGA-61-2102 TCGA-61-2102-01A Stage IIIC -27256 197 0 197 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.5 G3 TCGA-61-2102.f0521e47-1cc3-4f72-9efd-3d128f57e614.pdf 2102 WITH TUMOR YES NO Primary Tumor 01 0.3 61 Ovary A DECEASED 1999 TCGA-61-2102-01 TCGA-61-2102-01 5b4f1e0c-f04d-4aa1-a794-5936189506d7 TCGA-61-2102-01 TCGA-61-2102-01A-01D-0667-05 TCGA-61-2102-01A-21-1560-20 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01D-0663-01 TCGA-61-2102-01 0f492d79-0174-4e9f-8693-2827ba83fd7c TCGA-61-2102-01A-01D-0663-01 7ac6af79-c14a-4026-84aa-a288afcb96da 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01W-0722-08 TCGA-61-2102-01 TCGA-61-2102-01 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01W-0722-08 TCGA-61-2102-01A-01R-0670-07 +TCGA-61-2104-01 TCGA-61-2104-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2104 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-61-2104-F28442 TCGA-61-2104 TCGA-61-2104-01A Stage IIC -19432 0 2338 1680 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.6 NO 1.5 G2 Recurrence TCGA-61-2104.38d2e115-ec9a-40e5-bfa0-30fb1db60691.pdf 2104 YES Complete Remission/Response Imaging Study NO Primary Tumor 01 0.4 61 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-61-2104-01 TCGA-61-2104-01 28510e09-fb60-4595-802a-48b0aafc09b9 TCGA-61-2104-01 TCGA-61-2104-01A-01D-0667-05 TCGA-61-2104-01A-21-1560-20 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01D-0663-01 TCGA-61-2104-01 14d97fdf-fcf4-4471-8595-4b6b5401caf6 TCGA-61-2104-01A-01D-0663-01 721a8fc8-bb54-4ec3-a19c-340c35f05280 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01W-0722-08 TCGA-61-2104-01 TCGA-61-2104-01 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01W-0722-08 TCGA-61-2104-01A-01R-0670-07 +TCGA-61-2109-01 TCGA-61-2109-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2109 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2109-F28450 TCGA-61-2109 TCGA-61-2109-01A Stage IIIC -14900 629 0 629 465 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.8 NO 1.7 NO G3 Recurrence TCGA-61-2109.c16bfe93-016f-49d4-8895-05b9055344c9.pdf 2109 WITH TUMOR YES Molecular Markers NO Primary Tumor 01 0.2 61 >20 mm Ovary NO A DECEASED 1999 TCGA-61-2109-01 TCGA-61-2109-01 37fc46df-f46d-462f-8761-d82c66b8a3a1 TCGA-61-2109-01 TCGA-61-2109-01A-01D-0667-05 TCGA-61-2109-01A-21-1560-20 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01D-0663-01 TCGA-61-2109-01 d3e2505d-0838-4a9c-a626-ad04f9254dd1 TCGA-61-2109-01A-01D-0663-01 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01W-0722-08 TCGA-61-2109-01 TCGA-61-2109-01 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01W-0722-08 TCGA-61-2109-01A-01R-0670-07 +TCGA-61-2110-01 TCGA-61-2110-01 Squamous C9-OV OV-like c1 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-61-2110 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 56 Bilateral TCGA-61-2110-F28456 TCGA-61-2110 TCGA-61-2110-01A Stage IIIC -20718 1354 0 1354 213 2009-12-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 0.4 Recurrence TCGA-61-2110.d7a597dc-d607-4e20-90a9-a181d6c11d17.pdf 2110 WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO Primary Tumor 01 0.1 61 No Macroscopic disease Ovary A DECEASED 1998 TCGA-61-2110-01 TCGA-61-2110-01 8f17192c-1ecb-4f31-8df0-a6dde0b8ce96 TCGA-61-2110-01 TCGA-61-2110-01A-01D-0667-05 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01D-0663-01 TCGA-61-2110-01 TCGA-61-2110-01A-01D-0663-01 6561cdb8-8499-41a6-8a79-ef0119e34c66 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01W-0722-08 TCGA-61-2110-01 TCGA-61-2110-01 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01W-0722-08 TCGA-61-2110-01A-01R-0670-07 +TCGA-61-2111-01 TCGA-61-2111-01 Squamous C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA c1uster 10 cluster 5 mutation cluster 5 TCGA-61-2111 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Left TCGA-61-2111-F28467 TCGA-61-2111 TCGA-61-2111-01A Stage IV -22517 0 3825 2205 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1.4 NO 1.5 G3 Recurrence TCGA-61-2111.351930bc-ac4d-468e-9fe2-ba6f16c01444.pdf 2111 WITH TUMOR YES Complete Remission/Response Other Method NO Primary Tumor 01 0.3 61 Ovary A LIVING 1998 TCGA-61-2111-01 TCGA-61-2111-01 3ee05aa8-a556-4d87-8aab-a76491d30640 TCGA-61-2111-01 TCGA-61-2111-01A-01D-0667-05 TCGA-61-2111-01A-21-1560-20 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01D-0663-01 TCGA-61-2111-01 975fb889-32f1-46e2-a558-b32d8a1b353f TCGA-61-2111-01A-01D-0663-01 25c0888a-25b9-4cc0-a02f-6d363a341e8f 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01W-0722-08 TCGA-61-2111-01 TCGA-61-2111-01 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01W-0722-08 TCGA-61-2111-01A-01R-0670-07 +TCGA-61-2113-01 TCGA-61-2113-01 High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-61-2113 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Right TCGA-61-2113-F28479 TCGA-61-2113 TCGA-61-2113-01A Stage IIC -19722 676 0 676 291 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.8 NO 1.6 YES G3 Recurrence TCGA-61-2113.d10e1b61-73c4-4ab7-bc4b-8c7827856602.pdf 2113 YES NO Primary Tumor 01 0.4 61 Ovary YES A DECEASED 1999 TCGA-61-2113-01 TCGA-61-2113-01 9467c678-f573-4a50-83d9-ae3a0880354b TCGA-61-2113-01 TCGA-61-2113-01A-01D-0667-05 TCGA-61-2113-01A-21-1562-20 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01D-0663-01 TCGA-61-2113-01 a8827db2-9eab-4285-bf50-ab2b9e19be57 TCGA-61-2113-01A-01D-0663-01 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01W-0722-08 TCGA-61-2113-01 TCGA-61-2113-01 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01W-0722-08 TCGA-61-2113-01A-01R-0670-07 +TCGA-61-2610-01 TCGA-61-2610-01 OV-like c4 TCGA-61-2610 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Left TCGA-61-2610-F28484 TCGA-61-2610 TCGA-61-2610-01A Stage IIIC -22481 1579 0 1579 524 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 1 NO 1 G3 Recurrence TCGA-61-2610.a5914371-94ab-4079-a6ea-11c79e9db4a1.pdf 2610 WITH TUMOR YES Stable Disease Imaging Study NO R1 Primary Tumor 01 0.4 61 11-20 mm Ovary A DECEASED 1998 TCGA-61-2610-01A-21-20 a3cbaeb1-63e7-4818-aa6b-ce817827231b +TCGA-61-2610-02 TCGA-61-2610-02 OV-like c1 TCGA-61-2610 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Left TCGA-61-2610-F28484 TCGA-61-2610 TCGA-61-2610-02A Stage IIIC -22481 1579 0 1579 524 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 0.6 G3 Recurrence TCGA-61-2610.361A67F5-2116-457D-988A-5B1E5D1A689B.pdf 2610 WITH TUMOR YES Stable Disease Imaging Study NO R1 Recurrent Tumor 02 0.3 61 11-20 mm Ovary A DECEASED 1998 30ed8178-1e57-4d4e-af54-ea8097a33bbe TCGA-61-2610-02A-01D-1138-05 TCGA-61-2610-02A-01W-1092-09 TCGA-61-2610-02A-01R-1141-07 +TCGA-61-2611-02 TCGA-61-2611-02 Low purity c2 TCGA-61-2611 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2611-F28491 TCGA-61-2611 TCGA-61-2611-02A Stage IIIC -14782 483 0 483 383 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) 0.6 NO 0.7 G3 Recurrence TCGA-61-2611.29965B48-14CA-467F-B825-8BC99A99544B.pdf 2611 WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO R1 Recurrent Tumor 02 0.3 61 1-10 mm Ovary YES A DECEASED 2008 2983d372-ea74-4ceb-a26e-7b4e6a8acf8f TCGA-61-2611-02A-01D-1138-05 TCGA-61-2611-02A-01W-1092-09 TCGA-61-2611-02A-01R-1141-07 +TCGA-61-2612-01 TCGA-61-2612-01 High OV-like c1 OV-like c4 TCGA-61-2612 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-61-2612-F28496 TCGA-61-2612 TCGA-61-2612-01A Stage IIIC -23074 193 0 193 179 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 2 NO 2.5 YES G3 Recurrence TCGA-61-2612.48d32d40-9eef-43d2-beb6-75fcc071c52b.pdf 2612 WITH TUMOR YES Stable Disease First Seen At Further Surgery NO R1 Primary Tumor 01 0.4 61 1-10 mm Ovary YES A DECEASED 2002 9b739900-7aff-4e27-aa8b-5feaaaa77247 TCGA-61-2612-01A-01D-1138-05 TCGA-61-2612-01A-21-20 TCGA-61-2612-01A-01W-1092-09 TCGA-61-2612-01A-01D-1134-01 TCGA-61-2612-01 7055e7b7-38bb-4fe4-841b-1419a6273bad TCGA-61-2612-01A-01D-1134-01 TCGA-61-2612-01 TCGA-61-2612-01A-01R-1141-07 +TCGA-61-2613-01 TCGA-61-2613-01 Squamous OV-like c1 OV-like c4 TCGA-61-2613 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-61-2613-F28500 TCGA-61-2613 TCGA-61-2613-01A Stage IIIC -26779 945 0 945 358 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.5 NO 1.1 G3 Recurrence TCGA-61-2613.6d7a40b1-02f0-4d7e-b3e2-e467e404a241.pdf 2613 WITH TUMOR YES Stable Disease Imaging Study NO R1 Primary Tumor 01 0.3 61 11-20 mm Ovary A DECEASED 1998 4f3e6b8b-2c5b-4c59-aca0-d3a6b7ee46b5 TCGA-61-2613-01A-01D-1138-05 TCGA-61-2613-01A-21-20 TCGA-61-2613-01A-01W-1092-09 TCGA-61-2613-01A-01D-1134-01 TCGA-61-2613-01 fce6b5fb-7b97-4af7-a919-0215363156f0 TCGA-61-2613-01A-01D-1134-01 TCGA-61-2613-01 TCGA-61-2613-01A-01R-1141-07 +TCGA-61-2614-01 TCGA-61-2614-01 High OV-like c1 OV-like c4 TCGA-61-2614 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-61-2614-F28505 TCGA-61-2614 TCGA-61-2614-01A Stage IIIC -26142 262 0 262 38 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 0.4 NO 1.6 YES G3 Recurrence TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b.pdf 2614 WITH TUMOR NO Stable Disease Imaging Study NO R1 Primary Tumor 01 0.3 61 1-10 mm Ovary YES A DECEASED 2007 59193352-8a67-49d4-9ca0-430c36fe0d12 TCGA-61-2614-01A-01D-1138-05 TCGA-61-2614-01A-21-20 TCGA-61-2614-01A-01W-1092-09 TCGA-61-2614-01A-01D-1134-01 TCGA-61-2614-01 81ab2618-ccb2-4a64-bab2-83e69633defe TCGA-61-2614-01A-01D-1134-01 TCGA-61-2614-01 TCGA-61-2614-01A-01R-1141-07 +TCGA-72-4231-01 TCGA-72-4231-01 OV-like c1 TCGA-72-4231 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4231-01A 0.3 NO 0.5 Primary Tumor 01 0.1 A TCGA-72-4231-01A-01D-1011-05 TCGA-72-4231-01A-01D-1017-01 TCGA-72-4231-01A-01D-1017-01 +TCGA-72-4232-01 TCGA-72-4232-01 OV-like c1 TCGA-72-4232 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4232-01A 0.5 NO 0.6 Primary Tumor 01 0.1 A TCGA-72-4232-01A-01D-1011-05 TCGA-72-4232-01A-01D-1017-01 TCGA-72-4232-01A-01D-1017-01 +TCGA-72-4233-01 TCGA-72-4233-01 OV-like c1 TCGA-72-4233 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4233-01A 0.3 NO 0.5 Primary Tumor 01 0.1 A TCGA-72-4233-01A-01D-1011-05 TCGA-72-4233-01A-01D-1017-01 TCGA-72-4233-01A-01D-1017-01 +TCGA-72-4234-01 TCGA-72-4234-01 OV-like c1 TCGA-72-4234 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4234-01A 0.2 NO 1.2 Primary Tumor 01 0.1 A TCGA-72-4234-01A-01D-1011-05 TCGA-72-4234-01A-01D-1017-01 TCGA-72-4234-01A-01D-1017-01 +TCGA-72-4235-01 TCGA-72-4235-01 OV-like c1 TCGA-72-4235 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4235-01A 0.6 NO 1 Primary Tumor 01 0.1 A TCGA-72-4235-01A-01D-1011-05 TCGA-72-4235-01A-01D-1017-01 TCGA-72-4235-01A-01D-1017-01 +TCGA-72-4236-01 TCGA-72-4236-01 OV-like c1 TCGA-72-4236 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4236-01A 0.2 NO 0.4 Primary Tumor 01 0.1 A TCGA-72-4236-01A-01D-1011-05 TCGA-72-4236-01A-01D-1017-01 TCGA-72-4236-01A-01D-1017-01 +TCGA-72-4237-01 TCGA-72-4237-01 OV-like c1 TCGA-72-4237 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4237-01A 0.3 NO 1.5 Primary Tumor 01 0.1 A TCGA-72-4237-01A-01D-1011-05 TCGA-72-4237-01A-01D-1017-01 TCGA-72-4237-01A-01D-1017-01 +TCGA-72-4238-01 TCGA-72-4238-01 OV-like c1 TCGA-72-4238 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4238-01A 0.4 NO 1.5 Primary Tumor 01 0.1 A TCGA-72-4238-01A-01D-1011-05 TCGA-72-4238-01A-01D-1017-01 TCGA-72-4238-01A-01D-1017-01 +TCGA-72-4240-01 TCGA-72-4240-01 OV-like c1 TCGA-72-4240 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4240-01A 1 NO 1 Primary Tumor 01 0.1 A TCGA-72-4240-01A-01D-1011-05 TCGA-72-4240-01A-01D-1017-01 TCGA-72-4240-01A-01D-1017-01 +TCGA-72-4241-01 TCGA-72-4241-01 OV-like c1 TCGA-72-4241 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary TCGA-72-4241-01A 0.3 NO 2 Primary Tumor 01 0.1 A TCGA-72-4241-01A-01D-1011-05 TCGA-72-4241-01A-01D-1017-01 TCGA-72-4241-01A-01D-1017-01 +TCGA-OY-A56P-01 TCGA-OY-A56P-01 TCGA-OY-A56P TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 48 Right TCGA-OY-A56P-F56664 TCGA-OY-A56P TCGA-OY-A56P-01A Stage IIIB -17580 796 0 1207 Scheduled Follow-up Submission Stable Disease 2014-2-17 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Tumor resection 390 NO NO NO G3 YES false No TCGA-OY-A56P.D916ED58-54D5-43FC-A5B0-6E4844A7F677.pdf A56P WITH TUMOR YES Complete Remission/Response NO R2 Primary Tumor 01 YES NO OY 1-10 mm Ovary NO A LIVING 2010 TCGA-OY-A56P-01 TCGA-OY-A56P-01 TCGA-OY-A56P-01A-12D-A409-05 TCGA-OY-A56P-01 05689fed-96dd-4c52-b51d-5dc799422b9a TCGA-OY-A56P-01A-12D-A402-01 31FB79CF-D6E4-48CF-8EFD-45A81701E359 TCGA-OY-A56P-01A-12R-A406-31 TCGA-OY-A56P-01A-12D-A402-01 05689fed-96dd-4c52-b51d-5dc799422b9a TCGA-OY-A56P-01A-12R-A406-31 05689fed-96dd-4c52-b51d-5dc799422b9a TCGA-OY-A56P-01 05689fed-96dd-4c52-b51d-5dc799422b9a +TCGA-OY-A56Q-01 TCGA-OY-A56Q-01 TCGA-OY-A56Q TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 78 Left TCGA-OY-A56Q-F57585 TCGA-OY-A56Q TCGA-OY-A56Q-01A Stage IIA -28623 120 0 576 Scheduled Follow-up Submission Complete Remission/Response 2014-3-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 370 NO NO NO G3 NO false No TCGA-OY-A56Q.3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D.pdf A56Q TUMOR FREE YES Complete Remission/Response NO RX Primary Tumor 01 YES NO OY No Macroscopic disease Ovary NO A LIVING 2012 TCGA-OY-A56Q-01 TCGA-OY-A56Q-01 TCGA-OY-A56Q-01A-11D-A409-05 TCGA-OY-A56Q-01 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 TCGA-OY-A56Q-01A-11D-A402-01 7029EE0E-6B69-4B6F-8648-FA831B7B70A5 TCGA-OY-A56Q-01A-11R-A406-31 TCGA-OY-A56Q-01A-11D-A402-01 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 TCGA-OY-A56Q-01A-11R-A406-31 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 TCGA-OY-A56Q-01 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 +TCGA-VG-A8LO-01 TCGA-VG-A8LO-01 TCGA-VG-A8LO TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 55 Right TCGA-VG-A8LO TCGA-VG-A8LO-01A Stage IV -20274 122 24 0 4 2014-3-25 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Excisional Biopsy 260 NO 50 GB NO false No TCGA-VG-A8LO.6FF4C359-F127-44E6-A1A2-641D60A3665F.pdf A8LO Other WITH TUMOR YES NO R2 Primary Tumor 01 YES NO VG >20 mm Ovary A DECEASED 2013 TCGA-VG-A8LO-01 TCGA-VG-A8LO-01 TCGA-VG-A8LO-01A-11D-A409-05 TCGA-VG-A8LO-01 fbad0ba1-131d-48af-9957-e9ca56f54e84 TCGA-VG-A8LO-01A-11D-A402-01 0AA665F9-6A46-4A4C-B2E1-11D8EE17B447 TCGA-VG-A8LO-01A-11R-A406-31 TCGA-VG-A8LO-01A-11D-A402-01 fbad0ba1-131d-48af-9957-e9ca56f54e84 TCGA-VG-A8LO-01A-11R-A406-31 fbad0ba1-131d-48af-9957-e9ca56f54e84 TCGA-VG-A8LO-01 fbad0ba1-131d-48af-9957-e9ca56f54e84 +TCGA-WR-A838-01 TCGA-WR-A838-01 TCGA-WR-A838 TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary 72 Right TCGA-WR-A838-F66184 TCGA-WR-A838 TCGA-WR-A838-01A Stage IIIC -26418 110 304 0 245 245 1 Scheduled Follow-up Submission Progressive Disease 2014-10-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 200 NO NO YES G3 Progression of Disease NO false No TCGA-WR-A838.8F364931-727D-4099-A1D2-E96C61461479.pdf A838 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO Primary Tumor 01 NO YES WR Ovary YES A DECEASED 2013 TCGA-WR-A838-01 TCGA-WR-A838-01 TCGA-WR-A838-01A-12D-A409-05 TCGA-WR-A838-01 010e9bf0-b7a0-4c68-b028-90299840fbaf TCGA-WR-A838-01A-12D-A402-01 95C1EF06-FB7C-4817-86A5-1E608DDA7102 TCGA-WR-A838-01A-12R-A406-31 TCGA-WR-A838-01A-12D-A402-01 010e9bf0-b7a0-4c68-b028-90299840fbaf TCGA-WR-A838-01A-12R-A406-31 010e9bf0-b7a0-4c68-b028-90299840fbaf TCGA-WR-A838-01 010e9bf0-b7a0-4c68-b028-90299840fbaf